data_2k5p_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k5p _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.618 ' HE3' HD12 ' A' ' 3' ' ' LEU . 26.7 ptt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.771 0.319 . . . . 64.299999999999997 111.583 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -75.47 130.12 38.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.126 0.417 . . . . 62.009999999999998 112.126 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.618 HD12 ' HE3' ' A' ' 1' ' ' MET . 94.8 mt -141.73 118.19 10.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.198 -0.456 . . . . 53.030000000000001 111.475 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' LYS . 67.2 m -76.19 97.82 4.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.182 0.515 . . . . 70.319999999999993 110.985 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 46.5 t -93.05 107.84 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.288 -0.414 . . . . 74.25 111.21 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.03 35.51 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.939 0.4 . . . . 53.119999999999997 112.031 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.42 76.23 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.048 -0.596 . . . . 65.439999999999998 113.645 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 4' ' ' THR . 28.5 mtpp -91.96 113.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 122.438 -0.448 . . . . 73.129999999999995 111.272 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.62 65.41 4.73 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.554 2.17 . . . . 74.519999999999996 112.182 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t -102.83 176.74 5.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.455 0.645 . . . . 74.450000000000003 111.661 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -148.95 134.42 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.887 -0.597 . . . . 74.400000000000006 111.234 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.63 119.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.276 -0.42 . . . . 73.239999999999995 110.004 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.76 111.05 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.155 0.502 . . . . 72.530000000000001 111.796 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.47 2.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.908 -0.587 . . . . 42.409999999999997 112.936 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.84 92.53 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.3 0.571 . . . . 73.400000000000006 111.827 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -79.91 84.33 5.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.15 0.5 . . . . 74.150000000000006 110.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.6 p 61.63 114.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.176 0.99 . . . . 51.030000000000001 112.598 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.4 mt -130.61 131.59 45.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.413 -0.358 . . . . 74.439999999999998 110.994 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.5 p-10 -80.46 171.86 14.5 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.198 -0.314 . . . . 75.230000000000004 110.363 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.2 t -56.5 -37.98 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.717 0.294 . . . . 74.209999999999994 111.156 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.0 m -55.73 -46.65 77.74 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.891 0.377 . . . . 75.420000000000002 111.116 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -67.38 -29.95 69.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.175 0.435 . . . . 52.049999999999997 112.175 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.01 -37.37 81.33 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.095 0.474 . . . . 61.210000000000001 110.329 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.556 HD12 HG12 ' A' ' 35' ' ' VAL . 91.0 mt -63.75 -37.86 88.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.161 -0.472 . . . . 75.239999999999995 111.298 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -76.54 -38.19 55.46 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.434 -0.348 . . . . 64.040000000000006 111.117 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.03 90.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.036 0.446 . . . . 54.329999999999998 111.397 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -80.26 -17.99 50.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.274 0.559 . . . . 70.230000000000004 110.478 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 tptt 67.02 82.52 0.18 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.212 -0.904 . . . . 73.420000000000002 112.753 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.85 142.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.967 -0.56 . . . . 64.129999999999995 110.77 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -42.84 15.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.794 0.33 . . . . 60.049999999999997 111.729 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -87.94 76.58 8.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.099 0.476 . . . . 54.009999999999998 111.064 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.38 -23.9 67.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.271 0.471 . . . . 61.119999999999997 112.271 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -93.26 -8.8 41.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.257 0.466 . . . . 62.0 112.257 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.43 4.71 6.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 74.420000000000002 112.031 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.556 HG12 HD12 ' A' ' 24' ' ' LEU . 7.2 p -68.62 130.35 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.452 0.644 . . . . 74.230000000000004 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -112.96 112.06 23.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.062 -0.517 . . . . 70.239999999999995 111.016 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.33 158.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.35 -0.386 . . . . 73.049999999999997 111.402 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 3.5 pm0 -132.26 169.62 16.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.194 0.521 . . . . 71.049999999999997 110.945 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.4 pp -133.98 124.59 26.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 64.340000000000003 110.669 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 56.47 18.87 3.75 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 111.531 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.62 2.18 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.324 -0.465 . . . . 60.219999999999999 113.744 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.19 120.57 15.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.925 0.363 . . . . 64.209999999999994 111.195 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.79 143.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.918 0.39 . . . . 72.109999999999999 111.71 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -91.59 139.3 30.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.076 0.465 . . . . 74.120000000000005 111.732 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.47 163.61 24.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.058 -0.519 . . . . 75.319999999999993 111.009 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 46' ' ' ARG . 9.1 ptp85 -47.74 -24.04 0.85 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.355 0.872 . . . . 62.420000000000002 113.355 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -119.92 7.11 10.88 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.482 0.549 . . . . 75.129999999999995 112.482 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -12.11 34.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.102 0.408 . . . . 75.420000000000002 112.102 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.448 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 62.7 m-85 -62.17 -38.84 90.57 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.065 0.395 . . . . 75.349999999999994 112.065 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.77 -56.2 5.6 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.422 0.527 . . . . 71.319999999999993 112.422 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.69 88.21 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.886 0.698 . . . . 61.520000000000003 112.886 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.428 HG23 HD21 ' A' ' 39' ' ' LEU . 99.7 m -74.32 98.15 3.17 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.236 0.541 . . . . 75.120000000000005 112.04 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 62.6 p -84.81 127.72 34.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.926 -0.579 . . . . 71.439999999999998 111.341 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.02 151.67 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.103 0.478 . . . . 73.329999999999998 110.881 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.08 -170.02 2.78 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.979 0.418 . . . . 73.040000000000006 111.916 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 136.68 56.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.437 -0.347 . . . . 75.409999999999997 111.487 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 50.43 5.25 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.168 -0.539 . . . . 53.140000000000001 113.366 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.57 -178.78 5.67 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.629 -0.336 . . . . 65.450000000000003 110.523 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.64 107.74 6.75 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.29 0.478 . . . . 73.040000000000006 112.29 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.6 p -103.11 116.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.441 0.638 . . . . 72.040000000000006 111.129 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.571 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 46.9 mt-10 -96.45 110.47 22.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.209 0.528 . . . . 71.329999999999998 111.08 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.57 114.7 28.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.863 -0.608 . . . . 74.299999999999997 111.032 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.951 0.405 . . . . 74.150000000000006 111.687 -178.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.256 0.551 . . . . 73.319999999999993 111.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.5 121.06 29.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.381 -0.372 . . . . 62.210000000000001 111.625 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.22 114.03 18.44 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.809 0.338 . . . . 75.040000000000006 111.25 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 28.5 m -76.05 77.5 2.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.558 0.694 . . . . 75.409999999999997 110.917 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.7 t -74.22 114.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.018 -0.537 . . . . 55.420000000000002 111.886 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.548 HD21 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.09 19.83 11.16 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.411 -0.359 . . . . 43.219999999999999 111.771 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.67 55.71 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.923 -0.656 . . . . 63.32 113.52 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.49 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.98 115.65 65.67 Favored Pre-proline 0 N--CA 1.471 0.596 0 O-C-N 122.3 -0.529 . . . . 75.439999999999998 111.236 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.85 96.15 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.868 2.379 . . . . 73.049999999999997 112.303 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 m -97.47 100.86 12.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.141 0.496 . . . . 72.340000000000003 111.243 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.6 m -73.96 84.09 1.74 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.346 -0.388 . . . . 71.219999999999999 111.083 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -97.33 113.43 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 73.450000000000003 111.057 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.87 -179.82 3.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.94 -0.475 . . . . 72.420000000000002 111.151 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.4 84.77 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.058 -0.592 . . . . 73.340000000000003 112.318 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.36 98.01 2.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.043 0.449 . . . . 74.150000000000006 110.225 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.38 82.17 2.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.306 -0.407 . . . . 74.239999999999995 112.025 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p 64.51 143.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 74.519999999999996 113.545 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.6 pp -156.34 175.43 14.02 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.807 -0.633 . . . . 74.140000000000001 111.268 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -97.85 172.24 7.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.739 0.304 . . . . 64.230000000000004 110.972 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.02 -36.58 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.882 0.372 . . . . 71.140000000000001 111.757 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -56.3 -45.78 80.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.189 0.518 . . . . 72.510000000000005 111.264 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 12.0 mm-40 -64.13 -41.36 97.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.2 -0.454 . . . . 72.120000000000005 110.978 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.77 -51.39 56.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.319 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 HD12 HG22 ' A' ' 35' ' ' VAL . 4.5 mm? -55.33 -44.72 76.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.901 0.382 . . . . 71.310000000000002 111.481 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 t -67.58 -27.96 67.37 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.271 -0.422 . . . . 72.439999999999998 111.791 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.71 -41.71 44.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.968 0.414 . . . . 75.299999999999997 111.578 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.55 -6.99 59.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.045 0.387 . . . . 71.549999999999997 112.045 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.788 0.435 . . . . 52.149999999999999 111.78 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.69 120.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.057 0.456 . . . . 71.010000000000005 111.737 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.03 36.38 0.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.955 0.502 . . . . 75.319999999999993 112.204 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.95 35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.216 0.451 . . . . 72.25 112.216 -174.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.64 50.29 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.132 0.419 . . . . 64.150000000000006 112.132 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.08 -24.54 28.04 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.117 0.484 . . . . 74.120000000000005 111.928 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -107.56 -4.45 18.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.739 0.304 . . . . 71.450000000000003 111.76 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.467 HG22 HD12 ' A' ' 24' ' ' LEU . 7.4 p -68.27 89.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.868 0.842 . . . . 73.549999999999997 113.058 -172.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -82.18 93.42 7.06 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.907 -0.588 . . . . 71.409999999999997 110.941 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 62' ' ' PHE . 17.2 m -110.8 141.14 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.099 0.476 . . . . 73.200000000000003 111.63 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.77 119.85 27.9 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.573 0.702 . . . . 71.25 111.751 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.444 ' HB2' HD23 ' A' ' 44' ' ' LEU . 4.1 mm? -82.11 115.76 21.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.704 -0.68 . . . . 71.030000000000001 110.849 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 27.51 17.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.802 0.334 . . . . 75.120000000000005 111.697 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.61 5.26 66.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.343 -0.455 . . . . 72.430000000000007 113.633 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -114.54 117.85 32.07 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.529 -0.395 . . . . 73.400000000000006 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -74.27 139.72 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.956 0.408 . . . . 71.530000000000001 111.74 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 39' ' ' LEU . 3.3 mm? -101.35 153.69 19.44 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.264 0.554 . . . . 74.239999999999995 112.261 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 157.25 30.13 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.797 -0.638 . . . . 74.230000000000004 110.571 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -60.18 -33.01 71.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.961 0.41 . . . . 73.439999999999998 111.567 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -70.92 -32.65 69.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.393 0.616 . . . . 74.230000000000004 110.528 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -71.99 -13.75 61.7 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.093 -0.503 . . . . 63.409999999999997 112.191 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -56.71 -45.6 81.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.021 0.439 . . . . 71.0 111.034 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.5 -21.31 35.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.113 -0.494 . . . . 64.209999999999994 111.281 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . . . -97.76 21.82 9.96 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.389 0.514 . . . . 61.219999999999999 112.389 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.8 m -133.82 113.69 12.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.81 0.338 . . . . 75.329999999999998 111.169 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.3 p -81.66 126.83 32.25 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.11 0.481 . . . . 64.5 111.837 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.52 113.65 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.622 -0.717 . . . . 75.019999999999996 109.538 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.643 ' HD3' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -144.74 -161.46 1.3 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.934 0.397 . . . . 74.209999999999994 111.597 -170.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.11 93.35 0.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.937 -0.477 . . . . 75.140000000000001 112.119 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.0 10.88 1.69 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.114 -0.565 . . . . 41.5 114.488 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.06 130.19 40.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.154 0.977 . . . . 63.43 112.108 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -85.93 66.14 9.46 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.399 0.619 . . . . 64.329999999999998 110.428 175.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.1 p -73.69 99.71 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.718 0.771 . . . . 42.119999999999997 112.009 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.49 78.57 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.304 0.573 . . . . 60.539999999999999 110.954 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.554 ' HA ' HG13 ' A' ' 37' ' ' VAL . 36.0 t80 -73.77 96.37 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.102 -0.703 . . . . 75.5 109.102 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 113.037 0.755 . . . . 72.299999999999997 113.037 -170.684 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 111.659 0.244 . . . . 74.439999999999998 111.659 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.64 127.81 45.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.824 0.345 . . . . 75.409999999999997 111.246 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.55 140.85 49.86 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.975 0.417 . . . . 73.25 111.519 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -91.2 76.7 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.437 0.637 . . . . 61.200000000000003 110.133 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.566 HG12 HD21 ' A' ' 6' ' ' ASN . 39.5 t -74.0 110.01 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.892 -0.595 . . . . 74.120000000000005 111.827 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.566 HD21 HG12 ' A' ' 5' ' ' VAL . 47.6 m-80 58.95 26.02 14.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.824 0.45 . . . . 72.400000000000006 111.559 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.28 -4.77 74.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.94 -0.647 . . . . 42.5 113.243 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 11.6 mptt -101.28 139.16 20.22 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.366 -0.49 . . . . 65.510000000000005 110.894 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.66 121.97 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.509 2.139 . . . . 74.109999999999999 113.0 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.2 t -133.65 156.54 47.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.008 -0.542 . . . . 73.299999999999997 110.539 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -135.85 113.91 11.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.204 -0.31 . . . . 75.120000000000005 111.524 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.438 HG21 ' H2 ' ' A' ' 1' ' ' MET . 30.3 m -91.57 108.55 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.334 0.588 . . . . 55.100000000000001 110.919 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.92 143.22 30.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.943 -0.571 . . . . 51.340000000000003 111.113 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.96 21.96 31.8 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.406 -0.426 . . . . 55.329999999999998 112.836 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.03 136.42 4.12 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.197 0.443 . . . . 72.209999999999994 112.197 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.06 -40.94 7.37 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.766 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.0 p -164.32 112.38 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 111.267 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.76 160.31 32.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.218 -0.446 . . . . 61.43 110.536 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -72.86 162.54 29.36 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.654 0.264 . . . . 73.540000000000006 110.319 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.4 t -59.33 -34.83 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 122.152 -0.343 . . . . 54.039999999999999 111.433 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -60.29 -53.72 54.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.76 0.314 . . . . 75.109999999999999 111.819 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.81 0.338 . . . . 72.239999999999995 111.192 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.5 -45.95 91.91 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.804 -0.443 . . . . 51.310000000000002 109.804 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 95.0 mt -59.3 -39.73 83.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.947 0.403 . . . . 72.439999999999998 111.136 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -69.97 -32.18 70.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.084 0.469 . . . . 75.209999999999994 111.441 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.05 -47.35 58.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.909 0.385 . . . . 55.32 111.477 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.59 -20.43 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.276 -0.42 . . . . 73.219999999999999 111.331 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 65.78 76.49 0.32 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.697 0.761 . . . . 65.430000000000007 111.541 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.67 146.2 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.581 -0.736 . . . . 73.400000000000006 110.915 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.18 3.18 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.174 0.435 . . . . 72.420000000000002 112.174 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.38 98.98 10.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.939 0.399 . . . . 74.109999999999999 111.8 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.52 -29.51 22.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.166 0.507 . . . . 52.240000000000002 111.311 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -79.41 -23.54 43.15 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.013 -0.54 . . . . 74.409999999999997 111.536 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -112.43 11.57 19.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 75.430000000000007 112.116 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG23 HG12 ' A' ' 37' ' ' VAL . 7.3 p -75.73 88.91 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.838 0.828 . . . . 50.039999999999999 112.147 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -76.54 95.94 4.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.181 -0.463 . . . . 74.150000000000006 111.812 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 62' ' ' PHE . 35.4 m -120.3 158.42 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.428 -0.351 . . . . 60.340000000000003 110.975 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.6 134.45 43.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.78 0.8 . . . . 74.140000000000001 112.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.559 HD13 ' ND2' ' A' ' 40' ' ' ASN . 1.0 OUTLIER -78.24 103.23 8.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.968 -1.015 . . . . 73.219999999999999 110.757 -176.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.7 OUTLIER 58.14 24.41 11.27 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.875 0.369 . . . . 74.310000000000002 111.728 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.82 40.63 4.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.941 -0.647 . . . . 63.539999999999999 112.608 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.32 105.66 3.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.788 0.435 . . . . 75.109999999999999 110.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.66 138.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.641 0.608 . . . . 75.109999999999999 112.641 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -89.86 153.77 20.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.357 0.599 . . . . 73.510000000000005 111.72 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.19 160.5 26.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.091 -0.504 . . . . 74.340000000000003 111.399 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 38.0 ptt180 -37.07 -48.04 0.77 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.013 1.116 . . . . 74.439999999999998 114.013 -176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 13.8 pt-20 -107.41 0.52 22.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.278 0.473 . . . . 74.409999999999997 112.278 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.71 65.28 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.945 0.402 . . . . 74.040000000000006 111.279 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -58.83 -41.24 86.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.133 -0.485 . . . . 63.32 111.44 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -82.02 -32.17 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.134 -0.484 . . . . 74.400000000000006 110.963 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.81 46.08 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.821 0.674 . . . . 74.310000000000002 112.821 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.3 m -96.47 122.2 39.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.871 0.367 . . . . 74.140000000000001 111.606 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 m -91.64 106.94 18.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.418 -0.355 . . . . 74.25 111.226 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.42 115.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.953 0.406 . . . . 74.400000000000006 110.997 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -112.0 -167.43 1.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.854 0.359 . . . . 75.219999999999999 111.648 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.39 133.83 37.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.872 0.368 . . . . 74.109999999999999 111.887 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.99 43.62 8.1 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.353 -0.451 . . . . 43.420000000000002 113.669 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -116.08 140.72 49.0 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.556 -0.379 . . . . 74.049999999999997 110.808 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.86 74.12 2.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.234 0.54 . . . . 61.109999999999999 111.643 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 34.6 m -82.4 125.39 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.407 0.622 . . . . 73.319999999999993 111.365 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -92.04 101.42 13.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.384 0.612 . . . . 70.549999999999997 111.157 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HA ' HG13 ' A' ' 37' ' ' VAL . 5.2 t80 -103.92 99.9 9.67 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.471 -0.786 . . . . 74.099999999999994 109.553 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 113.105 0.78 . . . . 74.340000000000003 113.105 -167.905 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.651 ' HE3' HD12 ' A' ' 3' ' ' LEU . 25.5 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.819 0.343 . . . . 62.310000000000002 111.584 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.35 127.2 34.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.407 -0.36 . . . . 72.200000000000003 110.88 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.651 HD12 ' HE3' ' A' ' 1' ' ' MET . 92.9 mt -133.33 176.01 8.9 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.117 0.484 . . . . 75.430000000000007 111.109 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 m -141.04 132.23 26.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.374 -0.375 . . . . 73.329999999999998 111.185 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.53 121.12 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.74 0.305 . . . . 74.120000000000005 111.376 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 65.72 14.36 9.49 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.01 0.374 . . . . 73.200000000000003 112.01 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.73 -2.41 72.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.238 -0.506 . . . . 44.109999999999999 112.087 -172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -97.7 110.78 56.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.379 0.671 . . . . 70.219999999999999 110.655 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.8 123.54 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.189 2.593 . . . . 74.239999999999995 113.724 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -136.51 100.86 4.47 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.216 0.531 . . . . 75.310000000000002 111.314 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.8 m -80.65 95.57 6.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.036 0.446 . . . . 75.420000000000002 111.66 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' VAL . 16.9 m -81.96 79.6 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.967 0.889 . . . . 65.510000000000005 110.463 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.533 ' HA ' ' H2 ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.54 170.69 14.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.945 -0.571 . . . . 73.109999999999999 111.168 -176.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 25.3 68.31 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.581 -0.819 . . . . 75.409999999999997 111.533 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.29 123.2 10.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.728 0.411 . . . . 63.340000000000003 110.698 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -74.54 -68.73 0.51 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.205 0.526 . . . . 75.329999999999998 111.785 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -167.26 132.96 2.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.393 -0.821 . . . . 74.329999999999998 109.274 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 1.2 pp -149.99 163.07 39.09 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.039 0.755 . . . . 73.400000000000006 113.039 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.05 159.16 20.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.047 -0.524 . . . . 43.329999999999998 111.102 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.45 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 50.6 t -57.33 -43.74 82.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.015 0.435 . . . . 72.530000000000001 110.485 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.1 m -60.34 -45.65 92.68 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.42 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -59.72 -36.99 77.69 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.035 0.445 . . . . 54.439999999999998 110.632 176.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.94 -44.18 97.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.191 0.52 . . . . 73.319999999999993 110.385 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 89.1 mt -58.64 -34.72 71.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.01 -0.541 . . . . 65.109999999999999 110.759 174.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.9 t -68.19 -43.02 79.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.58 . . . . 54.219999999999999 111.406 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -46.29 76.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.261 0.467 . . . . 64.409999999999997 112.261 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.11 -6.89 43.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.662 -0.244 . . . . 61.32 111.626 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.663 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 7.0 ttpm? 57.49 89.02 0.05 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.395 0.617 . . . . 71.319999999999993 111.649 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.826 -0.624 . . . . 64.319999999999993 111.686 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.85 -49.13 18.86 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.041 0.448 . . . . 71.540000000000006 111.517 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -123.15 142.38 50.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.964 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.517 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -110.71 -40.2 4.64 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.294 0.568 . . . . 54.310000000000002 111.974 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.63 -30.4 36.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 70.329999999999998 111.118 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -91.23 -7.15 52.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.403 0.52 . . . . 73.140000000000001 112.403 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 32' ' ' ALA . 9.7 p -58.7 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 122.007 0.908 . . . . 74.450000000000003 112.211 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -84.52 92.21 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.758 -0.655 . . . . 74.329999999999998 110.949 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -125.0 141.95 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.953 -0.567 . . . . 74.310000000000002 110.999 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.8 pt-20 -118.26 122.16 42.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.686 0.755 . . . . 74.519999999999996 111.818 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.476 HD12 ' ND2' ' A' ' 40' ' ' ASN . 1.6 tm? -81.22 107.22 13.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.585 -0.734 . . . . 73.310000000000002 109.89 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' ND2' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER 64.24 38.46 8.04 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.0 0.428 . . . . 64.519999999999996 111.282 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.85 29.67 58.85 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.206 -0.521 . . . . 62.450000000000003 113.665 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.443 ' N ' ' HB2' ' A' ' 38' ' ' GLU . 41.4 tt0 -148.91 115.75 5.99 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.466 -0.432 . . . . 64.510000000000005 110.798 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 14.7 p -77.37 147.44 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 113.069 0.766 . . . . 73.120000000000005 113.069 -173.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -106.37 157.79 17.36 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.059 -0.519 . . . . 74.25 111.008 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 tt0 -76.4 159.59 30.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.858 0.361 . . . . 74.310000000000002 111.437 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.567 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -49.65 -49.24 48.01 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 73.409999999999997 113.936 -169.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.78 -23.14 39.52 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.564 -0.71 . . . . 75.040000000000006 111.689 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.13 49.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.285 0.476 . . . . 70.120000000000005 112.285 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.99 -30.53 70.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.778 0.323 . . . . 73.420000000000002 111.719 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.96 -21.48 27.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.795 0.331 . . . . 73.530000000000001 111.479 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.02 1.96 56.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.095 0.406 . . . . 75.230000000000004 112.095 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -116.1 116.45 27.89 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.582 0.229 . . . . 64.549999999999997 111.471 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -89.4 109.83 20.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.116 0.484 . . . . 71.349999999999994 111.65 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.35 137.32 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 74.200000000000003 110.521 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -135.67 176.08 9.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.232 0.539 . . . . 71.140000000000001 111.771 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.65 105.61 0.32 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.023 -0.535 . . . . 73.129999999999995 112.095 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.81 7.89 12.67 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.483 -0.389 . . . . 65.129999999999995 113.343 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.94 153.47 21.56 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.52 . . . . 65.239999999999995 111.764 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.85 107.65 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 75.420000000000002 111.631 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.27 110.85 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.114 -0.494 . . . . 71.209999999999994 110.792 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -98.89 111.65 23.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.387 0.613 . . . . 63.420000000000002 112.339 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -80.77 130.92 35.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.383 -0.826 . . . . 74.510000000000005 111.468 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.513 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.47 0.561 0 O-C-N 122.083 -0.386 . . . . 64.519999999999996 112.011 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG3' HD21 ' A' ' 3' ' ' LEU . 23.1 ptp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.679 0.276 . . . . 75.109999999999999 111.641 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -99.29 124.39 44.34 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.407 -0.36 . . . . 71.120000000000005 111.001 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.479 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.7 mm? -119.5 129.06 54.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.734 0.302 . . . . 75.510000000000005 111.155 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -78.69 73.02 5.25 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.414 0.626 . . . . 75.340000000000003 110.185 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.586 HG22 HD21 ' A' ' 6' ' ' ASN . 7.1 p -70.81 110.4 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.332 0.586 . . . . 75.420000000000002 112.099 -173.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.586 HD21 HG22 ' A' ' 5' ' ' VAL . 48.7 m-80 59.71 21.48 10.23 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.134 -0.485 . . . . 54.25 111.879 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.1 -4.29 62.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.869 -0.681 . . . . 75.409999999999997 113.035 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 3.0 mptp? -102.53 136.51 19.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.377 0.271 . . . . 71.439999999999998 110.685 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.37 104.55 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.264 1.976 . . . . 72.519999999999996 113.178 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 t -114.0 153.53 29.19 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.148 -0.345 . . . . 72.319999999999993 110.655 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -135.51 114.34 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.096 0.406 . . . . 62.100000000000001 112.096 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.69 112.08 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.508 0.67 . . . . 71.25 110.104 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.72 148.55 50.22 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.633 -0.712 . . . . 71.430000000000007 112.367 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.77 -58.35 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.498 -0.382 . . . . 63.530000000000001 113.44 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.38 110.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.175 0.435 . . . . 72.329999999999998 112.175 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' HE3' ' A' ' 1' ' ' MET . 42.8 mt-10 -94.18 -55.46 3.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 74.540000000000006 111.494 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 p -143.4 115.86 8.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.391 -0.368 . . . . 73.299999999999997 111.44 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -157.63 165.35 35.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.371 -0.377 . . . . 74.329999999999998 111.855 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 40.3 m-20 -66.37 160.95 23.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.605 0.241 . . . . 61.340000000000003 111.27 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 56.3 t -56.17 -41.9 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.014 0.435 . . . . 71.239999999999995 110.6 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 m -59.03 -47.21 86.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.083 0.468 . . . . 74.040000000000006 111.346 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 51.7 mt-10 -65.73 -31.6 72.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.955 0.407 . . . . 74.409999999999997 111.102 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.5 -46.74 78.5 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.856 -0.424 . . . . 72.209999999999994 109.856 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 90.6 mt -56.8 -36.21 69.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.161 -0.472 . . . . 71.510000000000005 111.047 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.6 t -64.52 -55.81 18.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 71.140000000000001 111.328 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.89 78.47 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 64.239999999999995 112.378 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 tp -79.6 -22.85 43.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.843 0.354 . . . . 60.240000000000002 111.42 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? 63.1 81.65 0.2 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.321 0.581 . . . . 73.420000000000002 109.731 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 31' ' ' GLN . 12.5 p -93.62 151.42 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.977 -0.556 . . . . 37.939999999999998 111.737 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.41 70.27 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.005 0.372 . . . . 61.539999999999999 112.005 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.507 ' H ' HG22 ' A' ' 29' ' ' VAL . 61.8 mm-40 -127.03 134.85 50.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.612 -0.267 . . . . 52.210000000000001 110.683 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.83 9.3 8.82 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.397 0.618 . . . . 64.319999999999993 111.48 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -32.45 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.524 -0.762 . . . . 74.319999999999993 111.305 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.48 -19.74 29.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.787 0.327 . . . . 72.5 111.54 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 37' ' ' VAL . 7.1 p -68.56 126.15 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.789 0.663 . . . . 72.030000000000001 112.789 -173.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -102.52 98.84 8.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 110.713 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 35' ' ' VAL . 14.6 m -103.57 95.87 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.463 0.649 . . . . 72.319999999999993 111.283 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 10.1 pt-20 -95.48 94.35 7.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.482 0.658 . . . . 73.439999999999998 111.314 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.447 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -68.41 114.95 7.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.359 0.599 . . . . 64.140000000000001 112.025 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 59.09 39.49 23.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.901 -0.59 . . . . 50.509999999999998 111.748 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.82 48.66 40.31 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.032 -0.604 . . . . 75.019999999999996 113.194 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.06 108.58 3.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.957 0.408 . . . . 62.420000000000002 110.657 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.84 136.4 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.579 0.585 . . . . 75.319999999999993 112.579 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.453 HD21 ' N ' ' A' ' 44' ' ' LEU . 2.7 mm? -101.74 152.35 20.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.033 -0.531 . . . . 74.129999999999995 110.824 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.414 ' N ' ' HB2' ' A' ' 48' ' ' ALA . 45.4 mt-10 -68.56 169.35 11.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.282 0.563 . . . . 74.540000000000006 111.969 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -58.85 -35.68 73.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.867 -0.606 . . . . 72.150000000000006 110.451 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.54 -42.12 22.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.794 -0.639 . . . . 74.400000000000006 111.43 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 45' ' ' GLU . . . -56.66 -20.85 23.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.09 0.774 . . . . 63.32 113.09 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -56.03 -34.25 65.69 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.042 0.449 . . . . 63.210000000000001 111.136 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -81.62 -32.6 31.91 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.364 -0.38 . . . . 73.030000000000001 111.17 175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.39 59.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.629 0.603 . . . . 75.409999999999997 112.629 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -113.11 119.24 37.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.756 0.313 . . . . 75.209999999999994 111.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 83.4 m -96.16 124.69 40.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.335 0.588 . . . . 71.340000000000003 112.328 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.64 151.77 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.889 -0.596 . . . . 74.430000000000007 110.897 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -147.76 -178.19 6.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.875 0.369 . . . . 74.349999999999994 111.624 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 26.2 t70 -58.46 119.01 6.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.163 0.506 . . . . 73.299999999999997 112.359 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.38 54.22 1.1 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.188 -0.46 . . . . 62.240000000000002 113.662 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.04 154.71 48.25 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.884 0.342 . . . . 64.340000000000003 111.035 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.82 1.83 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 39' ' ' LEU . 30.2 m -82.18 107.87 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.409999999999997 111.182 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 44.1 mt-10 -77.46 93.33 4.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.519 0.675 . . . . 73.129999999999995 110.804 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -80.08 92.11 5.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.365 -0.834 . . . . 73.5 110.431 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.172 0.511 . . . . 72.420000000000002 112.225 -176.236 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 20.4 ptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.91 0.386 . . . . 71.109999999999999 111.847 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -75.89 129.91 37.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.087 -0.506 . . . . 64.209999999999994 111.788 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.8 mt -139.12 153.07 47.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.947 0.404 . . . . 70.340000000000003 111.661 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.5 m -109.18 126.47 53.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.934 0.397 . . . . 74.329999999999998 111.34 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 HG21 ' H ' ' A' ' 62' ' ' PHE . 4.7 p -133.83 124.08 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.5 -0.318 . . . . 71.430000000000007 110.95 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.53 26.39 15.68 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 111.163 -179.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.28 16.8 80.41 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.24 -0.505 . . . . 72.019999999999996 112.74 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -103.35 117.98 58.87 Favored Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 122.761 -0.258 . . . . 64.129999999999995 110.793 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.21 116.44 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.447 2.098 . . . . 73.099999999999994 111.528 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 t -141.77 -173.95 3.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.933 0.397 . . . . 75.129999999999995 111.448 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -159.55 126.68 4.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 72.239999999999995 111.734 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 12' ' ' VAL . 18.9 m -96.05 99.09 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.595 0.712 . . . . 54.240000000000002 110.437 175.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.45 137.71 33.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.993 -0.549 . . . . 74.120000000000005 110.875 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.5 56.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.28 -0.486 . . . . 41.130000000000003 113.207 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.01 97.57 8.41 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.412 -0.464 . . . . 75.400000000000006 111.517 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.45 76.73 3.99 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.317 0.579 . . . . 70.450000000000003 111.669 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.2 m 53.48 71.19 0.52 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.952 -0.567 . . . . 73.349999999999994 111.463 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 80.5 mt -93.3 145.75 24.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.272 0.558 . . . . 62.109999999999999 112.106 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 18.2 m-20 -70.51 163.98 25.71 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.857 -0.611 . . . . 75.140000000000001 110.037 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.5 -41.53 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.818 0.342 . . . . 71.329999999999998 110.608 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -61.69 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.926 0.393 . . . . 75.519999999999996 111.842 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 43.0 mt-10 -68.4 -43.75 76.56 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.11 0.481 . . . . 71.340000000000003 111.131 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.28 -37.66 86.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.311 0.577 . . . . 75.319999999999993 109.968 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.13 -34.95 70.79 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.699 -0.682 . . . . 64.340000000000003 110.833 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -74.66 -33.59 62.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.369 -0.378 . . . . 72.310000000000002 111.327 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.77 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.157 0.504 . . . . 61.310000000000002 111.6 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.0 mt -90.44 -29.77 17.77 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.286 0.565 . . . . 72.540000000000006 110.216 171.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 57.51 86.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.057 -0.974 . . . . 74.120000000000005 112.565 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.2 159.42 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.558 -0.746 . . . . 71.340000000000003 110.538 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.73 -63.77 1.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.054 0.454 . . . . 65.099999999999994 111.773 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -102.3 136.96 41.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.551 -0.295 . . . . 75.340000000000003 110.676 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.26 -55.52 2.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 75.409999999999997 111.545 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -11.72 21.08 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.826 -0.625 . . . . 62.100000000000001 112.301 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.81 3.02 36.26 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.322 0.49 . . . . 75.140000000000001 112.322 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.39 138.19 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.321 0.581 . . . . 71.019999999999996 112.341 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.4 m -115.83 108.54 16.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.128 -0.487 . . . . 72.349999999999994 110.575 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.519 HG13 ' HA ' ' A' ' 62' ' ' PHE . 28.0 m -134.04 162.23 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.19 0.519 . . . . 71.140000000000001 111.891 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.09 169.61 17.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.577 -0.738 . . . . 74.150000000000006 110.563 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.0 pt? -143.92 129.09 18.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 72.030000000000001 111.078 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.75 21.08 11.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.173 0.511 . . . . 74.25 111.005 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 55.78 2.98 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.04 -0.527 . . . . 74.400000000000006 113.374 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 126.15 2.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.914 0.357 . . . . 73.409999999999997 110.651 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.76 136.04 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.21 0.528 . . . . 74.310000000000002 112.352 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.58 166.78 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.667 0.746 . . . . 73.030000000000001 112.547 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.06 149.46 33.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.5 -0.773 . . . . 65.209999999999994 110.964 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 9.1 mpt_? -64.34 -41.31 96.84 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.185 -0.322 . . . . 72.430000000000007 111.864 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.25 -29.76 69.48 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.19 0.519 . . . . 74.299999999999997 111.058 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.28 65.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.279 -0.419 . . . . 73.439999999999998 111.585 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -62.13 -30.63 71.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.697 0.284 . . . . 74.299999999999997 111.508 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.7 -35.82 72.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.873 0.368 . . . . 70.430000000000007 111.54 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.87 -29.81 24.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.203 0.446 . . . . 73.310000000000002 112.203 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 m -82.03 113.69 20.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.758 0.314 . . . . 71.140000000000001 111.832 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.0 m -96.87 140.61 31.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.229 0.538 . . . . 73.040000000000006 111.881 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 55' ' ' LYS . 17.4 t -90.44 160.64 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.116 -0.493 . . . . 71.010000000000005 111.112 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.9 pttm -141.38 169.94 16.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.979 0.418 . . . . 72.129999999999995 111.805 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 27.8 t70 -70.88 111.45 6.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.133 0.492 . . . . 63.340000000000003 110.97 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.71 39.77 3.79 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.175 -0.466 . . . . 52.210000000000001 112.096 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -122.82 175.32 6.61 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 110.006 -0.368 . . . . 71.319999999999993 110.006 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.67 143.77 43.3 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.245 0.545 . . . . 71.409999999999997 112.459 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 5' ' ' VAL . 24.0 m -130.5 71.06 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.805 0.812 . . . . 75.239999999999995 109.677 172.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.21 83.11 0.73 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.763 0.792 . . . . 62.219999999999999 111.568 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.519 ' HA ' HG13 ' A' ' 37' ' ' VAL . 2.6 m-85 -77.4 92.26 3.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.09 -0.959 . . . . 73.450000000000003 111.767 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.346 0.593 . . . . 73.239999999999995 112.027 -177.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.508 ' HG3' HD22 ' A' ' 3' ' ' LEU . 21.1 ptp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.693 0.282 . . . . 63.32 111.272 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.6 m-20 -95.46 119.98 34.92 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.803 0.335 . . . . 74.25 111.166 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 1' ' ' MET . 1.3 mm? -114.2 124.06 51.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.688 0.28 . . . . 75.310000000000002 111.201 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.4 m -78.06 79.46 4.52 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 74.239999999999995 110.343 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.28 122.09 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.085 -0.507 . . . . 63.450000000000003 112.334 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 17.9 m120 56.93 23.02 7.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.099 -0.5 . . . . 72.519999999999996 112.081 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.4 64.63 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.329 -0.462 . . . . 52.329999999999998 113.474 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 3.2 mptp? -116.72 122.02 32.17 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 122.235 -0.567 . . . . 74.230000000000004 110.859 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.49 125.65 19.21 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.931 2.421 . . . . 75.120000000000005 113.816 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 173.32 11.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.958 -0.565 . . . . 75.239999999999995 109.946 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 4.6 t -157.28 129.47 7.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.313 0.857 . . . . 74.530000000000001 113.313 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.22 108.22 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.537 0.684 . . . . 64.209999999999994 110.465 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.56 123.35 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.857 -0.61 . . . . 74.140000000000001 111.673 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.82 -33.48 4.75 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.24 -0.505 . . . . 73.5 113.161 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -74.48 127.64 33.56 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.726 0.298 . . . . 71.510000000000005 111.671 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -137.79 108.71 6.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.201 0.524 . . . . 73.439999999999998 111.647 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 m 62.66 25.07 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.268 0.84 . . . . 64.530000000000001 113.268 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.7 159.49 27.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.193 0.521 . . . . 75.230000000000004 111.853 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.5 p-10 -84.06 156.43 22.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.389 -0.369 . . . . 70.439999999999998 111.6 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.8 -36.94 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.683 0.623 . . . . 73.420000000000002 112.683 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -52.92 -43.7 66.45 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.035 0.445 . . . . 74.129999999999995 111.568 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.42 -32.03 29.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.474 -0.33 . . . . 63.210000000000001 111.826 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.79 -44.83 82.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.361 -0.607 . . . . 72.150000000000006 109.361 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 32' ' ' ALA . 26.7 tp -60.94 -44.49 97.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.635 -0.711 . . . . 61.149999999999999 110.661 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -63.79 -27.92 69.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.807 -0.633 . . . . 64.200000000000003 111.905 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.74 84.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.956 0.407 . . . . 73.310000000000002 111.585 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.5 mp -81.12 -2.53 48.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.301 -0.409 . . . . 62.509999999999998 110.931 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.6 tttt 64.0 25.72 13.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.996 -0.547 . . . . 73.030000000000001 111.51 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.52 130.61 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.357 -0.383 . . . . 75.310000000000002 111.537 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.57 80.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.368 0.507 . . . . 73.549999999999997 112.368 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -96.04 167.65 11.1 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.116 0.484 . . . . 73.409999999999997 111.557 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HA ' HD23 ' A' ' 24' ' ' LEU . . . -146.05 -62.16 0.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.214 0.53 . . . . 38.039999999999999 110.803 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -31.74 62.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.592 -0.731 . . . . 75.409999999999997 112.049 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -83.34 -16.49 45.89 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.67 0.618 . . . . 71.230000000000004 112.67 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.469 HG13 HG12 ' A' ' 37' ' ' VAL . 6.1 t -81.46 80.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.237 0.541 . . . . 52.409999999999997 111.621 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.6 m -70.87 84.14 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.083 -0.508 . . . . 75.450000000000003 111.442 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 35' ' ' VAL . 32.8 m -86.45 147.94 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.122 0.487 . . . . 72.310000000000002 111.464 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 13.2 pt-20 -136.44 127.14 27.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.25 0.547 . . . . 73.400000000000006 110.981 174.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.559 ' HG ' HD23 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -99.47 134.95 41.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 71.340000000000003 111.169 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.667 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.5 OUTLIER 60.66 18.92 8.93 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.067 0.461 . . . . 75.030000000000001 111.403 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.2 20.28 57.5 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.311 -0.471 . . . . 64.310000000000002 113.616 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -124.77 112.47 16.75 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.122 0.486 . . . . 74.140000000000001 111.105 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 8.9 p -70.6 144.41 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.371 0.878 . . . . 62.43 113.371 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 39' ' ' LEU . 3.2 mm? -99.49 166.26 11.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.22 0.533 . . . . 74.019999999999996 111.667 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.38 155.18 20.7 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.049 -0.523 . . . . 73.510000000000005 110.743 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.51 -22.73 5.18 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.116 0.784 . . . . 63.130000000000003 113.116 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.86 26.84 5.51 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.115 0.483 . . . . 54.439999999999998 111.771 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.24 5.37 42.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.286 -0.415 . . . . 71.439999999999998 111.376 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.23 -27.77 59.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.809 0.338 . . . . 73.450000000000003 111.527 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.46 -38.79 65.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 75.329999999999998 111.065 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.17 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.168 -0.469 . . . . 60.509999999999998 112.055 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.0 m -75.32 107.55 7.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.999 0.428 . . . . 41.539999999999999 111.986 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 63.8 p -92.85 130.25 38.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 111.388 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.6 147.41 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.356 -0.383 . . . . 73.150000000000006 111.116 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.07 -174.75 3.52 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.241 0.543 . . . . 74.129999999999995 111.349 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.26 111.36 3.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.045 -0.525 . . . . 72.540000000000006 111.243 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.35 66.9 0.74 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.045 -0.597 . . . . 61.329999999999998 113.958 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -149.71 162.08 40.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 110.147 -0.316 . . . . 75.450000000000003 110.147 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.42 99.32 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.511 0.56 . . . . 60.340000000000003 112.511 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -95.96 131.25 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.002 0.43 . . . . 75.200000000000003 111.097 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 40.8 mt-10 -109.03 121.2 44.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.262 0.553 . . . . 72.310000000000002 112.282 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -99.66 132.14 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.78 -0.645 . . . . 74.329999999999998 111.522 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.098 0.475 . . . . 73.420000000000002 112.092 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.479 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 23.0 ptp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.941 0.4 . . . . 71.099999999999994 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -101.6 106.24 17.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.978 0.418 . . . . 72.349999999999994 110.724 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 58' ' ' ASP . 82.4 mt -100.25 176.45 5.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 73.120000000000005 111.536 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.3 m -130.68 110.84 11.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 110.979 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 29.8 m -105.11 118.39 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.956 0.407 . . . . 71.409999999999997 111.577 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 62.12 22.26 13.0 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.865 0.364 . . . . 74.25 111.943 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.11 -0.87 64.44 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.161 -0.543 . . . . 63.229999999999997 113.36 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.23 141.7 24.44 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 122.526 -0.396 . . . . 65.150000000000006 111.273 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 119.79 6.03 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.411 2.074 . . . . 60.530000000000001 112.978 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -120.4 113.24 20.05 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.983 0.42 . . . . 71.109999999999999 111.49 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.8 m -95.12 110.25 22.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.253 -0.431 . . . . 63.350000000000001 111.444 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.66 124.64 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.131 0.491 . . . . 72.400000000000006 110.968 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.78 144.6 41.31 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.089 -0.505 . . . . 62.240000000000002 111.921 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.69 -49.59 4.22 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.192 -0.458 . . . . 70.120000000000005 113.756 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 105.74 0.42 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.779 . . . . 45.450000000000003 113.102 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.1 -44.37 5.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.298 -0.41 . . . . 75.019999999999996 111.148 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.6 m -141.46 126.33 18.15 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.71 0.29 . . . . 73.230000000000004 110.86 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.96 169.63 16.2 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.728 0.299 . . . . 73.439999999999998 111.521 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -103.02 160.6 14.48 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.45 -0.204 . . . . 75.530000000000001 110.45 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 58.1 t -48.07 -40.82 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 112.917 0.71 . . . . 62.549999999999997 112.917 -172.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.6 m -48.0 -47.47 33.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.142 0.496 . . . . 71.140000000000001 111.581 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.44 -33.02 64.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.052 0.454 . . . . 74.030000000000001 111.203 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.05 -41.69 98.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.451 . . . . 73.530000000000001 110.239 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 91.8 mt -56.7 -28.66 61.32 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.132 -0.486 . . . . 74.120000000000005 111.507 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.7 t -80.17 -48.34 13.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.409 -0.36 . . . . 74.209999999999994 111.391 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.78 90.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.058 0.456 . . . . 74.209999999999994 111.864 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.14 -30.62 60.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.148 -0.478 . . . . 71.099999999999994 110.915 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 69.25 88.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.463 0.649 . . . . 73.409999999999997 111.332 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 24' ' ' LEU . 8.0 p -102.15 149.52 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.773 -0.649 . . . . 74.329999999999998 111.91 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.58 126.9 35.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 110.72 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 58.88 67.57 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.234 0.54 . . . . 73.140000000000001 111.507 -174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -63.85 -30.69 71.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 112.015 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.939 0.399 . . . . 73.109999999999999 111.491 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -129.93 12.36 5.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.53 -0.304 . . . . 74.040000000000006 111.64 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.455 HG22 HG13 ' A' ' 37' ' ' VAL . 7.6 p -68.0 118.71 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.452 0.644 . . . . 70.439999999999998 112.508 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.1 m -92.97 108.58 20.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 111.03 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG13 HG22 ' A' ' 35' ' ' VAL . 18.0 m -140.92 146.35 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.146 -0.479 . . . . 73.430000000000007 111.164 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.2 pm0 -123.54 132.48 53.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.899 0.381 . . . . 74.439999999999998 111.745 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 2.1 pt? -97.02 124.53 41.03 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.932 -0.395 . . . . 71.310000000000002 109.932 175.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.18 22.62 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.98 0.419 . . . . 52.240000000000002 111.798 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -20.44 32.02 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.275 0.47 . . . . 74.549999999999997 114.275 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -95.45 122.47 38.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.677 0.739 . . . . 72.140000000000001 111.464 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.9 p -78.23 138.89 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 65.319999999999993 112.003 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.457 ' N ' HD13 ' A' ' 44' ' ' LEU . 5.0 mp -92.72 121.65 34.33 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.101 -0.5 . . . . 72.409999999999997 111.335 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.12 152.39 45.22 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.383 -0.371 . . . . 70.450000000000003 111.632 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.527 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 39.0 ptt180 -48.72 -36.81 17.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.635 0.605 . . . . 70.409999999999997 112.635 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -81.27 -24.62 37.16 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.214 0.53 . . . . 75.120000000000005 111.754 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.07 -16.65 57.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.054 0.761 . . . . 71.319999999999993 113.054 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 22.2 m-85 -53.06 -39.53 63.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.857 0.688 . . . . 72.510000000000005 112.857 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.81 -23.09 31.57 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.06 -0.4 . . . . 74.109999999999999 111.678 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.21 -2.21 52.86 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.621 0.6 . . . . 74.120000000000005 112.621 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.0 m -105.29 118.02 35.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.184 -0.323 . . . . 75.299999999999997 111.671 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.7 m -89.22 138.58 31.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.097 0.475 . . . . 74.150000000000006 112.017 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.49 147.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.942 0.497 . . . . 73.219999999999999 110.961 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.01 -168.47 2.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.123 0.487 . . . . 74.0 111.63 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 36.3 t70 -70.22 79.31 0.52 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.149 0.499 . . . . 62.130000000000003 111.5 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.84 65.31 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.154 -0.546 . . . . 75.109999999999999 113.52 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HB2' HD21 ' A' ' 3' ' ' LEU . 5.0 m-20 -131.51 131.81 43.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.421 -0.458 . . . . 71.230000000000004 110.657 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -93.19 66.98 4.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.995 0.368 . . . . 74.120000000000005 111.995 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.2 p -82.83 114.77 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.285 0.564 . . . . 60.130000000000003 111.466 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -88.75 114.82 25.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.045 0.387 . . . . 75.239999999999995 112.045 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HA ' HG11 ' A' ' 37' ' ' VAL . 7.2 m-85 -101.32 118.45 37.0 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 75.519999999999996 111.647 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 CA--C 1.539 0.539 0 CA-C-N 116.402 -0.363 . . . . 71.209999999999994 111.521 -178.584 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.748 ' HE1' HD12 ' A' ' 3' ' ' LEU . 25.4 ptt? . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.764 0.316 . . . . 63.409999999999997 111.505 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -80.49 118.88 22.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.359 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.748 HD12 ' HE1' ' A' ' 1' ' ' MET . 68.0 mt -123.34 148.4 46.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.156 0.503 . . . . 74.150000000000006 112.079 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 16.7 m -85.0 82.67 8.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.122 0.487 . . . . 75.239999999999995 110.431 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.36 134.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.431 -0.349 . . . . 71.430000000000007 110.973 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.1 8.26 6.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.556 0.342 . . . . 73.019999999999996 111.298 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.67 68.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.98 -0.629 . . . . 52.43 111.868 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HZ2' ' HB3' ' A' ' 8' ' ' LYS . 5.6 mtpm? -124.15 154.4 68.42 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.311 0.644 . . . . 74.439999999999998 110.768 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.78 115.86 4.29 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.294 1.996 . . . . 63.100000000000001 113.212 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -142.17 -176.79 4.95 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.579 0.352 . . . . 52.43 110.708 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -162.85 137.99 6.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.39 0.515 . . . . 54.100000000000001 112.39 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.33 86.84 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.358 0.599 . . . . 75.099999999999994 111.095 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.2 t70 59.71 174.5 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.505 -0.77 . . . . 75.420000000000002 112.455 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.13 -4.83 69.25 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.292 -0.48 . . . . 63.520000000000003 113.144 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 126.42 8.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.826 0.451 . . . . 73.540000000000006 111.95 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.53 -66.04 0.6 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 62.420000000000002 112.521 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -133.05 124.17 27.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.643 0.259 . . . . 73.409999999999997 111.329 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 91.3 mt -132.38 142.6 49.37 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.741 0.305 . . . . 74.209999999999994 111.257 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.26 162.8 5.6 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.575 -0.284 . . . . 74.209999999999994 110.818 175.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 39.7 t -61.09 -40.15 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.981 -0.449 . . . . 64.530000000000001 110.298 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -59.78 -47.75 84.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.256 -0.429 . . . . 74.140000000000001 111.167 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 2.5 mm-40 -58.47 -38.03 76.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.0 0.428 . . . . 73.230000000000004 111.256 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.69 -45.44 92.09 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.199 -0.455 . . . . 64.439999999999998 110.049 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.465 HD12 ' HB1' ' A' ' 32' ' ' ALA . 72.4 mt -56.91 -39.34 74.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.181 0.515 . . . . 62.539999999999999 111.262 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -78.05 -29.19 49.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.161 -0.472 . . . . 55.149999999999999 112.121 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -47.21 20.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.164 0.507 . . . . 54.149999999999999 111.754 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD21 ' O ' ' A' ' 27' ' ' LEU . 7.2 tt -76.79 -16.43 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.082 -0.508 . . . . 72.230000000000004 110.615 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 66.77 74.04 0.34 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.352 0.596 . . . . 54.200000000000003 110.501 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 HD22 ' A' ' 27' ' ' LEU . 53.5 t -104.21 130.91 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.691 0.626 . . . . 72.25 112.691 -174.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.69 146.0 30.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.32 -0.4 . . . . 73.420000000000002 110.209 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 62.07 33.23 17.22 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.925 0.393 . . . . 72.209999999999994 110.79 -172.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HB1' HD12 ' A' ' 24' ' ' LEU . . . -53.39 -51.9 61.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.281 0.474 . . . . 72.140000000000001 112.281 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.03 -12.45 61.61 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.191 0.519 . . . . 65.340000000000003 111.813 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.06 2.69 12.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.479 0.548 . . . . 74.25 112.479 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 32' ' ' ALA . 10.8 p -73.09 146.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 65.209999999999994 111.875 -176.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.5 m -100.3 108.85 21.01 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.471 -0.331 . . . . 74.040000000000006 110.456 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 62' ' ' PHE . 26.8 m -133.17 134.0 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.217 0.532 . . . . 74.349999999999994 111.698 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 1.7 pm0 -104.88 125.3 50.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.308 0.575 . . . . 73.25 111.508 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.631 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.14 106.43 7.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.836 -0.62 . . . . 62.409999999999997 110.216 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 53.08 26.96 5.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.84 0.456 . . . . 71.329999999999998 112.05 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.13 4.38 41.39 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.304 -0.474 . . . . 72.010000000000005 113.947 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.88 108.07 13.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.278 0.539 . . . . 71.219999999999999 111.418 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 8.8 p -60.27 137.51 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.318 0.488 . . . . 71.340000000000003 112.318 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 39' ' ' LEU . 2.1 mm? -94.2 151.81 19.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.145 0.497 . . . . 73.099999999999994 111.807 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -71.99 160.91 31.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.114 -0.494 . . . . 75.420000000000002 110.946 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -51.37 -46.73 62.85 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.321 0.489 . . . . 71.150000000000006 112.321 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.19 -6.48 55.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.417 0.525 . . . . 74.439999999999998 112.417 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.75 -27.49 66.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.769 0.319 . . . . 54.310000000000002 111.364 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -50.68 -38.03 44.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.198 -0.455 . . . . 71.230000000000004 111.544 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.54 -42.88 61.12 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.914 -0.584 . . . . 63.409999999999997 111.573 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.89 -4.78 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.084 0.772 . . . . 75.409999999999997 113.084 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -101.82 116.96 33.86 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.709 0.29 . . . . 73.409999999999997 111.561 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 65.2 p -100.5 116.96 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.16 0.43 . . . . 74.239999999999995 112.16 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.88 152.52 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.824 -0.625 . . . . 73.549999999999997 110.903 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -139.89 175.89 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.878 0.371 . . . . 74.049999999999997 111.42 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.14 137.63 58.29 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.117 0.484 . . . . 75.319999999999993 111.391 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.36 33.94 24.37 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.147 -0.479 . . . . 37.5 113.164 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.448 ' HB3' HD23 ' A' ' 3' ' ' LEU . 12.7 t70 -109.88 177.45 4.72 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 122.684 -0.303 . . . . 70.140000000000001 110.867 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -139.99 92.13 2.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.429 0.529 . . . . 52.210000000000001 112.429 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.1 p -98.17 115.76 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.344 0.592 . . . . 73.140000000000001 111.219 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.558 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 44.0 mt-10 -84.15 93.45 8.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.217 0.532 . . . . 73.109999999999999 112.414 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.435 ' HA ' HG11 ' A' ' 37' ' ' VAL . 12.8 m-85 -78.9 120.27 23.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.941 -0.572 . . . . 75.129999999999995 110.875 169.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.633 0.254 . . . . 61.539999999999999 110.807 176.8 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.564 ' HB3' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.22 0.452 . . . . 75.329999999999998 112.22 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -94.89 124.15 38.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.157 -0.474 . . . . 50.149999999999999 111.505 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.425 HD22 ' HG2' ' A' ' 1' ' ' MET . 2.9 mm? -120.99 174.42 6.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.068 0.461 . . . . 72.049999999999997 111.103 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 m -129.04 95.29 4.03 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.072 0.463 . . . . 72.239999999999995 110.692 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.591 HG12 HD21 ' A' ' 6' ' ' ASN . 61.8 t -88.13 113.97 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.436 -0.347 . . . . 73.239999999999995 111.774 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.591 HD21 HG12 ' A' ' 5' ' ' VAL . 53.8 m-80 57.91 29.68 17.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.005 0.522 . . . . 74.25 112.001 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.88 75.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.89 -0.671 . . . . 71.109999999999999 113.301 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -114.11 122.07 35.31 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.625 -0.338 . . . . 74.310000000000002 110.975 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.83 119.45 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.739 2.293 . . . . 74.310000000000002 112.997 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.8 p -130.08 127.74 40.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.155 0.502 . . . . 53.140000000000001 111.258 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.4 m -102.7 117.18 34.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.159 -0.338 . . . . 65.040000000000006 111.51 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 HG22 ' H1 ' ' A' ' 1' ' ' MET . 19.6 m -89.56 131.8 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.892 0.377 . . . . 75.409999999999997 110.373 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.3 155.03 20.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.446 0.536 . . . . 71.329999999999998 112.446 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.49 -72.04 1.77 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.986 -0.552 . . . . 63.450000000000003 113.77 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.97 12.95 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.416 0.524 . . . . 72.129999999999995 112.416 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 10.0 pt-20 -129.06 -31.93 2.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 74.329999999999998 112.177 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -140.08 130.64 25.58 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.003 0.43 . . . . 73.140000000000001 112.122 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -170.72 165.45 8.09 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.967 -0.56 . . . . 72.450000000000003 111.5 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.747 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 48.7 m-20 -61.84 155.82 22.22 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.753 0.311 . . . . 73.530000000000001 111.376 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.88 -38.77 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.071 0.462 . . . . 74.329999999999998 110.56 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.4 m -59.33 -41.92 90.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.082 -0.508 . . . . 71.409999999999997 111.783 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.747 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 15.3 mm-40 -63.58 -48.57 76.86 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.069 0.461 . . . . 74.510000000000005 110.527 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.53 -46.3 84.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.136 -0.484 . . . . 75.030000000000001 111.068 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.03 -44.02 91.68 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.103 0.478 . . . . 72.420000000000002 111.043 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -66.76 -30.42 70.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.021 0.439 . . . . 74.409999999999997 111.161 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.93 77.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 73.420000000000002 111.013 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.14 -32.56 63.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.122 -0.49 . . . . 65.409999999999997 111.844 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 64.95 85.54 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.881 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.6 149.7 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 75.25 112.106 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.88 121.84 20.65 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.451 -0.34 . . . . 70.439999999999998 110.98 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 21.6 mt-30 61.99 80.46 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.262 0.553 . . . . 64.430000000000007 110.759 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -55.31 -35.92 65.64 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.671 0.989 . . . . 55.149999999999999 113.671 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.45 -22.72 43.78 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.216 0.451 . . . . 61.219999999999999 112.216 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' ' 31' ' ' GLN . 9.4 m-85 -86.98 -11.85 49.25 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.512 0.56 . . . . 72.140000000000001 112.512 -171.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 32' ' ' ALA . 7.9 p -79.42 131.7 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.235 0.54 . . . . 64.540000000000006 111.366 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -115.89 128.3 55.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.503 -0.317 . . . . 70.439999999999998 111.457 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 62' ' ' PHE . 34.9 m -137.67 140.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.106 0.479 . . . . 74.299999999999997 111.274 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -111.09 113.25 25.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.458 0.647 . . . . 74.310000000000002 110.088 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -75.23 104.96 6.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.009 -0.541 . . . . 74.349999999999994 112.195 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.62 28.35 17.76 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.861 -0.609 . . . . 71.25 111.789 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.47 -20.04 14.06 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.362 -0.447 . . . . 61.229999999999997 113.727 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.84 135.8 45.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.044 0.422 . . . . 74.329999999999998 111.376 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.23 134.82 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.934 0.397 . . . . 74.420000000000002 111.728 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.65 141.98 43.15 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.313 0.578 . . . . 71.400000000000006 111.832 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -79.84 167.67 20.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.896 -0.593 . . . . 74.519999999999996 111.021 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -57.15 -35.02 69.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.73 0.641 . . . . 73.0 112.73 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -96.55 -4.91 40.47 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.07 0.396 . . . . 71.319999999999993 112.07 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.53 56.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.254 0.464 . . . . 50.219999999999999 112.254 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.35 -24.74 63.62 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.056 0.455 . . . . 73.0 111.957 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.78 -29.11 44.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.32 -0.4 . . . . 64.140000000000001 111.847 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.54 12.36 7.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.155 0.798 . . . . 70.319999999999993 113.155 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.1 m -141.69 120.24 12.47 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.726 -0.609 . . . . 72.329999999999998 111.782 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.7 m -92.96 106.89 18.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.097 -0.501 . . . . 75.040000000000006 111.158 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.5 148.14 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.363 -0.38 . . . . 73.140000000000001 110.893 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 17.0 ptpt -144.11 -173.18 3.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.839 0.352 . . . . 65.340000000000003 111.665 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 10.2 t70 -66.94 112.74 4.49 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 55.509999999999998 111.463 -176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.66 63.42 0.66 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.105 -0.498 . . . . 75.230000000000004 113.042 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -154.2 172.58 17.37 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.895 -0.409 . . . . 75.349999999999994 109.895 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.23 94.56 4.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.811 0.671 . . . . 62.109999999999999 112.811 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.499 HG11 HG22 ' A' ' 5' ' ' VAL . 4.8 p -88.94 95.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.491 0.662 . . . . 63.229999999999997 110.809 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -79.88 103.16 9.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.376 0.608 . . . . 75.430000000000007 111.42 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.508 ' HA ' HG11 ' A' ' 37' ' ' VAL . 45.0 t80 -91.69 109.49 20.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.809 -0.632 . . . . 74.299999999999997 110.911 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.066 0.46 . . . . 73.140000000000001 112.202 -177.046 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 24.9 ptp . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.742 0.306 . . . . 73.200000000000003 111.072 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -98.04 114.44 26.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.464 -0.334 . . . . 65.439999999999998 110.86 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 91.3 mt -121.94 131.16 53.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.938 0.399 . . . . 74.109999999999999 111.715 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 39.6 m -85.78 85.45 7.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.04 0.448 . . . . 72.310000000000002 111.001 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.3 p -82.44 117.03 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.024 0.44 . . . . 71.530000000000001 111.615 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 59.29 15.04 4.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.615 0.598 . . . . 72.129999999999995 112.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.22 -4.43 33.46 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.319 -0.467 . . . . 74.540000000000006 113.218 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.62 106.57 58.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 122.584 -0.362 . . . . 73.439999999999998 111.545 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 20.4 Cg_exo -65.82 99.5 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.798 2.332 . . . . 72.310000000000002 112.877 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 t -112.79 139.14 48.67 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 63.420000000000002 111.556 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.0 m -89.3 99.97 12.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.38 . . . . 74.329999999999998 111.355 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.89 111.04 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.22 0.533 . . . . 71.530000000000001 110.198 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.55 161.09 18.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.233 0.539 . . . . 74.420000000000002 112.211 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.75 84.51 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.971 -0.559 . . . . 71.230000000000004 112.869 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.91 102.72 4.48 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.641 -0.329 . . . . 73.129999999999995 111.474 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.79 -29.94 13.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.732 0.301 . . . . 75.109999999999999 111.731 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -160.62 106.4 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.564 -0.289 . . . . 71.040000000000006 111.156 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.5 pp -143.79 156.53 44.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.163 0.506 . . . . 73.530000000000001 111.649 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 49' ' ' PHE . 4.6 p-10 -83.09 164.27 20.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.359 -0.382 . . . . 73.299999999999997 110.973 177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.84 -33.93 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.749 0.648 . . . . 71.019999999999996 112.749 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 m -52.03 -54.67 27.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.274 0.559 . . . . 71.010000000000005 111.403 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.56 -33.0 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.985 -0.552 . . . . 53.119999999999997 111.592 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.92 -44.68 78.51 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.035 0.445 . . . . 64.540000000000006 110.333 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.15 -32.62 72.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.929 0.395 . . . . 61.340000000000003 111.252 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.6 t -66.34 -35.46 80.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.291 -0.413 . . . . 65.109999999999999 111.29 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.95 92.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.112 0.482 . . . . 52.439999999999998 111.639 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' N ' HD11 ' A' ' 27' ' ' LEU . 6.5 mp -82.48 -24.48 34.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.174 0.511 . . . . 71.530000000000001 110.777 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 tttm 63.04 84.8 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.7 0.8 . . . . 71.209999999999994 111.961 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.14 145.89 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.701 -0.681 . . . . 72.25 110.691 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.08 -55.32 8.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.023 0.439 . . . . 74.430000000000007 111.324 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 22.8 mp0 -91.73 78.44 5.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.407 -0.36 . . . . 72.019999999999996 110.822 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -64.93 -44.56 89.07 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.175 0.512 . . . . 72.120000000000005 111.356 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -63.58 -33.42 75.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.036 -0.529 . . . . 64.030000000000001 111.916 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 26.1 m-85 -109.11 9.1 26.26 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.763 0.653 . . . . 74.439999999999998 112.763 -167.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 32' ' ' ALA . 8.7 p -86.44 124.74 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.982 0.42 . . . . 70.530000000000001 110.998 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -85.09 109.52 18.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.17 0.51 . . . . 75.120000000000005 111.231 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.68 145.55 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.915 -0.584 . . . . 61.520000000000003 111.105 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -136.57 147.7 47.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 111.068 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.5 ' HB3' HD21 ' A' ' 40' ' ' ASN . 10.6 mp -112.49 131.27 55.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.815 0.302 . . . . 63.039999999999999 111.815 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 39' ' ' LEU . 32.7 m-80 56.23 27.32 11.54 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.598 0.592 . . . . 73.230000000000004 112.598 171.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.26 18.57 57.17 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.481 -0.39 . . . . 71.230000000000004 113.721 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -131.98 131.69 42.81 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.364 -0.492 . . . . 51.32 110.199 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.66 127.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.366 0.603 . . . . 74.209999999999994 112.286 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 39' ' ' LEU . 10.5 mp -94.39 136.79 34.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.523 0.677 . . . . 71.439999999999998 112.317 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.25 142.2 57.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.56 -0.745 . . . . 74.5 110.711 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -52.25 -45.95 65.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.219 0.533 . . . . 74.150000000000006 111.177 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.92 9.66 3.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.037 -0.529 . . . . 62.32 112.112 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.59 -10.21 15.72 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.186 -0.322 . . . . 72.129999999999995 111.376 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 22.5 m-30 -60.93 -24.75 66.28 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.159 0.429 . . . . 74.209999999999994 112.159 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 3.6 p30 -84.34 -29.75 26.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.848 0.356 . . . . 73.439999999999998 111.663 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.19 -53.14 6.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.331 -0.395 . . . . 74.120000000000005 111.861 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.422 HG23 HD22 ' A' ' 44' ' ' LEU . 62.4 m -63.2 98.74 0.15 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.831 0.348 . . . . 73.25 111.124 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.2 m -85.2 108.59 17.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.882 0.373 . . . . 71.209999999999994 111.21 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.45 133.67 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.977 0.418 . . . . 73.25 111.377 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -128.86 -177.65 4.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.451 0.643 . . . . 71.0 112.063 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.62 122.57 15.61 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.593 -0.73 . . . . 72.340000000000003 111.884 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.29 31.58 7.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.353 -0.385 . . . . 37.600000000000001 113.603 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.96 160.62 15.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 117.04 0.42 . . . . 72.140000000000001 110.54 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.17 99.11 6.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.053 0.454 . . . . 74.519999999999996 111.701 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -95.64 131.19 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.227 0.537 . . . . 63.109999999999999 111.739 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.93 109.62 21.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.376 0.607 . . . . 65.409999999999997 110.829 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -113.05 108.88 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.703 -0.68 . . . . 73.239999999999995 110.54 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 mt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.052 0.453 . . . . 73.430000000000007 111.841 -176.646 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.474 ' HG3' HD12 ' A' ' 3' ' ' LEU . 19.7 ptp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.719 0.295 . . . . 71.019999999999996 111.403 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -101.81 133.28 46.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.624 0.37 . . . . 65.209999999999994 110.652 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.474 HD12 ' HG3' ' A' ' 1' ' ' MET . 1.6 mp -133.95 157.17 46.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.132 -0.355 . . . . 71.519999999999996 111.338 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 36.7 m -107.54 105.7 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.888 -0.412 . . . . 74.109999999999999 109.888 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 60' ' ' VAL . 31.8 m -119.5 136.83 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.197 -0.456 . . . . 71.140000000000001 111.163 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.17 30.06 19.75 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.486 0.315 . . . . 73.019999999999996 111.443 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.28 21.0 79.5 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.923 -0.656 . . . . 75.209999999999994 113.372 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -128.86 142.89 46.59 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.568 0.347 . . . . 65.239999999999995 111.717 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.96 143.47 32.89 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.256 1.971 . . . . 74.230000000000004 111.859 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.7 p -146.1 162.81 37.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.183 -0.323 . . . . 61.210000000000001 111.406 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -142.42 107.64 4.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.738 0.304 . . . . 71.230000000000004 111.508 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -103.59 128.28 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.994 0.426 . . . . 52.130000000000003 111.21 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.39 157.26 29.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.067 0.461 . . . . 73.439999999999998 111.818 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.78 -64.4 4.31 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.475 -0.393 . . . . 63.409999999999997 113.378 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.23 107.03 1.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.185 0.439 . . . . 73.409999999999997 112.185 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.04 -45.11 8.07 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.404 -0.362 . . . . 74.519999999999996 111.582 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -153.68 129.41 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.851 0.357 . . . . 62.229999999999997 111.194 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.2 pp -158.05 152.5 24.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.137 0.421 . . . . 71.540000000000006 112.137 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 50' ' ' ASP . 12.2 p-10 -61.35 154.68 23.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.321 -0.399 . . . . 73.439999999999998 111.457 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.1 t -53.38 -33.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.886 0.374 . . . . 70.109999999999999 111.518 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -53.84 -49.47 68.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.381 -0.372 . . . . 73.150000000000006 111.545 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -68.96 -35.85 77.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.565 0.221 . . . . 71.510000000000005 111.454 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.586 HD22 HG23 ' A' ' 54' ' ' VAL . 64.8 tp -54.39 -50.82 66.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.095 0.474 . . . . 75.310000000000002 110.908 174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -57.73 -41.56 82.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.164 0.507 . . . . 72.25 110.871 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 t -68.36 -29.5 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.817 -0.628 . . . . 73.109999999999999 111.597 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.75 77.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.027 0.441 . . . . 74.430000000000007 111.189 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.84 -21.51 57.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.082 0.468 . . . . 71.450000000000003 110.501 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 tttp 65.57 36.95 6.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.359 -0.837 . . . . 73.209999999999994 111.579 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.01 129.73 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.134 -0.484 . . . . 70.140000000000001 111.401 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.49 81.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.275 0.472 . . . . 64.519999999999996 112.275 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -101.44 89.67 3.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.932 0.396 . . . . 71.349999999999994 111.422 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -92.42 -45.87 7.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.314 0.578 . . . . 71.129999999999995 110.635 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.66 -25.66 40.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.676 -0.693 . . . . 75.530000000000001 111.719 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -122.41 28.16 7.55 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.093 0.405 . . . . 72.25 112.093 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 32' ' ' ALA . 11.7 p -89.5 139.46 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.306 0.574 . . . . 71.219999999999999 111.971 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -97.95 99.82 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.351 -0.386 . . . . 73.540000000000006 110.444 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.27 136.59 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.852 0.358 . . . . 73.329999999999998 111.579 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.0 pt-20 -122.24 131.88 54.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.155 0.502 . . . . 71.430000000000007 111.377 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.742 ' HB2' HD11 ' A' ' 44' ' ' LEU . 2.4 tm? -88.35 99.9 12.6 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.413 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.548 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 63.89 1.34 1.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.133 0.79 . . . . 72.25 113.133 176.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.32 -6.85 0.82 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.403 -0.904 . . . . 74.430000000000007 114.856 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.85 128.77 41.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.86 0.83 . . . . 74.040000000000006 112.102 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.7 p -66.34 139.54 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.129 0.49 . . . . 75.040000000000006 112.304 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 39' ' ' LEU . 6.0 mp -92.5 147.16 23.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.159 -0.473 . . . . 75.510000000000005 111.445 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.87 149.77 37.75 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.098 -0.501 . . . . 72.209999999999994 110.336 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -48.33 -55.68 10.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.591 0.589 . . . . 61.329999999999998 112.591 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -81.98 23.93 0.67 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.326 0.584 . . . . 72.549999999999997 111.967 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.75 1.94 13.56 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.734 -0.604 . . . . 65.5 111.836 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -64.69 -30.28 71.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.207 0.447 . . . . 62.340000000000003 112.207 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 14.5 m-20 -83.12 -32.5 26.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.875 0.369 . . . . 61.149999999999999 111.001 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.33 91.35 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.09 -0.505 . . . . 74.409999999999997 112.082 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -95.85 119.96 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.99 0.424 . . . . 74.219999999999999 111.723 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.6 m -96.09 116.43 28.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.938 0.399 . . . . 64.230000000000004 111.616 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 HD22 ' A' ' 23' ' ' LEU . 49.3 t -74.6 142.03 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 116.005 -0.543 . . . . 75.129999999999995 111.096 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -142.83 -175.84 4.65 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.389 0.614 . . . . 74.25 111.61 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.22 104.39 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.756 -0.656 . . . . 71.109999999999999 111.972 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.74 32.2 2.14 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.197 -0.525 . . . . 44.130000000000003 113.818 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.74 138.1 48.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.328 0.585 . . . . 72.109999999999999 112.315 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -95.66 104.52 16.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.651 -0.704 . . . . 62.039999999999999 111.49 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' O ' HG22 ' A' ' 60' ' ' VAL . 28.7 m -109.02 98.37 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.622 0.725 . . . . 75.439999999999998 110.404 175.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -72.94 99.54 2.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.731 0.777 . . . . 74.239999999999995 112.628 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -85.01 143.71 28.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.869 -1.06 . . . . 74.310000000000002 110.151 170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.536 0.439 0 CA-C-O 121.284 0.564 . . . . 72.040000000000006 111.771 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.731 ' HE2' HD12 ' A' ' 3' ' ' LEU . 26.5 ptt? . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.916 0.389 . . . . 75.420000000000002 111.313 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.78 126.41 37.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.309 -0.405 . . . . 73.540000000000006 111.122 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.731 HD12 ' HE2' ' A' ' 1' ' ' MET . 92.6 mt -126.36 134.92 50.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.937 0.399 . . . . 63.229999999999997 111.373 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -94.6 99.35 11.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.959 0.409 . . . . 72.099999999999994 111.004 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -100.19 124.21 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.965 0.412 . . . . 72.25 111.464 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 55.6 m-80 54.87 43.22 30.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.115 0.483 . . . . 73.219999999999999 111.371 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.69 12.83 62.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.872 -0.603 . . . . 73.409999999999997 113.872 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -126.89 125.31 24.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 122.596 -0.355 . . . . 74.310000000000002 110.917 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.0 142.18 19.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.684 2.256 . . . . 74.230000000000004 113.819 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.9 t -137.86 125.88 22.78 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.027 -0.533 . . . . 74.129999999999995 110.628 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -87.33 94.27 9.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.003 0.43 . . . . 72.019999999999996 111.536 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -94.78 95.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.491 0.662 . . . . 74.0 111.322 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.74 159.66 30.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.119 0.485 . . . . 64.400000000000006 111.373 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.78 -52.34 2.62 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.097 -0.573 . . . . 73.420000000000002 111.693 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.61 123.36 23.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.724 0.297 . . . . 38.109999999999999 110.569 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.06 -48.02 3.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.264 0.554 . . . . 70.129999999999995 111.423 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -157.64 106.6 2.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.224 -0.444 . . . . 72.019999999999996 110.632 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.02 151.81 50.27 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.346 -0.388 . . . . 74.099999999999994 111.29 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 20.4 p-10 -74.49 157.22 35.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.136 -0.32 . . . . 71.400000000000006 110.136 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 60.7 t -51.01 -37.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.86 0.319 . . . . 72.430000000000007 111.86 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -53.62 -51.75 62.07 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.821 0.343 . . . . 73.420000000000002 111.597 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 52.2 mm-40 -71.18 -29.2 64.88 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 122.246 -0.284 . . . . 61.399999999999999 111.756 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.631 HD12 HG12 ' A' ' 60' ' ' VAL . 7.6 tt -60.39 -45.3 94.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.527 -0.546 . . . . 74.140000000000001 109.527 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 78.0 mt -63.88 -41.02 97.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 70.450000000000003 110.206 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 37.0 t -60.47 -27.78 67.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.673 -0.694 . . . . 72.209999999999994 112.002 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -42.32 93.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.058 0.456 . . . . 73.120000000000005 111.314 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 27' ' ' LEU . 5.8 mp -88.68 -0.75 57.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 110.465 174.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt 57.71 48.91 13.19 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.75 0.786 . . . . 70.439999999999998 111.101 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 56.3 t -81.54 88.51 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.853 -0.612 . . . . 72.420000000000002 110.259 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.92 -27.94 33.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.838 -0.619 . . . . 53.520000000000003 112.368 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 11.7 mm100 -83.92 45.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.282 -0.417 . . . . 74.510000000000005 112.024 -176.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -36.99 74.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.474 0.546 . . . . 72.120000000000005 112.474 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.44 -7.64 56.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 75.200000000000003 111.449 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 5.8 m-85 -104.42 -50.61 3.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.276 -0.42 . . . . 74.219999999999999 111.455 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.46 136.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.195 0.521 . . . . 61.399999999999999 112.323 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.2 m -112.06 140.41 46.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.109 -0.496 . . . . 74.140000000000001 111.053 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 62' ' ' PHE . 28.7 m -133.8 151.39 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.678 0.275 . . . . 71.219999999999999 110.842 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.56 126.12 51.29 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.709 0.766 . . . . 65.439999999999998 111.818 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.48 120.7 34.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.581 -0.736 . . . . 75.0 110.197 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.51 26.36 10.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.988 0.423 . . . . 73.439999999999998 111.779 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 12.92 68.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.092 -0.575 . . . . 45.140000000000001 113.226 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.79 124.88 53.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.654 0.382 . . . . 72.109999999999999 110.438 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.01 128.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.199 0.523 . . . . 73.340000000000003 111.945 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.15 139.99 35.03 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.428 -0.351 . . . . 72.319999999999993 111.179 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -68.94 160.77 30.18 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.351 -0.386 . . . . 53.049999999999997 110.771 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.09 -36.14 65.34 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.023 0.44 . . . . 71.340000000000003 111.726 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.78 -39.21 80.31 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.246 0.545 . . . . 62.439999999999998 111.416 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.3 63.77 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.538 0.57 . . . . 52.43 112.538 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -63.43 -33.48 75.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.985 0.422 . . . . 73.409999999999997 111.685 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.79 -32.26 59.8 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.37 -0.377 . . . . 71.299999999999997 111.46 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.95 6.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.329 0.492 . . . . 54.450000000000003 112.329 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -57.59 115.64 2.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.352 0.501 . . . . 74.299999999999997 112.352 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 73.8 p -99.37 119.63 38.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.049 0.452 . . . . 62.149999999999999 111.44 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -96.22 140.52 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.172 -0.467 . . . . 60.25 111.09 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.26 -172.34 2.82 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.663 0.616 . . . . 73.430000000000007 112.663 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.1 t70 -63.14 132.04 50.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.778 -0.646 . . . . 75.400000000000006 112.258 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.05 42.28 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.004 -0.544 . . . . 73.340000000000003 113.467 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -119.16 150.06 40.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.425 -0.456 . . . . 73.450000000000003 110.714 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.33 83.71 2.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.129 0.49 . . . . 62.229999999999997 112.185 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 23' ' ' LEU . 3.6 p -88.31 91.71 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.357 0.598 . . . . 65.120000000000005 110.343 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 33.8 tt0 -71.35 92.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.526 0.679 . . . . 73.019999999999996 110.859 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' HA ' HG13 ' A' ' 37' ' ' VAL . 71.6 t80 -73.25 110.19 7.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.284 -0.871 . . . . 72.340000000000003 111.139 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.123 0.487 . . . . 65.140000000000001 110.766 178.478 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HE3' HD11 ' A' ' 3' ' ' LEU . 25.9 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.674 0.273 . . . . 74.040000000000006 111.527 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -89.09 132.04 34.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.508 -0.315 . . . . 74.140000000000001 111.073 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.536 HD11 ' HE3' ' A' ' 1' ' ' MET . 95.9 mt -136.36 131.22 33.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.981 0.42 . . . . 64.329999999999998 111.377 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 89.3 m -81.85 89.47 6.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.288 0.566 . . . . 74.129999999999995 110.073 172.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.59 120.09 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 74.420000000000002 111.552 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.41 ' OD1' ' NZ ' ' A' ' 8' ' ' LYS . 6.2 t-20 62.43 22.62 13.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.118 0.485 . . . . 72.530000000000001 111.67 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.04 64.5 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.284 -0.484 . . . . 41.200000000000003 113.22 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 3.9 mppt? -113.91 127.07 27.23 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.667 -0.314 . . . . 64.310000000000002 111.427 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 90.3 Cg_endo -79.34 139.12 14.46 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.648 2.232 . . . . 75.319999999999993 113.543 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.1 t -149.75 159.36 44.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.748 0.309 . . . . 74.030000000000001 111.385 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -109.72 112.39 24.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 111.362 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 1' ' ' MET . 31.4 m -112.01 119.49 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.953 0.406 . . . . 72.219999999999999 111.464 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.87 166.38 20.96 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.724 0.297 . . . . 72.319999999999993 110.517 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.51 4.01 73.63 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.933 -0.651 . . . . 73.430000000000007 112.524 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.4 108.34 11.57 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.862 0.363 . . . . 65.319999999999993 110.987 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -101.81 -60.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.387 0.613 . . . . 75.129999999999995 110.457 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -149.75 101.4 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.789 -0.642 . . . . 74.040000000000006 109.634 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 96.3 mt -125.03 133.06 53.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.145 0.424 . . . . 70.409999999999997 112.145 -170.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.7 p-10 -63.59 149.67 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.597 -0.274 . . . . 60.310000000000002 110.452 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.83 -42.14 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.641 0.608 . . . . 70.109999999999999 112.641 -173.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.427 ' HB ' ' ND2' ' A' ' 19' ' ' ASN . 86.6 m -50.83 -48.51 59.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.824 0.345 . . . . 60.119999999999997 111.795 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 25.4 mm-40 -65.04 -32.77 74.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.336 . . . . 61.210000000000001 111.25 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 60' ' ' VAL . 6.9 tt -61.68 -50.04 74.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.937 0.398 . . . . 63.329999999999998 109.967 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD12 HG13 ' A' ' 29' ' ' VAL . 3.9 mm? -63.21 -33.66 75.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.861 0.362 . . . . 73.329999999999998 111.032 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -64.04 -41.34 97.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.150000000000006 111.365 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -33.23 70.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.155 0.502 . . . . 74.140000000000001 111.07 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.603 HD22 ' HB ' ' A' ' 29' ' ' VAL . 5.6 tt -71.25 -35.07 71.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.015 -0.539 . . . . 63.140000000000001 110.368 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 60.17 73.45 0.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.518 0.675 . . . . 75.319999999999993 111.461 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.603 ' HB ' HD22 ' A' ' 27' ' ' LEU . 12.5 p -117.18 143.81 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.889 -0.596 . . . . 74.040000000000006 111.36 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.91 142.85 41.97 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 42.43 111.262 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 66.6 mt-30 71.12 37.58 1.21 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.852 -0.613 . . . . 74.510000000000005 112.124 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.24 75.16 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.946 0.403 . . . . 74.230000000000004 111.93 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -73.4 -3.27 26.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.14 0.495 . . . . 74.0 111.555 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 23.5 m-85 -119.76 -13.45 9.1 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.021 -0.425 . . . . 74.519999999999996 112.029 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.11 130.49 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 74.5 112.341 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -93.93 117.2 29.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.311 -0.404 . . . . 70.409999999999997 111.057 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.23 158.82 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 72.409999999999997 110.984 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 11.6 pt-20 -127.87 133.01 49.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.628 0.728 . . . . 54.200000000000003 111.981 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.525 ' HB2' HD23 ' A' ' 44' ' ' LEU . 2.9 tm? -91.52 104.04 16.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.338 -0.846 . . . . 71.430000000000007 109.689 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.4 HD21 HD13 ' A' ' 39' ' ' LEU . 32.4 m-80 55.18 46.21 24.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.098 0.475 . . . . 65.519999999999996 111.408 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.02 -3.79 74.38 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.474 -0.393 . . . . 60.450000000000003 113.946 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -96.59 111.38 23.54 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.567 -0.372 . . . . 61.210000000000001 111.112 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.25 125.34 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 112.219 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 39' ' ' LEU . 1.4 mm? -97.76 152.1 19.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.003 0.43 . . . . 75.450000000000003 111.213 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.2 149.44 46.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.911 -0.774 . . . . 64.420000000000002 108.911 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -54.13 -38.11 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.174 0.435 . . . . 73.030000000000001 112.174 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.56 -29.96 46.6 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.194 0.521 . . . . 74.340000000000003 111.193 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.35 -17.01 40.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.461 -0.336 . . . . 74.319999999999993 111.846 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.95 -32.55 66.13 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.181 0.515 . . . . 73.299999999999997 111.201 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.81 -24.85 35.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.094 -0.503 . . . . 75.409999999999997 111.431 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.13 -23.06 19.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.262 0.467 . . . . 60.210000000000001 112.262 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 106.65 18.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.144 -0.348 . . . . 74.219999999999999 111.56 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 76.3 p -85.57 115.6 23.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.01 0.433 . . . . 74.400000000000006 112.017 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.17 132.78 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.35 -0.386 . . . . 71.349999999999994 110.804 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -125.65 -177.32 3.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.149 0.5 . . . . 73.150000000000006 112.105 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.33 143.23 45.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 43.219999999999999 111.872 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.43 34.74 90.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 113.809 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.81 -177.12 3.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.022 0.411 . . . . 71.0 110.081 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.16 102.98 6.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.074 0.768 . . . . 51.109999999999999 113.074 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.476 HG12 HD12 ' A' ' 23' ' ' LEU . 4.0 p -96.69 111.22 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.309 0.576 . . . . 74.319999999999993 110.394 173.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 42.2 mt-10 -101.25 105.23 16.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.593 0.711 . . . . 70.030000000000001 111.957 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -81.87 117.07 21.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.286 -0.87 . . . . 64.319999999999993 110.443 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 74.549999999999997 112.54 -175.476 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' HD12 ' A' ' 3' ' ' LEU . 24.5 ptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.664 0.268 . . . . 75.019999999999996 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.24 118.67 26.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.66 -0.246 . . . . 75.319999999999993 110.528 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.508 HD12 ' SD ' ' A' ' 1' ' ' MET . 63.7 mt -127.93 169.7 13.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.178 0.513 . . . . 73.120000000000005 111.437 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -111.36 96.87 6.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.626 -0.509 . . . . 72.329999999999998 109.626 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 48.0 t -100.85 123.91 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 60.43 111.306 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.856 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.8 OUTLIER 64.53 24.25 13.04 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.292 -0.413 . . . . 72.25 111.718 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.2 6.31 88.12 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.348 -0.453 . . . . 37.469999999999999 113.078 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -118.35 126.62 27.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 O-C-N 122.549 -0.383 . . . . 73.519999999999996 110.835 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.65 95.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.421 2.081 . . . . 71.049999999999997 112.43 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.1 m -113.5 118.04 33.35 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.077 -0.511 . . . . 64.209999999999994 111.093 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.4 m -96.99 114.35 25.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 111.487 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -93.68 120.64 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.125 0.488 . . . . 65.010000000000005 110.562 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.61 154.78 30.0 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.032 -0.531 . . . . 54.450000000000003 112.022 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.19 -45.46 3.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.257 -0.497 . . . . 75.310000000000002 113.298 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.15 117.06 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.831 0.348 . . . . 70.329999999999998 111.906 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -107.23 -55.88 2.28 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.306 -0.407 . . . . 73.040000000000006 110.566 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -141.93 122.39 14.08 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.821 0.343 . . . . 72.219999999999999 111.853 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -157.72 160.58 38.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.264 -0.425 . . . . 64.239999999999995 111.021 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.7 p30 -86.73 168.86 13.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.917 0.389 . . . . 73.310000000000002 111.175 177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.1 -29.28 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.55 -0.295 . . . . 72.219999999999999 111.449 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.3 m -61.62 -42.17 98.51 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.742 0.306 . . . . 74.5 111.586 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.29 -47.91 77.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.796 0.331 . . . . 73.030000000000001 110.908 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.92 -43.6 77.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.022 0.439 . . . . 54.140000000000001 110.825 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.01 -43.39 98.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.982 -0.554 . . . . 72.409999999999997 110.6 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -74.68 -17.34 60.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.235 -0.438 . . . . 71.349999999999994 111.891 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.61 35.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.861 0.362 . . . . 61.299999999999997 111.315 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 28' ' ' LYS . 2.8 pp -87.76 -17.79 30.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.519 -0.309 . . . . 75.400000000000006 111.705 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' HD12 ' A' ' 27' ' ' LEU . 57.4 mtmt 60.06 85.56 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 72.129999999999995 112.833 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.35 117.32 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.184 0.516 . . . . 75.040000000000006 110.959 176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.69 68.66 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.158 -0.473 . . . . 70.349999999999994 112.207 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -84.81 40.45 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.384 -0.371 . . . . 74.310000000000002 111.877 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.72 62.21 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.131 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.65 -36.31 75.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 111.552 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -99.33 -17.16 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.554 0.576 . . . . 65.030000000000001 112.554 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.2 113.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.976 0.732 . . . . 75.019999999999996 112.976 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 m -94.69 107.47 19.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.988 -0.551 . . . . 71.129999999999995 111.297 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 62' ' ' PHE . 31.5 m -141.32 147.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.426 -0.352 . . . . 70.239999999999995 111.195 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.29 137.03 43.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.039 0.447 . . . . 73.430000000000007 111.746 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.669 HD21 HD23 ' A' ' 44' ' ' LEU . 4.1 mm? -83.22 106.48 15.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.027 0.441 . . . . 61.420000000000002 110.621 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 61.6 11.02 3.62 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.377 0.671 . . . . 63.450000000000003 112.526 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.63 -10.26 7.61 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.992 -0.623 . . . . 44.530000000000001 113.914 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.54 114.94 29.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.294 -0.533 . . . . 75.310000000000002 111.639 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.56 148.89 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.109 0.48 . . . . 63.439999999999998 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.669 HD23 HD21 ' A' ' 39' ' ' LEU . 3.1 mm? -101.16 143.26 31.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.318 0.58 . . . . 64.25 112.259 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.94 156.79 16.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.777 -0.647 . . . . 71.540000000000006 109.304 170.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 46' ' ' ARG . 61.3 mtt85 -40.43 -54.63 2.42 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.573 0.583 . . . . 75.420000000000002 112.573 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -79.25 -14.28 59.14 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.319 0.489 . . . . 72.010000000000005 112.319 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.03 62.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 75.150000000000006 111.222 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.66 -37.23 73.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.895 0.379 . . . . 71.209999999999994 111.519 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.49 -36.59 52.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.97 0.414 . . . . 71.239999999999995 111.705 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.21 -56.99 4.34 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.268 0.47 . . . . 52.149999999999999 112.268 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.5 m -72.59 126.12 29.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.039 0.447 . . . . 70.230000000000004 112.045 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 75.6 p -105.95 138.3 42.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.203 0.525 . . . . 71.200000000000003 112.011 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.515 HG22 HD12 ' A' ' 39' ' ' LEU . 43.9 t -95.22 129.79 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.086 -0.507 . . . . 73.319999999999993 110.895 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.77 -179.76 5.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.279 0.561 . . . . 73.409999999999997 111.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.98 102.82 0.09 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.974 -0.557 . . . . 64.230000000000004 112.267 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.53 4.42 8.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.313 -0.47 . . . . 65.049999999999997 113.838 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.44 145.04 25.24 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.42 0.629 . . . . 74.010000000000005 112.162 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.15 131.76 51.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.78 -0.645 . . . . 51.020000000000003 111.168 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -143.96 117.71 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.403 0.62 . . . . 72.349999999999994 111.435 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.856 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 28.6 tt0 -101.38 96.56 7.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.5 0.666 . . . . 73.150000000000006 111.896 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HA ' HG11 ' A' ' 37' ' ' VAL . 18.6 t80 -78.06 92.2 4.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.928 -0.578 . . . . 74.239999999999995 110.069 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 113.29 0.848 . . . . 74.439999999999998 113.29 -175.05 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.543 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 22.8 ptp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.793 0.33 . . . . 72.409999999999997 111.517 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -101.9 114.56 28.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.398 -0.365 . . . . 64.549999999999997 111.017 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.86 127.76 53.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.081 0.467 . . . . 72.340000000000003 111.411 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.2 m -82.4 97.7 8.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.28 -0.418 . . . . 72.340000000000003 111.462 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.569 HG12 HD21 ' A' ' 6' ' ' ASN . 31.5 t -85.72 110.83 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.918 0.389 . . . . 62.43 111.837 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.569 HD21 HG12 ' A' ' 5' ' ' VAL . 52.2 m-80 57.74 25.62 12.07 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.164 0.586 . . . . 63.329999999999998 112.37 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.03 -11.55 58.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.212 -0.518 . . . . 65.549999999999997 113.086 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 9.9 mptt -102.48 114.62 65.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.672 -0.311 . . . . 74.209999999999994 110.93 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 25.6 Cg_exo -63.32 116.45 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.8 2.333 . . . . 71.239999999999995 113.148 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -114.01 158.74 20.78 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.348 -0.387 . . . . 63.149999999999999 110.558 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -126.31 110.28 13.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.894 0.378 . . . . 64.510000000000005 111.868 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 m -98.81 102.08 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.451 0.644 . . . . 72.340000000000003 110.666 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.04 136.22 37.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.758 -0.655 . . . . 73.219999999999999 111.534 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.65 59.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.18 -0.533 . . . . 51.119999999999997 113.001 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' HG2' ' A' ' 1' ' ' MET . . . -103.04 101.74 11.73 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.592 -0.358 . . . . 73.430000000000007 111.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.82 88.12 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.932 0.396 . . . . 73.120000000000005 111.181 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m 49.29 91.96 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.752 -0.658 . . . . 74.299999999999997 112.454 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.4 pp -129.0 153.83 47.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.062 0.458 . . . . 71.400000000000006 111.611 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 27.7 m-20 -72.34 160.73 31.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.469 -0.332 . . . . 75.219999999999999 110.828 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 t -56.38 -36.65 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.568 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -56.36 -52.03 66.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.96 0.41 . . . . 62.350000000000001 110.999 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 41.7 mt-10 -63.83 -34.45 77.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.305 -0.407 . . . . 71.129999999999995 111.44 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.3 -45.93 80.02 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.919 0.39 . . . . 75.140000000000001 110.434 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -56.25 -32.93 64.95 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.983 0.42 . . . . 71.239999999999995 111.499 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.4 t -77.97 -32.82 51.57 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.122 -0.49 . . . . 70.129999999999995 111.291 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.59 -46.38 63.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.082 0.468 . . . . 74.219999999999999 111.417 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.52 -30.42 65.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.909 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.89 87.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.58 0.752 . . . . 70.120000000000005 112.575 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.11 148.53 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.792 -0.64 . . . . 73.040000000000006 110.936 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.99 171.81 14.52 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.87 0.367 . . . . 64.409999999999997 111.867 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 57.17 39.07 29.13 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.057 0.455 . . . . 74.340000000000003 111.729 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -33.27 71.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.459 . . . . 75.299999999999997 111.961 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.72 -13.34 62.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.984 0.365 . . . . 74.25 111.984 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.17 4.7 5.82 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.458 0.54 . . . . 74.340000000000003 112.458 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 37' ' ' VAL . 14.6 p -70.71 132.06 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.551 0.691 . . . . 73.200000000000003 112.338 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.9 m -95.26 98.89 10.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 111.221 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.482 HG13 HG22 ' A' ' 35' ' ' VAL . 29.7 m -133.15 163.34 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.265 0.555 . . . . 75.349999999999994 112.08 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.39 154.71 32.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.983 -0.553 . . . . 62.0 111.298 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.528 ' O ' HD11 ' A' ' 39' ' ' LEU . 3.4 pp -123.17 137.95 54.77 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.531 -0.304 . . . . 54.399999999999999 111.286 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 59.21 16.08 4.66 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 116.358 -0.383 . . . . 71.030000000000001 112.024 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.27 15.41 53.65 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.347 -0.454 . . . . 55.340000000000003 113.825 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.15 118.3 28.33 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.3 -0.529 . . . . 73.010000000000005 111.368 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.68 135.13 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.11 0.481 . . . . 72.450000000000003 111.927 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.0 mm? -109.67 150.72 27.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.131 0.491 . . . . 60.43 112.092 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 mp0 -69.36 162.18 27.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.146 -0.479 . . . . 72.430000000000007 110.76 170.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -57.02 -39.43 74.74 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.714 0.292 . . . . 64.010000000000005 111.32 178.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.56 -35.94 68.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.038 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -22.41 66.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.333 -0.394 . . . . 74.310000000000002 111.369 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CD2' ' HA ' ' A' ' 46' ' ' ARG . 17.5 m-30 -57.57 -39.33 76.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.646 0.26 . . . . 74.329999999999998 111.558 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 22.2 t70 -83.34 -35.51 25.11 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.241 0.543 . . . . 73.129999999999995 110.82 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.36 -23.57 67.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.258 -0.428 . . . . 74.010000000000005 112.09 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -103.77 115.78 31.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.787 0.327 . . . . 64.219999999999999 111.565 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 88.6 m -94.73 110.19 22.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.23 0.538 . . . . 71.209999999999994 111.801 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.48 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.901 -0.591 . . . . 74.409999999999997 111.24 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -130.07 -167.12 1.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.183 0.516 . . . . 72.340000000000003 111.929 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 2.8 t0 -78.97 42.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.931 0.396 . . . . 73.450000000000003 112.045 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.59 52.92 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.406 -0.902 . . . . 64.230000000000004 113.426 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.12 123.7 38.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.237 0.541 . . . . 74.439999999999998 110.956 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.82 82.96 3.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.267 -0.424 . . . . 70.239999999999995 111.577 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.7 p -83.47 104.93 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.529 0.68 . . . . 74.420000000000002 111.561 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 41.3 mt-10 -85.84 100.61 12.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.442 0.639 . . . . 73.310000000000002 111.167 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -101.71 110.9 22.99 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.291 -0.868 . . . . 73.519999999999996 110.676 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pt? . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.521 0.563 . . . . 74.329999999999998 112.521 -173.456 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.654 ' HE2' HD12 ' A' ' 3' ' ' LEU . 26.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.846 0.355 . . . . 62.539999999999999 111.914 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.22 126.8 36.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.44 -0.345 . . . . 72.530000000000001 111.543 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.654 HD12 ' HE2' ' A' ' 1' ' ' MET . 74.7 mt -125.31 130.65 52.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.824 0.345 . . . . 74.450000000000003 110.889 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.7 m -94.58 86.08 4.7 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 73.510000000000005 111.151 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.1 122.44 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.43 . . . . 64.540000000000006 111.181 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.69 23.42 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.762 0.315 . . . . 73.040000000000006 111.568 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.5 79.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.827 -0.701 . . . . 63.200000000000003 112.464 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -113.23 131.58 22.82 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 122.78 0.432 . . . . 63.100000000000001 110.821 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.73 96.3 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.414 2.076 . . . . 72.150000000000006 112.961 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -98.76 102.15 13.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.098 0.475 . . . . 71.219999999999999 111.25 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.3 m -82.54 94.2 7.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 74.319999999999993 110.767 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 12' ' ' VAL . 30.9 m -93.63 102.99 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.539 0.685 . . . . 72.040000000000006 111.401 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -89.0 151.79 22.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.306 -0.407 . . . . 64.430000000000007 110.559 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.07 18.53 53.67 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.555 -0.618 . . . . 65.040000000000006 111.555 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.46 116.2 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.119 0.568 . . . . 72.239999999999995 110.527 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -91.23 -62.65 1.4 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.416 0.626 . . . . 61.340000000000003 111.213 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.451 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 33.2 p -171.53 104.21 0.2 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.305 -0.861 . . . . 45.439999999999998 110.061 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -131.88 162.08 31.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.488 0.551 . . . . 63.030000000000001 112.488 -170.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -64.1 156.2 29.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.407 -0.36 . . . . 72.409999999999997 110.936 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.5 -35.6 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.001 0.429 . . . . 75.439999999999998 110.437 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -59.03 -49.07 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.143 -0.48 . . . . 61.509999999999998 110.992 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 44.0 mt-10 -61.44 -35.81 78.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.275 -0.42 . . . . 75.430000000000007 110.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.53 -45.92 92.08 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.897 0.38 . . . . 63.020000000000003 110.815 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.07 -34.78 73.92 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 62.329999999999998 110.821 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -67.9 -41.75 82.24 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.19 -0.459 . . . . 73.400000000000006 111.119 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.69 90.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.261 -0.427 . . . . 41.420000000000002 111.709 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.49 -11.36 59.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.991 0.425 . . . . 75.239999999999995 111.081 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 58.91 64.66 1.37 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 74.340000000000003 111.914 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.49 114.05 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.811 -0.632 . . . . 74.439999999999998 110.784 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.46 80.42 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.13 0.419 . . . . 62.32 112.13 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 78.8 mt-30 -95.79 83.13 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.802 0.335 . . . . 74.530000000000001 111.649 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.83 -37.43 22.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.654 0.74 . . . . 75.239999999999995 110.421 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -67.36 -20.25 65.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.098 -0.955 . . . . 74.430000000000007 111.692 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -123.52 11.74 9.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.773 0.657 . . . . 74.140000000000001 112.773 -173.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 31' ' ' GLN . 14.8 p -83.7 131.94 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 75.120000000000005 112.19 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -95.11 102.14 13.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.412 -0.358 . . . . 61.009999999999998 110.897 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 35.3 m -122.95 139.96 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.827 0.346 . . . . 51.340000000000003 111.621 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.34 110.68 11.7 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.409 0.623 . . . . 74.049999999999997 111.555 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.495 HD22 HG22 ' A' ' 54' ' ' VAL . 10.0 mp -77.37 129.82 36.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.243 -0.435 . . . . 62.240000000000002 111.273 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.06 21.23 9.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.979 0.419 . . . . 70.420000000000002 111.549 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.76 19.82 49.92 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.311 -0.471 . . . . 73.129999999999995 113.343 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -133.79 125.58 28.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.952 0.376 . . . . 70.409999999999997 111.129 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.22 144.49 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 120.985 0.421 . . . . 70.129999999999995 112.021 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.82 -179.78 4.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.419 0.628 . . . . 63.039999999999999 112.294 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -107.77 149.18 28.51 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.702 -0.681 . . . . 64.400000000000006 110.578 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 2.1 ptm180 -47.16 -52.98 14.15 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.71 1.004 . . . . 72.409999999999997 113.71 -171.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 19.5 tt0 -95.39 -6.49 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.452 0.644 . . . . 42.340000000000003 110.753 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.86 63.97 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.9 -0.591 . . . . 74.510000000000005 110.539 171.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -51.14 -42.08 60.51 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.225 0.536 . . . . 73.109999999999999 110.893 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.16 -34.62 78.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.712 -0.676 . . . . 73.219999999999999 111.561 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.95 -5.57 50.43 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.751 0.648 . . . . 64.299999999999997 112.751 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -104.81 116.18 31.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 122.286 -0.258 . . . . 75.219999999999999 111.437 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.1 p -95.59 113.18 24.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.699 0.629 . . . . 74.0 112.699 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 39' ' ' LEU . 65.0 t -79.11 133.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 110.798 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 17' ' ' SER . 43.9 mtmt -131.92 -171.84 2.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.263 0.554 . . . . 74.510000000000005 112.024 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.9 t70 -66.17 124.53 22.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 72.430000000000007 111.632 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 30.16 11.45 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.276 -0.488 . . . . 54.109999999999999 113.317 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.505 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.5 t70 -93.54 176.96 6.18 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.756 -0.261 . . . . 65.549999999999997 110.344 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.22 42.46 1.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.829 0.347 . . . . 63.399999999999999 111.918 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 3.7 p -56.2 102.2 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.671 0.748 . . . . 74.040000000000006 111.846 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.75 116.78 28.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.054 -0.521 . . . . 64.540000000000006 111.957 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -88.93 135.75 33.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.052 -0.522 . . . . 72.319999999999993 111.292 173.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.537 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-N 116.469 -0.332 . . . . 75.510000000000005 111.253 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.66 ' SD ' HD11 ' A' ' 3' ' ' LEU . 21.5 ptp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.039 0.447 . . . . 62.100000000000001 111.728 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -85.18 108.66 17.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.495 -0.32 . . . . 65.319999999999993 110.825 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.66 HD11 ' SD ' ' A' ' 1' ' ' MET . 70.5 mt -118.83 113.89 21.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.997 0.427 . . . . 63.340000000000003 111.762 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.7 m -75.69 99.04 4.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.317 -0.401 . . . . 70.140000000000001 110.577 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.51 121.64 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 111.207 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.401 HD22 ' C ' ' A' ' 62' ' ' PHE . 7.8 m120 64.35 27.14 13.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.924 0.49 . . . . 73.120000000000005 110.715 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.62 0.03 88.04 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.859 -0.686 . . . . 38.159999999999997 113.595 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -104.39 110.05 63.64 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 117.298 0.549 . . . . 73.120000000000005 111.326 178.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 37.1 Cg_exo -61.33 103.92 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.848 2.365 . . . . 60.509999999999998 112.216 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -109.97 110.35 21.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.988 0.423 . . . . 65.019999999999996 111.842 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -82.67 96.97 8.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.882 0.373 . . . . 73.040000000000006 111.383 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -93.74 104.72 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.733 0.778 . . . . 72.010000000000005 110.844 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -72.81 147.59 45.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.251 -0.886 . . . . 71.049999999999997 111.407 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.14 -12.83 65.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.467 -0.397 . . . . 63.329999999999998 113.772 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 1' ' ' MET . . . -108.92 119.36 39.33 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.433 -0.451 . . . . 42.5 112.027 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.5 -73.8 0.33 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.207 -0.451 . . . . 73.510000000000005 112.194 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.0 p -163.07 135.56 5.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.652 -0.249 . . . . 64.030000000000001 110.707 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -148.67 157.04 43.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.944 0.402 . . . . 75.319999999999993 111.944 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -72.31 170.02 15.02 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.708 -0.224 . . . . 61.119999999999997 110.852 177.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 49' ' ' PHE . 58.8 t -62.16 -40.94 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 109.973 -0.38 . . . . 74.239999999999995 109.973 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.0 m -53.94 -52.85 59.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.196 0.522 . . . . 74.109999999999999 110.597 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 8.5 mm-40 -61.5 -33.78 74.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 112.006 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.52 -56.36 18.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.979 0.418 . . . . 75.450000000000003 111.139 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.52 -30.75 71.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.785 0.326 . . . . 75.209999999999994 110.961 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.7 t -66.57 -37.51 85.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.027 0.441 . . . . 72.129999999999995 111.274 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.86 80.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.33 -0.395 . . . . 71.109999999999999 111.204 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.51 -29.08 62.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.299 -0.41 . . . . 73.400000000000006 111.085 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 67.26 16.07 10.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.174 0.59 . . . . 73.219999999999999 112.145 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.55 HG22 ' H ' ' A' ' 31' ' ' GLN . 11.4 p -72.5 140.01 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.064 0.459 . . . . 74.0 111.438 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.58 -14.83 57.87 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.885 0.698 . . . . 74.439999999999998 112.885 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.55 ' H ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.07 30.77 1.8 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.281 -0.262 . . . . 54.130000000000003 111.39 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.87 79.74 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.424 0.528 . . . . 71.510000000000005 112.424 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.07 -10.79 59.93 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.156 0.503 . . . . 75.120000000000005 111.376 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.19 21.94 11.57 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.208 0.447 . . . . 71.340000000000003 112.208 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' CE2' ' A' ' 62' ' ' PHE . 6.4 p -110.88 133.57 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.166 0.507 . . . . 71.049999999999997 112.068 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.8 m -74.76 84.36 2.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.278 0.561 . . . . 74.329999999999998 110.936 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -99.11 110.33 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.971 -0.559 . . . . 74.209999999999994 110.31 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 10.5 pt-20 -118.2 119.65 35.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.734 0.778 . . . . 73.439999999999998 112.128 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.652 ' HB2' HD23 ' A' ' 44' ' ' LEU . 2.0 tm? -73.29 107.67 5.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.412 -0.813 . . . . 71.519999999999996 110.417 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.526 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 58.53 15.84 3.85 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.044 -0.525 . . . . 73.439999999999998 111.818 -178.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 15.83 11.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.996 -0.621 . . . . 43.43 113.886 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -132.11 110.55 10.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 117.396 0.598 . . . . 74.310000000000002 110.899 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 12.4 p -64.58 141.88 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.787 0.662 . . . . 63.219999999999999 112.787 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 39' ' ' LEU . 2.8 mm? -94.02 143.74 26.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.407 0.622 . . . . 74.120000000000005 112.485 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -77.4 154.43 32.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.717 -0.674 . . . . 50.439999999999998 110.536 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -48.26 -41.03 26.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.147 0.425 . . . . 71.519999999999996 112.147 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.32 -40.73 85.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.183 0.516 . . . . 74.109999999999999 111.485 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -24.15 63.51 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.311 0.486 . . . . 65.099999999999994 112.311 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.58 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 7.7 m-85 -49.48 -42.0 42.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.914 0.388 . . . . 75.530000000000001 111.728 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.77 -29.85 29.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.908 0.385 . . . . 74.230000000000004 111.648 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 -15.77 46.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.942 0.719 . . . . 73.140000000000001 112.942 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -104.18 123.08 46.67 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.073 -0.392 . . . . 60.109999999999999 111.483 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 89.5 m -111.14 110.81 21.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.201 0.524 . . . . 74.319999999999993 111.726 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.6 123.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.853 -0.612 . . . . 61.439999999999998 110.447 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -133.51 -175.37 3.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.977 0.417 . . . . 70.439999999999998 111.851 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.05 129.6 42.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.045 0.45 . . . . 74.109999999999999 111.715 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 42.49 12.81 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.378 -0.439 . . . . 38.159999999999997 112.733 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -119.6 -173.15 2.47 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.699 -0.482 . . . . 72.219999999999999 109.699 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 102.65 4.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 71.129999999999995 110.972 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.16 100.11 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.57 0.7 . . . . 73.319999999999993 110.557 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.544 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 5.1 mm-40 -76.86 105.99 8.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.839 0.828 . . . . 74.319999999999993 111.214 -176.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CE2' HG22 ' A' ' 35' ' ' VAL . 12.1 t80 -119.11 99.32 6.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.47 -1.241 . . . . 73.010000000000005 109.395 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.116 0.784 . . . . 72.510000000000005 113.116 -168.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.743 ' HE1' HD12 ' A' ' 3' ' ' LEU . 24.8 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.086 0.47 . . . . 72.439999999999998 111.895 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -90.75 117.12 29.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.921 -0.582 . . . . 74.450000000000003 111.307 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.743 HD12 ' HE1' ' A' ' 1' ' ' MET . 24.0 mt -116.82 179.14 4.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 110.309 -0.256 . . . . 62.0 110.309 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 26.6 m -146.84 134.58 21.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.697 0.284 . . . . 64.510000000000005 111.006 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.7 113.36 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 122.259 -0.276 . . . . 70.409999999999997 110.778 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.9 OUTLIER 63.27 38.28 10.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.894 0.378 . . . . 75.109999999999999 111.203 179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.08 -2.91 67.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.887 -0.673 . . . . 52.210000000000001 113.791 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.99 113.99 65.46 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.075 0.438 . . . . 73.319999999999993 111.094 176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.52 151.11 77.64 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.848 2.366 . . . . 71.420000000000002 112.922 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -151.3 109.73 3.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.277 0.561 . . . . 62.0 111.3 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.0 m -85.24 107.35 17.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.908 -0.587 . . . . 74.409999999999997 111.245 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.6 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.047 0.451 . . . . 71.519999999999996 112.091 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.07 149.84 40.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.899 0.381 . . . . 70.439999999999998 111.143 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.99 32.28 2.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.32 -0.4 . . . . 64.319999999999993 113.111 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.96 123.24 13.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.567 -0.372 . . . . 72.230000000000004 111.013 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.22 83.4 1.89 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.068 0.395 . . . . 72.219999999999999 112.068 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m 49.45 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.975 0.732 . . . . 74.239999999999995 112.975 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -135.17 154.49 51.6 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.19 0.441 . . . . 72.310000000000002 112.19 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p30 -71.73 167.8 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.037 0.446 . . . . 72.129999999999995 111.904 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.21 -42.21 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.288 -0.414 . . . . 62.119999999999997 111.939 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 32' ' ' ALA . 92.7 m -59.86 -44.44 94.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.671 0.272 . . . . 74.0 111.538 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.91 -37.17 83.84 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.245 -0.285 . . . . 60.219999999999999 111.271 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.452 HD22 HG23 ' A' ' 54' ' ' VAL . 56.4 tp -56.01 -56.55 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.084 0.469 . . . . 74.420000000000002 111.341 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.567 HD23 HG13 ' A' ' 35' ' ' VAL . 4.5 pp -68.09 -26.4 65.81 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.918 0.389 . . . . 73.120000000000005 111.53 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -65.77 -36.69 84.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.882 0.372 . . . . 64.209999999999994 111.015 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.34 67.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 73.0 111.165 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -85.31 -3.06 58.71 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.279 0.561 . . . . 64.150000000000006 109.925 175.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 65.74 28.2 11.04 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.189 0.596 . . . . 64.209999999999994 112.018 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 27' ' ' LEU . 58.3 t -73.2 113.03 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.526 -0.306 . . . . 64.319999999999993 111.007 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.69 158.04 19.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.488 -0.324 . . . . 53.340000000000003 111.287 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 41.3 mt-30 60.69 72.44 0.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.492 0.663 . . . . 73.049999999999997 110.769 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' HG21 ' A' ' 21' ' ' THR . . . -67.82 -16.24 64.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.07 0.767 . . . . 45.039999999999999 113.07 -171.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -41.58 3.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.62 -0.264 . . . . 60.119999999999997 111.465 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 22.5 m-85 -60.41 -21.18 61.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.037 0.384 . . . . 74.430000000000007 112.037 -177.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 24' ' ' LEU . 10.1 p -60.26 149.61 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.092 0.472 . . . . 74.150000000000006 111.306 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -116.04 113.81 23.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.745 0.307 . . . . 72.439999999999998 111.024 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.38 149.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.959 0.409 . . . . 74.5 111.176 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 9.2 pt-20 -128.91 125.99 38.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.002 0.43 . . . . 74.010000000000005 111.597 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.68 110.36 17.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.223 -0.444 . . . . 65.219999999999999 110.797 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 63.03 29.63 16.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.204 0.526 . . . . 73.019999999999996 110.912 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.51 85.42 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.043 -0.598 . . . . 73.120000000000005 113.456 -175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.79 111.32 23.78 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.644 -0.327 . . . . 65.329999999999998 110.92 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.28 138.03 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.409 0.522 . . . . 65.049999999999997 112.409 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -109.65 161.48 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.037 0.446 . . . . 75.120000000000005 111.103 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.71 155.17 19.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 109.892 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 2.3 mpt_? -53.99 -38.28 64.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.654 0.613 . . . . 75.25 112.654 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.35 -31.1 69.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.219 0.533 . . . . 73.010000000000005 110.804 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.52 -24.0 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.519999999999996 111.848 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -55.83 -41.1 73.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.403 0.621 . . . . 74.540000000000006 110.869 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -70.19 -37.86 75.21 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.202 -0.908 . . . . 63.219999999999999 111.869 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.66 -33.75 60.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.191 0.441 . . . . 74.019999999999996 112.191 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -82.05 104.61 12.52 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.788 0.327 . . . . 72.519999999999996 111.046 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 74.0 p -94.39 110.74 22.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 111.781 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.452 HG23 HD22 ' A' ' 23' ' ' LEU . 97.1 t -74.14 127.46 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.718 -0.674 . . . . 42.210000000000001 111.454 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 19.6 ptmt -167.99 87.99 0.25 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 111.684 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.9 t70 66.02 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.14 -0.482 . . . . 44.5 112.241 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.12 40.13 83.1 Favored Glycine 0 N--CA 1.464 0.532 0 C-N-CA 120.899 -0.667 . . . . 63.530000000000001 112.245 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' HB3' HD21 ' A' ' 3' ' ' LEU . 17.2 t70 -106.83 164.18 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.905 0.482 . . . . 74.030000000000001 111.957 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.537 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -151.52 72.55 1.04 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.838 -0.619 . . . . 72.209999999999994 110.699 175.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 60' ' ' VAL . 7.3 p -83.32 95.95 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.801 0.81 . . . . 71.540000000000006 112.012 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.567 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 2.4 mp0 -73.7 103.7 4.36 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.189 0.518 . . . . 63.340000000000003 112.104 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.495 ' HZ ' ' HB3' ' A' ' 24' ' ' LEU . 11.7 m-85 -87.03 134.12 33.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.942 -0.572 . . . . 74.310000000000002 110.47 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 63' ' ' LEU . 2.1 pt? . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 112.625 0.602 . . . . 72.109999999999999 112.625 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.045 0.45 . . . . 70.409999999999997 112.01 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 2.3 m-20 -98.2 134.4 41.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.962 0.505 . . . . 73.439999999999998 110.803 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.502 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.7 mm? -126.48 134.9 50.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.773 0.321 . . . . 74.099999999999994 111.354 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -84.19 77.86 9.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.209 0.528 . . . . 74.109999999999999 110.357 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -80.82 121.89 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.023 0.44 . . . . 63.439999999999998 111.923 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 61.04 18.54 9.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.34 -0.391 . . . . 72.439999999999998 111.683 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.94 -3.15 64.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.28 -0.486 . . . . 38.469999999999999 113.091 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 10.3 mptt -108.29 132.87 20.8 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.819 0.31 . . . . 64.549999999999997 110.917 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 97.75 1.15 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.501 2.134 . . . . 60.130000000000003 113.61 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.1 t -98.47 179.42 4.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.035 -0.53 . . . . 44.240000000000002 111.096 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 93.9 m -149.73 121.41 8.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.106 0.41 . . . . 73.209999999999994 112.106 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 12' ' ' VAL . 34.9 m -100.26 109.03 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.564 0.697 . . . . 74.319999999999993 110.488 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.42 151.46 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.104 -0.498 . . . . 71.310000000000002 111.788 -176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.7 -43.06 3.14 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.293 -0.48 . . . . 74.349999999999994 113.314 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.9 153.9 21.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.295 0.48 . . . . 72.329999999999998 112.295 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.91 -72.26 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.344 -0.389 . . . . 73.019999999999996 111.496 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -110.25 96.01 5.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.884 0.373 . . . . 74.430000000000007 111.38 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 83.6 mt -127.36 152.03 48.01 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.728 0.299 . . . . 74.120000000000005 111.637 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -76.47 166.7 23.05 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.494 0.188 . . . . 54.229999999999997 110.613 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.42 -38.35 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.079 0.466 . . . . 73.219999999999999 110.352 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -59.62 -40.72 88.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.776 172.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 6.0 mm-40 -69.58 -26.0 64.25 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.409 -0.36 . . . . 65.400000000000006 111.803 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.541 HD12 HG23 ' A' ' 54' ' ' VAL . 39.1 mt -63.71 -41.46 98.09 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.927 -0.397 . . . . 71.319999999999993 109.927 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.88 -41.08 90.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.281 -0.418 . . . . 61.439999999999998 110.408 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 m -59.36 -54.17 49.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.04 -0.527 . . . . 62.509999999999998 111.409 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.02 68.52 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.158 0.429 . . . . 38.469999999999999 112.158 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.6 mt -75.63 -6.22 49.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.503 -0.317 . . . . 64.439999999999998 111.715 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt 54.72 51.91 13.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.439999999999998 111.065 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.7 t -87.13 119.49 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 74.030000000000001 111.1 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.56 -28.86 65.22 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.934 0.397 . . . . 71.230000000000004 111.519 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.46 87.94 6.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.856 0.36 . . . . 64.409999999999997 111.513 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.75 -13.92 21.12 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.744 0.783 . . . . 75.420000000000002 110.624 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.26 -48.82 3.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.822 -1.081 . . . . 63.200000000000003 110.117 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.64 44.78 1.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.448 -0.796 . . . . 74.540000000000006 111.577 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.12 149.04 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 112.673 0.62 . . . . 64.409999999999997 112.673 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 m -145.41 112.44 6.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.056 -0.52 . . . . 61.409999999999997 111.027 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 62' ' ' PHE . 35.7 m -144.46 160.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.422 0.289 . . . . 63.299999999999997 111.427 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -133.62 147.86 51.5 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.561 0.696 . . . . 73.329999999999998 111.249 172.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.474 ' HB2' HD23 ' A' ' 44' ' ' LEU . 2.6 tm? -108.54 105.09 14.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.724 -0.671 . . . . 63.229999999999997 110.233 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 56.2 35.58 25.97 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.795 0.331 . . . . 71.439999999999998 111.434 -175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.43 -17.56 57.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 121.127 -0.558 . . . . 51.039999999999999 113.617 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.58 100.34 11.35 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.447 -0.443 . . . . 74.140000000000001 111.121 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.46 140.42 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.363 . . . . 74.450000000000003 111.387 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -99.72 136.53 39.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.921 0.391 . . . . 55.240000000000002 111.552 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.75 146.5 37.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.436 -0.347 . . . . 72.310000000000002 110.499 172.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -53.02 -21.82 4.98 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.1 0.476 . . . . 74.540000000000006 111.893 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.81 -27.67 24.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.558 0.577 . . . . 73.030000000000001 112.558 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.18 11.19 37.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.589 0.959 . . . . 65.200000000000003 113.589 -169.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 18.4 m-85 -59.68 -49.17 78.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.245 0.461 . . . . 65.200000000000003 112.245 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.12 -23.86 54.89 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.074 0.464 . . . . 64.030000000000001 111.202 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.97 -17.12 57.53 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.11 0.411 . . . . 38.469999999999999 112.11 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.8 m -103.64 120.87 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.725 0.298 . . . . 63.310000000000002 111.377 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.4 p -89.9 150.14 22.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.424 0.63 . . . . 75.019999999999996 112.146 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.541 HG23 HD12 ' A' ' 23' ' ' LEU . 46.4 t -115.81 142.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.633 -0.712 . . . . 70.439999999999998 110.724 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -137.47 176.35 8.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.442 . . . . 73.209999999999994 112.005 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.46 145.85 50.69 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.026 0.441 . . . . 73.340000000000003 111.975 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.56 30.71 78.06 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.062 -0.517 . . . . 71.109999999999999 113.063 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -109.56 142.52 40.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.821 0.343 . . . . 72.049999999999997 111.121 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.0 85.57 5.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.88 0.696 . . . . 65.409999999999997 112.88 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 3' ' ' LEU . 5.6 p -86.94 107.96 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.492 0.663 . . . . 71.030000000000001 110.461 173.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 34.1 mt-10 -94.21 97.62 10.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.383 0.611 . . . . 74.140000000000001 111.247 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.588 ' HA ' HG12 ' A' ' 37' ' ' VAL . 42.5 t80 -89.56 115.9 27.31 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.528 -0.76 . . . . 73.239999999999995 111.22 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.87 0.367 . . . . 73.420000000000002 111.5 -179.365 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.618 ' HE3' HD12 ' A' ' 3' ' ' LEU . 26.7 ptt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.771 0.319 . . . . 64.299999999999997 111.583 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -75.47 130.12 38.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.126 0.417 . . . . 62.009999999999998 112.126 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.618 HD12 ' HE3' ' A' ' 1' ' ' MET . 94.8 mt -141.73 118.19 10.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.198 -0.456 . . . . 53.030000000000001 111.475 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 8' ' ' LYS . 67.2 m -76.19 97.82 4.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.182 0.515 . . . . 70.319999999999993 110.985 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 46.5 t -93.05 107.84 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.288 -0.414 . . . . 74.25 111.21 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.03 35.51 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.939 0.4 . . . . 53.119999999999997 112.031 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.42 76.23 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.048 -0.596 . . . . 65.439999999999998 113.645 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 4' ' ' THR . 28.5 mtpp -91.96 113.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 122.438 -0.448 . . . . 73.129999999999995 111.272 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.62 65.41 4.73 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.554 2.17 . . . . 74.519999999999996 112.182 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t -102.83 176.74 5.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.455 0.645 . . . . 74.450000000000003 111.661 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -148.95 134.42 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.887 -0.597 . . . . 74.400000000000006 111.234 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.63 119.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.276 -0.42 . . . . 73.239999999999995 110.004 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.76 111.05 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.155 0.502 . . . . 72.530000000000001 111.796 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.47 2.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.908 -0.587 . . . . 42.409999999999997 112.936 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.84 92.53 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.3 0.571 . . . . 73.400000000000006 111.827 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -79.91 84.33 5.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.15 0.5 . . . . 74.150000000000006 110.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.6 p 61.63 114.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.176 0.99 . . . . 51.030000000000001 112.598 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.4 mt -130.61 131.59 45.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.413 -0.358 . . . . 74.439999999999998 110.994 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.5 p-10 -80.46 171.86 14.5 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.198 -0.314 . . . . 75.230000000000004 110.363 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.2 t -56.5 -37.98 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.717 0.294 . . . . 74.209999999999994 111.156 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.0 m -55.73 -46.65 77.74 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.891 0.377 . . . . 75.420000000000002 111.116 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -67.38 -29.95 69.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.175 0.435 . . . . 52.049999999999997 112.175 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.01 -37.37 81.33 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.095 0.474 . . . . 61.210000000000001 110.329 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.556 HD12 HG12 ' A' ' 35' ' ' VAL . 91.0 mt -63.75 -37.86 88.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.161 -0.472 . . . . 75.239999999999995 111.298 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -76.54 -38.19 55.46 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.434 -0.348 . . . . 64.040000000000006 111.117 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.03 90.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.036 0.446 . . . . 54.329999999999998 111.397 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -80.26 -17.99 50.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.274 0.559 . . . . 70.230000000000004 110.478 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 tptt 67.02 82.52 0.18 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.212 -0.904 . . . . 73.420000000000002 112.753 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.85 142.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.967 -0.56 . . . . 64.129999999999995 110.77 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -42.84 15.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.794 0.33 . . . . 60.049999999999997 111.729 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -87.94 76.58 8.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.099 0.476 . . . . 54.009999999999998 111.064 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.38 -23.9 67.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.271 0.471 . . . . 61.119999999999997 112.271 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -93.26 -8.8 41.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.257 0.466 . . . . 62.0 112.257 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.43 4.71 6.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 74.420000000000002 112.031 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.556 HG12 HD12 ' A' ' 24' ' ' LEU . 7.2 p -68.62 130.35 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.452 0.644 . . . . 74.230000000000004 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -112.96 112.06 23.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.062 -0.517 . . . . 70.239999999999995 111.016 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 29.8 m -139.33 158.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.35 -0.386 . . . . 73.049999999999997 111.402 178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.571 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 3.5 pm0 -132.26 169.62 16.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.194 0.521 . . . . 71.049999999999997 110.945 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 39' ' ' LEU . 2.4 pp -133.98 124.59 26.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 64.340000000000003 110.669 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 56.47 18.87 3.75 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 111.531 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.62 2.18 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.324 -0.465 . . . . 60.219999999999999 113.744 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.19 120.57 15.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.925 0.363 . . . . 64.209999999999994 111.195 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.79 143.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.918 0.39 . . . . 72.109999999999999 111.71 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.413 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -91.59 139.3 30.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.076 0.465 . . . . 74.120000000000005 111.732 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.47 163.61 24.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.058 -0.519 . . . . 75.319999999999993 111.009 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 46' ' ' ARG . 9.1 ptp85 -47.74 -24.04 0.85 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.355 0.872 . . . . 62.420000000000002 113.355 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -119.92 7.11 10.88 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.482 0.549 . . . . 75.129999999999995 112.482 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -12.11 34.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.102 0.408 . . . . 75.420000000000002 112.102 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.448 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 62.7 m-85 -62.17 -38.84 90.57 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.065 0.395 . . . . 75.349999999999994 112.065 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -72.77 -56.2 5.6 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.422 0.527 . . . . 71.319999999999993 112.422 -176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.69 88.21 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.886 0.698 . . . . 61.520000000000003 112.886 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.428 HG23 HD21 ' A' ' 39' ' ' LEU . 99.7 m -74.32 98.15 3.17 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.236 0.541 . . . . 75.120000000000005 112.04 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 62.6 p -84.81 127.72 34.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.926 -0.579 . . . . 71.439999999999998 111.341 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.02 151.67 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.103 0.478 . . . . 73.329999999999998 110.881 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.08 -170.02 2.78 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.979 0.418 . . . . 73.040000000000006 111.916 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 136.68 56.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.437 -0.347 . . . . 75.409999999999997 111.487 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 50.43 5.25 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.168 -0.539 . . . . 53.140000000000001 113.366 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.57 -178.78 5.67 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.629 -0.336 . . . . 65.450000000000003 110.523 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.64 107.74 6.75 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.29 0.478 . . . . 73.040000000000006 112.29 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.6 p -103.11 116.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.441 0.638 . . . . 72.040000000000006 111.129 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.571 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 46.9 mt-10 -96.45 110.47 22.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.209 0.528 . . . . 71.329999999999998 111.08 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 56.5 t80 -100.57 114.7 28.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.863 -0.608 . . . . 74.299999999999997 111.032 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.6 mt -88.09 137.31 32.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.951 0.405 . . . . 74.150000000000006 111.687 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -105.76 24.68 11.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.155 0.502 . . . . 73.049999999999997 111.033 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -52.49 157.46 1.5 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.415 0.894 . . . . 73.409999999999997 113.415 -174.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.486 ' HG3' ' H ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 69.2 167.16 0.28 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.331 -0.85 . . . . 73.019999999999996 111.925 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.486 ' H ' ' HG3' ' A' ' 66' ' ' MET . . . 179.36 -96.68 0.1 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.065 -0.588 . . . . 64.430000000000007 112.275 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.02 134.64 2.58 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.02 -0.609 . . . . 62.329999999999998 112.813 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.33 7.35 72.07 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.098 -0.573 . . . . 44.399999999999999 113.789 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -167.05 103.73 0.55 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.187 0.493 . . . . 74.219999999999999 111.171 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.4 16.7 5.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.306 -0.406 . . . . 73.420000000000002 111.44 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -68.75 110.97 4.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.932 0.716 . . . . 63.43 112.932 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -141.46 -47.76 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.648 -0.705 . . . . 63.109999999999999 109.971 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 65.6 121.33 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.405 0.621 . . . . 74.319999999999993 112.437 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -81.59 43.5 0.75 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.868 -0.605 . . . . 73.329999999999998 111.883 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -85.05 129.22 34.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.139 0.495 . . . . 71.400000000000006 111.61 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -150.38 143.69 24.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.929 -0.578 . . . . 71.109999999999999 110.325 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.738 -0.649 . . . . 63.130000000000003 111.852 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.256 0.551 . . . . 73.319999999999993 111.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.5 121.06 29.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.381 -0.372 . . . . 62.210000000000001 111.625 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.22 114.03 18.44 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.809 0.338 . . . . 75.040000000000006 111.25 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.446 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 28.5 m -76.05 77.5 2.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.558 0.694 . . . . 75.409999999999997 110.917 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.7 t -74.22 114.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.018 -0.537 . . . . 55.420000000000002 111.886 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.548 HD21 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.09 19.83 11.16 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.411 -0.359 . . . . 43.219999999999999 111.771 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.67 55.71 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.923 -0.656 . . . . 63.32 113.52 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.49 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.98 115.65 65.67 Favored Pre-proline 0 N--CA 1.471 0.596 0 O-C-N 122.3 -0.529 . . . . 75.439999999999998 111.236 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.85 96.15 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.868 2.379 . . . . 73.049999999999997 112.303 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 m -97.47 100.86 12.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.141 0.496 . . . . 72.340000000000003 111.243 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.6 m -73.96 84.09 1.74 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.346 -0.388 . . . . 71.219999999999999 111.083 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -97.33 113.43 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 73.450000000000003 111.057 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.87 -179.82 3.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.94 -0.475 . . . . 72.420000000000002 111.151 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.4 84.77 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.058 -0.592 . . . . 73.340000000000003 112.318 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.36 98.01 2.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.043 0.449 . . . . 74.150000000000006 110.225 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.38 82.17 2.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.306 -0.407 . . . . 74.239999999999995 112.025 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p 64.51 143.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 74.519999999999996 113.545 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.6 pp -156.34 175.43 14.02 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.807 -0.633 . . . . 74.140000000000001 111.268 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -97.85 172.24 7.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.739 0.304 . . . . 64.230000000000004 110.972 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.02 -36.58 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.882 0.372 . . . . 71.140000000000001 111.757 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -56.3 -45.78 80.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.189 0.518 . . . . 72.510000000000005 111.264 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 12.0 mm-40 -64.13 -41.36 97.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.2 -0.454 . . . . 72.120000000000005 110.978 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.77 -51.39 56.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.204 -0.453 . . . . 75.010000000000005 111.319 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 HD12 HG22 ' A' ' 35' ' ' VAL . 4.5 mm? -55.33 -44.72 76.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.901 0.382 . . . . 71.310000000000002 111.481 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 t -67.58 -27.96 67.37 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.271 -0.422 . . . . 72.439999999999998 111.791 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.71 -41.71 44.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.968 0.414 . . . . 75.299999999999997 111.578 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.55 -6.99 59.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.045 0.387 . . . . 71.549999999999997 112.045 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.788 0.435 . . . . 52.149999999999999 111.78 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.69 120.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.057 0.456 . . . . 71.010000000000005 111.737 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.03 36.38 0.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.955 0.502 . . . . 75.319999999999993 112.204 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.95 35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.216 0.451 . . . . 72.25 112.216 -174.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.64 50.29 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.132 0.419 . . . . 64.150000000000006 112.132 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.08 -24.54 28.04 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.117 0.484 . . . . 74.120000000000005 111.928 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -107.56 -4.45 18.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.739 0.304 . . . . 71.450000000000003 111.76 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.467 HG22 HD12 ' A' ' 24' ' ' LEU . 7.4 p -68.27 89.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.868 0.842 . . . . 73.549999999999997 113.058 -172.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -82.18 93.42 7.06 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.907 -0.588 . . . . 71.409999999999997 110.941 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.554 HG13 ' HA ' ' A' ' 62' ' ' PHE . 17.2 m -110.8 141.14 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.099 0.476 . . . . 73.200000000000003 111.63 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.77 119.85 27.9 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.573 0.702 . . . . 71.25 111.751 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.444 ' HB2' HD23 ' A' ' 44' ' ' LEU . 4.1 mm? -82.11 115.76 21.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.704 -0.68 . . . . 71.030000000000001 110.849 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 27.51 17.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.802 0.334 . . . . 75.120000000000005 111.697 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.61 5.26 66.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.343 -0.455 . . . . 72.430000000000007 113.633 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -114.54 117.85 32.07 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.529 -0.395 . . . . 73.400000000000006 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -74.27 139.72 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.956 0.408 . . . . 71.530000000000001 111.74 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.444 HD23 ' HB2' ' A' ' 39' ' ' LEU . 3.3 mm? -101.35 153.69 19.44 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.264 0.554 . . . . 74.239999999999995 112.261 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 157.25 30.13 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.797 -0.638 . . . . 74.230000000000004 110.571 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -60.18 -33.01 71.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.961 0.41 . . . . 73.439999999999998 111.567 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -70.92 -32.65 69.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.393 0.616 . . . . 74.230000000000004 110.528 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.544 ' HA ' ' HB2' ' A' ' 51' ' ' ALA . . . -71.99 -13.75 61.7 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.093 -0.503 . . . . 63.409999999999997 112.191 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -56.71 -45.6 81.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.021 0.439 . . . . 71.0 111.034 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.5 -21.31 35.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.113 -0.494 . . . . 64.209999999999994 111.281 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.544 ' HB2' ' HA ' ' A' ' 48' ' ' ALA . . . -97.76 21.82 9.96 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.389 0.514 . . . . 61.219999999999999 112.389 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.8 m -133.82 113.69 12.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.81 0.338 . . . . 75.329999999999998 111.169 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.3 p -81.66 126.83 32.25 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.11 0.481 . . . . 64.5 111.837 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.52 113.65 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.622 -0.717 . . . . 75.019999999999996 109.538 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.643 ' HD3' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -144.74 -161.46 1.3 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.934 0.397 . . . . 74.209999999999994 111.597 -170.825 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.11 93.35 0.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.937 -0.477 . . . . 75.140000000000001 112.119 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.0 10.88 1.69 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.114 -0.565 . . . . 41.5 114.488 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.06 130.19 40.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.154 0.977 . . . . 63.43 112.108 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -85.93 66.14 9.46 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.399 0.619 . . . . 64.329999999999998 110.428 175.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.1 p -73.69 99.71 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.718 0.771 . . . . 42.119999999999997 112.009 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.49 78.57 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.304 0.573 . . . . 60.539999999999999 110.954 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.554 ' HA ' HG13 ' A' ' 37' ' ' VAL . 36.0 t80 -73.77 96.37 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.102 -0.703 . . . . 75.5 109.102 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.8 mt -72.0 137.84 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.037 0.755 . . . . 72.299999999999997 113.037 -170.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -79.31 0.71 27.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.759 -0.655 . . . . 74.209999999999994 110.641 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 63.15 22.2 13.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.881 -0.599 . . . . 71.230000000000004 111.669 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.41 22.42 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.323 0.49 . . . . 72.209999999999994 112.323 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.02 -13.19 20.42 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.764 -0.534 . . . . 64.209999999999994 111.764 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 132.31 11.49 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.529 -0.367 . . . . 53.409999999999997 112.767 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.61 74.84 1.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.278 -0.487 . . . . 73.510000000000005 114.107 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.582 ' O ' ' HD2' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -81.35 129.92 34.82 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.123 0.487 . . . . 72.439999999999998 110.901 174.563 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.09 138.43 54.18 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.068 -0.395 . . . . 70.140000000000001 111.963 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -65.05 129.92 41.45 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.507 -0.553 . . . . 64.109999999999999 109.507 171.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.496 ' HD2' ' HB2' ' A' ' 75' ' ' HIS . 14.2 t60 -67.59 -24.46 65.5 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.183 0.438 . . . . 73.120000000000005 112.183 -170.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.1 m80 58.88 19.92 7.54 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.329 0.863 . . . . 64.420000000000002 113.329 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.496 ' HB2' ' HD2' ' A' ' 73' ' ' HIS . 82.3 t60 -69.23 117.65 11.14 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.014 -0.429 . . . . 73.109999999999999 110.775 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -62.56 129.23 39.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.03 0.443 . . . . 74.140000000000001 111.422 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -153.35 141.42 20.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.113 -0.494 . . . . 75.430000000000007 111.437 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.986 -0.53 . . . . 73.530000000000001 111.569 179.12 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 111.659 0.244 . . . . 74.439999999999998 111.659 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.64 127.81 45.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.824 0.345 . . . . 75.409999999999997 111.246 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.55 140.85 49.86 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.975 0.417 . . . . 73.25 111.519 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -91.2 76.7 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.437 0.637 . . . . 61.200000000000003 110.133 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.566 HG12 HD21 ' A' ' 6' ' ' ASN . 39.5 t -74.0 110.01 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.892 -0.595 . . . . 74.120000000000005 111.827 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.566 HD21 HG12 ' A' ' 5' ' ' VAL . 47.6 m-80 58.95 26.02 14.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.824 0.45 . . . . 72.400000000000006 111.559 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.28 -4.77 74.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.94 -0.647 . . . . 42.5 113.243 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.518 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 11.6 mptt -101.28 139.16 20.22 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.366 -0.49 . . . . 65.510000000000005 110.894 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.66 121.97 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.509 2.139 . . . . 74.109999999999999 113.0 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.2 t -133.65 156.54 47.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.008 -0.542 . . . . 73.299999999999997 110.539 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -135.85 113.91 11.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.204 -0.31 . . . . 75.120000000000005 111.524 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.438 HG21 ' H2 ' ' A' ' 1' ' ' MET . 30.3 m -91.57 108.55 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.334 0.588 . . . . 55.100000000000001 110.919 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.92 143.22 30.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.943 -0.571 . . . . 51.340000000000003 111.113 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.96 21.96 31.8 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.406 -0.426 . . . . 55.329999999999998 112.836 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.03 136.42 4.12 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.197 0.443 . . . . 72.209999999999994 112.197 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.06 -40.94 7.37 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.19 -0.459 . . . . 73.510000000000005 110.766 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.0 p -164.32 112.38 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 75.219999999999999 111.267 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.76 160.31 32.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.218 -0.446 . . . . 61.43 110.536 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -72.86 162.54 29.36 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.654 0.264 . . . . 73.540000000000006 110.319 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.521 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.4 t -59.33 -34.83 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 122.152 -0.343 . . . . 54.039999999999999 111.433 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -60.29 -53.72 54.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.76 0.314 . . . . 75.109999999999999 111.819 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.81 0.338 . . . . 72.239999999999995 111.192 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.5 -45.95 91.91 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.804 -0.443 . . . . 51.310000000000002 109.804 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 95.0 mt -59.3 -39.73 83.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.947 0.403 . . . . 72.439999999999998 111.136 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -69.97 -32.18 70.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.084 0.469 . . . . 75.209999999999994 111.441 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.05 -47.35 58.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.909 0.385 . . . . 55.32 111.477 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.59 -20.43 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.276 -0.42 . . . . 73.219999999999999 111.331 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 65.78 76.49 0.32 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.697 0.761 . . . . 65.430000000000007 111.541 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.67 146.2 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.581 -0.736 . . . . 73.400000000000006 110.915 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.18 3.18 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.174 0.435 . . . . 72.420000000000002 112.174 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.38 98.98 10.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.939 0.399 . . . . 74.109999999999999 111.8 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -86.52 -29.51 22.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.166 0.507 . . . . 52.240000000000002 111.311 177.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -79.41 -23.54 43.15 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.013 -0.54 . . . . 74.409999999999997 111.536 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -112.43 11.57 19.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 75.430000000000007 112.116 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG23 HG12 ' A' ' 37' ' ' VAL . 7.3 p -75.73 88.91 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.838 0.828 . . . . 50.039999999999999 112.147 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -76.54 95.94 4.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.181 -0.463 . . . . 74.150000000000006 111.812 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 62' ' ' PHE . 35.4 m -120.3 158.42 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.428 -0.351 . . . . 60.340000000000003 110.975 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.6 134.45 43.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.78 0.8 . . . . 74.140000000000001 112.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.559 HD13 ' ND2' ' A' ' 40' ' ' ASN . 1.0 OUTLIER -78.24 103.23 8.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.968 -1.015 . . . . 73.219999999999999 110.757 -176.177 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.7 OUTLIER 58.14 24.41 11.27 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.875 0.369 . . . . 74.310000000000002 111.728 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.82 40.63 4.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.941 -0.647 . . . . 63.539999999999999 112.608 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.32 105.66 3.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.788 0.435 . . . . 75.109999999999999 110.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.66 138.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.641 0.608 . . . . 75.109999999999999 112.641 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.4 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -89.86 153.77 20.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.357 0.599 . . . . 73.510000000000005 111.72 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.19 160.5 26.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.091 -0.504 . . . . 74.340000000000003 111.399 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 38.0 ptt180 -37.07 -48.04 0.77 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.013 1.116 . . . . 74.439999999999998 114.013 -176.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 13.8 pt-20 -107.41 0.52 22.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.278 0.473 . . . . 74.409999999999997 112.278 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.71 65.28 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.945 0.402 . . . . 74.040000000000006 111.279 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -58.83 -41.24 86.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.133 -0.485 . . . . 63.32 111.44 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -82.02 -32.17 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.134 -0.484 . . . . 74.400000000000006 110.963 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.81 46.08 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.821 0.674 . . . . 74.310000000000002 112.821 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.3 m -96.47 122.2 39.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.871 0.367 . . . . 74.140000000000001 111.606 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 m -91.64 106.94 18.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.418 -0.355 . . . . 74.25 111.226 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.42 115.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.953 0.406 . . . . 74.400000000000006 110.997 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -112.0 -167.43 1.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.854 0.359 . . . . 75.219999999999999 111.648 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.39 133.83 37.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.872 0.368 . . . . 74.109999999999999 111.887 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.99 43.62 8.1 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.353 -0.451 . . . . 43.420000000000002 113.669 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -116.08 140.72 49.0 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.556 -0.379 . . . . 74.049999999999997 110.808 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.86 74.12 2.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.234 0.54 . . . . 61.109999999999999 111.643 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 34.6 m -82.4 125.39 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.407 0.622 . . . . 73.319999999999993 111.365 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -92.04 101.42 13.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.384 0.612 . . . . 70.549999999999997 111.157 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' HA ' HG13 ' A' ' 37' ' ' VAL . 5.2 t80 -103.92 99.9 9.67 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.471 -0.786 . . . . 74.099999999999994 109.553 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -125.67 136.3 53.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.105 0.78 . . . . 74.340000000000003 113.105 -167.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 69.1 11.69 8.34 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.12 0.785 . . . . 71.329999999999998 113.12 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -130.92 147.52 52.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.289 0.566 . . . . 73.049999999999997 111.828 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -164.56 -170.46 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.678 -0.692 . . . . 64.310000000000002 110.401 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.95 -72.18 0.03 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.474 -0.87 . . . . 62.109999999999999 113.666 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.69 -45.27 2.9 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.285 -0.483 . . . . 64.140000000000001 113.136 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.61 93.97 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.528 -0.368 . . . . 73.040000000000006 113.457 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -115.63 148.6 39.47 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.226 0.536 . . . . 74.409999999999997 112.149 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 71' ' ' LEU . 2.3 pt? -150.57 -165.33 2.24 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.643 -0.708 . . . . 72.120000000000005 110.289 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.22 133.67 39.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.492 -0.13 . . . . 75.25 110.859 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -57.14 135.02 56.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.59 0.234 . . . . 75.540000000000006 111.123 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -56.19 93.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.583 0.706 . . . . 74.25 112.738 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -76.95 -168.68 1.11 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 74.299999999999997 110.92 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -60.27 134.56 57.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.877 0.37 . . . . 73.329999999999998 110.804 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -144.38 143.27 30.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.252 -0.431 . . . . 75.450000000000003 110.89 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 119.33 -0.367 . . . . 72.319999999999993 111.812 178.036 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.651 ' HE3' HD12 ' A' ' 3' ' ' LEU . 25.5 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.819 0.343 . . . . 62.310000000000002 111.584 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.35 127.2 34.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.407 -0.36 . . . . 72.200000000000003 110.88 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.651 HD12 ' HE3' ' A' ' 1' ' ' MET . 92.9 mt -133.33 176.01 8.9 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.117 0.484 . . . . 75.430000000000007 111.109 177.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 m -141.04 132.23 26.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.374 -0.375 . . . . 73.329999999999998 111.185 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.53 121.12 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.74 0.305 . . . . 74.120000000000005 111.376 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 15.9 m120 65.72 14.36 9.49 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.01 0.374 . . . . 73.200000000000003 112.01 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.73 -2.41 72.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.238 -0.506 . . . . 44.109999999999999 112.087 -172.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -97.7 110.78 56.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.379 0.671 . . . . 70.219999999999999 110.655 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.8 123.54 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.189 2.593 . . . . 74.239999999999995 113.724 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -136.51 100.86 4.47 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.216 0.531 . . . . 75.310000000000002 111.314 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.8 m -80.65 95.57 6.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.036 0.446 . . . . 75.420000000000002 111.66 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' VAL . 16.9 m -81.96 79.6 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.967 0.889 . . . . 65.510000000000005 110.463 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.533 ' HA ' ' H2 ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -82.54 170.69 14.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.945 -0.571 . . . . 73.109999999999999 111.168 -176.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 25.3 68.31 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.581 -0.819 . . . . 75.409999999999997 111.533 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.29 123.2 10.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.728 0.411 . . . . 63.340000000000003 110.698 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -74.54 -68.73 0.51 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.205 0.526 . . . . 75.329999999999998 111.785 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -167.26 132.96 2.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.393 -0.821 . . . . 74.329999999999998 109.274 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 1.2 pp -149.99 163.07 39.09 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.039 0.755 . . . . 73.400000000000006 113.039 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.05 159.16 20.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.047 -0.524 . . . . 43.329999999999998 111.102 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.45 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 50.6 t -57.33 -43.74 82.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.015 0.435 . . . . 72.530000000000001 110.485 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.1 m -60.34 -45.65 92.68 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.42 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -59.72 -36.99 77.69 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.035 0.445 . . . . 54.439999999999998 110.632 176.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.94 -44.18 97.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.191 0.52 . . . . 73.319999999999993 110.385 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 89.1 mt -58.64 -34.72 71.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.01 -0.541 . . . . 65.109999999999999 110.759 174.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.9 t -68.19 -43.02 79.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.58 . . . . 54.219999999999999 111.406 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -46.29 76.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.261 0.467 . . . . 64.409999999999997 112.261 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.11 -6.89 43.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.662 -0.244 . . . . 61.32 111.626 178.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.663 ' HZ3' ' HB3' ' A' ' 28' ' ' LYS . 7.0 ttpm? 57.49 89.02 0.05 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.395 0.617 . . . . 71.319999999999993 111.649 -175.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.826 -0.624 . . . . 64.319999999999993 111.686 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.85 -49.13 18.86 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.041 0.448 . . . . 71.540000000000006 111.517 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -123.15 142.38 50.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.199 -0.455 . . . . 74.340000000000003 110.964 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.517 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -110.71 -40.2 4.64 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.294 0.568 . . . . 54.310000000000002 111.974 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.63 -30.4 36.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 70.329999999999998 111.118 175.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -91.23 -7.15 52.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.403 0.52 . . . . 73.140000000000001 112.403 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG11 ' O ' ' A' ' 32' ' ' ALA . 9.7 p -58.7 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 122.007 0.908 . . . . 74.450000000000003 112.211 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -84.52 92.21 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.758 -0.655 . . . . 74.329999999999998 110.949 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 28.7 m -125.0 141.95 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.953 -0.567 . . . . 74.310000000000002 110.999 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.8 pt-20 -118.26 122.16 42.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.686 0.755 . . . . 74.519999999999996 111.818 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.476 HD12 ' ND2' ' A' ' 40' ' ' ASN . 1.6 tm? -81.22 107.22 13.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.585 -0.734 . . . . 73.310000000000002 109.89 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.476 ' ND2' HD12 ' A' ' 39' ' ' LEU . 0.9 OUTLIER 64.24 38.46 8.04 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.0 0.428 . . . . 64.519999999999996 111.282 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.85 29.67 58.85 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.206 -0.521 . . . . 62.450000000000003 113.665 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.443 ' N ' ' HB2' ' A' ' 38' ' ' GLU . 41.4 tt0 -148.91 115.75 5.99 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.466 -0.432 . . . . 64.510000000000005 110.798 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 14.7 p -77.37 147.44 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 113.069 0.766 . . . . 73.120000000000005 113.069 -173.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 44' ' ' LEU . 3.0 mm? -106.37 157.79 17.36 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.059 -0.519 . . . . 74.25 111.008 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.567 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 tt0 -76.4 159.59 30.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.858 0.361 . . . . 74.310000000000002 111.437 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.567 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -49.65 -49.24 48.01 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 73.409999999999997 113.936 -169.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.78 -23.14 39.52 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.564 -0.71 . . . . 75.040000000000006 111.689 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.13 49.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.285 0.476 . . . . 70.120000000000005 112.285 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.99 -30.53 70.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.778 0.323 . . . . 73.420000000000002 111.719 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.96 -21.48 27.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.795 0.331 . . . . 73.530000000000001 111.479 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.02 1.96 56.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.095 0.406 . . . . 75.230000000000004 112.095 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -116.1 116.45 27.89 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.582 0.229 . . . . 64.549999999999997 111.471 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -89.4 109.83 20.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.116 0.484 . . . . 71.349999999999994 111.65 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.35 137.32 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 74.200000000000003 110.521 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -135.67 176.08 9.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.232 0.539 . . . . 71.140000000000001 111.771 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.65 105.61 0.32 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.023 -0.535 . . . . 73.129999999999995 112.095 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.81 7.89 12.67 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.483 -0.389 . . . . 65.129999999999995 113.343 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.94 153.47 21.56 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.52 . . . . 65.239999999999995 111.764 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.85 107.65 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 75.420000000000002 111.631 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.27 110.85 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.114 -0.494 . . . . 71.209999999999994 110.792 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -98.89 111.65 23.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.387 0.613 . . . . 63.420000000000002 112.339 -175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -80.77 130.92 35.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.383 -0.826 . . . . 74.510000000000005 111.468 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.513 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.7 pt? -141.81 168.26 20.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.083 -0.386 . . . . 64.519999999999996 112.011 177.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 73.91 -37.08 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.644 0.778 . . . . 75.430000000000007 112.298 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -72.13 -13.04 61.46 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.57 0.582 . . . . 74.219999999999999 112.57 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 -178.9 6.14 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.802 0.334 . . . . 73.430000000000007 111.701 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.53 79.74 0.32 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.684 -0.566 . . . . 72.120000000000005 111.684 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.95 0.65 30.15 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.186 -0.531 . . . . 63.109999999999999 114.393 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.21 27.16 67.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.989 -0.624 . . . . 53.240000000000002 113.836 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -99.42 101.13 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.516 -0.403 . . . . 65.319999999999993 110.718 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 71' ' ' LEU . 6.8 mp 52.27 23.87 2.59 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.81 0.814 . . . . 75.150000000000006 110.121 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -88.33 19.95 3.53 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.093 -0.958 . . . . 74.200000000000003 111.742 -167.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -75.27 92.68 2.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.905 0.384 . . . . 74.239999999999995 110.325 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -132.01 123.44 27.3 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.432 -0.349 . . . . 74.299999999999997 111.192 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -63.67 115.08 4.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.986 0.422 . . . . 72.150000000000006 110.895 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -81.5 152.38 27.35 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.069 0.461 . . . . 74.0 112.18 -173.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -79.19 -179.96 7.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.228 -0.442 . . . . 74.109999999999999 111.725 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 119.308 -0.377 . . . . 63.539999999999999 111.692 178.207 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HG3' HD21 ' A' ' 3' ' ' LEU . 23.1 ptp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.679 0.276 . . . . 75.109999999999999 111.641 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -99.29 124.39 44.34 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.407 -0.36 . . . . 71.120000000000005 111.001 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.479 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.7 mm? -119.5 129.06 54.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.734 0.302 . . . . 75.510000000000005 111.155 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -78.69 73.02 5.25 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.414 0.626 . . . . 75.340000000000003 110.185 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.586 HG22 HD21 ' A' ' 6' ' ' ASN . 7.1 p -70.81 110.4 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.332 0.586 . . . . 75.420000000000002 112.099 -173.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.586 HD21 HG22 ' A' ' 5' ' ' VAL . 48.7 m-80 59.71 21.48 10.23 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.134 -0.485 . . . . 54.25 111.879 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.1 -4.29 62.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.869 -0.681 . . . . 75.409999999999997 113.035 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 mptp? -102.53 136.51 19.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.377 0.271 . . . . 71.439999999999998 110.685 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.37 104.55 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.264 1.976 . . . . 72.519999999999996 113.178 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 t -114.0 153.53 29.19 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.148 -0.345 . . . . 72.319999999999993 110.655 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -135.51 114.34 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.096 0.406 . . . . 62.100000000000001 112.096 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.69 112.08 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.508 0.67 . . . . 71.25 110.104 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.72 148.55 50.22 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.633 -0.712 . . . . 71.430000000000007 112.367 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.77 -58.35 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.498 -0.382 . . . . 63.530000000000001 113.44 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.38 110.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.175 0.435 . . . . 72.329999999999998 112.175 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' HE3' ' A' ' 1' ' ' MET . 42.8 mt-10 -94.18 -55.46 3.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 74.540000000000006 111.494 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 p -143.4 115.86 8.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.391 -0.368 . . . . 73.299999999999997 111.44 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -157.63 165.35 35.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.371 -0.377 . . . . 74.329999999999998 111.855 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 40.3 m-20 -66.37 160.95 23.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.605 0.241 . . . . 61.340000000000003 111.27 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 56.3 t -56.17 -41.9 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.014 0.435 . . . . 71.239999999999995 110.6 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 m -59.03 -47.21 86.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.083 0.468 . . . . 74.040000000000006 111.346 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.489 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 51.7 mt-10 -65.73 -31.6 72.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.955 0.407 . . . . 74.409999999999997 111.102 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.5 -46.74 78.5 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.856 -0.424 . . . . 72.209999999999994 109.856 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 90.6 mt -56.8 -36.21 69.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.161 -0.472 . . . . 71.510000000000005 111.047 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.6 t -64.52 -55.81 18.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 71.140000000000001 111.328 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.89 78.47 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 64.239999999999995 112.378 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 tp -79.6 -22.85 43.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.843 0.354 . . . . 60.240000000000002 111.42 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? 63.1 81.65 0.2 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.321 0.581 . . . . 73.420000000000002 109.731 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.507 HG22 ' H ' ' A' ' 31' ' ' GLN . 12.5 p -93.62 151.42 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.977 -0.556 . . . . 37.939999999999998 111.737 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.41 70.27 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.005 0.372 . . . . 61.539999999999999 112.005 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.507 ' H ' HG22 ' A' ' 29' ' ' VAL . 61.8 mm-40 -127.03 134.85 50.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.612 -0.267 . . . . 52.210000000000001 110.683 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.83 9.3 8.82 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.397 0.618 . . . . 64.319999999999993 111.48 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -32.45 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.524 -0.762 . . . . 74.319999999999993 111.305 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.48 -19.74 29.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.787 0.327 . . . . 72.5 111.54 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG23 HG13 ' A' ' 37' ' ' VAL . 7.1 p -68.56 126.15 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.789 0.663 . . . . 72.030000000000001 112.789 -173.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -102.52 98.84 8.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 110.713 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.445 HG13 HG23 ' A' ' 35' ' ' VAL . 14.6 m -103.57 95.87 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.463 0.649 . . . . 72.319999999999993 111.283 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.442 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 10.1 pt-20 -95.48 94.35 7.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.482 0.658 . . . . 73.439999999999998 111.314 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.447 ' HB3' HG13 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -68.41 114.95 7.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.359 0.599 . . . . 64.140000000000001 112.025 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 59.09 39.49 23.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.901 -0.59 . . . . 50.509999999999998 111.748 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.82 48.66 40.31 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.032 -0.604 . . . . 75.019999999999996 113.194 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.06 108.58 3.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.957 0.408 . . . . 62.420000000000002 110.657 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.84 136.4 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.579 0.585 . . . . 75.319999999999993 112.579 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.453 ' N ' HD21 ' A' ' 44' ' ' LEU . 2.7 mm? -101.74 152.35 20.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.033 -0.531 . . . . 74.129999999999995 110.824 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.414 ' N ' ' HB2' ' A' ' 48' ' ' ALA . 45.4 mt-10 -68.56 169.35 11.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.282 0.563 . . . . 74.540000000000006 111.969 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -58.85 -35.68 73.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.867 -0.606 . . . . 72.150000000000006 110.451 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.54 -42.12 22.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.794 -0.639 . . . . 74.400000000000006 111.43 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.414 ' HB2' ' N ' ' A' ' 45' ' ' GLU . . . -56.66 -20.85 23.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.09 0.774 . . . . 63.32 113.09 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -56.03 -34.25 65.69 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.042 0.449 . . . . 63.210000000000001 111.136 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -81.62 -32.6 31.91 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.364 -0.38 . . . . 73.030000000000001 111.17 175.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.39 59.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.629 0.603 . . . . 75.409999999999997 112.629 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -113.11 119.24 37.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.756 0.313 . . . . 75.209999999999994 111.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 83.4 m -96.16 124.69 40.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.335 0.588 . . . . 71.340000000000003 112.328 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.64 151.77 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.889 -0.596 . . . . 74.430000000000007 110.897 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -147.76 -178.19 6.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.875 0.369 . . . . 74.349999999999994 111.624 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 26.2 t70 -58.46 119.01 6.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.163 0.506 . . . . 73.299999999999997 112.359 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.38 54.22 1.1 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.188 -0.46 . . . . 62.240000000000002 113.662 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.04 154.71 48.25 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.884 0.342 . . . . 64.340000000000003 111.035 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.82 1.83 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.447 HG13 ' HB3' ' A' ' 39' ' ' LEU . 30.2 m -82.18 107.87 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.409999999999997 111.182 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 44.1 mt-10 -77.46 93.33 4.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.519 0.675 . . . . 73.129999999999995 110.804 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -80.08 92.11 5.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.365 -0.834 . . . . 73.5 110.431 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.32 127.64 33.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.172 0.511 . . . . 72.420000000000002 112.225 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -91.19 19.38 5.92 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.141 -0.481 . . . . 74.109999999999999 111.797 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -54.99 -17.22 3.47 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.174 0.805 . . . . 71.409999999999997 113.174 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.658 ' HA ' ' HE2' ' A' ' 66' ' ' MET . 4.7 mmt -64.38 -31.29 72.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.045 0.45 . . . . 64.25 111.375 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.15 59.3 0.24 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 116.353 -0.385 . . . . 62.32 112.249 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.78 152.75 23.73 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.168 -0.539 . . . . 75.420000000000002 112.904 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.93 18.65 0.66 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.882 -0.675 . . . . 53.009999999999998 113.78 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -67.47 94.77 0.42 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.238 0.519 . . . . 74.340000000000003 109.9 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.13 110.84 13.33 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.189 0.518 . . . . 64.230000000000004 111.899 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.17 178.52 5.97 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.2 -0.455 . . . . 72.400000000000006 110.536 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -56.58 126.22 25.68 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.254 -0.43 . . . . 74.450000000000003 110.389 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 10.7 t60 -63.42 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.623 -0.262 . . . . 73.230000000000004 111.195 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 74' ' ' HIS . 62.8 m170 72.84 162.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.577 0.751 . . . . 73.299999999999997 111.865 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -73.11 105.67 4.65 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.26 -0.427 . . . . 72.510000000000005 111.947 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -120.77 -160.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.06 0.457 . . . . 70.209999999999994 110.299 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 118.678 -0.677 . . . . 74.400000000000006 110.13 170.391 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.453 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 20.4 ptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.91 0.386 . . . . 71.109999999999999 111.847 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -75.89 129.91 37.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.087 -0.506 . . . . 64.209999999999994 111.788 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.8 mt -139.12 153.07 47.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.947 0.404 . . . . 70.340000000000003 111.661 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.5 m -109.18 126.47 53.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.934 0.397 . . . . 74.329999999999998 111.34 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 HG21 ' H ' ' A' ' 62' ' ' PHE . 4.7 p -133.83 124.08 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.5 -0.318 . . . . 71.430000000000007 110.95 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.533 HD21 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.53 26.39 15.68 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.143 0.497 . . . . 74.140000000000001 111.163 -179.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.28 16.8 80.41 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.24 -0.505 . . . . 72.019999999999996 112.74 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -103.35 117.98 58.87 Favored Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 122.761 -0.258 . . . . 64.129999999999995 110.793 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.21 116.44 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.447 2.098 . . . . 73.099999999999994 111.528 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 t -141.77 -173.95 3.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.933 0.397 . . . . 75.129999999999995 111.448 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -159.55 126.68 4.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 72.239999999999995 111.734 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.413 HG21 ' O ' ' A' ' 12' ' ' VAL . 18.9 m -96.05 99.09 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.595 0.712 . . . . 54.240000000000002 110.437 175.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.45 137.71 33.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.993 -0.549 . . . . 74.120000000000005 110.875 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.5 56.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.28 -0.486 . . . . 41.130000000000003 113.207 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.01 97.57 8.41 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.412 -0.464 . . . . 75.400000000000006 111.517 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.45 76.73 3.99 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.317 0.579 . . . . 70.450000000000003 111.669 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.2 m 53.48 71.19 0.52 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.952 -0.567 . . . . 73.349999999999994 111.463 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.448 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 80.5 mt -93.3 145.75 24.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.272 0.558 . . . . 62.109999999999999 112.106 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 18.2 m-20 -70.51 163.98 25.71 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.857 -0.611 . . . . 75.140000000000001 110.037 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.5 -41.53 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.818 0.342 . . . . 71.329999999999998 110.608 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -61.69 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.926 0.393 . . . . 75.519999999999996 111.842 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.448 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 43.0 mt-10 -68.4 -43.75 76.56 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.11 0.481 . . . . 71.340000000000003 111.131 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.28 -37.66 86.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.311 0.577 . . . . 75.319999999999993 109.968 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.13 -34.95 70.79 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.699 -0.682 . . . . 64.340000000000003 110.833 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -74.66 -33.59 62.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.369 -0.378 . . . . 72.310000000000002 111.327 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.77 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.157 0.504 . . . . 61.310000000000002 111.6 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.0 mt -90.44 -29.77 17.77 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.286 0.565 . . . . 72.540000000000006 110.216 171.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 57.51 86.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.057 -0.974 . . . . 74.120000000000005 112.565 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.2 159.42 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.558 -0.746 . . . . 71.340000000000003 110.538 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.73 -63.77 1.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.054 0.454 . . . . 65.099999999999994 111.773 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -102.3 136.96 41.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.551 -0.295 . . . . 75.340000000000003 110.676 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.26 -55.52 2.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 75.409999999999997 111.545 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 -11.72 21.08 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.826 -0.625 . . . . 62.100000000000001 112.301 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.81 3.02 36.26 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.322 0.49 . . . . 75.140000000000001 112.322 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 81.3 t -74.39 138.19 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.321 0.581 . . . . 71.019999999999996 112.341 -177.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.51 ' HB ' ' CE1' ' A' ' 65' ' ' PHE . 89.4 m -115.83 108.54 16.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.128 -0.487 . . . . 72.349999999999994 110.575 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.519 HG13 ' HA ' ' A' ' 62' ' ' PHE . 28.0 m -134.04 162.23 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.19 0.519 . . . . 71.140000000000001 111.891 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.09 169.61 17.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.577 -0.738 . . . . 74.150000000000006 110.563 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.454 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.0 pt? -143.92 129.09 18.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 72.030000000000001 111.078 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.75 21.08 11.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.173 0.511 . . . . 74.25 111.005 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 55.78 2.98 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.04 -0.527 . . . . 74.400000000000006 113.374 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 126.15 2.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.914 0.357 . . . . 73.409999999999997 110.651 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.76 136.04 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.21 0.528 . . . . 74.310000000000002 112.352 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.58 166.78 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.667 0.746 . . . . 73.030000000000001 112.547 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.06 149.46 33.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.5 -0.773 . . . . 65.209999999999994 110.964 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.526 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 9.1 mpt_? -64.34 -41.31 96.84 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.185 -0.322 . . . . 72.430000000000007 111.864 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.25 -29.76 69.48 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.19 0.519 . . . . 74.299999999999997 111.058 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.28 65.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.279 -0.419 . . . . 73.439999999999998 111.585 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -62.13 -30.63 71.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.697 0.284 . . . . 74.299999999999997 111.508 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.7 -35.82 72.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.873 0.368 . . . . 70.430000000000007 111.54 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.87 -29.81 24.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.203 0.446 . . . . 73.310000000000002 112.203 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 m -82.03 113.69 20.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.758 0.314 . . . . 71.140000000000001 111.832 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.555 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.0 m -96.87 140.61 31.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.229 0.538 . . . . 73.040000000000006 111.881 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 55' ' ' LYS . 17.4 t -90.44 160.64 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.116 -0.493 . . . . 71.010000000000005 111.112 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.9 pttm -141.38 169.94 16.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.979 0.418 . . . . 72.129999999999995 111.805 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.453 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 27.8 t70 -70.88 111.45 6.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.133 0.492 . . . . 63.340000000000003 110.97 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.71 39.77 3.79 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.175 -0.466 . . . . 52.210000000000001 112.096 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -122.82 175.32 6.61 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 110.006 -0.368 . . . . 71.319999999999993 110.006 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.67 143.77 43.3 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.245 0.545 . . . . 71.409999999999997 112.459 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG22 ' HB ' ' A' ' 5' ' ' VAL . 24.0 m -130.5 71.06 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.805 0.812 . . . . 75.239999999999995 109.677 172.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.21 83.11 0.73 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.763 0.792 . . . . 62.219999999999999 111.568 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.519 ' HA ' HG13 ' A' ' 37' ' ' VAL . 2.6 m-85 -77.4 92.26 3.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.09 -0.959 . . . . 73.450000000000003 111.767 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.53 87.68 6.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.346 0.593 . . . . 73.239999999999995 112.027 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 70.96 -19.72 0.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.096 1.147 . . . . 73.519999999999996 114.096 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' CE1' ' HB ' ' A' ' 36' ' ' THR . 78.7 m-85 -72.67 74.69 1.1 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.817 -0.552 . . . . 73.340000000000003 111.079 174.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.1 mtt -121.0 -34.05 3.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.295 -0.412 . . . . 74.209999999999994 112.017 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 -31.63 4.68 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.269 -0.491 . . . . 60.130000000000003 112.027 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.58 -84.58 0.76 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.378 -0.439 . . . . 63.520000000000003 114.024 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.8 49.38 4.23 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 114.379 0.512 . . . . 71.420000000000002 114.379 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.21 145.76 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.107 0.454 . . . . 64.209999999999994 110.734 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.58 112.29 5.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.708 0.289 . . . . 73.519999999999996 111.362 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.08 154.69 27.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.884 0.373 . . . . 43.009999999999998 111.429 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -55.23 124.12 15.95 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.919 0.39 . . . . 74.439999999999998 111.849 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.47 80.76 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.196 0.522 . . . . 72.430000000000007 110.875 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -120.23 152.18 38.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.13 -0.486 . . . . 74.049999999999997 110.929 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -72.54 139.69 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.111 0.481 . . . . 74.109999999999999 111.593 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -77.2 132.65 38.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.356 0.502 . . . . 72.010000000000005 112.356 -173.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 m170 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.866 -0.588 . . . . 64.409999999999997 111.814 177.869 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.508 ' HG3' HD22 ' A' ' 3' ' ' LEU . 21.1 ptp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.693 0.282 . . . . 63.32 111.272 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.6 m-20 -95.46 119.98 34.92 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.803 0.335 . . . . 74.25 111.166 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 1' ' ' MET . 1.3 mm? -114.2 124.06 51.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.688 0.28 . . . . 75.310000000000002 111.201 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.4 m -78.06 79.46 4.52 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 74.239999999999995 110.343 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.28 122.09 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.085 -0.507 . . . . 63.450000000000003 112.334 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 17.9 m120 56.93 23.02 7.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.099 -0.5 . . . . 72.519999999999996 112.081 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.4 64.63 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.329 -0.462 . . . . 52.329999999999998 113.474 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 3.2 mptp? -116.72 122.02 32.17 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 122.235 -0.567 . . . . 74.230000000000004 110.859 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.49 125.65 19.21 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.931 2.421 . . . . 75.120000000000005 113.816 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.463 ' OG ' HD23 ' A' ' 71' ' ' LEU . 40.7 t -135.23 173.32 11.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.958 -0.565 . . . . 75.239999999999995 109.946 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 4.6 t -157.28 129.47 7.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.313 0.857 . . . . 74.530000000000001 113.313 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.22 108.22 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.537 0.684 . . . . 64.209999999999994 110.465 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.56 123.35 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.857 -0.61 . . . . 74.140000000000001 111.673 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.82 -33.48 4.75 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.24 -0.505 . . . . 73.5 113.161 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -74.48 127.64 33.56 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.726 0.298 . . . . 71.510000000000005 111.671 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -137.79 108.71 6.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.201 0.524 . . . . 73.439999999999998 111.647 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 m 62.66 25.07 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.268 0.84 . . . . 64.530000000000001 113.268 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.7 159.49 27.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.193 0.521 . . . . 75.230000000000004 111.853 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.5 p-10 -84.06 156.43 22.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.389 -0.369 . . . . 70.439999999999998 111.6 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.8 -36.94 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.683 0.623 . . . . 73.420000000000002 112.683 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -52.92 -43.7 66.45 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.035 0.445 . . . . 74.129999999999995 111.568 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.42 -32.03 29.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.474 -0.33 . . . . 63.210000000000001 111.826 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.79 -44.83 82.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.361 -0.607 . . . . 72.150000000000006 109.361 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 32' ' ' ALA . 26.7 tp -60.94 -44.49 97.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.635 -0.711 . . . . 61.149999999999999 110.661 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -63.79 -27.92 69.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.807 -0.633 . . . . 64.200000000000003 111.905 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.74 84.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.956 0.407 . . . . 73.310000000000002 111.585 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.414 ' N ' HD12 ' A' ' 27' ' ' LEU . 7.5 mp -81.12 -2.53 48.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.301 -0.409 . . . . 62.509999999999998 110.931 175.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.6 tttt 64.0 25.72 13.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.996 -0.547 . . . . 73.030000000000001 111.51 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.52 130.61 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.357 -0.383 . . . . 75.310000000000002 111.537 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.57 80.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.368 0.507 . . . . 73.549999999999997 112.368 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -96.04 167.65 11.1 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.116 0.484 . . . . 73.409999999999997 111.557 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' HA ' HD23 ' A' ' 24' ' ' LEU . . . -146.05 -62.16 0.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.214 0.53 . . . . 38.039999999999999 110.803 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.53 -31.74 62.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.592 -0.731 . . . . 75.409999999999997 112.049 177.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -83.34 -16.49 45.89 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.67 0.618 . . . . 71.230000000000004 112.67 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.469 HG13 HG12 ' A' ' 37' ' ' VAL . 6.1 t -81.46 80.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.237 0.541 . . . . 52.409999999999997 111.621 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.6 m -70.87 84.14 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.083 -0.508 . . . . 75.450000000000003 111.442 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG12 HG13 ' A' ' 35' ' ' VAL . 32.8 m -86.45 147.94 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.122 0.487 . . . . 72.310000000000002 111.464 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.408 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 13.2 pt-20 -136.44 127.14 27.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.25 0.547 . . . . 73.400000000000006 110.981 174.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.559 ' HG ' HD23 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -99.47 134.95 41.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 71.340000000000003 111.169 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.667 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.5 OUTLIER 60.66 18.92 8.93 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.067 0.461 . . . . 75.030000000000001 111.403 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.2 20.28 57.5 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.311 -0.471 . . . . 64.310000000000002 113.616 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -124.77 112.47 16.75 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.122 0.486 . . . . 74.140000000000001 111.105 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 8.9 p -70.6 144.41 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.371 0.878 . . . . 62.43 113.371 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.559 HD23 ' HG ' ' A' ' 39' ' ' LEU . 3.2 mm? -99.49 166.26 11.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.22 0.533 . . . . 74.019999999999996 111.667 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.38 155.18 20.7 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.049 -0.523 . . . . 73.510000000000005 110.743 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.51 -22.73 5.18 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.116 0.784 . . . . 63.130000000000003 113.116 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.86 26.84 5.51 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.115 0.483 . . . . 54.439999999999998 111.771 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.24 5.37 42.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.286 -0.415 . . . . 71.439999999999998 111.376 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.23 -27.77 59.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.809 0.338 . . . . 73.450000000000003 111.527 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.46 -38.79 65.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 75.329999999999998 111.065 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.17 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.168 -0.469 . . . . 60.509999999999998 112.055 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.0 m -75.32 107.55 7.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.999 0.428 . . . . 41.539999999999999 111.986 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 63.8 p -92.85 130.25 38.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.185 -0.461 . . . . 73.439999999999998 111.388 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.6 147.41 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.356 -0.383 . . . . 73.150000000000006 111.116 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.07 -174.75 3.52 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.241 0.543 . . . . 74.129999999999995 111.349 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.26 111.36 3.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.045 -0.525 . . . . 72.540000000000006 111.243 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.35 66.9 0.74 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.045 -0.597 . . . . 61.329999999999998 113.958 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -149.71 162.08 40.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 110.147 -0.316 . . . . 75.450000000000003 110.147 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.42 99.32 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.511 0.56 . . . . 60.340000000000003 112.511 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -95.96 131.25 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.002 0.43 . . . . 75.200000000000003 111.097 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.492 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 40.8 mt-10 -109.03 121.2 44.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.262 0.553 . . . . 72.310000000000002 112.282 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -99.66 132.14 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.78 -0.645 . . . . 74.329999999999998 111.522 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -126.07 112.24 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.098 0.475 . . . . 73.420000000000002 112.092 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 68.05 -3.28 1.26 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.247 0.832 . . . . 73.439999999999998 113.247 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.2 119.8 27.82 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.996 -0.44 . . . . 73.430000000000007 111.838 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.0 mmm -83.93 146.04 28.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.896 -0.593 . . . . 72.310000000000002 111.815 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.89 -45.21 0.17 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.539 -0.755 . . . . 43.32 111.47 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.19 109.23 0.78 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.217 0.447 . . . . 42.549999999999997 114.217 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.9 63.0 1.86 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.872 -0.891 . . . . 71.209999999999994 110.872 171.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.09 104.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.947 0.721 . . . . 74.310000000000002 112.947 -171.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.463 HD23 ' OG ' ' A' ' 10' ' ' SER . 91.8 mt -88.51 -174.93 4.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.0 -0.545 . . . . 74.319999999999993 110.516 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 62.95 92.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.288 0.566 . . . . 71.25 111.753 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -135.01 168.27 19.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.175 -0.466 . . . . 74.040000000000006 111.475 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -60.65 116.44 4.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.24 -0.437 . . . . 73.329999999999998 110.135 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -54.79 110.27 0.63 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.469 . . . . 74.519999999999996 112.091 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -68.83 134.75 50.11 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.002 -0.545 . . . . 71.109999999999999 111.589 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -155.55 146.73 22.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.858 0.361 . . . . 72.340000000000003 111.059 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.851 -0.595 . . . . 74.209999999999994 111.415 176.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.479 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 23.0 ptp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.941 0.4 . . . . 71.099999999999994 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -101.6 106.24 17.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.978 0.418 . . . . 72.349999999999994 110.724 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.417 HD21 ' HB2' ' A' ' 58' ' ' ASP . 82.4 mt -100.25 176.45 5.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 73.120000000000005 111.536 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.3 m -130.68 110.84 11.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.852 0.358 . . . . 72.230000000000004 110.979 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 29.8 m -105.11 118.39 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.956 0.407 . . . . 71.409999999999997 111.577 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 62.12 22.26 13.0 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.865 0.364 . . . . 74.25 111.943 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.11 -0.87 64.44 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.161 -0.543 . . . . 63.229999999999997 113.36 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.23 141.7 24.44 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 122.526 -0.396 . . . . 65.150000000000006 111.273 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 119.79 6.03 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.411 2.074 . . . . 60.530000000000001 112.978 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -120.4 113.24 20.05 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.983 0.42 . . . . 71.109999999999999 111.49 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.8 m -95.12 110.25 22.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.253 -0.431 . . . . 63.350000000000001 111.444 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.66 124.64 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.131 0.491 . . . . 72.400000000000006 110.968 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.78 144.6 41.31 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.089 -0.505 . . . . 62.240000000000002 111.921 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.69 -49.59 4.22 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.192 -0.458 . . . . 70.120000000000005 113.756 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 105.74 0.42 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.779 . . . . 45.450000000000003 113.102 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.1 -44.37 5.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.298 -0.41 . . . . 75.019999999999996 111.148 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.6 m -141.46 126.33 18.15 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.71 0.29 . . . . 73.230000000000004 110.86 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.96 169.63 16.2 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.728 0.299 . . . . 73.439999999999998 111.521 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -103.02 160.6 14.48 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.45 -0.204 . . . . 75.530000000000001 110.45 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 58.1 t -48.07 -40.82 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 112.917 0.71 . . . . 62.549999999999997 112.917 -172.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.6 m -48.0 -47.47 33.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.142 0.496 . . . . 71.140000000000001 111.581 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.44 -33.02 64.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.052 0.454 . . . . 74.030000000000001 111.203 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.05 -41.69 98.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.451 . . . . 73.530000000000001 110.239 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 91.8 mt -56.7 -28.66 61.32 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.132 -0.486 . . . . 74.120000000000005 111.507 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.7 t -80.17 -48.34 13.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.409 -0.36 . . . . 74.209999999999994 111.391 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.78 90.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.058 0.456 . . . . 74.209999999999994 111.864 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.14 -30.62 60.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.148 -0.478 . . . . 71.099999999999994 110.915 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 69.25 88.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.463 0.649 . . . . 73.409999999999997 111.332 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 HG12 HD21 ' A' ' 24' ' ' LEU . 8.0 p -102.15 149.52 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.773 -0.649 . . . . 74.329999999999998 111.91 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.58 126.9 35.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 110.72 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 58.88 67.57 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.234 0.54 . . . . 73.140000000000001 111.507 -174.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -63.85 -30.69 71.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.217 -0.447 . . . . 75.019999999999996 112.015 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.939 0.399 . . . . 73.109999999999999 111.491 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -129.93 12.36 5.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.53 -0.304 . . . . 74.040000000000006 111.64 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.455 HG22 HG13 ' A' ' 37' ' ' VAL . 7.6 p -68.0 118.71 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.452 0.644 . . . . 70.439999999999998 112.508 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.1 m -92.97 108.58 20.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.173 -0.467 . . . . 74.340000000000003 111.03 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG13 HG22 ' A' ' 35' ' ' VAL . 18.0 m -140.92 146.35 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.146 -0.479 . . . . 73.430000000000007 111.164 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.2 pm0 -123.54 132.48 53.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.899 0.381 . . . . 74.439999999999998 111.745 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 2.1 pt? -97.02 124.53 41.03 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.932 -0.395 . . . . 71.310000000000002 109.932 175.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.18 22.62 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.98 0.419 . . . . 52.240000000000002 111.798 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -20.44 32.02 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.275 0.47 . . . . 74.549999999999997 114.275 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -95.45 122.47 38.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.677 0.739 . . . . 72.140000000000001 111.464 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.9 p -78.23 138.89 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 65.319999999999993 112.003 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.457 ' N ' HD13 ' A' ' 44' ' ' LEU . 5.0 mp -92.72 121.65 34.33 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.101 -0.5 . . . . 72.409999999999997 111.335 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.12 152.39 45.22 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.383 -0.371 . . . . 70.450000000000003 111.632 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.527 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 39.0 ptt180 -48.72 -36.81 17.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.635 0.605 . . . . 70.409999999999997 112.635 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -81.27 -24.62 37.16 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.214 0.53 . . . . 75.120000000000005 111.754 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.07 -16.65 57.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.054 0.761 . . . . 71.319999999999993 113.054 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.527 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 22.2 m-85 -53.06 -39.53 63.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.857 0.688 . . . . 72.510000000000005 112.857 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.81 -23.09 31.57 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.06 -0.4 . . . . 74.109999999999999 111.678 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.21 -2.21 52.86 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.621 0.6 . . . . 74.120000000000005 112.621 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.0 m -105.29 118.02 35.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.184 -0.323 . . . . 75.299999999999997 111.671 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.7 m -89.22 138.58 31.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.097 0.475 . . . . 74.150000000000006 112.017 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.49 147.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.942 0.497 . . . . 73.219999999999999 110.961 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.01 -168.47 2.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.123 0.487 . . . . 74.0 111.63 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 36.3 t70 -70.22 79.31 0.52 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.149 0.499 . . . . 62.130000000000003 111.5 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.84 65.31 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.154 -0.546 . . . . 75.109999999999999 113.52 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' HB2' HD21 ' A' ' 3' ' ' LEU . 5.0 m-20 -131.51 131.81 43.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.421 -0.458 . . . . 71.230000000000004 110.657 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -93.19 66.98 4.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.995 0.368 . . . . 74.120000000000005 111.995 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.2 p -82.83 114.77 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.285 0.564 . . . . 60.130000000000003 111.466 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -88.75 114.82 25.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.045 0.387 . . . . 75.239999999999995 112.045 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HA ' HG11 ' A' ' 37' ' ' VAL . 7.2 m-85 -101.32 118.45 37.0 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 75.519999999999996 111.647 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.77 132.38 38.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.402 -0.363 . . . . 71.209999999999994 111.521 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 67.06 -3.28 0.99 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.168 0.803 . . . . 73.540000000000006 113.168 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 66' ' ' MET . 96.0 m-85 -120.65 27.87 8.29 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.139 -0.351 . . . . 70.099999999999994 111.252 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 81.2 mtp 72.63 103.81 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.206 0.602 . . . . 75.049999999999997 112.11 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.81 35.71 1.9 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.23 -0.509 . . . . 61.229999999999997 113.26 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -115.33 72.85 0.25 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.357 -0.449 . . . . 38.049999999999997 113.355 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.53 44.52 3.34 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.92 -0.657 . . . . 65.040000000000006 113.603 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -145.62 -178.21 5.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 60.240000000000002 112.08 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.484 HD23 ' N ' ' A' ' 71' ' ' LEU . 1.9 pt? -147.28 134.75 20.82 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.975 -1.011 . . . . 61.109999999999999 109.06 171.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.53 118.46 11.59 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.247 0.546 . . . . 61.409999999999997 111.55 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -96.62 113.02 24.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.028 -0.533 . . . . 65.209999999999994 111.27 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -62.86 87.32 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.749 0.785 . . . . 75.450000000000003 110.822 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.43 ' H ' ' CD2' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -101.53 139.64 36.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.609 -0.723 . . . . 75.519999999999996 111.815 -175.37 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 65.63 128.21 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.383 0.611 . . . . 71.25 112.111 -175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -87.53 169.71 11.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.256 0.55 . . . . 73.340000000000003 112.191 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.0 p80 . . . . . 0 C--O 1.25 1.129 0 CA-C-N 115.754 -0.657 . . . . 71.230000000000004 111.747 -178.491 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.748 ' HE1' HD12 ' A' ' 3' ' ' LEU . 25.4 ptt? . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.764 0.316 . . . . 63.409999999999997 111.505 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -80.49 118.88 22.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.937 0.398 . . . . 74.400000000000006 111.359 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.748 HD12 ' HE1' ' A' ' 1' ' ' MET . 68.0 mt -123.34 148.4 46.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.156 0.503 . . . . 74.150000000000006 112.079 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.421 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 16.7 m -85.0 82.67 8.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.122 0.487 . . . . 75.239999999999995 110.431 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.36 134.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.431 -0.349 . . . . 71.430000000000007 110.973 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.1 8.26 6.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.556 0.342 . . . . 73.019999999999996 111.298 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.67 68.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.98 -0.629 . . . . 52.43 111.868 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HZ2' ' HB3' ' A' ' 8' ' ' LYS . 5.6 mtpm? -124.15 154.4 68.42 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.311 0.644 . . . . 74.439999999999998 110.768 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.78 115.86 4.29 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.294 1.996 . . . . 63.100000000000001 113.212 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -142.17 -176.79 4.95 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.579 0.352 . . . . 52.43 110.708 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -162.85 137.99 6.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.39 0.515 . . . . 54.100000000000001 112.39 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.33 86.84 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.358 0.599 . . . . 75.099999999999994 111.095 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.2 t70 59.71 174.5 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.505 -0.77 . . . . 75.420000000000002 112.455 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.13 -4.83 69.25 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.292 -0.48 . . . . 63.520000000000003 113.144 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 126.42 8.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.826 0.451 . . . . 73.540000000000006 111.95 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.53 -66.04 0.6 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 62.420000000000002 112.521 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -133.05 124.17 27.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.643 0.259 . . . . 73.409999999999997 111.329 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 91.3 mt -132.38 142.6 49.37 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.741 0.305 . . . . 74.209999999999994 111.257 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.26 162.8 5.6 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.575 -0.284 . . . . 74.209999999999994 110.818 175.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 39.7 t -61.09 -40.15 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.981 -0.449 . . . . 64.530000000000001 110.298 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -59.78 -47.75 84.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.256 -0.429 . . . . 74.140000000000001 111.167 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 2.5 mm-40 -58.47 -38.03 76.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.0 0.428 . . . . 73.230000000000004 111.256 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.69 -45.44 92.09 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.199 -0.455 . . . . 64.439999999999998 110.049 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.465 HD12 ' HB1' ' A' ' 32' ' ' ALA . 72.4 mt -56.91 -39.34 74.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.181 0.515 . . . . 62.539999999999999 111.262 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -78.05 -29.19 49.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.161 -0.472 . . . . 55.149999999999999 112.121 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -47.21 20.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.164 0.507 . . . . 54.149999999999999 111.754 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD21 ' O ' ' A' ' 27' ' ' LEU . 7.2 tt -76.79 -16.43 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.082 -0.508 . . . . 72.230000000000004 110.615 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 66.77 74.04 0.34 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.352 0.596 . . . . 54.200000000000003 110.501 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.4 HG21 HD22 ' A' ' 27' ' ' LEU . 53.5 t -104.21 130.91 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.691 0.626 . . . . 72.25 112.691 -174.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.69 146.0 30.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.32 -0.4 . . . . 73.420000000000002 110.209 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 62.07 33.23 17.22 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.925 0.393 . . . . 72.209999999999994 110.79 -172.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HB1' HD12 ' A' ' 24' ' ' LEU . . . -53.39 -51.9 61.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.281 0.474 . . . . 72.140000000000001 112.281 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.03 -12.45 61.61 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.191 0.519 . . . . 65.340000000000003 111.813 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.06 2.69 12.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.479 0.548 . . . . 74.25 112.479 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.416 HG11 ' O ' ' A' ' 32' ' ' ALA . 10.8 p -73.09 146.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 65.209999999999994 111.875 -176.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.5 m -100.3 108.85 21.01 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.471 -0.331 . . . . 74.040000000000006 110.456 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 62' ' ' PHE . 26.8 m -133.17 134.0 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.217 0.532 . . . . 74.349999999999994 111.698 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.558 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 1.7 pm0 -104.88 125.3 50.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.308 0.575 . . . . 73.25 111.508 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.631 ' HB2' HD23 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.14 106.43 7.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.836 -0.62 . . . . 62.409999999999997 110.216 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 53.08 26.96 5.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.84 0.456 . . . . 71.329999999999998 112.05 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.13 4.38 41.39 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.304 -0.474 . . . . 72.010000000000005 113.947 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.88 108.07 13.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.278 0.539 . . . . 71.219999999999999 111.418 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 8.8 p -60.27 137.51 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.318 0.488 . . . . 71.340000000000003 112.318 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.631 HD23 ' HB2' ' A' ' 39' ' ' LEU . 2.1 mm? -94.2 151.81 19.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.145 0.497 . . . . 73.099999999999994 111.807 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -71.99 160.91 31.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.114 -0.494 . . . . 75.420000000000002 110.946 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -51.37 -46.73 62.85 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.321 0.489 . . . . 71.150000000000006 112.321 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.19 -6.48 55.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.417 0.525 . . . . 74.439999999999998 112.417 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.75 -27.49 66.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.769 0.319 . . . . 54.310000000000002 111.364 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -50.68 -38.03 44.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.198 -0.455 . . . . 71.230000000000004 111.544 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.54 -42.88 61.12 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.914 -0.584 . . . . 63.409999999999997 111.573 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.89 -4.78 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.084 0.772 . . . . 75.409999999999997 113.084 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -101.82 116.96 33.86 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.709 0.29 . . . . 73.409999999999997 111.561 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 65.2 p -100.5 116.96 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.16 0.43 . . . . 74.239999999999995 112.16 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.88 152.52 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.824 -0.625 . . . . 73.549999999999997 110.903 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -139.89 175.89 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.878 0.371 . . . . 74.049999999999997 111.42 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.14 137.63 58.29 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.117 0.484 . . . . 75.319999999999993 111.391 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.36 33.94 24.37 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.147 -0.479 . . . . 37.5 113.164 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.448 ' HB3' HD23 ' A' ' 3' ' ' LEU . 12.7 t70 -109.88 177.45 4.72 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 122.684 -0.303 . . . . 70.140000000000001 110.867 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -139.99 92.13 2.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.429 0.529 . . . . 52.210000000000001 112.429 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.1 p -98.17 115.76 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.344 0.592 . . . . 73.140000000000001 111.219 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.558 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 44.0 mt-10 -84.15 93.45 8.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.217 0.532 . . . . 73.109999999999999 112.414 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.435 ' HA ' HG11 ' A' ' 37' ' ' VAL . 12.8 m-85 -78.9 120.27 23.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.941 -0.572 . . . . 75.129999999999995 110.875 169.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.3 mt -124.03 136.1 54.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.633 0.254 . . . . 61.539999999999999 110.807 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 34.66 0.22 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.528 0.566 . . . . 74.540000000000006 112.528 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 66.41 149.5 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.119 0.785 . . . . 73.409999999999997 113.119 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.99 76.64 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.234 0.54 . . . . 71.430000000000007 110.486 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -151.65 -14.77 0.07 OUTLIER Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.151 -0.547 . . . . 72.420000000000002 113.666 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.8 -61.54 3.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.331 -0.462 . . . . 63.200000000000003 113.746 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 41.67 10.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.987 -0.625 . . . . 75.409999999999997 112.84 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 66.44 158.33 0.12 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.498 0.666 . . . . 74.450000000000003 112.477 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 74' ' ' HIS . 1.4 tt -78.27 90.47 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.144 -0.48 . . . . 75.319999999999993 110.124 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -37.69 48.63 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.586 0.958 . . . . 70.219999999999999 113.586 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -170.99 -54.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.033 -0.358 . . . . 70.239999999999995 110.033 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.451 ' HA ' HD23 ' A' ' 71' ' ' LEU . 9.2 t60 -179.97 66.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.145 -0.479 . . . . 72.430000000000007 111.013 173.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.77 127.89 34.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 120.929 0.395 . . . . 74.420000000000002 111.284 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -67.25 11.18 0.12 Allowed 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 113.678 0.992 . . . . 74.540000000000006 113.678 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -158.47 -175.97 5.62 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.77 -0.581 . . . . 73.530000000000001 110.963 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 55.5 m80 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.15 -0.929 . . . . 75.349999999999994 110.231 174.353 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.564 ' HB3' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.22 0.452 . . . . 75.329999999999998 112.22 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -94.89 124.15 38.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.157 -0.474 . . . . 50.149999999999999 111.505 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.425 HD22 ' HG2' ' A' ' 1' ' ' MET . 2.9 mm? -120.99 174.42 6.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.068 0.461 . . . . 72.049999999999997 111.103 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 m -129.04 95.29 4.03 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.072 0.463 . . . . 72.239999999999995 110.692 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.591 HG12 HD21 ' A' ' 6' ' ' ASN . 61.8 t -88.13 113.97 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.436 -0.347 . . . . 73.239999999999995 111.774 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.591 HD21 HG12 ' A' ' 5' ' ' VAL . 53.8 m-80 57.91 29.68 17.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.005 0.522 . . . . 74.25 112.001 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.88 75.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.89 -0.671 . . . . 71.109999999999999 113.301 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -114.11 122.07 35.31 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.625 -0.338 . . . . 74.310000000000002 110.975 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.83 119.45 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.739 2.293 . . . . 74.310000000000002 112.997 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.8 p -130.08 127.74 40.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.155 0.502 . . . . 53.140000000000001 111.258 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.4 m -102.7 117.18 34.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.159 -0.338 . . . . 65.040000000000006 111.51 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 HG22 ' H1 ' ' A' ' 1' ' ' MET . 19.6 m -89.56 131.8 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.892 0.377 . . . . 75.409999999999997 110.373 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.3 155.03 20.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.446 0.536 . . . . 71.329999999999998 112.446 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.49 -72.04 1.77 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.986 -0.552 . . . . 63.450000000000003 113.77 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.97 12.95 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.416 0.524 . . . . 72.129999999999995 112.416 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.564 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 10.0 pt-20 -129.06 -31.93 2.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 74.329999999999998 112.177 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -140.08 130.64 25.58 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.003 0.43 . . . . 73.140000000000001 112.122 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -170.72 165.45 8.09 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.967 -0.56 . . . . 72.450000000000003 111.5 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.747 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 48.7 m-20 -61.84 155.82 22.22 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.753 0.311 . . . . 73.530000000000001 111.376 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.88 -38.77 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.071 0.462 . . . . 74.329999999999998 110.56 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.4 m -59.33 -41.92 90.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.082 -0.508 . . . . 71.409999999999997 111.783 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.747 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 15.3 mm-40 -63.58 -48.57 76.86 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.069 0.461 . . . . 74.510000000000005 110.527 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.53 -46.3 84.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.136 -0.484 . . . . 75.030000000000001 111.068 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.03 -44.02 91.68 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.103 0.478 . . . . 72.420000000000002 111.043 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -66.76 -30.42 70.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.021 0.439 . . . . 74.409999999999997 111.161 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.93 77.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 73.420000000000002 111.013 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.14 -32.56 63.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.122 -0.49 . . . . 65.409999999999997 111.844 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 64.95 85.54 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.387 0.613 . . . . 75.439999999999998 110.881 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.6 149.7 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 75.25 112.106 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.88 121.84 20.65 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.451 -0.34 . . . . 70.439999999999998 110.98 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 21.6 mt-30 61.99 80.46 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.262 0.553 . . . . 64.430000000000007 110.759 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.421 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -55.31 -35.92 65.64 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.671 0.989 . . . . 55.149999999999999 113.671 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.45 -22.72 43.78 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.216 0.451 . . . . 61.219999999999999 112.216 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' CD1' ' HB3' ' A' ' 31' ' ' GLN . 9.4 m-85 -86.98 -11.85 49.25 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.512 0.56 . . . . 72.140000000000001 112.512 -171.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.421 HG12 ' O ' ' A' ' 32' ' ' ALA . 7.9 p -79.42 131.7 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.235 0.54 . . . . 64.540000000000006 111.366 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -115.89 128.3 55.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.503 -0.317 . . . . 70.439999999999998 111.457 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 62' ' ' PHE . 34.9 m -137.67 140.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.106 0.479 . . . . 74.299999999999997 111.274 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -111.09 113.25 25.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.458 0.647 . . . . 74.310000000000002 110.088 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -75.23 104.96 6.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.009 -0.541 . . . . 74.349999999999994 112.195 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.62 28.35 17.76 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.861 -0.609 . . . . 71.25 111.789 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.47 -20.04 14.06 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.362 -0.447 . . . . 61.229999999999997 113.727 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.84 135.8 45.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.044 0.422 . . . . 74.329999999999998 111.376 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.23 134.82 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.934 0.397 . . . . 74.420000000000002 111.728 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.65 141.98 43.15 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.313 0.578 . . . . 71.400000000000006 111.832 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -79.84 167.67 20.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.896 -0.593 . . . . 74.519999999999996 111.021 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -57.15 -35.02 69.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.73 0.641 . . . . 73.0 112.73 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -96.55 -4.91 40.47 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.07 0.396 . . . . 71.319999999999993 112.07 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.53 56.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.254 0.464 . . . . 50.219999999999999 112.254 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.35 -24.74 63.62 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.056 0.455 . . . . 73.0 111.957 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.78 -29.11 44.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.32 -0.4 . . . . 64.140000000000001 111.847 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.54 12.36 7.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.155 0.798 . . . . 70.319999999999993 113.155 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.1 m -141.69 120.24 12.47 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.726 -0.609 . . . . 72.329999999999998 111.782 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.7 m -92.96 106.89 18.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.097 -0.501 . . . . 75.040000000000006 111.158 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.5 148.14 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.363 -0.38 . . . . 73.140000000000001 110.893 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 17.0 ptpt -144.11 -173.18 3.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.839 0.352 . . . . 65.340000000000003 111.665 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.525 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 10.2 t70 -66.94 112.74 4.49 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 55.509999999999998 111.463 -176.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.66 63.42 0.66 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.105 -0.498 . . . . 75.230000000000004 113.042 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -154.2 172.58 17.37 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.895 -0.409 . . . . 75.349999999999994 109.895 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.23 94.56 4.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.811 0.671 . . . . 62.109999999999999 112.811 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.499 HG11 HG22 ' A' ' 5' ' ' VAL . 4.8 p -88.94 95.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.491 0.662 . . . . 63.229999999999997 110.809 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -79.88 103.16 9.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.376 0.608 . . . . 75.430000000000007 111.42 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.508 ' HA ' HG11 ' A' ' 37' ' ' VAL . 45.0 t80 -91.69 109.49 20.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.809 -0.632 . . . . 74.299999999999997 110.911 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.76 149.8 43.37 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.066 0.46 . . . . 73.140000000000001 112.202 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -104.62 21.7 16.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.331 0.493 . . . . 65.129999999999995 112.331 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -59.26 148.33 32.35 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.275 0.56 . . . . 72.430000000000007 112.47 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 mtt -74.37 115.13 13.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.102 -0.499 . . . . 74.209999999999994 111.239 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -129.37 24.76 4.64 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.254 -0.498 . . . . 50.030000000000001 112.908 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.63 -36.47 6.87 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.042 -0.599 . . . . 73.25 113.476 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.09 -61.4 4.67 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.292 -0.48 . . . . 62.240000000000002 113.009 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -70.7 118.38 13.42 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.874 0.368 . . . . 71.310000000000002 111.62 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.9 tp -109.91 112.61 24.74 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.016 0.436 . . . . 73.239999999999995 110.538 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.4 18.3 10.56 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.645 0.609 . . . . 62.219999999999999 112.645 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.82 162.68 0.09 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.16 0.505 . . . . 74.129999999999995 111.307 -170.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -133.48 -58.49 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.762 -0.586 . . . . 70.140000000000001 112.316 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -160.17 149.61 17.71 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.762 0.653 . . . . 74.420000000000002 112.762 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -106.81 150.34 26.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.197 0.522 . . . . 71.409999999999997 112.189 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -111.67 176.55 4.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.681 -0.69 . . . . 75.219999999999999 110.353 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 119.228 -0.415 . . . . 71.030000000000001 111.977 -178.502 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 24.9 ptp . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.742 0.306 . . . . 73.200000000000003 111.072 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -98.04 114.44 26.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.464 -0.334 . . . . 65.439999999999998 110.86 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.425 ' HG ' ' HG3' ' A' ' 1' ' ' MET . 91.3 mt -121.94 131.16 53.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.938 0.399 . . . . 74.109999999999999 111.715 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 39.6 m -85.78 85.45 7.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.04 0.448 . . . . 72.310000000000002 111.001 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.3 p -82.44 117.03 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.024 0.44 . . . . 71.530000000000001 111.615 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 59.29 15.04 4.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.615 0.598 . . . . 72.129999999999995 112.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.22 -4.43 33.46 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.319 -0.467 . . . . 74.540000000000006 113.218 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.62 106.57 58.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 122.584 -0.362 . . . . 73.439999999999998 111.545 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 20.4 Cg_exo -65.82 99.5 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.798 2.332 . . . . 72.310000000000002 112.877 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 t -112.79 139.14 48.67 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 63.420000000000002 111.556 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.0 m -89.3 99.97 12.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.38 . . . . 74.329999999999998 111.355 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.89 111.04 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.22 0.533 . . . . 71.530000000000001 110.198 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.55 161.09 18.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.233 0.539 . . . . 74.420000000000002 112.211 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.75 84.51 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.971 -0.559 . . . . 71.230000000000004 112.869 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.91 102.72 4.48 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.641 -0.329 . . . . 73.129999999999995 111.474 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.79 -29.94 13.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.732 0.301 . . . . 75.109999999999999 111.731 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -160.62 106.4 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.564 -0.289 . . . . 71.040000000000006 111.156 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.411 ' O ' HD11 ' A' ' 18' ' ' LEU . 1.5 pp -143.79 156.53 44.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.163 0.506 . . . . 73.530000000000001 111.649 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 49' ' ' PHE . 4.6 p-10 -83.09 164.27 20.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.359 -0.382 . . . . 73.299999999999997 110.973 177.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.1 t -53.84 -33.93 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.749 0.648 . . . . 71.019999999999996 112.749 -172.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 m -52.03 -54.67 27.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.274 0.559 . . . . 71.010000000000005 111.403 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.56 -33.0 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.985 -0.552 . . . . 53.119999999999997 111.592 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.92 -44.68 78.51 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.035 0.445 . . . . 64.540000000000006 110.333 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.15 -32.62 72.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.929 0.395 . . . . 61.340000000000003 111.252 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.6 t -66.34 -35.46 80.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.291 -0.413 . . . . 65.109999999999999 111.29 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.95 92.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.112 0.482 . . . . 52.439999999999998 111.639 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' N ' HD11 ' A' ' 27' ' ' LEU . 6.5 mp -82.48 -24.48 34.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.174 0.511 . . . . 71.530000000000001 110.777 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 tttm 63.04 84.8 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.7 0.8 . . . . 71.209999999999994 111.961 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.14 145.89 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.701 -0.681 . . . . 72.25 110.691 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.08 -55.32 8.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.023 0.439 . . . . 74.430000000000007 111.324 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 22.8 mp0 -91.73 78.44 5.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.407 -0.36 . . . . 72.019999999999996 110.822 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -64.93 -44.56 89.07 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.175 0.512 . . . . 72.120000000000005 111.356 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -63.58 -33.42 75.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.036 -0.529 . . . . 64.030000000000001 111.916 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 26.1 m-85 -109.11 9.1 26.26 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.763 0.653 . . . . 74.439999999999998 112.763 -167.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.418 HG11 ' O ' ' A' ' 32' ' ' ALA . 8.7 p -86.44 124.74 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.982 0.42 . . . . 70.530000000000001 110.998 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -85.09 109.52 18.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.17 0.51 . . . . 75.120000000000005 111.231 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.68 145.55 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.915 -0.584 . . . . 61.520000000000003 111.105 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -136.57 147.7 47.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.911 0.386 . . . . 75.310000000000002 111.068 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.5 ' HB3' HD21 ' A' ' 40' ' ' ASN . 10.6 mp -112.49 131.27 55.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.815 0.302 . . . . 63.039999999999999 111.815 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.5 HD21 ' HB3' ' A' ' 39' ' ' LEU . 32.7 m-80 56.23 27.32 11.54 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.598 0.592 . . . . 73.230000000000004 112.598 171.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.26 18.57 57.17 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.481 -0.39 . . . . 71.230000000000004 113.721 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -131.98 131.69 42.81 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.364 -0.492 . . . . 51.32 110.199 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.66 127.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.366 0.603 . . . . 74.209999999999994 112.286 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.433 HD21 HD13 ' A' ' 39' ' ' LEU . 10.5 mp -94.39 136.79 34.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.523 0.677 . . . . 71.439999999999998 112.317 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -66.25 142.2 57.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.56 -0.745 . . . . 74.5 110.711 172.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -52.25 -45.95 65.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.219 0.533 . . . . 74.150000000000006 111.177 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -77.92 9.66 3.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.037 -0.529 . . . . 62.32 112.112 178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.59 -10.21 15.72 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.186 -0.322 . . . . 72.129999999999995 111.376 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 22.5 m-30 -60.93 -24.75 66.28 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.159 0.429 . . . . 74.209999999999994 112.159 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.461 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 3.6 p30 -84.34 -29.75 26.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.848 0.356 . . . . 73.439999999999998 111.663 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.19 -53.14 6.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.331 -0.395 . . . . 74.120000000000005 111.861 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.422 HG23 HD22 ' A' ' 44' ' ' LEU . 62.4 m -63.2 98.74 0.15 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.831 0.348 . . . . 73.25 111.124 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.2 m -85.2 108.59 17.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.882 0.373 . . . . 71.209999999999994 111.21 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.45 133.67 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.977 0.418 . . . . 73.25 111.377 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -128.86 -177.65 4.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.451 0.643 . . . . 71.0 112.063 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.62 122.57 15.61 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.593 -0.73 . . . . 72.340000000000003 111.884 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.29 31.58 7.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.353 -0.385 . . . . 37.600000000000001 113.603 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.96 160.62 15.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 117.04 0.42 . . . . 72.140000000000001 110.54 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.17 99.11 6.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.053 0.454 . . . . 74.519999999999996 111.701 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -95.64 131.19 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.227 0.537 . . . . 63.109999999999999 111.739 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.93 109.62 21.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.376 0.607 . . . . 65.409999999999997 110.829 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -113.05 108.88 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.703 -0.68 . . . . 73.239999999999995 110.54 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 mt -87.36 128.42 35.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.052 0.453 . . . . 73.430000000000007 111.841 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -81.63 33.94 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.304 0.483 . . . . 74.400000000000006 112.304 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -77.19 134.7 38.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.06 0.457 . . . . 65.150000000000006 111.733 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.8 mtp -127.59 132.04 49.87 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.315 -0.402 . . . . 72.129999999999995 110.863 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -142.06 39.73 1.36 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.214 -0.517 . . . . 62.020000000000003 112.662 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.72 23.11 22.67 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.433 -0.413 . . . . 54.409999999999997 113.41 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.83 -101.08 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.285 -0.483 . . . . 62.530000000000001 113.227 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 66.58 116.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.619 0.723 . . . . 73.420000000000002 112.284 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.6 pp -81.56 157.85 24.62 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.706 0.632 . . . . 74.109999999999999 112.706 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -107.82 146.71 31.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.999 -0.546 . . . . 74.319999999999993 111.191 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -175.11 122.59 0.22 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.506 0.193 . . . . 70.239999999999995 111.314 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -119.59 114.59 22.47 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.927 0.394 . . . . 73.5 112.019 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -69.78 155.11 41.03 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.334 -0.393 . . . . 61.43 111.534 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -103.15 146.78 27.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.219 0.533 . . . . 71.209999999999994 111.695 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -114.79 139.71 49.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.018 -0.537 . . . . 72.450000000000003 111.267 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.4 m80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.484 -0.77 . . . . 75.219999999999999 111.081 178.519 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HG3' HD12 ' A' ' 3' ' ' LEU . 19.7 ptp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.719 0.295 . . . . 71.019999999999996 111.403 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -101.81 133.28 46.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.624 0.37 . . . . 65.209999999999994 110.652 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.474 HD12 ' HG3' ' A' ' 1' ' ' MET . 1.6 mp -133.95 157.17 46.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.132 -0.355 . . . . 71.519999999999996 111.338 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 36.7 m -107.54 105.7 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.888 -0.412 . . . . 74.109999999999999 109.888 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG11 HG22 ' A' ' 60' ' ' VAL . 31.8 m -119.5 136.83 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.197 -0.456 . . . . 71.140000000000001 111.163 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.17 30.06 19.75 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.486 0.315 . . . . 73.019999999999996 111.443 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.28 21.0 79.5 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.923 -0.656 . . . . 75.209999999999994 113.372 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -128.86 142.89 46.59 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.568 0.347 . . . . 65.239999999999995 111.717 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.96 143.47 32.89 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.256 1.971 . . . . 74.230000000000004 111.859 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.7 p -146.1 162.81 37.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.183 -0.323 . . . . 61.210000000000001 111.406 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -142.42 107.64 4.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.738 0.304 . . . . 71.230000000000004 111.508 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -103.59 128.28 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.994 0.426 . . . . 52.130000000000003 111.21 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.39 157.26 29.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.067 0.461 . . . . 73.439999999999998 111.818 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.78 -64.4 4.31 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.475 -0.393 . . . . 63.409999999999997 113.378 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.23 107.03 1.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.185 0.439 . . . . 73.409999999999997 112.185 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.04 -45.11 8.07 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.404 -0.362 . . . . 74.519999999999996 111.582 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -153.68 129.41 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.851 0.357 . . . . 62.229999999999997 111.194 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.2 pp -158.05 152.5 24.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.137 0.421 . . . . 71.540000000000006 112.137 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 50' ' ' ASP . 12.2 p-10 -61.35 154.68 23.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.321 -0.399 . . . . 73.439999999999998 111.457 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.1 t -53.38 -33.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.886 0.374 . . . . 70.109999999999999 111.518 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -53.84 -49.47 68.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.381 -0.372 . . . . 73.150000000000006 111.545 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -68.96 -35.85 77.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.565 0.221 . . . . 71.510000000000005 111.454 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.586 HD22 HG23 ' A' ' 54' ' ' VAL . 64.8 tp -54.39 -50.82 66.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.095 0.474 . . . . 75.310000000000002 110.908 174.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -57.73 -41.56 82.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.164 0.507 . . . . 72.25 110.871 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 t -68.36 -29.5 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.817 -0.628 . . . . 73.109999999999999 111.597 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.75 77.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.027 0.441 . . . . 74.430000000000007 111.189 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.84 -21.51 57.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.082 0.468 . . . . 71.450000000000003 110.501 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 tttp 65.57 36.95 6.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.359 -0.837 . . . . 73.209999999999994 111.579 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.01 129.73 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.134 -0.484 . . . . 70.140000000000001 111.401 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.49 81.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.275 0.472 . . . . 64.519999999999996 112.275 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -101.44 89.67 3.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.932 0.396 . . . . 71.349999999999994 111.422 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' HG11 ' A' ' 35' ' ' VAL . . . -92.42 -45.87 7.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.314 0.578 . . . . 71.129999999999995 110.635 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.66 -25.66 40.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.676 -0.693 . . . . 75.530000000000001 111.719 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -122.41 28.16 7.55 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.093 0.405 . . . . 72.25 112.093 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 32' ' ' ALA . 11.7 p -89.5 139.46 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.306 0.574 . . . . 71.219999999999999 111.971 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -97.95 99.82 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.351 -0.386 . . . . 73.540000000000006 110.444 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.27 136.59 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.852 0.358 . . . . 73.329999999999998 111.579 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.0 pt-20 -122.24 131.88 54.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.155 0.502 . . . . 71.430000000000007 111.377 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.742 ' HB2' HD11 ' A' ' 44' ' ' LEU . 2.4 tm? -88.35 99.9 12.6 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.208 -0.451 . . . . 74.310000000000002 110.413 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.548 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 63.89 1.34 1.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.133 0.79 . . . . 72.25 113.133 176.522 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.32 -6.85 0.82 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.403 -0.904 . . . . 74.430000000000007 114.856 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.85 128.77 41.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.86 0.83 . . . . 74.040000000000006 112.102 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.7 p -66.34 139.54 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.129 0.49 . . . . 75.040000000000006 112.304 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.742 HD11 ' HB2' ' A' ' 39' ' ' LEU . 6.0 mp -92.5 147.16 23.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.159 -0.473 . . . . 75.510000000000005 111.445 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.87 149.77 37.75 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.098 -0.501 . . . . 72.209999999999994 110.336 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -48.33 -55.68 10.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.591 0.589 . . . . 61.329999999999998 112.591 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -81.98 23.93 0.67 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.326 0.584 . . . . 72.549999999999997 111.967 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.75 1.94 13.56 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.734 -0.604 . . . . 65.5 111.836 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -64.69 -30.28 71.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.207 0.447 . . . . 62.340000000000003 112.207 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 14.5 m-20 -83.12 -32.5 26.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.875 0.369 . . . . 61.149999999999999 111.001 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.33 91.35 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.09 -0.505 . . . . 74.409999999999997 112.082 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -95.85 119.96 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.99 0.424 . . . . 74.219999999999999 111.723 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.6 m -96.09 116.43 28.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.938 0.399 . . . . 64.230000000000004 111.616 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.586 HG23 HD22 ' A' ' 23' ' ' LEU . 49.3 t -74.6 142.03 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 116.005 -0.543 . . . . 75.129999999999995 111.096 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -142.83 -175.84 4.65 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.389 0.614 . . . . 74.25 111.61 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.22 104.39 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.756 -0.656 . . . . 71.109999999999999 111.972 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.74 32.2 2.14 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.197 -0.525 . . . . 44.130000000000003 113.818 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.74 138.1 48.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.328 0.585 . . . . 72.109999999999999 112.315 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -95.66 104.52 16.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.651 -0.704 . . . . 62.039999999999999 111.49 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.469 ' O ' HG22 ' A' ' 60' ' ' VAL . 28.7 m -109.02 98.37 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.622 0.725 . . . . 75.439999999999998 110.404 175.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -72.94 99.54 2.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.731 0.777 . . . . 74.239999999999995 112.628 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -85.01 143.71 28.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.869 -1.06 . . . . 74.310000000000002 110.151 170.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.522 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.3 pt? -148.52 114.59 5.8 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.284 0.564 . . . . 72.040000000000006 111.771 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 64.64 22.4 12.61 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.774 -0.648 . . . . 74.200000000000003 112.087 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -112.98 121.35 44.38 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.756 0.313 . . . . 63.549999999999997 110.947 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 85.1 mtp -138.71 -174.21 3.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.9 0.381 . . . . 65.340000000000003 111.674 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.18 42.99 0.06 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.083 -0.579 . . . . 61.119999999999997 112.961 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.16 -107.71 2.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.415 -0.422 . . . . 70.310000000000002 113.658 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.78 -57.24 4.79 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.26 -0.495 . . . . 54.32 113.653 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.599 ' HZ3' ' HB3' ' A' ' 70' ' ' LYS . 9.7 mtpm? 67.99 113.12 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.394 0.616 . . . . 74.109999999999999 112.092 -178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.0 tp -76.95 96.79 4.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.298 0.57 . . . . 74.010000000000005 110.805 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -80.48 115.6 20.08 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.177 -0.465 . . . . 42.420000000000002 111.866 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -148.27 102.29 3.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.919 0.39 . . . . 74.209999999999994 110.934 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -86.95 147.18 25.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.673 0.389 . . . . 63.520000000000003 111.422 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -92.53 130.78 38.08 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.91 0.386 . . . . 74.400000000000006 111.433 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -68.53 -41.72 79.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.405 -0.361 . . . . 74.200000000000003 111.554 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -129.88 159.44 36.59 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.676 0.274 . . . . 61.310000000000002 110.788 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.775 -0.631 . . . . 70.230000000000004 111.394 178.63 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.731 ' HE2' HD12 ' A' ' 3' ' ' LEU . 26.5 ptt? . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.916 0.389 . . . . 75.420000000000002 111.313 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.78 126.41 37.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.309 -0.405 . . . . 73.540000000000006 111.122 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.731 HD12 ' HE2' ' A' ' 1' ' ' MET . 92.6 mt -126.36 134.92 50.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.937 0.399 . . . . 63.229999999999997 111.373 178.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -94.6 99.35 11.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.959 0.409 . . . . 72.099999999999994 111.004 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.432 HG11 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -100.19 124.21 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.965 0.412 . . . . 72.25 111.464 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 55.6 m-80 54.87 43.22 30.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.115 0.483 . . . . 73.219999999999999 111.371 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.69 12.83 62.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.872 -0.603 . . . . 73.409999999999997 113.872 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -126.89 125.31 24.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 122.596 -0.355 . . . . 74.310000000000002 110.917 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.0 142.18 19.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.684 2.256 . . . . 74.230000000000004 113.819 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.9 t -137.86 125.88 22.78 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.027 -0.533 . . . . 74.129999999999995 110.628 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -87.33 94.27 9.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.003 0.43 . . . . 72.019999999999996 111.536 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -94.78 95.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.491 0.662 . . . . 74.0 111.322 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.74 159.66 30.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.119 0.485 . . . . 64.400000000000006 111.373 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.78 -52.34 2.62 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.097 -0.573 . . . . 73.420000000000002 111.693 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.61 123.36 23.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.724 0.297 . . . . 38.109999999999999 110.569 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.06 -48.02 3.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.264 0.554 . . . . 70.129999999999995 111.423 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -157.64 106.6 2.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.224 -0.444 . . . . 72.019999999999996 110.632 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.02 151.81 50.27 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.346 -0.388 . . . . 74.099999999999994 111.29 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 20.4 p-10 -74.49 157.22 35.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.136 -0.32 . . . . 71.400000000000006 110.136 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 60.7 t -51.01 -37.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.86 0.319 . . . . 72.430000000000007 111.86 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -53.62 -51.75 62.07 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.821 0.343 . . . . 73.420000000000002 111.597 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 52.2 mm-40 -71.18 -29.2 64.88 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 122.246 -0.284 . . . . 61.399999999999999 111.756 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.631 HD12 HG12 ' A' ' 60' ' ' VAL . 7.6 tt -60.39 -45.3 94.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.527 -0.546 . . . . 74.140000000000001 109.527 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 78.0 mt -63.88 -41.02 97.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 70.450000000000003 110.206 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.408 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 37.0 t -60.47 -27.78 67.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.673 -0.694 . . . . 72.209999999999994 112.002 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -42.32 93.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.058 0.456 . . . . 73.120000000000005 111.314 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.473 ' N ' HD13 ' A' ' 27' ' ' LEU . 5.8 mp -88.68 -0.75 57.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.165 0.507 . . . . 72.409999999999997 110.465 174.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt 57.71 48.91 13.19 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.75 0.786 . . . . 70.439999999999998 111.101 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 56.3 t -81.54 88.51 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.853 -0.612 . . . . 72.420000000000002 110.259 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.92 -27.94 33.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.838 -0.619 . . . . 53.520000000000003 112.368 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 11.7 mm100 -83.92 45.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.282 -0.417 . . . . 74.510000000000005 112.024 -176.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -36.99 74.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.474 0.546 . . . . 72.120000000000005 112.474 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.44 -7.64 56.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 75.200000000000003 111.449 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.448 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 5.8 m-85 -104.42 -50.61 3.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.276 -0.42 . . . . 74.219999999999999 111.455 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG22 ' HB2' ' A' ' 65' ' ' PHE . 7.5 p -70.46 136.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.195 0.521 . . . . 61.399999999999999 112.323 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.2 m -112.06 140.41 46.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.109 -0.496 . . . . 74.140000000000001 111.053 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 62' ' ' PHE . 28.7 m -133.8 151.39 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.678 0.275 . . . . 71.219999999999999 110.842 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.56 126.12 51.29 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.709 0.766 . . . . 65.439999999999998 111.818 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.48 120.7 34.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.581 -0.736 . . . . 75.0 110.197 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.51 26.36 10.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.988 0.423 . . . . 73.439999999999998 111.779 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 12.92 68.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.092 -0.575 . . . . 45.140000000000001 113.226 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.79 124.88 53.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.654 0.382 . . . . 72.109999999999999 110.438 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.01 128.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.199 0.523 . . . . 73.340000000000003 111.945 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.15 139.99 35.03 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.428 -0.351 . . . . 72.319999999999993 111.179 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -68.94 160.77 30.18 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.351 -0.386 . . . . 53.049999999999997 110.771 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.09 -36.14 65.34 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.023 0.44 . . . . 71.340000000000003 111.726 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.78 -39.21 80.31 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.246 0.545 . . . . 62.439999999999998 111.416 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.3 63.77 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.538 0.57 . . . . 52.43 112.538 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -63.43 -33.48 75.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.985 0.422 . . . . 73.409999999999997 111.685 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.79 -32.26 59.8 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.37 -0.377 . . . . 71.299999999999997 111.46 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.95 6.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.329 0.492 . . . . 54.450000000000003 112.329 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -57.59 115.64 2.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.352 0.501 . . . . 74.299999999999997 112.352 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 73.8 p -99.37 119.63 38.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.049 0.452 . . . . 62.149999999999999 111.44 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -96.22 140.52 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.172 -0.467 . . . . 60.25 111.09 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.26 -172.34 2.82 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.663 0.616 . . . . 73.430000000000007 112.663 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.401 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.1 t70 -63.14 132.04 50.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.778 -0.646 . . . . 75.400000000000006 112.258 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.05 42.28 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.004 -0.544 . . . . 73.340000000000003 113.467 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -119.16 150.06 40.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.425 -0.456 . . . . 73.450000000000003 110.714 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.33 83.71 2.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.129 0.49 . . . . 62.229999999999997 112.185 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.631 HG12 HD12 ' A' ' 23' ' ' LEU . 3.6 p -88.31 91.71 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.357 0.598 . . . . 65.120000000000005 110.343 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 33.8 tt0 -71.35 92.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.526 0.679 . . . . 73.019999999999996 110.859 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' HA ' HG13 ' A' ' 37' ' ' VAL . 71.6 t80 -73.25 110.19 7.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.284 -0.871 . . . . 72.340000000000003 111.139 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.7 mt -74.31 152.84 39.55 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.123 0.487 . . . . 65.140000000000001 110.766 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.0 46.78 1.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.323 0.582 . . . . 55.509999999999998 112.441 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.508 ' HB2' HG22 ' A' ' 35' ' ' VAL . 56.0 m-85 -61.26 -9.06 4.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.325 -0.398 . . . . 71.439999999999998 112.063 172.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.471 ' HE1' ' HE2' ' A' ' 62' ' ' PHE . 54.7 mtm -81.16 101.54 9.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.934 0.397 . . . . 73.340000000000003 111.108 176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.9 -6.16 28.51 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 116.294 -0.412 . . . . 71.209999999999994 112.189 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.26 142.43 44.5 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.596 -0.335 . . . . 71.299999999999997 113.129 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 -42.77 53.91 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.029 -0.605 . . . . 74.109999999999999 113.444 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 66.92 118.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.173 0.589 . . . . 74.329999999999998 111.166 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -48.75 -25.37 1.79 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 74.25 114.783 -170.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.41 -45.56 11.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.22 0.452 . . . . 62.310000000000002 112.22 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 63.14 -174.11 0.16 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.199 0.524 . . . . 72.319999999999993 112.164 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -113.96 20.94 15.33 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 120.998 0.428 . . . . 75.519999999999996 111.547 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -62.86 130.4 44.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.507 -0.315 . . . . 75.109999999999999 111.013 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -134.13 170.08 16.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.601 0.715 . . . . 75.329999999999998 112.654 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.67 152.1 45.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.293 -0.867 . . . . 73.400000000000006 110.189 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.91 -0.567 . . . . 54.520000000000003 111.316 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HE3' HD11 ' A' ' 3' ' ' LEU . 25.9 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.674 0.273 . . . . 74.040000000000006 111.527 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -89.09 132.04 34.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.508 -0.315 . . . . 74.140000000000001 111.073 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.536 HD11 ' HE3' ' A' ' 1' ' ' MET . 95.9 mt -136.36 131.22 33.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.981 0.42 . . . . 64.329999999999998 111.377 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 89.3 m -81.85 89.47 6.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.288 0.566 . . . . 74.129999999999995 110.073 172.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.59 120.09 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 74.420000000000002 111.552 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' OD1' ' NZ ' ' A' ' 8' ' ' LYS . 6.2 t-20 62.43 22.62 13.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.118 0.485 . . . . 72.530000000000001 111.67 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.04 64.5 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.284 -0.484 . . . . 41.200000000000003 113.22 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 3.9 mppt? -113.91 127.07 27.23 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.667 -0.314 . . . . 64.310000000000002 111.427 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.575 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 90.3 Cg_endo -79.34 139.12 14.46 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.648 2.232 . . . . 75.319999999999993 113.543 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.1 t -149.75 159.36 44.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.748 0.309 . . . . 74.030000000000001 111.385 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -109.72 112.39 24.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.93 0.395 . . . . 74.409999999999997 111.362 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' O ' ' N ' ' A' ' 1' ' ' MET . 31.4 m -112.01 119.49 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.953 0.406 . . . . 72.219999999999999 111.464 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.87 166.38 20.96 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.724 0.297 . . . . 72.319999999999993 110.517 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.51 4.01 73.63 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.933 -0.651 . . . . 73.430000000000007 112.524 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.4 108.34 11.57 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.862 0.363 . . . . 65.319999999999993 110.987 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -101.81 -60.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.387 0.613 . . . . 75.129999999999995 110.457 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -149.75 101.4 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.789 -0.642 . . . . 74.040000000000006 109.634 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 96.3 mt -125.03 133.06 53.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.145 0.424 . . . . 70.409999999999997 112.145 -170.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.557 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.7 p-10 -63.59 149.67 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.597 -0.274 . . . . 60.310000000000002 110.452 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.83 -42.14 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.641 0.608 . . . . 70.109999999999999 112.641 -173.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.427 ' HB ' ' ND2' ' A' ' 19' ' ' ASN . 86.6 m -50.83 -48.51 59.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.824 0.345 . . . . 60.119999999999997 111.795 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 25.4 mm-40 -65.04 -32.77 74.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.336 . . . . 61.210000000000001 111.25 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 60' ' ' VAL . 6.9 tt -61.68 -50.04 74.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.937 0.398 . . . . 63.329999999999998 109.967 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD12 HG13 ' A' ' 29' ' ' VAL . 3.9 mm? -63.21 -33.66 75.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.861 0.362 . . . . 73.329999999999998 111.032 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -64.04 -41.34 97.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.150000000000006 111.365 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -33.23 70.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.155 0.502 . . . . 74.140000000000001 111.07 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.603 HD22 ' HB ' ' A' ' 29' ' ' VAL . 5.6 tt -71.25 -35.07 71.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.015 -0.539 . . . . 63.140000000000001 110.368 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 60.17 73.45 0.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.518 0.675 . . . . 75.319999999999993 111.461 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.603 ' HB ' HD22 ' A' ' 27' ' ' LEU . 12.5 p -117.18 143.81 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.889 -0.596 . . . . 74.040000000000006 111.36 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.542 ' HB2' ' HA2' ' A' ' 68' ' ' GLY . . . -75.91 142.85 41.97 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 42.43 111.262 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 66.6 mt-30 71.12 37.58 1.21 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.852 -0.613 . . . . 74.510000000000005 112.124 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.24 75.16 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.946 0.403 . . . . 74.230000000000004 111.93 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -73.4 -3.27 26.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.14 0.495 . . . . 74.0 111.555 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 23.5 m-85 -119.76 -13.45 9.1 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.021 -0.425 . . . . 74.519999999999996 112.029 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.609 HG22 ' HB2' ' A' ' 65' ' ' PHE . 7.5 p -86.11 130.49 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 74.5 112.341 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.418 ' HB ' ' CE1' ' A' ' 65' ' ' PHE . 70.3 m -93.93 117.2 29.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.311 -0.404 . . . . 70.409999999999997 111.057 175.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.23 158.82 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 72.409999999999997 110.984 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 11.6 pt-20 -127.87 133.01 49.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.628 0.728 . . . . 54.200000000000003 111.981 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.525 ' HB2' HD23 ' A' ' 44' ' ' LEU . 2.9 tm? -91.52 104.04 16.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.338 -0.846 . . . . 71.430000000000007 109.689 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.4 HD21 HD13 ' A' ' 39' ' ' LEU . 32.4 m-80 55.18 46.21 24.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.098 0.475 . . . . 65.519999999999996 111.408 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.02 -3.79 74.38 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.474 -0.393 . . . . 60.450000000000003 113.946 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -96.59 111.38 23.54 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.567 -0.372 . . . . 61.210000000000001 111.112 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.25 125.34 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.206 0.527 . . . . 72.140000000000001 112.219 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 HD23 ' HB2' ' A' ' 39' ' ' LEU . 1.4 mm? -97.76 152.1 19.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.003 0.43 . . . . 75.450000000000003 111.213 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.2 149.44 46.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.911 -0.774 . . . . 64.420000000000002 108.911 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -54.13 -38.11 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.174 0.435 . . . . 73.030000000000001 112.174 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.56 -29.96 46.6 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.194 0.521 . . . . 74.340000000000003 111.193 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.35 -17.01 40.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.461 -0.336 . . . . 74.319999999999993 111.846 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.95 -32.55 66.13 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.181 0.515 . . . . 73.299999999999997 111.201 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.81 -24.85 35.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.094 -0.503 . . . . 75.409999999999997 111.431 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.13 -23.06 19.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.262 0.467 . . . . 60.210000000000001 112.262 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 106.65 18.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.144 -0.348 . . . . 74.219999999999999 111.56 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 76.3 p -85.57 115.6 23.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.01 0.433 . . . . 74.400000000000006 112.017 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.17 132.78 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.35 -0.386 . . . . 71.349999999999994 110.804 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -125.65 -177.32 3.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.149 0.5 . . . . 73.150000000000006 112.105 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.33 143.23 45.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 43.219999999999999 111.872 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.43 34.74 90.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 116.23 -0.441 . . . . 64.129999999999995 113.809 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.81 -177.12 3.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.022 0.411 . . . . 71.0 110.081 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.16 102.98 6.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.074 0.768 . . . . 51.109999999999999 113.074 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.476 HG12 HD12 ' A' ' 23' ' ' LEU . 4.0 p -96.69 111.22 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.309 0.576 . . . . 74.319999999999993 110.394 173.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 42.2 mt-10 -101.25 105.23 16.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.593 0.711 . . . . 70.030000000000001 111.957 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -81.87 117.07 21.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.286 -0.87 . . . . 64.319999999999993 110.443 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.1 -176.9 5.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 74.549999999999997 112.54 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -56.56 -2.26 0.07 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.975 1.472 . . . . 75.209999999999994 114.975 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.609 ' HB2' HG22 ' A' ' 35' ' ' VAL . 84.7 m-85 -69.1 94.32 0.65 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.473 0.579 . . . . 75.120000000000005 111.695 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.9 ttm -147.23 153.15 39.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.396 -0.366 . . . . 54.43 110.912 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.27 -21.02 2.96 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.005 -0.617 . . . . 54.119999999999997 113.305 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA2' ' HB2' ' A' ' 30' ' ' ALA . . . 76.93 -58.14 3.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.227 -0.511 . . . . 52.43 113.469 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.4 -52.07 4.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.196 -0.526 . . . . 64.219999999999999 112.904 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -81.12 75.24 8.1 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.841 0.353 . . . . 62.140000000000001 111.031 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.468 HD13 ' HB2' ' A' ' 74' ' ' HIS . 43.3 tp 31.07 90.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.13 1.159 . . . . 74.420000000000002 114.13 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -101.22 -25.06 14.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.759 0.314 . . . . 75.5 111.405 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -142.33 126.28 17.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.219 0.451 . . . . 72.409999999999997 112.219 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . 0.468 ' HB2' HD13 ' A' ' 71' ' ' LEU . 59.0 t-80 -124.36 120.81 33.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.71 -0.478 . . . . 75.530000000000001 109.71 171.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -95.12 146.34 24.37 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.06 0.457 . . . . 75.549999999999997 112.111 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -88.05 105.69 17.65 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.36 -0.382 . . . . 75.219999999999999 110.387 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -144.47 146.52 32.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.808 0.337 . . . . 73.120000000000005 111.256 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 119.412 -0.327 . . . . 74.25 111.593 176.611 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.508 ' SD ' HD12 ' A' ' 3' ' ' LEU . 24.5 ptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.664 0.268 . . . . 75.019999999999996 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.24 118.67 26.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.66 -0.246 . . . . 75.319999999999993 110.528 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.508 HD12 ' SD ' ' A' ' 1' ' ' MET . 63.7 mt -127.93 169.7 13.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.178 0.513 . . . . 73.120000000000005 111.437 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -111.36 96.87 6.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.626 -0.509 . . . . 72.329999999999998 109.626 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 48.0 t -100.85 123.91 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 60.43 111.306 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.856 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.8 OUTLIER 64.53 24.25 13.04 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.292 -0.413 . . . . 72.25 111.718 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.2 6.31 88.12 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.348 -0.453 . . . . 37.469999999999999 113.078 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -118.35 126.62 27.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 O-C-N 122.549 -0.383 . . . . 73.519999999999996 110.835 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.65 95.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.421 2.081 . . . . 71.049999999999997 112.43 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.1 m -113.5 118.04 33.35 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.077 -0.511 . . . . 64.209999999999994 111.093 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.4 m -96.99 114.35 25.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.877 0.37 . . . . 74.319999999999993 111.487 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -93.68 120.64 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.125 0.488 . . . . 65.010000000000005 110.562 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.61 154.78 30.0 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.032 -0.531 . . . . 54.450000000000003 112.022 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.19 -45.46 3.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.257 -0.497 . . . . 75.310000000000002 113.298 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.15 117.06 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.831 0.348 . . . . 70.329999999999998 111.906 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -107.23 -55.88 2.28 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.306 -0.407 . . . . 73.040000000000006 110.566 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -141.93 122.39 14.08 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.821 0.343 . . . . 72.219999999999999 111.853 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -157.72 160.58 38.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.264 -0.425 . . . . 64.239999999999995 111.021 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.7 p30 -86.73 168.86 13.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.917 0.389 . . . . 73.310000000000002 111.175 177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.1 -29.28 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.55 -0.295 . . . . 72.219999999999999 111.449 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.3 m -61.62 -42.17 98.51 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.742 0.306 . . . . 74.5 111.586 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.29 -47.91 77.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.796 0.331 . . . . 73.030000000000001 110.908 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.92 -43.6 77.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.022 0.439 . . . . 54.140000000000001 110.825 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.01 -43.39 98.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.982 -0.554 . . . . 72.409999999999997 110.6 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -74.68 -17.34 60.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.235 -0.438 . . . . 71.349999999999994 111.891 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.61 35.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.861 0.362 . . . . 61.299999999999997 111.315 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 28' ' ' LYS . 2.8 pp -87.76 -17.79 30.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.519 -0.309 . . . . 75.400000000000006 111.705 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.423 ' N ' HD12 ' A' ' 27' ' ' LEU . 57.4 mtmt 60.06 85.56 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 72.129999999999995 112.833 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.35 117.32 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.184 0.516 . . . . 75.040000000000006 110.959 176.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.69 68.66 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.158 -0.473 . . . . 70.349999999999994 112.207 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.663 ' HG2' ' HG2' ' A' ' 66' ' ' MET . 23.4 mp0 -84.81 40.45 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.384 -0.371 . . . . 74.310000000000002 111.877 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.72 62.21 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.18 0.514 . . . . 74.120000000000005 112.131 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.65 -36.31 75.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.16 -0.473 . . . . 73.340000000000003 111.552 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -99.33 -17.16 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.554 0.576 . . . . 65.030000000000001 112.554 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.2 113.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.976 0.732 . . . . 75.019999999999996 112.976 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 m -94.69 107.47 19.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.988 -0.551 . . . . 71.129999999999995 111.297 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG11 ' HA ' ' A' ' 62' ' ' PHE . 31.5 m -141.32 147.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.426 -0.352 . . . . 70.239999999999995 111.195 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.29 137.03 43.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.039 0.447 . . . . 73.430000000000007 111.746 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.669 HD21 HD23 ' A' ' 44' ' ' LEU . 4.1 mm? -83.22 106.48 15.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.027 0.441 . . . . 61.420000000000002 110.621 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 61.6 11.02 3.62 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.377 0.671 . . . . 63.450000000000003 112.526 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.63 -10.26 7.61 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.992 -0.623 . . . . 44.530000000000001 113.914 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.54 114.94 29.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.294 -0.533 . . . . 75.310000000000002 111.639 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.56 148.89 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.109 0.48 . . . . 63.439999999999998 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.669 HD23 HD21 ' A' ' 39' ' ' LEU . 3.1 mm? -101.16 143.26 31.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.318 0.58 . . . . 64.25 112.259 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.94 156.79 16.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.777 -0.647 . . . . 71.540000000000006 109.304 170.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 46' ' ' ARG . 61.3 mtt85 -40.43 -54.63 2.42 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.573 0.583 . . . . 75.420000000000002 112.573 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -79.25 -14.28 59.14 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.319 0.489 . . . . 72.010000000000005 112.319 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.03 62.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 75.150000000000006 111.222 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.66 -37.23 73.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.895 0.379 . . . . 71.209999999999994 111.519 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.49 -36.59 52.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.97 0.414 . . . . 71.239999999999995 111.705 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.21 -56.99 4.34 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.268 0.47 . . . . 52.149999999999999 112.268 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.5 m -72.59 126.12 29.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.039 0.447 . . . . 70.230000000000004 112.045 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 75.6 p -105.95 138.3 42.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.203 0.525 . . . . 71.200000000000003 112.011 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.515 HG22 HD12 ' A' ' 39' ' ' LEU . 43.9 t -95.22 129.79 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.086 -0.507 . . . . 73.319999999999993 110.895 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.77 -179.76 5.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.279 0.561 . . . . 73.409999999999997 111.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.98 102.82 0.09 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.974 -0.557 . . . . 64.230000000000004 112.267 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.53 4.42 8.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.313 -0.47 . . . . 65.049999999999997 113.838 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.44 145.04 25.24 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.42 0.629 . . . . 74.010000000000005 112.162 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.15 131.76 51.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.78 -0.645 . . . . 51.020000000000003 111.168 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -143.96 117.71 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.403 0.62 . . . . 72.349999999999994 111.435 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.856 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 28.6 tt0 -101.38 96.56 7.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.5 0.666 . . . . 73.150000000000006 111.896 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HA ' HG11 ' A' ' 37' ' ' VAL . 18.6 t80 -78.06 92.2 4.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.928 -0.578 . . . . 74.239999999999995 110.069 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.78 135.5 56.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.29 0.848 . . . . 74.439999999999998 113.29 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -83.37 18.98 1.63 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 73.310000000000002 111.88 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -54.74 -31.51 58.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.027 0.441 . . . . 75.430000000000007 111.816 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.663 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 18.0 tpt -102.32 117.91 35.74 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.115 -0.493 . . . . 65.150000000000006 111.189 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.7 13.6 2.48 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.077 -0.583 . . . . 43.509999999999998 113.347 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.58 -18.47 4.62 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.213 -0.518 . . . . 73.430000000000007 114.142 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.89 81.67 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.328 -0.463 . . . . 64.129999999999995 113.88 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -90.57 88.76 7.26 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.349 -0.501 . . . . 72.329999999999998 112.114 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.448 HD11 ' N ' ' A' ' 71' ' ' LEU . 6.0 mp -106.34 155.23 19.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.576 -0.528 . . . . 71.420000000000002 109.576 170.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.37 95.47 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.055 0.455 . . . . 74.230000000000004 111.755 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -88.2 119.75 28.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.377 -0.374 . . . . 75.030000000000001 110.426 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -73.86 -43.05 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.467 0.543 . . . . 74.329999999999998 112.467 -173.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 68.35 164.59 0.23 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.517 0.327 . . . . 73.439999999999998 110.845 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -107.73 147.77 30.35 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.707 -0.621 . . . . 65.430000000000007 112.505 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -150.63 111.37 4.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.621 -0.718 . . . . 75.530000000000001 109.761 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.785 -0.626 . . . . 71.239999999999995 111.997 -173.249 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.543 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 22.8 ptp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.793 0.33 . . . . 72.409999999999997 111.517 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -101.9 114.56 28.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.398 -0.365 . . . . 64.549999999999997 111.017 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.86 127.76 53.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.081 0.467 . . . . 72.340000000000003 111.411 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.444 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.2 m -82.4 97.7 8.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.28 -0.418 . . . . 72.340000000000003 111.462 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.569 HG12 HD21 ' A' ' 6' ' ' ASN . 31.5 t -85.72 110.83 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.918 0.389 . . . . 62.43 111.837 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.569 HD21 HG12 ' A' ' 5' ' ' VAL . 52.2 m-80 57.74 25.62 12.07 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.164 0.586 . . . . 63.329999999999998 112.37 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.03 -11.55 58.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.212 -0.518 . . . . 65.549999999999997 113.086 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 9.9 mptt -102.48 114.62 65.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.672 -0.311 . . . . 74.209999999999994 110.93 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 25.6 Cg_exo -63.32 116.45 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.8 2.333 . . . . 71.239999999999995 113.148 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -114.01 158.74 20.78 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.348 -0.387 . . . . 63.149999999999999 110.558 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -126.31 110.28 13.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.894 0.378 . . . . 64.510000000000005 111.868 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 m -98.81 102.08 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.451 0.644 . . . . 72.340000000000003 110.666 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.04 136.22 37.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.758 -0.655 . . . . 73.219999999999999 111.534 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.65 59.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.18 -0.533 . . . . 51.119999999999997 113.001 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HB1' ' HG2' ' A' ' 1' ' ' MET . . . -103.04 101.74 11.73 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.592 -0.358 . . . . 73.430000000000007 111.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.82 88.12 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.932 0.396 . . . . 73.120000000000005 111.181 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m 49.29 91.96 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.752 -0.658 . . . . 74.299999999999997 112.454 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.4 pp -129.0 153.83 47.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.062 0.458 . . . . 71.400000000000006 111.611 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 27.7 m-20 -72.34 160.73 31.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.469 -0.332 . . . . 75.219999999999999 110.828 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.416 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 t -56.38 -36.65 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.968 0.413 . . . . 74.209999999999994 110.568 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -56.36 -52.03 66.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.96 0.41 . . . . 62.350000000000001 110.999 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.404 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 41.7 mt-10 -63.83 -34.45 77.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.305 -0.407 . . . . 71.129999999999995 111.44 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.3 -45.93 80.02 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.919 0.39 . . . . 75.140000000000001 110.434 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -56.25 -32.93 64.95 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.983 0.42 . . . . 71.239999999999995 111.499 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.4 t -77.97 -32.82 51.57 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.122 -0.49 . . . . 70.129999999999995 111.291 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.59 -46.38 63.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.082 0.468 . . . . 74.219999999999999 111.417 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.52 -30.42 65.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.161 -0.472 . . . . 74.230000000000004 110.909 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.89 87.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.58 0.752 . . . . 70.120000000000005 112.575 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.11 148.53 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.792 -0.64 . . . . 73.040000000000006 110.936 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.99 171.81 14.52 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.87 0.367 . . . . 64.409999999999997 111.867 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 57.17 39.07 29.13 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.057 0.455 . . . . 74.340000000000003 111.729 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -33.27 71.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.459 . . . . 75.299999999999997 111.961 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.72 -13.34 62.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.984 0.365 . . . . 74.25 111.984 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.17 4.7 5.82 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.458 0.54 . . . . 74.340000000000003 112.458 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.482 HG22 HG13 ' A' ' 37' ' ' VAL . 14.6 p -70.71 132.06 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.551 0.691 . . . . 73.200000000000003 112.338 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.9 m -95.26 98.89 10.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.119 -0.491 . . . . 74.109999999999999 111.221 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG13 HG22 ' A' ' 35' ' ' VAL . 29.7 m -133.15 163.34 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.265 0.555 . . . . 75.349999999999994 112.08 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.39 154.71 32.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.983 -0.553 . . . . 62.0 111.298 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.528 ' O ' HD11 ' A' ' 39' ' ' LEU . 3.4 pp -123.17 137.95 54.77 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.531 -0.304 . . . . 54.399999999999999 111.286 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 59.21 16.08 4.66 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 116.358 -0.383 . . . . 71.030000000000001 112.024 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.27 15.41 53.65 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.347 -0.454 . . . . 55.340000000000003 113.825 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.15 118.3 28.33 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.3 -0.529 . . . . 73.010000000000005 111.368 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.68 135.13 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.11 0.481 . . . . 72.450000000000003 111.927 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 44' ' ' LEU . 2.0 mm? -109.67 150.72 27.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.131 0.491 . . . . 60.43 112.092 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.446 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 mp0 -69.36 162.18 27.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.146 -0.479 . . . . 72.430000000000007 110.76 170.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.446 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -57.02 -39.43 74.74 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.714 0.292 . . . . 64.010000000000005 111.32 178.443 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.56 -35.94 68.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.153 0.501 . . . . 73.310000000000002 111.038 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -22.41 66.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.333 -0.394 . . . . 74.310000000000002 111.369 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.423 ' CD2' ' HA ' ' A' ' 46' ' ' ARG . 17.5 m-30 -57.57 -39.33 76.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.646 0.26 . . . . 74.329999999999998 111.558 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 22.2 t70 -83.34 -35.51 25.11 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.241 0.543 . . . . 73.129999999999995 110.82 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.36 -23.57 67.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.258 -0.428 . . . . 74.010000000000005 112.09 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -103.77 115.78 31.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.787 0.327 . . . . 64.219999999999999 111.565 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 88.6 m -94.73 110.19 22.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.23 0.538 . . . . 71.209999999999994 111.801 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.48 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.901 -0.591 . . . . 74.409999999999997 111.24 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -130.07 -167.12 1.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.183 0.516 . . . . 72.340000000000003 111.929 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.543 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 2.8 t0 -78.97 42.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.931 0.396 . . . . 73.450000000000003 112.045 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.59 52.92 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.406 -0.902 . . . . 64.230000000000004 113.426 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.12 123.7 38.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.237 0.541 . . . . 74.439999999999998 110.956 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.82 82.96 3.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.267 -0.424 . . . . 70.239999999999995 111.577 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.7 p -83.47 104.93 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.529 0.68 . . . . 74.420000000000002 111.561 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 41.3 mt-10 -85.84 100.61 12.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.442 0.639 . . . . 73.310000000000002 111.167 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -101.71 110.9 22.99 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.291 -0.868 . . . . 73.519999999999996 110.676 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' HA ' ' HE1' ' A' ' 66' ' ' MET . 2.2 pt? -137.54 155.06 49.67 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.521 0.563 . . . . 74.329999999999998 112.521 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 65.24 9.11 5.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.764 1.024 . . . . 75.319999999999993 113.764 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -131.61 26.33 4.73 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.991 0.424 . . . . 74.439999999999998 111.505 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.431 ' N ' ' SD ' ' A' ' 66' ' ' MET . 1.5 mpt? -57.83 140.73 51.12 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.946 0.403 . . . . 64.040000000000006 111.617 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.68 -35.72 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.28 -0.486 . . . . 53.310000000000002 113.475 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.79 -117.35 5.1 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.173 -0.537 . . . . 74.349999999999994 113.151 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.04 33.6 69.96 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.305 -0.474 . . . . 53.439999999999998 113.053 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.89 126.05 55.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.329 0.585 . . . . 73.530000000000001 112.503 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 pp -88.91 178.66 6.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.985 -0.552 . . . . 60.409999999999997 110.397 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -148.06 132.22 17.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.837 0.351 . . . . 75.209999999999994 111.903 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -86.07 124.65 32.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.067 0.461 . . . . 72.310000000000002 111.488 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -58.47 120.74 9.35 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.845 -0.616 . . . . 74.109999999999999 111.962 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -84.73 140.4 31.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.466 -0.334 . . . . 71.540000000000006 111.014 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.5 t60 62.8 111.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.302 0.572 . . . . 63.25 112.157 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -139.12 -166.58 2.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.235 -0.438 . . . . 73.319999999999993 111.169 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 119.483 -0.294 . . . . 74.209999999999994 111.541 175.782 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.654 ' HE2' HD12 ' A' ' 3' ' ' LEU . 26.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.846 0.355 . . . . 62.539999999999999 111.914 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.22 126.8 36.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.44 -0.345 . . . . 72.530000000000001 111.543 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.654 HD12 ' HE2' ' A' ' 1' ' ' MET . 74.7 mt -125.31 130.65 52.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.824 0.345 . . . . 74.450000000000003 110.889 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.7 m -94.58 86.08 4.7 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 73.510000000000005 111.151 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.1 122.44 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.43 . . . . 64.540000000000006 111.181 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.482 ' OD1' ' HE2' ' A' ' 66' ' ' MET . 5.9 m120 62.69 23.42 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.762 0.315 . . . . 73.040000000000006 111.568 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.5 79.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.827 -0.701 . . . . 63.200000000000003 112.464 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -113.23 131.58 22.82 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 122.78 0.432 . . . . 63.100000000000001 110.821 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.73 96.3 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.414 2.076 . . . . 72.150000000000006 112.961 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -98.76 102.15 13.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.098 0.475 . . . . 71.219999999999999 111.25 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.3 m -82.54 94.2 7.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 74.319999999999993 110.767 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 12' ' ' VAL . 30.9 m -93.63 102.99 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.539 0.685 . . . . 72.040000000000006 111.401 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -89.0 151.79 22.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.306 -0.407 . . . . 64.430000000000007 110.559 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.07 18.53 53.67 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.555 -0.618 . . . . 65.040000000000006 111.555 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.46 116.2 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.119 0.568 . . . . 72.239999999999995 110.527 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -91.23 -62.65 1.4 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.416 0.626 . . . . 61.340000000000003 111.213 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.451 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 33.2 p -171.53 104.21 0.2 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.305 -0.861 . . . . 45.439999999999998 110.061 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -131.88 162.08 31.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.488 0.551 . . . . 63.030000000000001 112.488 -170.425 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -64.1 156.2 29.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.407 -0.36 . . . . 72.409999999999997 110.936 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.2 t -56.5 -35.6 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.001 0.429 . . . . 75.439999999999998 110.437 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -59.03 -49.07 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.143 -0.48 . . . . 61.509999999999998 110.992 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 44.0 mt-10 -61.44 -35.81 78.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.275 -0.42 . . . . 75.430000000000007 110.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 61.7 tp -60.53 -45.92 92.08 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.897 0.38 . . . . 63.020000000000003 110.815 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.07 -34.78 73.92 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 62.329999999999998 110.821 175.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -67.9 -41.75 82.24 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.19 -0.459 . . . . 73.400000000000006 111.119 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.69 90.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.261 -0.427 . . . . 41.420000000000002 111.709 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.49 -11.36 59.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.991 0.425 . . . . 75.239999999999995 111.081 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 58.91 64.66 1.37 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 74.340000000000003 111.914 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.49 114.05 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.811 -0.632 . . . . 74.439999999999998 110.784 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.46 80.42 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.13 0.419 . . . . 62.32 112.13 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 78.8 mt-30 -95.79 83.13 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.802 0.335 . . . . 74.530000000000001 111.649 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.83 -37.43 22.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.654 0.74 . . . . 75.239999999999995 110.421 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -67.36 -20.25 65.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.098 -0.955 . . . . 74.430000000000007 111.692 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -123.52 11.74 9.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.773 0.657 . . . . 74.140000000000001 112.773 -173.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 31' ' ' GLN . 14.8 p -83.7 131.94 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 75.120000000000005 112.19 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -95.11 102.14 13.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.412 -0.358 . . . . 61.009999999999998 110.897 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.469 HG12 HG22 ' A' ' 35' ' ' VAL . 35.3 m -122.95 139.96 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.827 0.346 . . . . 51.340000000000003 111.621 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.34 110.68 11.7 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.409 0.623 . . . . 74.049999999999997 111.555 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.495 HD22 HG22 ' A' ' 54' ' ' VAL . 10.0 mp -77.37 129.82 36.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.243 -0.435 . . . . 62.240000000000002 111.273 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.06 21.23 9.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.979 0.419 . . . . 70.420000000000002 111.549 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.76 19.82 49.92 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.311 -0.471 . . . . 73.129999999999995 113.343 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -133.79 125.58 28.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.952 0.376 . . . . 70.409999999999997 111.129 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.22 144.49 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 120.985 0.421 . . . . 70.129999999999995 112.021 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 9.9 mp -104.82 -179.78 4.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.419 0.628 . . . . 63.039999999999999 112.294 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -107.77 149.18 28.51 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.702 -0.681 . . . . 64.400000000000006 110.578 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.535 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 2.1 ptm180 -47.16 -52.98 14.15 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.71 1.004 . . . . 72.409999999999997 113.71 -171.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 19.5 tt0 -95.39 -6.49 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.452 0.644 . . . . 42.340000000000003 110.753 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.86 63.97 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.9 -0.591 . . . . 74.510000000000005 110.539 171.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -51.14 -42.08 60.51 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.225 0.536 . . . . 73.109999999999999 110.893 174.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.16 -34.62 78.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.712 -0.676 . . . . 73.219999999999999 111.561 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.95 -5.57 50.43 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.751 0.648 . . . . 64.299999999999997 112.751 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -104.81 116.18 31.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 122.286 -0.258 . . . . 75.219999999999999 111.437 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.1 p -95.59 113.18 24.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.699 0.629 . . . . 74.0 112.699 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG22 HD22 ' A' ' 39' ' ' LEU . 65.0 t -79.11 133.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 110.798 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 17' ' ' SER . 43.9 mtmt -131.92 -171.84 2.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.263 0.554 . . . . 74.510000000000005 112.024 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.9 t70 -66.17 124.53 22.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 72.430000000000007 111.632 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 30.16 11.45 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.276 -0.488 . . . . 54.109999999999999 113.317 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.505 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.5 t70 -93.54 176.96 6.18 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.756 -0.261 . . . . 65.549999999999997 110.344 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.22 42.46 1.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.829 0.347 . . . . 63.399999999999999 111.918 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 3.7 p -56.2 102.2 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.671 0.748 . . . . 74.040000000000006 111.846 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.75 116.78 28.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.054 -0.521 . . . . 64.540000000000006 111.957 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -88.93 135.75 33.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.052 -0.522 . . . . 72.319999999999993 111.292 173.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.537 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -137.83 133.5 34.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.469 -0.332 . . . . 75.510000000000005 111.253 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 70.36 -19.61 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.347 0.869 . . . . 72.530000000000001 113.347 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.68 80.66 1.81 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.891 -0.506 . . . . 74.510000000000005 111.863 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.482 ' HE2' ' OD1' ' A' ' 6' ' ' ASN . 65.9 mtt -145.38 120.99 10.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.107 -0.497 . . . . 63.240000000000002 111.319 178.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.71 -45.05 0.57 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.346 -0.454 . . . . 37.939999999999998 112.404 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.44 -25.25 28.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.355 -0.45 . . . . 74.109999999999999 113.315 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.12 -78.16 0.81 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.389 -0.434 . . . . 64.239999999999995 112.723 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 70' ' ' LYS . 59.1 pttt -89.0 104.03 16.6 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.322 0.582 . . . . 63.109999999999999 111.467 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.3 mp -78.0 102.14 7.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 73.219999999999999 110.903 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 57.03 -163.74 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.206 0.527 . . . . 73.0 111.883 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -123.72 -38.86 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.16 -0.473 . . . . 74.239999999999995 110.61 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.4 t60 67.59 123.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.482 0.658 . . . . 71.340000000000003 111.334 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -79.77 134.44 36.36 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.571 0.582 . . . . 72.299999999999997 112.571 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -113.22 157.51 21.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.022 -0.535 . . . . 72.409999999999997 110.036 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -137.04 -177.29 4.69 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.249 0.547 . . . . 73.5 112.274 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.817 -0.611 . . . . 74.409999999999997 111.302 -176.744 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.66 ' SD ' HD11 ' A' ' 3' ' ' LEU . 21.5 ptp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.039 0.447 . . . . 62.100000000000001 111.728 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -85.18 108.66 17.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.495 -0.32 . . . . 65.319999999999993 110.825 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.66 HD11 ' SD ' ' A' ' 1' ' ' MET . 70.5 mt -118.83 113.89 21.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.997 0.427 . . . . 63.340000000000003 111.762 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.44 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.7 m -75.69 99.04 4.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.317 -0.401 . . . . 70.140000000000001 110.577 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.51 121.64 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 75.530000000000001 111.207 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.401 HD22 ' C ' ' A' ' 62' ' ' PHE . 7.8 m120 64.35 27.14 13.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.924 0.49 . . . . 73.120000000000005 110.715 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.62 0.03 88.04 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.859 -0.686 . . . . 38.159999999999997 113.595 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -104.39 110.05 63.64 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 117.298 0.549 . . . . 73.120000000000005 111.326 178.37 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 37.1 Cg_exo -61.33 103.92 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.848 2.365 . . . . 60.509999999999998 112.216 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -109.97 110.35 21.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.988 0.423 . . . . 65.019999999999996 111.842 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -82.67 96.97 8.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.882 0.373 . . . . 73.040000000000006 111.383 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -93.74 104.72 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.733 0.778 . . . . 72.010000000000005 110.844 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -72.81 147.59 45.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.251 -0.886 . . . . 71.049999999999997 111.407 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.14 -12.83 65.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.467 -0.397 . . . . 63.329999999999998 113.772 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' HB2' ' HG2' ' A' ' 1' ' ' MET . . . -108.92 119.36 39.33 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.433 -0.451 . . . . 42.5 112.027 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.5 -73.8 0.33 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.207 -0.451 . . . . 73.510000000000005 112.194 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 87.0 p -163.07 135.56 5.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.652 -0.249 . . . . 64.030000000000001 110.707 -178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -148.67 157.04 43.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.944 0.402 . . . . 75.319999999999993 111.944 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.494 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -72.31 170.02 15.02 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.708 -0.224 . . . . 61.119999999999997 110.852 177.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 49' ' ' PHE . 58.8 t -62.16 -40.94 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 109.973 -0.38 . . . . 74.239999999999995 109.973 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.0 m -53.94 -52.85 59.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.196 0.522 . . . . 74.109999999999999 110.597 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 8.5 mm-40 -61.5 -33.78 74.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.028 -0.533 . . . . 74.120000000000005 112.006 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.52 -56.36 18.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.979 0.418 . . . . 75.450000000000003 111.139 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.52 -30.75 71.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.785 0.326 . . . . 75.209999999999994 110.961 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.7 t -66.57 -37.51 85.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.027 0.441 . . . . 72.129999999999995 111.274 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.86 80.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.33 -0.395 . . . . 71.109999999999999 111.204 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.51 -29.08 62.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.299 -0.41 . . . . 73.400000000000006 111.085 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 67.26 16.07 10.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.174 0.59 . . . . 73.219999999999999 112.145 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.55 HG22 ' H ' ' A' ' 31' ' ' GLN . 11.4 p -72.5 140.01 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.064 0.459 . . . . 74.0 111.438 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.58 -14.83 57.87 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.885 0.698 . . . . 74.439999999999998 112.885 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.55 ' H ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.07 30.77 1.8 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.281 -0.262 . . . . 54.130000000000003 111.39 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.87 79.74 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.424 0.528 . . . . 71.510000000000005 112.424 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.07 -10.79 59.93 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.156 0.503 . . . . 75.120000000000005 111.376 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.19 21.94 11.57 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.208 0.447 . . . . 71.340000000000003 112.208 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG22 ' CE2' ' A' ' 62' ' ' PHE . 6.4 p -110.88 133.57 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.166 0.507 . . . . 71.049999999999997 112.068 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.8 m -74.76 84.36 2.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.278 0.561 . . . . 74.329999999999998 110.936 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -99.11 110.33 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.971 -0.559 . . . . 74.209999999999994 110.31 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 10.5 pt-20 -118.2 119.65 35.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.734 0.778 . . . . 73.439999999999998 112.128 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.652 ' HB2' HD23 ' A' ' 44' ' ' LEU . 2.0 tm? -73.29 107.67 5.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.412 -0.813 . . . . 71.519999999999996 110.417 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.526 ' N ' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 58.53 15.84 3.85 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.044 -0.525 . . . . 73.439999999999998 111.818 -178.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 15.83 11.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.996 -0.621 . . . . 43.43 113.886 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -132.11 110.55 10.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 117.396 0.598 . . . . 74.310000000000002 110.899 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 12.4 p -64.58 141.88 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.787 0.662 . . . . 63.219999999999999 112.787 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 39' ' ' LEU . 2.8 mm? -94.02 143.74 26.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.407 0.622 . . . . 74.120000000000005 112.485 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -77.4 154.43 32.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.717 -0.674 . . . . 50.439999999999998 110.536 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -48.26 -41.03 26.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.147 0.425 . . . . 71.519999999999996 112.147 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.32 -40.73 85.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.183 0.516 . . . . 74.109999999999999 111.485 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -24.15 63.51 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.311 0.486 . . . . 65.099999999999994 112.311 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.58 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 7.7 m-85 -49.48 -42.0 42.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.914 0.388 . . . . 75.530000000000001 111.728 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.77 -29.85 29.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.908 0.385 . . . . 74.230000000000004 111.648 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 -15.77 46.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.942 0.719 . . . . 73.140000000000001 112.942 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -104.18 123.08 46.67 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.073 -0.392 . . . . 60.109999999999999 111.483 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 89.5 m -111.14 110.81 21.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.201 0.524 . . . . 74.319999999999993 111.726 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.6 123.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.853 -0.612 . . . . 61.439999999999998 110.447 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -133.51 -175.37 3.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.977 0.417 . . . . 70.439999999999998 111.851 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.05 129.6 42.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.045 0.45 . . . . 74.109999999999999 111.715 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 42.49 12.81 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.378 -0.439 . . . . 38.159999999999997 112.733 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -119.6 -173.15 2.47 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.699 -0.482 . . . . 72.219999999999999 109.699 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 102.65 4.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 71.129999999999995 110.972 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.16 100.11 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.57 0.7 . . . . 73.319999999999993 110.557 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.544 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 5.1 mm-40 -76.86 105.99 8.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.839 0.828 . . . . 74.319999999999993 111.214 -176.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.423 ' CE2' HG22 ' A' ' 35' ' ' VAL . 12.1 t80 -119.11 99.32 6.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.47 -1.241 . . . . 73.010000000000005 109.395 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.425 ' N ' HD21 ' A' ' 63' ' ' LEU . 1.7 pt? -134.5 143.04 47.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.116 0.784 . . . . 72.510000000000005 113.116 -168.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 67.33 12.29 8.84 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.271 0.841 . . . . 71.409999999999997 113.271 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.29 164.82 22.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.296 0.57 . . . . 61.210000000000001 112.275 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 27.3 ttt -73.23 124.39 25.57 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.5 -0.773 . . . . 60.5 112.055 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 -54.33 0.03 OUTLIER Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.347 -0.454 . . . . 53.25 113.038 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.42 -157.12 24.53 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.156 -0.545 . . . . 53.420000000000002 113.0 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 101.24 0.88 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.056 -0.593 . . . . 71.099999999999994 113.031 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -121.69 144.83 48.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.047 0.451 . . . . 53.210000000000001 111.575 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -96.56 54.85 1.38 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 61.109999999999999 109.803 176.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.34 71.55 3.03 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 75.099999999999994 112.474 -172.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 38.95 58.07 1.83 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.539 0.736 . . . . 73.420000000000002 112.422 174.288 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -73.49 155.49 39.17 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 74.519999999999996 112.084 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.65 113.26 2.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.838 -0.619 . . . . 71.0 111.272 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -81.21 141.23 34.36 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.767 0.318 . . . . 75.420000000000002 111.687 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -178.06 138.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.723 0.409 . . . . 75.239999999999995 110.958 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 p80 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 119.292 -0.385 . . . . 73.409999999999997 111.172 178.097 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.743 ' HE1' HD12 ' A' ' 3' ' ' LEU . 24.8 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.086 0.47 . . . . 72.439999999999998 111.895 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -90.75 117.12 29.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.921 -0.582 . . . . 74.450000000000003 111.307 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.743 HD12 ' HE1' ' A' ' 1' ' ' MET . 24.0 mt -116.82 179.14 4.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 110.309 -0.256 . . . . 62.0 110.309 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.537 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 26.6 m -146.84 134.58 21.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.697 0.284 . . . . 64.510000000000005 111.006 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.7 113.36 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 122.259 -0.276 . . . . 70.409999999999997 110.778 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.567 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.9 OUTLIER 63.27 38.28 10.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.894 0.378 . . . . 75.109999999999999 111.203 179.083 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.08 -2.91 67.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.887 -0.673 . . . . 52.210000000000001 113.791 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.99 113.99 65.46 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.075 0.438 . . . . 73.319999999999993 111.094 176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.52 151.11 77.64 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.848 2.366 . . . . 71.420000000000002 112.922 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -151.3 109.73 3.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.277 0.561 . . . . 62.0 111.3 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.0 m -85.24 107.35 17.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.908 -0.587 . . . . 74.409999999999997 111.245 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.6 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.047 0.451 . . . . 71.519999999999996 112.091 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.07 149.84 40.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.899 0.381 . . . . 70.439999999999998 111.143 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.99 32.28 2.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.32 -0.4 . . . . 64.319999999999993 113.111 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.96 123.24 13.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.567 -0.372 . . . . 72.230000000000004 111.013 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.22 83.4 1.89 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.068 0.395 . . . . 72.219999999999999 112.068 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m 49.45 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.975 0.732 . . . . 74.239999999999995 112.975 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -135.17 154.49 51.6 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.19 0.441 . . . . 72.310000000000002 112.19 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p30 -71.73 167.8 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.037 0.446 . . . . 72.129999999999995 111.904 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.21 -42.21 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.288 -0.414 . . . . 62.119999999999997 111.939 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 32' ' ' ALA . 92.7 m -59.86 -44.44 94.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.671 0.272 . . . . 74.0 111.538 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -66.91 -37.17 83.84 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.245 -0.285 . . . . 60.219999999999999 111.271 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.452 HD22 HG23 ' A' ' 54' ' ' VAL . 56.4 tp -56.01 -56.55 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.084 0.469 . . . . 74.420000000000002 111.341 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.567 HD23 HG13 ' A' ' 35' ' ' VAL . 4.5 pp -68.09 -26.4 65.81 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.918 0.389 . . . . 73.120000000000005 111.53 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -65.77 -36.69 84.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.882 0.372 . . . . 64.209999999999994 111.015 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.34 67.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 73.0 111.165 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.553 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -85.31 -3.06 58.71 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.279 0.561 . . . . 64.150000000000006 109.925 175.34 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 65.74 28.2 11.04 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.189 0.596 . . . . 64.209999999999994 112.018 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 27' ' ' LEU . 58.3 t -73.2 113.03 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.526 -0.306 . . . . 64.319999999999993 111.007 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.69 158.04 19.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.488 -0.324 . . . . 53.340000000000003 111.287 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 41.3 mt-30 60.69 72.44 0.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.492 0.663 . . . . 73.049999999999997 110.769 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.576 ' HB3' HG21 ' A' ' 21' ' ' THR . . . -67.82 -16.24 64.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.07 0.767 . . . . 45.039999999999999 113.07 -171.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -41.58 3.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.62 -0.264 . . . . 60.119999999999997 111.465 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 22.5 m-85 -60.41 -21.18 61.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.037 0.384 . . . . 74.430000000000007 112.037 -177.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.567 HG13 HD23 ' A' ' 24' ' ' LEU . 10.1 p -60.26 149.61 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.092 0.472 . . . . 74.150000000000006 111.306 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -116.04 113.81 23.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.745 0.307 . . . . 72.439999999999998 111.024 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.38 149.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.959 0.409 . . . . 74.5 111.176 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 9.2 pt-20 -128.91 125.99 38.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.002 0.43 . . . . 74.010000000000005 111.597 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.599 ' HB2' HD22 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.68 110.36 17.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.223 -0.444 . . . . 65.219999999999999 110.797 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 63.03 29.63 16.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.204 0.526 . . . . 73.019999999999996 110.912 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.51 85.42 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.043 -0.598 . . . . 73.120000000000005 113.456 -175.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.79 111.32 23.78 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.644 -0.327 . . . . 65.329999999999998 110.92 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.28 138.03 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.409 0.522 . . . . 65.049999999999997 112.409 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.599 HD22 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -109.65 161.48 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.037 0.446 . . . . 75.120000000000005 111.103 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.71 155.17 19.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.145 -0.48 . . . . 74.439999999999998 109.892 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 2.3 mpt_? -53.99 -38.28 64.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.654 0.613 . . . . 75.25 112.654 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.35 -31.1 69.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.219 0.533 . . . . 73.010000000000005 110.804 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.52 -24.0 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.519999999999996 111.848 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -55.83 -41.1 73.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.403 0.621 . . . . 74.540000000000006 110.869 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -70.19 -37.86 75.21 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.202 -0.908 . . . . 63.219999999999999 111.869 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.66 -33.75 60.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.191 0.441 . . . . 74.019999999999996 112.191 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -82.05 104.61 12.52 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.788 0.327 . . . . 72.519999999999996 111.046 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 74.0 p -94.39 110.74 22.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.198 0.523 . . . . 72.120000000000005 111.781 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.452 HG23 HD22 ' A' ' 23' ' ' LEU . 97.1 t -74.14 127.46 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.718 -0.674 . . . . 42.210000000000001 111.454 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.409 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 19.6 ptmt -167.99 87.99 0.25 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.146 -0.479 . . . . 74.430000000000007 111.684 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.9 t70 66.02 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.14 -0.482 . . . . 44.5 112.241 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.12 40.13 83.1 Favored Glycine 0 N--CA 1.464 0.532 0 C-N-CA 120.899 -0.667 . . . . 63.530000000000001 112.245 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' HB3' HD21 ' A' ' 3' ' ' LEU . 17.2 t70 -106.83 164.18 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.905 0.482 . . . . 74.030000000000001 111.957 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.537 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -151.52 72.55 1.04 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.838 -0.619 . . . . 72.209999999999994 110.699 175.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.419 HG11 ' O ' ' A' ' 60' ' ' VAL . 7.3 p -83.32 95.95 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.801 0.81 . . . . 71.540000000000006 112.012 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.567 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 2.4 mp0 -73.7 103.7 4.36 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.189 0.518 . . . . 63.340000000000003 112.104 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.495 ' HZ ' ' HB3' ' A' ' 24' ' ' LEU . 11.7 m-85 -87.03 134.12 33.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.942 -0.572 . . . . 74.310000000000002 110.47 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.474 ' N ' HD22 ' A' ' 63' ' ' LEU . 2.1 pt? -148.06 130.33 15.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.625 0.602 . . . . 72.109999999999999 112.625 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 73.31 -31.39 0.22 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.253 1.205 . . . . 71.450000000000003 114.253 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -84.39 53.2 2.57 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.837 -0.539 . . . . 63.25 112.382 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -155.01 139.19 16.55 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.52 -0.309 . . . . 61.530000000000001 110.708 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.495 ' N ' ' SD ' ' A' ' 66' ' ' MET . . . 174.99 -27.2 0.08 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.209 -0.519 . . . . 61.520000000000003 113.402 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.6 122.9 25.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.341 -0.457 . . . . 36.710000000000001 113.558 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.97 -22.72 3.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.367 -0.444 . . . . 51.310000000000002 113.562 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.8 tttm 67.8 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.474 0.654 . . . . 75.310000000000002 112.3 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.35 134.69 34.09 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.148 0.499 . . . . 63.219999999999999 111.166 174.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.39 -52.12 66.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.772 -0.649 . . . . 73.129999999999995 112.152 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -119.04 -77.65 0.58 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.883 0.327 . . . . 65.409999999999997 111.883 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -171.28 151.69 3.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.016 0.376 . . . . 75.329999999999998 112.016 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -87.72 -58.58 2.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.729 0.3 . . . . 74.019999999999996 111.053 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 67.11 104.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.993 -0.549 . . . . 65.049999999999997 110.919 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -153.74 132.92 12.62 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.043 0.449 . . . . 73.030000000000001 111.936 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.6 m80 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.846 -0.597 . . . . 61.340000000000003 110.919 172.707 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.045 0.45 . . . . 70.409999999999997 112.01 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 2.3 m-20 -98.2 134.4 41.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.962 0.505 . . . . 73.439999999999998 110.803 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.502 ' HB3' HG13 ' A' ' 60' ' ' VAL . 2.7 mm? -126.48 134.9 50.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.773 0.321 . . . . 74.099999999999994 111.354 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -84.19 77.86 9.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.209 0.528 . . . . 74.109999999999999 110.357 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -80.82 121.89 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.023 0.44 . . . . 63.439999999999998 111.923 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 61.04 18.54 9.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.34 -0.391 . . . . 72.439999999999998 111.683 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.94 -3.15 64.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.28 -0.486 . . . . 38.469999999999999 113.091 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 10.3 mptt -108.29 132.87 20.8 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.819 0.31 . . . . 64.549999999999997 110.917 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 97.75 1.15 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.501 2.134 . . . . 60.130000000000003 113.61 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.1 t -98.47 179.42 4.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.035 -0.53 . . . . 44.240000000000002 111.096 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 93.9 m -149.73 121.41 8.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.106 0.41 . . . . 73.209999999999994 112.106 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 12' ' ' VAL . 34.9 m -100.26 109.03 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.564 0.697 . . . . 74.319999999999993 110.488 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.42 151.46 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.104 -0.498 . . . . 71.310000000000002 111.788 -176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.7 -43.06 3.14 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.293 -0.48 . . . . 74.349999999999994 113.314 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.9 153.9 21.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.295 0.48 . . . . 72.329999999999998 112.295 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.91 -72.26 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.344 -0.389 . . . . 73.019999999999996 111.496 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -110.25 96.01 5.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.884 0.373 . . . . 74.430000000000007 111.38 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 83.6 mt -127.36 152.03 48.01 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.728 0.299 . . . . 74.120000000000005 111.637 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -76.47 166.7 23.05 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.494 0.188 . . . . 54.229999999999997 110.613 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.42 -38.35 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.079 0.466 . . . . 73.219999999999999 110.352 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -59.62 -40.72 88.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.177 0.513 . . . . 73.030000000000001 110.776 172.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.418 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 6.0 mm-40 -69.58 -26.0 64.25 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.409 -0.36 . . . . 65.400000000000006 111.803 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.541 HD12 HG23 ' A' ' 54' ' ' VAL . 39.1 mt -63.71 -41.46 98.09 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.927 -0.397 . . . . 71.319999999999993 109.927 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.88 -41.08 90.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.281 -0.418 . . . . 61.439999999999998 110.408 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 m -59.36 -54.17 49.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.04 -0.527 . . . . 62.509999999999998 111.409 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.02 68.52 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.158 0.429 . . . . 38.469999999999999 112.158 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.6 mt -75.63 -6.22 49.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.503 -0.317 . . . . 64.439999999999998 111.715 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt 54.72 51.91 13.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.439999999999998 111.065 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.7 t -87.13 119.49 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 74.030000000000001 111.1 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.56 -28.86 65.22 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.934 0.397 . . . . 71.230000000000004 111.519 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.46 87.94 6.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.856 0.36 . . . . 64.409999999999997 111.513 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.75 -13.92 21.12 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.744 0.783 . . . . 75.420000000000002 110.624 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.26 -48.82 3.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.822 -1.081 . . . . 63.200000000000003 110.117 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.64 44.78 1.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.448 -0.796 . . . . 74.540000000000006 111.577 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.12 149.04 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 112.673 0.62 . . . . 64.409999999999997 112.673 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 m -145.41 112.44 6.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.056 -0.52 . . . . 61.409999999999997 111.027 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 62' ' ' PHE . 35.7 m -144.46 160.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.422 0.289 . . . . 63.299999999999997 111.427 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.594 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -133.62 147.86 51.5 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.561 0.696 . . . . 73.329999999999998 111.249 172.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.474 ' HB2' HD23 ' A' ' 44' ' ' LEU . 2.6 tm? -108.54 105.09 14.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.724 -0.671 . . . . 63.229999999999997 110.233 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 56.2 35.58 25.97 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.795 0.331 . . . . 71.439999999999998 111.434 -175.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.43 -17.56 57.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 121.127 -0.558 . . . . 51.039999999999999 113.617 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.58 100.34 11.35 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.447 -0.443 . . . . 74.140000000000001 111.121 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.46 140.42 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.363 . . . . 74.450000000000003 111.387 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -99.72 136.53 39.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.921 0.391 . . . . 55.240000000000002 111.552 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.75 146.5 37.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.436 -0.347 . . . . 72.310000000000002 110.499 172.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.425 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -53.02 -21.82 4.98 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.1 0.476 . . . . 74.540000000000006 111.893 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.81 -27.67 24.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.558 0.577 . . . . 73.030000000000001 112.558 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.18 11.19 37.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.589 0.959 . . . . 65.200000000000003 113.589 -169.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.425 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 18.4 m-85 -59.68 -49.17 78.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.245 0.461 . . . . 65.200000000000003 112.245 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.12 -23.86 54.89 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.074 0.464 . . . . 64.030000000000001 111.202 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.97 -17.12 57.53 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.11 0.411 . . . . 38.469999999999999 112.11 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.8 m -103.64 120.87 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.725 0.298 . . . . 63.310000000000002 111.377 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.4 p -89.9 150.14 22.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.424 0.63 . . . . 75.019999999999996 112.146 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.541 HG23 HD12 ' A' ' 23' ' ' LEU . 46.4 t -115.81 142.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.633 -0.712 . . . . 70.439999999999998 110.724 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -137.47 176.35 8.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.442 . . . . 73.209999999999994 112.005 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.46 145.85 50.69 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.026 0.441 . . . . 73.340000000000003 111.975 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.56 30.71 78.06 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.062 -0.517 . . . . 71.109999999999999 113.063 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -109.56 142.52 40.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.821 0.343 . . . . 72.049999999999997 111.121 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.0 85.57 5.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.88 0.696 . . . . 65.409999999999997 112.88 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG13 ' HB3' ' A' ' 3' ' ' LEU . 5.6 p -86.94 107.96 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.492 0.663 . . . . 71.030000000000001 110.461 173.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.594 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 34.1 mt-10 -94.21 97.62 10.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.383 0.611 . . . . 74.140000000000001 111.247 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.588 ' HA ' HG12 ' A' ' 37' ' ' VAL . 42.5 t80 -89.56 115.9 27.31 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.528 -0.76 . . . . 73.239999999999995 111.22 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.0 mt -91.8 125.16 36.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.87 0.367 . . . . 73.420000000000002 111.5 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -81.27 22.63 0.65 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.902 0.334 . . . . 75.140000000000001 111.902 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 61.28 29.96 18.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.966 0.506 . . . . 74.519999999999996 111.729 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 66' ' ' MET . 0.0 OUTLIER 54.98 88.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.151 0.501 . . . . 71.140000000000001 111.179 -176.446 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.25 18.01 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.102 -0.57 . . . . 75.230000000000004 113.321 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.42 -22.24 17.35 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.085 -0.579 . . . . 53.509999999999998 113.159 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 -84.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.497 -0.383 . . . . 70.209999999999994 112.827 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.2 30.09 3.63 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.766 0.427 . . . . 64.420000000000002 110.842 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.2 mt 66.78 -172.55 0.19 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.054 -0.521 . . . . 64.310000000000002 111.714 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.63 115.38 8.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.064 0.459 . . . . 64.239999999999995 111.404 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -128.98 78.31 1.85 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.219 0.533 . . . . 74.349999999999994 111.512 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -87.54 -47.98 8.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 64.530000000000001 110.051 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 t60 65.15 153.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.077 -0.511 . . . . 73.439999999999998 111.626 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -55.48 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.002 -0.436 . . . . 74.109999999999999 111.599 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -133.34 140.16 47.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.864 0.364 . . . . 74.409999999999997 111.139 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.252 1.186 0 CA-C-N 116.279 -0.419 . . . . 72.019999999999996 111.449 178.487 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.771 0.319 . . . . 64.3 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -75.47 130.12 38.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.126 0.417 . . . . 62.01 112.126 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -141.73 118.19 10.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.198 -0.456 . . . . 53.03 111.475 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' LYS . 67.2 m -76.19 97.82 4.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.182 0.515 . . . . 70.32 110.985 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 46.5 t -93.05 107.84 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.288 -0.414 . . . . 74.25 111.21 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.03 35.51 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.939 0.4 . . . . 53.12 112.031 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.42 76.23 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.048 -0.596 . . . . 65.44 113.645 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' THR . 28.5 mtpp -91.96 113.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 122.438 -0.448 . . . . 73.13 111.272 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.62 65.41 4.73 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.554 2.17 . . . . 74.12 112.182 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t -102.83 176.74 5.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.455 0.645 . . . . 71.15 111.661 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -148.95 134.42 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.887 -0.597 . . . . 74.4 111.234 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.63 119.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.276 -0.42 . . . . 71.14 110.004 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.76 111.05 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.155 0.502 . . . . 72.53 111.796 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.47 2.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.908 -0.587 . . . . 42.41 112.936 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.84 92.53 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.3 0.571 . . . . 73.4 111.827 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -79.91 84.33 5.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.15 0.5 . . . . 74.15 110.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.6 p 61.63 114.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.176 0.99 . . . . 50.53 112.598 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.4 mt -130.61 131.59 45.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.413 -0.358 . . . . 74.44 110.994 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.5 p-10 -80.46 171.86 14.5 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.198 -0.314 . . . . 75.23 110.363 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.2 t -56.5 -37.98 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.717 0.294 . . . . 74.21 111.156 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.0 m -55.73 -46.65 77.74 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.891 0.377 . . . . 71.23 111.116 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -67.38 -29.95 69.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.175 0.435 . . . . 52.05 112.175 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.01 -37.37 81.33 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.095 0.474 . . . . 61.21 110.329 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 35' ' ' VAL . 91.0 mt -63.75 -37.86 88.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.161 -0.472 . . . . 75.24 111.298 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -76.54 -38.19 55.46 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.434 -0.348 . . . . 64.04 111.117 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.03 90.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.036 0.446 . . . . 54.33 111.397 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -80.26 -17.99 50.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.274 0.559 . . . . 70.23 110.478 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 tptt 67.02 82.52 0.18 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.212 -0.904 . . . . 73.42 112.753 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.85 142.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.967 -0.56 . . . . 64.13 110.77 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -42.84 15.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.794 0.33 . . . . 60.05 111.729 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -87.94 76.58 8.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.099 0.476 . . . . 54.01 111.064 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.38 -23.9 67.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.271 0.471 . . . . 61.12 112.271 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -93.26 -8.8 41.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.257 0.466 . . . . 51.43 112.257 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.43 4.71 6.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 71.22 112.031 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 24' ' ' LEU . 7.2 p -68.62 130.35 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.452 0.644 . . . . 71.33 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -112.96 112.06 23.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.062 -0.517 . . . . 70.24 111.016 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 62' ' ' PHE . 29.8 m -139.33 158.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.35 -0.386 . . . . 73.05 111.402 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 3.5 pm0 -132.26 169.62 16.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.194 0.521 . . . . 71.05 110.945 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 39' ' ' LEU . 2.4 pp -133.98 124.59 26.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.669 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 56.47 18.87 3.75 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.206 -0.452 . . . . 74.54 111.531 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.62 2.18 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.324 -0.465 . . . . 60.22 113.744 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.19 120.57 15.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.925 0.363 . . . . 64.21 111.195 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.79 143.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.918 0.39 . . . . 72.11 111.71 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -91.59 139.3 30.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.076 0.465 . . . . 74.12 111.732 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.47 163.61 24.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.058 -0.519 . . . . 75.32 111.009 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 46' ' ' ARG . 9.1 ptp85 -47.74 -24.04 0.85 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.355 0.872 . . . . 62.42 113.355 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -119.92 7.11 10.88 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.482 0.549 . . . . 52.53 112.482 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -12.11 34.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.102 0.408 . . . . 75.42 112.102 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 62.7 m-85 -62.17 -38.84 90.57 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.065 0.395 . . . . 73.15 112.065 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' HD22 ' A' ' 19' ' ' ASN . 26.1 m-20 -72.77 -56.2 5.6 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.422 0.527 . . . . 71.32 112.422 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.69 88.21 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.886 0.698 . . . . 61.52 112.886 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.458 HG21 HD21 ' A' ' 39' ' ' LEU . 99.7 m -74.32 98.15 3.17 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.236 0.541 . . . . 75.12 112.04 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 62.6 p -84.81 127.72 34.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.926 -0.579 . . . . 71.44 111.341 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.02 151.67 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.103 0.478 . . . . 64.32 110.881 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.08 -170.02 2.78 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.979 0.418 . . . . 73.04 111.916 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 136.68 56.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.437 -0.347 . . . . 75.41 111.487 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 50.43 5.25 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.168 -0.539 . . . . 53.14 113.366 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.57 -178.78 5.67 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.629 -0.336 . . . . 65.45 110.523 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.64 107.74 6.75 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.29 0.478 . . . . 73.04 112.29 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.6 p -103.11 116.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.441 0.638 . . . . 72.04 111.129 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 46.9 mt-10 -96.45 110.47 22.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.209 0.528 . . . . 71.33 111.08 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' VAL . 56.5 t80 -100.57 114.7 28.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.863 -0.608 . . . . 74.3 111.032 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.951 0.405 . . . . 74.15 111.687 -178.964 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.256 0.551 . . . . 73.32 111.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.5 121.06 29.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.381 -0.372 . . . . 62.21 111.625 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.22 114.03 18.44 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.809 0.338 . . . . 75.04 111.25 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 28.5 m -76.05 77.5 2.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.558 0.694 . . . . 75.41 110.917 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.7 t -74.22 114.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.018 -0.537 . . . . 53.01 111.886 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.09 19.83 11.16 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.411 -0.359 . . . . 43.22 111.771 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.67 55.71 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.923 -0.656 . . . . 63.32 113.52 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.98 115.65 65.67 Favored Pre-proline 0 N--CA 1.471 0.596 0 O-C-N 122.3 -0.529 . . . . 75.44 111.236 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.85 96.15 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.868 2.379 . . . . 73.05 112.303 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 m -97.47 100.86 12.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.141 0.496 . . . . 72.34 111.243 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.6 m -73.96 84.09 1.74 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.346 -0.388 . . . . 53.04 111.083 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -97.33 113.43 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 73.45 111.057 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.87 -179.82 3.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.94 -0.475 . . . . 72.42 111.151 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.4 84.77 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.058 -0.592 . . . . 73.34 112.318 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.36 98.01 2.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.043 0.449 . . . . 74.15 110.225 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.38 82.17 2.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.306 -0.407 . . . . 74.24 112.025 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p 64.51 143.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 74.52 113.545 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.6 pp -156.34 175.43 14.02 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.807 -0.633 . . . . 74.14 111.268 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -97.85 172.24 7.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.739 0.304 . . . . 64.23 110.972 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.02 -36.58 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.882 0.372 . . . . 71.14 111.757 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -56.3 -45.78 80.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.189 0.518 . . . . 34.44 111.264 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 12.0 mm-40 -64.13 -41.36 97.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.978 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.77 -51.39 56.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.204 -0.453 . . . . 75.01 111.319 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.481 HD11 HG21 ' A' ' 35' ' ' VAL . 4.5 mm? -55.33 -44.72 76.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.901 0.382 . . . . 42.43 111.481 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 t -67.58 -27.96 67.37 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.791 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.71 -41.71 44.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.968 0.414 . . . . 75.3 111.578 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.55 -6.99 59.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.045 0.387 . . . . 71.55 112.045 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.788 0.435 . . . . 52.15 111.78 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.69 120.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.057 0.456 . . . . 71.01 111.737 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.03 36.38 0.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.955 0.502 . . . . 75.32 112.204 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.95 35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.216 0.451 . . . . 72.25 112.216 -174.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.64 50.29 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.132 0.419 . . . . 64.15 112.132 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.08 -24.54 28.04 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.117 0.484 . . . . 74.12 111.928 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -107.56 -4.45 18.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.739 0.304 . . . . 64.12 111.76 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 37' ' ' VAL . 7.4 p -68.27 89.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.868 0.842 . . . . 72.41 113.058 -172.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -82.18 93.42 7.06 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.907 -0.588 . . . . 71.04 110.941 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 62' ' ' PHE . 17.2 m -110.8 141.14 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.099 0.476 . . . . 64.14 111.63 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.77 119.85 27.9 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.573 0.702 . . . . 71.25 111.751 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -82.11 115.76 21.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.704 -0.68 . . . . 71.03 110.849 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 27.51 17.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.802 0.334 . . . . 75.12 111.697 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.61 5.26 66.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.343 -0.455 . . . . 72.43 113.633 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -114.54 117.85 32.07 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.529 -0.395 . . . . 73.4 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -74.27 139.72 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.956 0.408 . . . . 62.32 111.74 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 39' ' ' LEU . 3.3 mm? -101.35 153.69 19.44 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.264 0.554 . . . . 63.25 112.261 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 157.25 30.13 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.571 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -60.18 -33.01 71.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.961 0.41 . . . . 73.44 111.567 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -70.92 -32.65 69.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.393 0.616 . . . . 74.23 110.528 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HA ' ' HB3' ' A' ' 51' ' ' ALA . . . -71.99 -13.75 61.7 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.093 -0.503 . . . . 63.41 112.191 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -56.71 -45.6 81.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.021 0.439 . . . . 71.0 111.034 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.5 -21.31 35.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.113 -0.494 . . . . 64.21 111.281 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . . . -97.76 21.82 9.96 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.389 0.514 . . . . 61.22 112.389 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.8 m -133.82 113.69 12.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.81 0.338 . . . . 75.33 111.169 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.3 p -81.66 126.83 32.25 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.11 0.481 . . . . 63.53 111.837 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.52 113.65 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.622 -0.717 . . . . 75.02 109.538 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -144.74 -161.46 1.3 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.934 0.397 . . . . 74.21 111.597 -170.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.11 93.35 0.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.937 -0.477 . . . . 75.14 112.119 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.0 10.88 1.69 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.114 -0.565 . . . . 41.5 114.488 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.06 130.19 40.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.154 0.977 . . . . 41.12 112.108 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -85.93 66.14 9.46 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.399 0.619 . . . . 64.33 110.428 175.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.1 p -73.69 99.71 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.718 0.771 . . . . 42.12 112.009 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.49 78.57 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.304 0.573 . . . . 60.54 110.954 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' VAL . 36.0 t80 -73.77 96.37 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.102 -0.703 . . . . 75.5 109.102 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 113.037 0.755 . . . . 72.3 113.037 -170.684 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 111.659 0.244 . . . . 74.44 111.659 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.64 127.81 45.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.824 0.345 . . . . 75.41 111.246 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.55 140.85 49.86 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.975 0.417 . . . . 73.25 111.519 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -91.2 76.7 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.437 0.637 . . . . 61.2 110.133 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 39.5 t -74.0 110.01 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.892 -0.595 . . . . 74.12 111.827 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 m120 58.95 26.02 14.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.824 0.45 . . . . 72.4 111.559 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.28 -4.77 74.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.94 -0.647 . . . . 42.5 113.243 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.6 mptt -101.28 139.16 20.22 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.366 -0.49 . . . . 65.51 110.894 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.66 121.97 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.509 2.139 . . . . 74.11 113.0 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.2 t -133.65 156.54 47.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.008 -0.542 . . . . 73.3 110.539 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -135.85 113.91 11.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.204 -0.31 . . . . 75.12 111.524 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.3 m -91.57 108.55 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.334 0.588 . . . . 55.1 110.919 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.92 143.22 30.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.943 -0.571 . . . . 51.34 111.113 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.96 21.96 31.8 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.406 -0.426 . . . . 55.33 112.836 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.03 136.42 4.12 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.197 0.443 . . . . 72.21 112.197 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.06 -40.94 7.37 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.19 -0.459 . . . . 65.3 110.766 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.0 p -164.32 112.38 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 75.22 111.267 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.76 160.31 32.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.218 -0.446 . . . . 61.43 110.536 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -72.86 162.54 29.36 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.654 0.264 . . . . 71.01 110.319 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.4 t -59.33 -34.83 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 122.152 -0.343 . . . . 45.54 111.433 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -60.29 -53.72 54.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.76 0.314 . . . . 75.11 111.819 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.81 0.338 . . . . 72.24 111.192 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.5 -45.95 91.91 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.804 -0.443 . . . . 51.31 109.804 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 95.0 mt -59.3 -39.73 83.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.947 0.403 . . . . 72.44 111.136 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -69.97 -32.18 70.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.084 0.469 . . . . 75.21 111.441 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.05 -47.35 58.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.909 0.385 . . . . 51.32 111.477 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.59 -20.43 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.276 -0.42 . . . . 73.22 111.331 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 65.78 76.49 0.32 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.697 0.761 . . . . 65.43 111.541 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.67 146.2 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.581 -0.736 . . . . 73.4 110.915 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.18 3.18 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.174 0.435 . . . . 72.42 112.174 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.38 98.98 10.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.939 0.399 . . . . 74.11 111.8 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -86.52 -29.51 22.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.166 0.507 . . . . 52.24 111.311 177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -79.41 -23.54 43.15 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.013 -0.54 . . . . 74.41 111.536 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -112.43 11.57 19.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 72.44 112.116 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 37' ' ' VAL . 7.3 p -75.73 88.91 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.838 0.828 . . . . 50.04 112.147 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -76.54 95.94 4.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.812 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 35' ' ' VAL . 35.4 m -120.3 158.42 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.428 -0.351 . . . . 60.34 110.975 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.6 134.45 43.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.78 0.8 . . . . 74.14 112.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD13 ' OD1' ' A' ' 40' ' ' ASN . 1.0 OUTLIER -78.24 103.23 8.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.968 -1.015 . . . . 73.22 110.757 -176.177 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 39' ' ' LEU . 2.4 m-20 58.14 24.41 11.27 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.875 0.369 . . . . 74.31 111.728 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.82 40.63 4.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.941 -0.647 . . . . 63.54 112.608 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.32 105.66 3.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.788 0.435 . . . . 75.11 110.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.66 138.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.641 0.608 . . . . 75.11 112.641 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -89.86 153.77 20.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.357 0.599 . . . . 73.51 111.72 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.19 160.5 26.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.399 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 38.0 ptt180 -37.07 -48.04 0.77 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.013 1.116 . . . . 74.44 114.013 -176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 13.8 pt-20 -107.41 0.52 22.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.278 0.473 . . . . 74.41 112.278 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.71 65.28 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.945 0.402 . . . . 74.04 111.279 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -58.83 -41.24 86.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.133 -0.485 . . . . 62.22 111.44 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -82.02 -32.17 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.134 -0.484 . . . . 74.11 110.963 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.81 46.08 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.821 0.674 . . . . 74.31 112.821 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.3 m -96.47 122.2 39.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.871 0.367 . . . . 74.14 111.606 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 m -91.64 106.94 18.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.418 -0.355 . . . . 74.25 111.226 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.42 115.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.953 0.406 . . . . 64.1 110.997 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -112.0 -167.43 1.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.854 0.359 . . . . 75.22 111.648 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.39 133.83 37.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.872 0.368 . . . . 74.11 111.887 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.99 43.62 8.1 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.353 -0.451 . . . . 43.42 113.669 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -116.08 140.72 49.0 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.556 -0.379 . . . . 74.05 110.808 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.86 74.12 2.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.234 0.54 . . . . 61.11 111.643 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 34.6 m -82.4 125.39 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.407 0.622 . . . . 73.32 111.365 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -92.04 101.42 13.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.384 0.612 . . . . 70.55 111.157 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 37' ' ' VAL . 5.2 t80 -103.92 99.9 9.67 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.471 -0.786 . . . . 71.12 109.553 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.6 pt? . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.819 0.343 . . . . 62.31 111.584 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.35 127.2 34.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.407 -0.36 . . . . 72.2 110.88 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -133.33 176.01 8.9 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.117 0.484 . . . . 75.43 111.109 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 m -141.04 132.23 26.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.374 -0.375 . . . . 73.33 111.185 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.53 121.12 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.74 0.305 . . . . 54.31 111.376 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 61' ' ' GLU . 15.9 m120 65.72 14.36 9.49 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.01 0.374 . . . . 73.2 112.01 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.73 -2.41 72.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.238 -0.506 . . . . 44.11 112.087 -172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -97.7 110.78 56.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.379 0.671 . . . . 70.22 110.655 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.8 123.54 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.189 2.593 . . . . 74.24 113.724 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -136.51 100.86 4.47 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.216 0.531 . . . . 75.31 111.314 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.8 m -80.65 95.57 6.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.036 0.446 . . . . 75.42 111.66 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 12' ' ' VAL . 16.9 m -81.96 79.6 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.967 0.889 . . . . 65.51 110.463 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.54 170.69 14.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.945 -0.571 . . . . 73.11 111.168 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 25.3 68.31 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.581 -0.819 . . . . 75.41 111.533 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.29 123.2 10.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.728 0.411 . . . . 63.34 110.698 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -74.54 -68.73 0.51 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.205 0.526 . . . . 72.33 111.785 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -167.26 132.96 2.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.393 -0.821 . . . . 71.41 109.274 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 1.2 pp -149.99 163.07 39.09 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.039 0.755 . . . . 73.4 113.039 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.05 159.16 20.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.047 -0.524 . . . . 43.33 111.102 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 50.6 t -57.33 -43.74 82.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.015 0.435 . . . . 72.53 110.485 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.1 m -60.34 -45.65 92.68 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.42 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -59.72 -36.99 77.69 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.035 0.445 . . . . 54.44 110.632 176.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.94 -44.18 97.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.191 0.52 . . . . 73.32 110.385 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 89.1 mt -58.64 -34.72 71.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.01 -0.541 . . . . 65.11 110.759 174.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.9 t -68.19 -43.02 79.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.58 . . . . 54.22 111.406 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -46.29 76.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.261 0.467 . . . . 64.41 112.261 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 mm? -94.11 -6.89 43.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.662 -0.244 . . . . 61.32 111.626 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? 57.49 89.02 0.05 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.395 0.617 . . . . 65.11 111.649 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.826 -0.624 . . . . 64.32 111.686 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.85 -49.13 18.86 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.041 0.448 . . . . 63.41 111.517 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -123.15 142.38 50.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.964 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -110.71 -40.2 4.64 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.294 0.568 . . . . 54.31 111.974 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -80.63 -30.4 36.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 70.33 111.118 175.545 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -91.23 -7.15 52.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.403 0.52 . . . . 73.14 112.403 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 32' ' ' ALA . 9.7 p -58.7 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 122.007 0.908 . . . . 52.41 112.211 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -84.52 92.21 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.758 -0.655 . . . . 74.33 110.949 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 35' ' ' VAL . 28.7 m -125.0 141.95 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.953 -0.567 . . . . 74.31 110.999 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.8 pt-20 -118.26 122.16 42.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.686 0.755 . . . . 74.52 111.818 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.22 107.22 13.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.585 -0.734 . . . . 73.31 109.89 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.24 38.46 8.04 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.0 0.428 . . . . 64.52 111.282 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.85 29.67 58.85 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.206 -0.521 . . . . 62.45 113.665 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 38' ' ' GLU . 41.4 tt0 -148.91 115.75 5.99 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.466 -0.432 . . . . 64.51 110.798 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 14.7 p -77.37 147.44 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 113.069 0.766 . . . . 73.12 113.069 -173.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -106.37 157.79 17.36 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.059 -0.519 . . . . 74.25 111.008 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.571 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 tt0 -76.4 159.59 30.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.858 0.361 . . . . 74.31 111.437 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -49.65 -49.24 48.01 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 73.41 113.936 -169.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -80.78 -23.14 39.52 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.564 -0.71 . . . . 75.04 111.689 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.13 49.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.285 0.476 . . . . 70.12 112.285 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.99 -30.53 70.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.778 0.323 . . . . 73.42 111.719 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.96 -21.48 27.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.795 0.331 . . . . 73.53 111.479 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.02 1.96 56.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.095 0.406 . . . . 75.23 112.095 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -116.1 116.45 27.89 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.582 0.229 . . . . 54.43 111.471 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -89.4 109.83 20.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.116 0.484 . . . . 71.35 111.65 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.35 137.32 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 74.2 110.521 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -135.67 176.08 9.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.232 0.539 . . . . 71.14 111.771 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.65 105.61 0.32 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.023 -0.535 . . . . 73.13 112.095 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.81 7.89 12.67 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.483 -0.389 . . . . 65.13 113.343 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.94 153.47 21.56 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.52 . . . . 65.24 111.764 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.85 107.65 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 75.42 111.631 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.27 110.85 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.792 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 6' ' ' ASN . 39.0 mt-10 -98.89 111.65 23.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.387 0.613 . . . . 63.42 112.339 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -80.77 130.92 35.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.383 -0.826 . . . . 74.51 111.468 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.47 0.561 0 O-C-N 122.083 -0.386 . . . . 64.4 112.011 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HD21 ' A' ' 3' ' ' LEU . 23.1 ptp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.679 0.276 . . . . 75.11 111.641 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -99.29 124.39 44.34 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.407 -0.36 . . . . 71.12 111.001 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.7 mm? -119.5 129.06 54.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.734 0.302 . . . . 75.51 111.155 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -78.69 73.02 5.25 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.414 0.626 . . . . 75.34 110.185 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -70.81 110.4 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.332 0.586 . . . . 75.42 112.099 -173.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.4 m120 59.71 21.48 10.23 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.134 -0.485 . . . . 54.25 111.879 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.1 -4.29 62.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.869 -0.681 . . . . 75.41 113.035 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 mptp? -102.53 136.51 19.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.377 0.271 . . . . 71.44 110.685 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.37 104.55 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.264 1.976 . . . . 72.52 113.178 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 t -114.0 153.53 29.19 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.148 -0.345 . . . . 71.54 110.655 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -135.51 114.34 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.096 0.406 . . . . 62.1 112.096 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.69 112.08 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.508 0.67 . . . . 71.25 110.104 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.72 148.55 50.22 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.633 -0.712 . . . . 71.43 112.367 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.77 -58.35 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.498 -0.382 . . . . 63.53 113.44 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.38 110.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.175 0.435 . . . . 72.33 112.175 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' HE2' ' A' ' 1' ' ' MET . 42.8 mt-10 -94.18 -55.46 3.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 74.54 111.494 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 p -143.4 115.86 8.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.391 -0.368 . . . . 61.44 111.44 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -157.63 165.35 35.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.371 -0.377 . . . . 74.33 111.855 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 40.3 m-20 -66.37 160.95 23.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.605 0.241 . . . . 61.34 111.27 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 56.3 t -56.17 -41.9 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.014 0.435 . . . . 71.24 110.6 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 m -59.03 -47.21 86.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.083 0.468 . . . . 74.04 111.346 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 51.7 mt-10 -65.73 -31.6 72.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.955 0.407 . . . . 74.41 111.102 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.5 -46.74 78.5 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.856 -0.424 . . . . 72.21 109.856 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 90.6 mt -56.8 -36.21 69.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.161 -0.472 . . . . 63.34 111.047 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.6 t -64.52 -55.81 18.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 71.14 111.328 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.89 78.47 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 64.24 112.378 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 tp -79.6 -22.85 43.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.843 0.354 . . . . 60.24 111.42 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? 63.1 81.65 0.2 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.321 0.581 . . . . 73.42 109.731 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 31' ' ' GLN . 12.5 p -93.62 151.42 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.977 -0.556 . . . . 33.51 111.737 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.41 70.27 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.005 0.372 . . . . 52.13 112.005 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.542 ' H ' HG22 ' A' ' 29' ' ' VAL . 61.8 mm-40 -127.03 134.85 50.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.612 -0.267 . . . . 52.21 110.683 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.83 9.3 8.82 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.397 0.618 . . . . 63.12 111.48 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -32.45 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.524 -0.762 . . . . 74.32 111.305 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.48 -19.74 29.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.787 0.327 . . . . 72.03 111.54 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 37' ' ' VAL . 7.1 p -68.56 126.15 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.789 0.663 . . . . 72.03 112.789 -173.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -102.52 98.84 8.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.713 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 HG22 ' A' ' 35' ' ' VAL . 14.6 m -103.57 95.87 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.463 0.649 . . . . 72.32 111.283 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 10.1 pt-20 -95.48 94.35 7.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.482 0.658 . . . . 73.44 111.314 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -68.41 114.95 7.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.359 0.599 . . . . 64.14 112.025 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 59.09 39.49 23.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.901 -0.59 . . . . 50.51 111.748 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.82 48.66 40.31 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.032 -0.604 . . . . 75.02 113.194 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.06 108.58 3.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.957 0.408 . . . . 62.42 110.657 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.84 136.4 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.579 0.585 . . . . 54.25 112.579 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.7 mm? -101.74 152.35 20.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.033 -0.531 . . . . 74.13 110.824 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' N ' ' HB3' ' A' ' 48' ' ' ALA . 45.4 mt-10 -68.56 169.35 11.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.282 0.563 . . . . 74.54 111.969 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -58.85 -35.68 73.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.867 -0.606 . . . . 72.15 110.451 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.54 -42.12 22.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.43 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' A' ' 45' ' ' GLU . . . -56.66 -20.85 23.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.09 0.774 . . . . 63.32 113.09 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -56.03 -34.25 65.69 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.042 0.449 . . . . 63.21 111.136 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -81.62 -32.6 31.91 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.364 -0.38 . . . . 73.03 111.17 175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.39 59.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.629 0.603 . . . . 75.41 112.629 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -113.11 119.24 37.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.756 0.313 . . . . 75.21 111.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 83.4 m -96.16 124.69 40.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.335 0.588 . . . . 71.34 112.328 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.64 151.77 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.889 -0.596 . . . . 74.43 110.897 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -147.76 -178.19 6.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.875 0.369 . . . . 74.35 111.624 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 26.2 t70 -58.46 119.01 6.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.163 0.506 . . . . 73.3 112.359 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.38 54.22 1.1 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.188 -0.46 . . . . 62.24 113.662 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.04 154.71 48.25 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.884 0.342 . . . . 64.34 111.035 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.82 1.83 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 39' ' ' LEU . 30.2 m -82.18 107.87 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.41 111.182 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 44.1 mt-10 -77.46 93.33 4.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.519 0.675 . . . . 73.13 110.804 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -80.08 92.11 5.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.365 -0.834 . . . . 73.5 110.431 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.172 0.511 . . . . 71.33 112.225 -176.236 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 20.4 ptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.91 0.386 . . . . 71.11 111.847 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -75.89 129.91 37.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.087 -0.506 . . . . 64.21 111.788 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.8 mt -139.12 153.07 47.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.947 0.404 . . . . 70.34 111.661 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.5 m -109.18 126.47 53.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.934 0.397 . . . . 74.33 111.34 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 62' ' ' PHE . 4.7 p -133.83 124.08 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.5 -0.318 . . . . 32.42 110.95 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.53 26.39 15.68 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.143 0.497 . . . . 74.14 111.163 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.28 16.8 80.41 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.24 -0.505 . . . . 72.02 112.74 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -103.35 117.98 58.87 Favored Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 122.761 -0.258 . . . . 64.13 110.793 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.21 116.44 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.447 2.098 . . . . 73.1 111.528 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 t -141.77 -173.95 3.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.933 0.397 . . . . 75.13 111.448 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -159.55 126.68 4.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 72.24 111.734 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 12' ' ' VAL . 18.9 m -96.05 99.09 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.595 0.712 . . . . 54.24 110.437 175.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.45 137.71 33.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.993 -0.549 . . . . 74.12 110.875 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.5 56.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.28 -0.486 . . . . 41.13 113.207 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.01 97.57 8.41 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.412 -0.464 . . . . 75.4 111.517 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -77.45 76.73 3.99 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.317 0.579 . . . . 70.45 111.669 -177.485 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.2 m 53.48 71.19 0.52 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.952 -0.567 . . . . 73.35 111.463 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 80.5 mt -93.3 145.75 24.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.272 0.558 . . . . 62.11 112.106 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 18.2 m-20 -70.51 163.98 25.71 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.857 -0.611 . . . . 75.14 110.037 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.5 -41.53 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.818 0.342 . . . . 71.33 110.608 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -61.69 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.926 0.393 . . . . 75.52 111.842 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 43.0 mt-10 -68.4 -43.75 76.56 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.11 0.481 . . . . 71.34 111.131 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.28 -37.66 86.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.311 0.577 . . . . 75.32 109.968 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.13 -34.95 70.79 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.699 -0.682 . . . . 64.34 110.833 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -74.66 -33.59 62.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.369 -0.378 . . . . 72.31 111.327 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.77 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.157 0.504 . . . . 61.31 111.6 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.0 mt -90.44 -29.77 17.77 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.286 0.565 . . . . 72.54 110.216 171.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 57.51 86.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.057 -0.974 . . . . 74.12 112.565 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.2 159.42 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.558 -0.746 . . . . 53.12 110.538 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.73 -63.77 1.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.054 0.454 . . . . 65.1 111.773 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -102.3 136.96 41.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.551 -0.295 . . . . 75.34 110.676 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.26 -55.52 2.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 75.41 111.545 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -63.02 -11.72 21.08 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.826 -0.625 . . . . 62.1 112.301 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.81 3.02 36.26 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.322 0.49 . . . . 75.14 112.322 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG12 HG13 ' A' ' 37' ' ' VAL . 81.3 t -74.39 138.19 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.321 0.581 . . . . 71.02 112.341 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.4 m -115.83 108.54 16.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.128 -0.487 . . . . 72.35 110.575 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.0 m -134.04 162.23 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.19 0.519 . . . . 71.14 111.891 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.09 169.61 17.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.577 -0.738 . . . . 74.15 110.563 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 39' ' ' LEU . 2.0 pt? -143.92 129.09 18.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 72.03 111.078 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.75 21.08 11.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.173 0.511 . . . . 55.21 111.005 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 55.78 2.98 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.04 -0.527 . . . . 74.4 113.374 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 126.15 2.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.914 0.357 . . . . 73.41 110.651 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.76 136.04 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.21 0.528 . . . . 74.31 112.352 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.58 166.78 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.667 0.746 . . . . 73.03 112.547 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.06 149.46 33.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.5 -0.773 . . . . 65.21 110.964 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 9.1 mpt_? -64.34 -41.31 96.84 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.185 -0.322 . . . . 72.43 111.864 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.25 -29.76 69.48 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.19 0.519 . . . . 74.3 111.058 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.28 65.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.279 -0.419 . . . . 73.44 111.585 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -62.13 -30.63 71.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.697 0.284 . . . . 74.3 111.508 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.7 -35.82 72.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.873 0.368 . . . . 70.43 111.54 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.87 -29.81 24.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.203 0.446 . . . . 73.31 112.203 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 m -82.03 113.69 20.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.758 0.314 . . . . 63.45 111.832 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.0 m -96.87 140.61 31.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.229 0.538 . . . . 73.04 111.881 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 55' ' ' LYS . 17.4 t -90.44 160.64 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.116 -0.493 . . . . 62.51 111.112 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.9 pttm -141.38 169.94 16.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.979 0.418 . . . . 72.13 111.805 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 27.8 t70 -70.88 111.45 6.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.133 0.492 . . . . 63.34 110.97 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.71 39.77 3.79 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.175 -0.466 . . . . 52.21 112.096 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -122.82 175.32 6.61 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 110.006 -0.368 . . . . 71.32 110.006 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.67 143.77 43.3 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.245 0.545 . . . . 53.24 112.459 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 5' ' ' VAL . 24.0 m -130.5 71.06 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.805 0.812 . . . . 75.24 109.677 172.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.21 83.11 0.73 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.763 0.792 . . . . 62.22 111.568 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.513 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.6 m-85 -77.4 92.26 3.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.09 -0.959 . . . . 73.45 111.767 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.346 0.593 . . . . 73.24 112.027 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.558 ' HG3' HD21 ' A' ' 3' ' ' LEU . 21.1 ptp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.693 0.282 . . . . 63.32 111.272 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.6 m-20 -95.46 119.98 34.92 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.803 0.335 . . . . 74.25 111.166 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.558 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.3 mm? -114.2 124.06 51.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.688 0.28 . . . . 75.31 111.201 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.4 m -78.06 79.46 4.52 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 74.24 110.343 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.28 122.09 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.085 -0.507 . . . . 63.45 112.334 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 39.7 m-80 56.93 23.02 7.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.099 -0.5 . . . . 72.52 112.081 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.4 64.63 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.329 -0.462 . . . . 52.33 113.474 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.2 mptp? -116.72 122.02 32.17 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 122.235 -0.567 . . . . 74.23 110.859 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.49 125.65 19.21 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.931 2.421 . . . . 75.12 113.816 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 173.32 11.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.958 -0.565 . . . . 75.24 109.946 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 4.6 t -157.28 129.47 7.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.22 108.22 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.537 0.684 . . . . 64.21 110.465 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.56 123.35 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.857 -0.61 . . . . 74.14 111.673 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.82 -33.48 4.75 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.24 -0.505 . . . . 73.5 113.161 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -74.48 127.64 33.56 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.726 0.298 . . . . 71.51 111.671 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -137.79 108.71 6.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.201 0.524 . . . . 65.54 111.647 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 m 62.66 25.07 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.268 0.84 . . . . 64.53 113.268 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.7 159.49 27.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.193 0.521 . . . . 75.23 111.853 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.5 p-10 -84.06 156.43 22.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.389 -0.369 . . . . 70.44 111.6 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.8 -36.94 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.683 0.623 . . . . 73.42 112.683 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -52.92 -43.7 66.45 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.035 0.445 . . . . 52.35 111.568 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.42 -32.03 29.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.474 -0.33 . . . . 63.21 111.826 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.79 -44.83 82.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.361 -0.607 . . . . 72.15 109.361 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 32' ' ' ALA . 26.7 tp -60.94 -44.49 97.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.635 -0.711 . . . . 61.15 110.661 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -63.79 -27.92 69.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.807 -0.633 . . . . 64.03 111.905 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.74 84.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.956 0.407 . . . . 73.31 111.585 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.12 -2.53 48.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.301 -0.409 . . . . 62.51 110.931 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.6 tttt 64.0 25.72 13.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.996 -0.547 . . . . 73.03 111.51 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.52 130.61 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.357 -0.383 . . . . 75.31 111.537 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.57 80.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.368 0.507 . . . . 73.55 112.368 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -96.04 167.65 11.1 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.116 0.484 . . . . 73.41 111.557 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -146.05 -62.16 0.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.214 0.53 . . . . 33.43 110.803 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -55.53 -31.74 62.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.592 -0.731 . . . . 75.41 112.049 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -83.34 -16.49 45.89 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.67 0.618 . . . . 64.43 112.67 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 37' ' ' VAL . 6.1 t -81.46 80.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.237 0.541 . . . . 52.41 111.621 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.6 m -70.87 84.14 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.083 -0.508 . . . . 75.45 111.442 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 35' ' ' VAL . 32.8 m -86.45 147.94 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.122 0.487 . . . . 64.33 111.464 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 13.2 pt-20 -136.44 127.14 27.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.25 0.547 . . . . 73.4 110.981 174.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -99.47 134.95 41.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 71.34 111.169 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 60.66 18.92 8.93 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.067 0.461 . . . . 75.03 111.403 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.2 20.28 57.5 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.311 -0.471 . . . . 64.31 113.616 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -124.77 112.47 16.75 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.122 0.486 . . . . 74.14 111.105 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 8.9 p -70.6 144.41 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.371 0.878 . . . . 62.43 113.371 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.569 HD21 ' HG ' ' A' ' 39' ' ' LEU . 3.2 mm? -99.49 166.26 11.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.22 0.533 . . . . 74.02 111.667 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.38 155.18 20.7 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.049 -0.523 . . . . 73.51 110.743 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.51 -22.73 5.18 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.116 0.784 . . . . 63.13 113.116 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.86 26.84 5.51 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.115 0.483 . . . . 54.44 111.771 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.24 5.37 42.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.286 -0.415 . . . . 71.44 111.376 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.23 -27.77 59.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.809 0.338 . . . . 73.45 111.527 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.46 -38.79 65.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 75.33 111.065 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.17 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.168 -0.469 . . . . 60.51 112.055 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.0 m -75.32 107.55 7.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.999 0.428 . . . . 35.24 111.986 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 63.8 p -92.85 130.25 38.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.185 -0.461 . . . . 72.0 111.388 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.6 147.41 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.356 -0.383 . . . . 73.15 111.116 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.07 -174.75 3.52 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.241 0.543 . . . . 74.13 111.349 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.26 111.36 3.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.045 -0.525 . . . . 72.54 111.243 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.35 66.9 0.74 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.045 -0.597 . . . . 61.33 113.958 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -149.71 162.08 40.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 110.147 -0.316 . . . . 75.45 110.147 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.42 99.32 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.511 0.56 . . . . 53.2 112.511 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -95.96 131.25 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.002 0.43 . . . . 75.2 111.097 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 40.8 mt-10 -109.03 121.2 44.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.262 0.553 . . . . 72.31 112.282 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -99.66 132.14 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.78 -0.645 . . . . 74.33 111.522 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.098 0.475 . . . . 73.42 112.092 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.487 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 23.0 ptp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.941 0.4 . . . . 71.1 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -101.6 106.24 17.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.978 0.418 . . . . 72.35 110.724 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 58' ' ' ASP . 82.4 mt -100.25 176.45 5.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 63.15 111.536 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.3 m -130.68 110.84 11.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.852 0.358 . . . . 54.03 110.979 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 29.8 m -105.11 118.39 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.956 0.407 . . . . 71.41 111.577 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 62.12 22.26 13.0 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.865 0.364 . . . . 74.25 111.943 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.11 -0.87 64.44 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.161 -0.543 . . . . 63.23 113.36 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.23 141.7 24.44 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 122.526 -0.396 . . . . 65.15 111.273 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 119.79 6.03 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.411 2.074 . . . . 60.53 112.978 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -120.4 113.24 20.05 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.983 0.42 . . . . 64.32 111.49 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.8 m -95.12 110.25 22.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.253 -0.431 . . . . 63.15 111.444 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.66 124.64 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.131 0.491 . . . . 72.4 110.968 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.78 144.6 41.31 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.089 -0.505 . . . . 62.24 111.921 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.69 -49.59 4.22 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.192 -0.458 . . . . 70.12 113.756 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 105.74 0.42 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.779 . . . . 45.45 113.102 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.1 -44.37 5.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.298 -0.41 . . . . 75.02 111.148 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.6 m -141.46 126.33 18.15 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.71 0.29 . . . . 73.23 110.86 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.96 169.63 16.2 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.728 0.299 . . . . 63.04 111.521 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -103.02 160.6 14.48 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.45 -0.204 . . . . 75.53 110.45 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 58.1 t -48.07 -40.82 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 112.917 0.71 . . . . 62.55 112.917 -172.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.6 m -48.0 -47.47 33.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.142 0.496 . . . . 65.3 111.581 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.44 -33.02 64.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.052 0.454 . . . . 74.03 111.203 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.05 -41.69 98.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.451 . . . . 73.53 110.239 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 91.8 mt -56.7 -28.66 61.32 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.132 -0.486 . . . . 74.12 111.507 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.7 t -80.17 -48.34 13.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.409 -0.36 . . . . 74.21 111.391 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.78 90.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.058 0.456 . . . . 74.21 111.864 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.14 -30.62 60.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.148 -0.478 . . . . 71.1 110.915 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 69.25 88.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.463 0.649 . . . . 63.14 111.332 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.472 HG11 HD22 ' A' ' 24' ' ' LEU . 8.0 p -102.15 149.52 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.773 -0.649 . . . . 74.33 111.91 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.58 126.9 35.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.72 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 58.88 67.57 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.234 0.54 . . . . 73.14 111.507 -174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -63.85 -30.69 71.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.217 -0.447 . . . . 60.43 112.015 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.939 0.399 . . . . 73.11 111.491 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -129.93 12.36 5.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.53 -0.304 . . . . 71.44 111.64 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 37' ' ' VAL . 7.6 p -68.0 118.71 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.452 0.644 . . . . 70.44 112.508 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.1 m -92.97 108.58 20.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.03 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.465 HG13 HG22 ' A' ' 35' ' ' VAL . 18.0 m -140.92 146.35 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.164 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.2 pm0 -123.54 132.48 53.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.899 0.381 . . . . 74.44 111.745 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 HD11 ' A' ' 44' ' ' LEU . 2.1 pt? -97.02 124.53 41.03 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.932 -0.395 . . . . 71.31 109.932 175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.18 22.62 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.98 0.419 . . . . 52.24 111.798 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -20.44 32.02 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.275 0.47 . . . . 74.55 114.275 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -95.45 122.47 38.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.677 0.739 . . . . 72.14 111.464 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.9 p -78.23 138.89 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 65.32 112.003 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -92.72 121.65 34.33 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.101 -0.5 . . . . 72.41 111.335 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.12 152.39 45.22 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.383 -0.371 . . . . 70.45 111.632 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 39.0 ptt180 -48.72 -36.81 17.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.635 0.605 . . . . 70.41 112.635 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -81.27 -24.62 37.16 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.214 0.53 . . . . 75.12 111.754 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.07 -16.65 57.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.054 0.761 . . . . 71.32 113.054 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 22.2 m-85 -53.06 -39.53 63.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.857 0.688 . . . . 72.51 112.857 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.81 -23.09 31.57 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.06 -0.4 . . . . 74.11 111.678 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.21 -2.21 52.86 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.621 0.6 . . . . 74.12 112.621 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.0 m -105.29 118.02 35.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.184 -0.323 . . . . 43.31 111.671 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.7 m -89.22 138.58 31.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.097 0.475 . . . . 74.15 112.017 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.49 147.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.942 0.497 . . . . 73.22 110.961 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.01 -168.47 2.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.123 0.487 . . . . 74.0 111.63 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 36.3 t70 -70.22 79.31 0.52 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.149 0.499 . . . . 62.13 111.5 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.84 65.31 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.154 -0.546 . . . . 75.11 113.52 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-20 -131.51 131.81 43.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.421 -0.458 . . . . 71.23 110.657 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -93.19 66.98 4.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.995 0.368 . . . . 74.12 111.995 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.2 p -82.83 114.77 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.285 0.564 . . . . 60.13 111.466 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -88.75 114.82 25.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.045 0.387 . . . . 75.24 112.045 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.462 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-85 -101.32 118.45 37.0 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 63.33 111.647 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.449 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.8 pt? . . . . . 0 CA--C 1.539 0.539 0 CA-C-N 116.402 -0.363 . . . . 71.21 111.521 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.607 ' HE3' HD11 ' A' ' 3' ' ' LEU . 25.4 ptt? . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.764 0.316 . . . . 63.41 111.505 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -80.49 118.88 22.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.937 0.398 . . . . 74.4 111.359 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.607 HD11 ' HE3' ' A' ' 1' ' ' MET . 68.0 mt -123.34 148.4 46.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.156 0.503 . . . . 74.15 112.079 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 16.7 m -85.0 82.67 8.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.122 0.487 . . . . 75.24 110.431 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.36 134.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.431 -0.349 . . . . 71.43 110.973 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.1 8.26 6.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.556 0.342 . . . . 73.02 111.298 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.67 68.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.98 -0.629 . . . . 52.43 111.868 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 5.6 mtpm? -124.15 154.4 68.42 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.311 0.644 . . . . 74.44 110.768 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.78 115.86 4.29 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.294 1.996 . . . . 63.1 113.212 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -142.17 -176.79 4.95 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.579 0.352 . . . . 52.43 110.708 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -162.85 137.99 6.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.39 0.515 . . . . 52.22 112.39 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.33 86.84 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.358 0.599 . . . . 75.1 111.095 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.2 t70 59.71 174.5 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.505 -0.77 . . . . 75.42 112.455 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.13 -4.83 69.25 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.292 -0.48 . . . . 63.52 113.144 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 126.42 8.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.826 0.451 . . . . 73.54 111.95 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.53 -66.04 0.6 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 62.42 112.521 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -133.05 124.17 27.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.643 0.259 . . . . 73.41 111.329 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 91.3 mt -132.38 142.6 49.37 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.741 0.305 . . . . 74.21 111.257 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.26 162.8 5.6 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.575 -0.284 . . . . 74.21 110.818 175.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 39.7 t -61.09 -40.15 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.981 -0.449 . . . . 64.53 110.298 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -59.78 -47.75 84.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.256 -0.429 . . . . 74.14 111.167 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 2.5 mm-40 -58.47 -38.03 76.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.0 0.428 . . . . 73.23 111.256 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.69 -45.44 92.09 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.049 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.489 HD13 ' HB1' ' A' ' 32' ' ' ALA . 72.4 mt -56.91 -39.34 74.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.181 0.515 . . . . 62.54 111.262 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -78.05 -29.19 49.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.161 -0.472 . . . . 55.15 112.121 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -47.21 20.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.164 0.507 . . . . 54.15 111.754 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 27' ' ' LEU . 7.2 tt -76.79 -16.43 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.615 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 66.77 74.04 0.34 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.352 0.596 . . . . 45.23 110.501 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 HD22 ' A' ' 27' ' ' LEU . 53.5 t -104.21 130.91 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.691 0.626 . . . . 72.25 112.691 -174.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.69 146.0 30.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.32 -0.4 . . . . 73.42 110.209 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 62.07 33.23 17.22 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.925 0.393 . . . . 54.22 110.79 -172.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' HD13 ' A' ' 24' ' ' LEU . . . -53.39 -51.9 61.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.281 0.474 . . . . 34.54 112.281 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.03 -12.45 61.61 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.191 0.519 . . . . 65.34 111.813 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.06 2.69 12.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.479 0.548 . . . . 74.25 112.479 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.8 p -73.09 146.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 65.21 111.875 -176.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.5 m -100.3 108.85 21.01 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.471 -0.331 . . . . 74.04 110.456 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 62' ' ' PHE . 26.8 m -133.17 134.0 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.217 0.532 . . . . 74.35 111.698 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.7 pm0 -104.88 125.3 50.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.308 0.575 . . . . 54.33 111.508 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.667 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.14 106.43 7.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.836 -0.62 . . . . 62.41 110.216 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 53.08 26.96 5.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.84 0.456 . . . . 64.24 112.05 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.13 4.38 41.39 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.304 -0.474 . . . . 72.01 113.947 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.88 108.07 13.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.278 0.539 . . . . 71.22 111.418 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 8.8 p -60.27 137.51 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.318 0.488 . . . . 64.43 112.318 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.1 mm? -94.2 151.81 19.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.145 0.497 . . . . 73.1 111.807 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -71.99 160.91 31.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.114 -0.494 . . . . 75.42 110.946 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -51.37 -46.73 62.85 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.321 0.489 . . . . 71.15 112.321 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.19 -6.48 55.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.417 0.525 . . . . 74.44 112.417 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.75 -27.49 66.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.769 0.319 . . . . 54.31 111.364 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -50.68 -38.03 44.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.198 -0.455 . . . . 71.23 111.544 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.54 -42.88 61.12 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.914 -0.584 . . . . 63.41 111.573 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.89 -4.78 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.084 0.772 . . . . 75.41 113.084 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -101.82 116.96 33.86 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.709 0.29 . . . . 72.21 111.561 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 65.2 p -100.5 116.96 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.16 0.43 . . . . 74.24 112.16 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.88 152.52 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.824 -0.625 . . . . 73.55 110.903 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -139.89 175.89 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.878 0.371 . . . . 74.05 111.42 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.14 137.63 58.29 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.117 0.484 . . . . 75.32 111.391 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.36 33.94 24.37 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.147 -0.479 . . . . 35.32 113.164 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' HD22 ' A' ' 3' ' ' LEU . 12.7 t70 -109.88 177.45 4.72 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 122.684 -0.303 . . . . 70.14 110.867 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -139.99 92.13 2.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.429 0.529 . . . . 52.21 112.429 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.1 p -98.17 115.76 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.344 0.592 . . . . 73.14 111.219 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 44.0 mt-10 -84.15 93.45 8.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.217 0.532 . . . . 72.23 112.414 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' VAL . 12.8 m-85 -78.9 120.27 23.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.941 -0.572 . . . . 75.13 110.875 169.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.633 0.254 . . . . 61.54 110.807 176.8 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.568 ' HB3' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.22 0.452 . . . . 75.33 112.22 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -94.89 124.15 38.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.157 -0.474 . . . . 50.15 111.505 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 1' ' ' MET . 2.9 mm? -120.99 174.42 6.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.068 0.461 . . . . 55.42 111.103 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 m -129.04 95.29 4.03 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.072 0.463 . . . . 71.14 110.692 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 60' ' ' VAL . 61.8 t -88.13 113.97 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.436 -0.347 . . . . 73.12 111.774 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.404 ' OD1' HG12 ' A' ' 5' ' ' VAL . 29.9 m120 57.91 29.68 17.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.005 0.522 . . . . 64.24 112.001 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.88 75.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.89 -0.671 . . . . 71.11 113.301 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -114.11 122.07 35.31 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.625 -0.338 . . . . 74.31 110.975 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.83 119.45 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.739 2.293 . . . . 74.31 112.997 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.8 p -130.08 127.74 40.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.155 0.502 . . . . 53.14 111.258 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.4 m -102.7 117.18 34.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.159 -0.338 . . . . 65.04 111.51 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' SD ' ' A' ' 1' ' ' MET . 19.6 m -89.56 131.8 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.892 0.377 . . . . 71.43 110.373 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.3 155.03 20.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.446 0.536 . . . . 71.33 112.446 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.49 -72.04 1.77 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.986 -0.552 . . . . 63.45 113.77 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.97 12.95 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.416 0.524 . . . . 72.13 112.416 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 10.0 pt-20 -129.06 -31.93 2.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 74.33 112.177 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -140.08 130.64 25.58 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.003 0.43 . . . . 73.14 112.122 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -170.72 165.45 8.09 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.967 -0.56 . . . . 72.45 111.5 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.754 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 48.7 m-20 -61.84 155.82 22.22 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.753 0.311 . . . . 73.53 111.376 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.88 -38.77 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.071 0.462 . . . . 74.33 110.56 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.4 m -59.33 -41.92 90.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.082 -0.508 . . . . 71.41 111.783 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 15.3 mm-40 -63.58 -48.57 76.86 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.069 0.461 . . . . 74.51 110.527 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.53 -46.3 84.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.136 -0.484 . . . . 75.03 111.068 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.03 -44.02 91.68 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.103 0.478 . . . . 72.42 111.043 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -66.76 -30.42 70.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.021 0.439 . . . . 74.41 111.161 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.93 77.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 73.42 111.013 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.14 -32.56 63.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.122 -0.49 . . . . 65.41 111.844 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 64.95 85.54 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.387 0.613 . . . . 75.44 110.881 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.6 149.7 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 75.25 112.106 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.88 121.84 20.65 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.451 -0.34 . . . . 70.44 110.98 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 95.8 mt-30 61.99 80.46 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.262 0.553 . . . . 64.43 110.759 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -55.31 -35.92 65.64 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.671 0.989 . . . . 55.15 113.671 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.45 -22.72 43.78 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.216 0.451 . . . . 61.22 112.216 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 31' ' ' GLN . 9.4 m-85 -86.98 -11.85 49.25 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.512 0.56 . . . . 72.14 112.512 -171.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 32' ' ' ALA . 7.9 p -79.42 131.7 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.235 0.54 . . . . 64.54 111.366 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -115.89 128.3 55.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.503 -0.317 . . . . 70.44 111.457 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 62' ' ' PHE . 34.9 m -137.67 140.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.106 0.479 . . . . 74.3 111.274 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -111.09 113.25 25.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.458 0.647 . . . . 74.31 110.088 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -75.23 104.96 6.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.009 -0.541 . . . . 74.35 112.195 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.62 28.35 17.76 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.861 -0.609 . . . . 71.25 111.789 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.47 -20.04 14.06 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.362 -0.447 . . . . 61.23 113.727 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.84 135.8 45.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.044 0.422 . . . . 74.33 111.376 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.23 134.82 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.934 0.397 . . . . 74.42 111.728 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.65 141.98 43.15 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.313 0.578 . . . . 71.4 111.832 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -79.84 167.67 20.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.021 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -57.15 -35.02 69.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.73 0.641 . . . . 73.0 112.73 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -96.55 -4.91 40.47 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.07 0.396 . . . . 71.32 112.07 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.53 56.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.254 0.464 . . . . 50.22 112.254 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.35 -24.74 63.62 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.056 0.455 . . . . 73.0 111.957 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.78 -29.11 44.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.32 -0.4 . . . . 64.14 111.847 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.54 12.36 7.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.155 0.798 . . . . 70.32 113.155 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.1 m -141.69 120.24 12.47 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.726 -0.609 . . . . 72.33 111.782 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.7 m -92.96 106.89 18.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.097 -0.501 . . . . 75.04 111.158 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.5 148.14 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.363 -0.38 . . . . 73.14 110.893 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 17.0 ptpt -144.11 -173.18 3.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.839 0.352 . . . . 65.34 111.665 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 10.2 t70 -66.94 112.74 4.49 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 55.51 111.463 -176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.66 63.42 0.66 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.105 -0.498 . . . . 75.23 113.042 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -154.2 172.58 17.37 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.895 -0.409 . . . . 75.35 109.895 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.23 94.56 4.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.811 0.671 . . . . 62.11 112.811 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG13 HG22 ' A' ' 5' ' ' VAL . 4.8 p -88.94 95.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.491 0.662 . . . . 63.23 110.809 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -79.88 103.16 9.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.376 0.608 . . . . 73.15 111.42 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 37' ' ' VAL . 45.0 t80 -91.69 109.49 20.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.809 -0.632 . . . . 74.3 110.911 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.066 0.46 . . . . 73.14 112.202 -177.046 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 3' ' ' LEU . 24.9 ptp . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.742 0.306 . . . . 73.2 111.072 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -98.04 114.44 26.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.464 -0.334 . . . . 65.44 110.86 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 1' ' ' MET . 91.3 mt -121.94 131.16 53.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.938 0.399 . . . . 74.11 111.715 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 39.6 m -85.78 85.45 7.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.04 0.448 . . . . 72.31 111.001 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.3 p -82.44 117.03 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.024 0.44 . . . . 71.53 111.615 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 59.29 15.04 4.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.615 0.598 . . . . 72.13 112.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.22 -4.43 33.46 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.319 -0.467 . . . . 74.54 113.218 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.62 106.57 58.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 122.584 -0.362 . . . . 73.44 111.545 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 20.4 Cg_exo -65.82 99.5 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.798 2.332 . . . . 72.31 112.877 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 t -112.79 139.14 48.67 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 63.42 111.556 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.0 m -89.3 99.97 12.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.38 . . . . 74.33 111.355 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.89 111.04 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.22 0.533 . . . . 71.53 110.198 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.55 161.09 18.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.233 0.539 . . . . 74.42 112.211 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.75 84.51 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.971 -0.559 . . . . 71.23 112.869 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.91 102.72 4.48 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.641 -0.329 . . . . 71.53 111.474 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.79 -29.94 13.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.732 0.301 . . . . 75.11 111.731 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -160.62 106.4 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.564 -0.289 . . . . 71.04 111.156 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.5 pp -143.79 156.53 44.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.163 0.506 . . . . 73.53 111.649 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 49' ' ' PHE . 4.6 p-10 -83.09 164.27 20.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.359 -0.382 . . . . 73.3 110.973 177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.408 HG21 ' CD2' ' A' ' 44' ' ' LEU . 46.1 t -53.84 -33.93 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.749 0.648 . . . . 71.02 112.749 -172.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 m -52.03 -54.67 27.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.274 0.559 . . . . 71.01 111.403 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.56 -33.0 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.985 -0.552 . . . . 53.12 111.592 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.92 -44.68 78.51 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.035 0.445 . . . . 64.54 110.333 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.15 -32.62 72.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.929 0.395 . . . . 60.12 111.252 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.6 t -66.34 -35.46 80.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.291 -0.413 . . . . 65.11 111.29 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.95 92.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.112 0.482 . . . . 52.22 111.639 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 27' ' ' LEU . 6.5 mp -82.48 -24.48 34.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.174 0.511 . . . . 71.53 110.777 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 tttm 63.04 84.8 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.7 0.8 . . . . 71.21 111.961 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.14 145.89 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.701 -0.681 . . . . 72.25 110.691 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.08 -55.32 8.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.023 0.439 . . . . 74.43 111.324 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 22.8 mp0 -91.73 78.44 5.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.407 -0.36 . . . . 72.02 110.822 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.424 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -64.93 -44.56 89.07 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.175 0.512 . . . . 72.12 111.356 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -63.58 -33.42 75.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.036 -0.529 . . . . 64.03 111.916 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 26.1 m-85 -109.11 9.1 26.26 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.763 0.653 . . . . 74.44 112.763 -167.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 32' ' ' ALA . 8.7 p -86.44 124.74 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.982 0.42 . . . . 70.53 110.998 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -85.09 109.52 18.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.17 0.51 . . . . 41.2 111.231 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.68 145.55 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.915 -0.584 . . . . 61.52 111.105 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -136.57 147.7 47.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.911 0.386 . . . . 75.31 111.068 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.6 mp -112.49 131.27 55.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.815 0.302 . . . . 61.42 111.815 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 m120 56.23 27.32 11.54 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.598 0.592 . . . . 73.23 112.598 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.26 18.57 57.17 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.481 -0.39 . . . . 71.23 113.721 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -131.98 131.69 42.81 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.364 -0.492 . . . . 51.32 110.199 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.66 127.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.366 0.603 . . . . 74.21 112.286 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' CD2' HG21 ' A' ' 20' ' ' VAL . 10.5 mp -94.39 136.79 34.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.523 0.677 . . . . 71.44 112.317 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 9.3 tp10 -66.25 142.2 57.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.56 -0.745 . . . . 74.5 110.711 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -52.25 -45.95 65.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.219 0.533 . . . . 74.15 111.177 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 40.4 mt-10 -77.92 9.66 3.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.037 -0.529 . . . . 62.32 112.112 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.59 -10.21 15.72 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.186 -0.322 . . . . 71.03 111.376 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 22.5 m-30 -60.93 -24.75 66.28 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.159 0.429 . . . . 71.21 112.159 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 3.6 p30 -84.34 -29.75 26.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.848 0.356 . . . . 73.44 111.663 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.19 -53.14 6.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.331 -0.395 . . . . 74.12 111.861 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.406 HG21 HD21 ' A' ' 44' ' ' LEU . 62.4 m -63.2 98.74 0.15 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.831 0.348 . . . . 73.25 111.124 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.2 m -85.2 108.59 17.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.882 0.373 . . . . 71.01 111.21 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.45 133.67 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.977 0.418 . . . . 64.32 111.377 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -128.86 -177.65 4.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.451 0.643 . . . . 71.0 112.063 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.62 122.57 15.61 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.593 -0.73 . . . . 72.34 111.884 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.29 31.58 7.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.353 -0.385 . . . . 23.33 113.603 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.96 160.62 15.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 117.04 0.42 . . . . 72.14 110.54 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.17 99.11 6.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.053 0.454 . . . . 74.52 111.701 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -95.64 131.19 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.227 0.537 . . . . 63.11 111.739 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.93 109.62 21.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.376 0.607 . . . . 65.41 110.829 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -113.05 108.88 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.703 -0.68 . . . . 73.24 110.54 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 mt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.052 0.453 . . . . 73.43 111.841 -176.646 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.57 ' HG3' HD11 ' A' ' 3' ' ' LEU . 19.7 ptp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.719 0.295 . . . . 71.02 111.403 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -101.81 133.28 46.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.624 0.37 . . . . 65.21 110.652 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 1' ' ' MET . 1.6 mp -133.95 157.17 46.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.132 -0.355 . . . . 71.52 111.338 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 36.7 m -107.54 105.7 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.888 -0.412 . . . . 73.44 109.888 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 60' ' ' VAL . 31.8 m -119.5 136.83 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.197 -0.456 . . . . 71.14 111.163 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 59.17 30.06 19.75 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.486 0.315 . . . . 73.02 111.443 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.28 21.0 79.5 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.923 -0.656 . . . . 75.21 113.372 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -128.86 142.89 46.59 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.568 0.347 . . . . 65.24 111.717 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.96 143.47 32.89 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.256 1.971 . . . . 74.23 111.859 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.7 p -146.1 162.81 37.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.183 -0.323 . . . . 61.21 111.406 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -142.42 107.64 4.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.738 0.304 . . . . 71.23 111.508 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -103.59 128.28 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.994 0.426 . . . . 52.13 111.21 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.39 157.26 29.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.067 0.461 . . . . 73.44 111.818 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.78 -64.4 4.31 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.475 -0.393 . . . . 63.41 113.378 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.23 107.03 1.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.185 0.439 . . . . 73.41 112.185 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.04 -45.11 8.07 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.404 -0.362 . . . . 74.52 111.582 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -153.68 129.41 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.851 0.357 . . . . 62.23 111.194 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.2 pp -158.05 152.5 24.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 50' ' ' ASP . 12.2 p-10 -61.35 154.68 23.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.321 -0.399 . . . . 73.44 111.457 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.1 t -53.38 -33.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.886 0.374 . . . . 45.52 111.518 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -53.84 -49.47 68.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.381 -0.372 . . . . 73.15 111.545 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -68.96 -35.85 77.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.565 0.221 . . . . 71.51 111.454 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' VAL . 64.8 tp -54.39 -50.82 66.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.095 0.474 . . . . 75.31 110.908 174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -57.73 -41.56 82.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.164 0.507 . . . . 72.25 110.871 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 t -68.36 -29.5 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.817 -0.628 . . . . 71.4 111.597 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.75 77.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.027 0.441 . . . . 74.43 111.189 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.84 -21.51 57.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.082 0.468 . . . . 71.45 110.501 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 tttp 65.57 36.95 6.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.359 -0.837 . . . . 73.21 111.579 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.01 129.73 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.134 -0.484 . . . . 70.14 111.401 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.49 81.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.275 0.472 . . . . 64.52 112.275 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -101.44 89.67 3.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.932 0.396 . . . . 71.35 111.422 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -92.42 -45.87 7.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.314 0.578 . . . . 64.0 110.635 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.66 -25.66 40.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.676 -0.693 . . . . 75.53 111.719 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -122.41 28.16 7.55 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.093 0.405 . . . . 72.25 112.093 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' ALA . 11.7 p -89.5 139.46 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.306 0.574 . . . . 71.22 111.971 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -97.95 99.82 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.351 -0.386 . . . . 73.54 110.444 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.27 136.59 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.852 0.358 . . . . 73.24 111.579 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.0 pt-20 -122.24 131.88 54.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.155 0.502 . . . . 71.43 111.377 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 44' ' ' LEU . 2.4 tm? -88.35 99.9 12.6 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.208 -0.451 . . . . 72.15 110.413 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.89 1.34 1.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.133 0.79 . . . . 72.25 113.133 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.32 -6.85 0.82 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.403 -0.904 . . . . 74.43 114.856 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.85 128.77 41.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.86 0.83 . . . . 74.04 112.102 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.7 p -66.34 139.54 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.129 0.49 . . . . 75.04 112.304 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 39' ' ' LEU . 6.0 mp -92.5 147.16 23.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.445 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.87 149.77 37.75 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.098 -0.501 . . . . 63.13 110.336 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -48.33 -55.68 10.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.591 0.589 . . . . 61.33 112.591 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -81.98 23.93 0.67 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.326 0.584 . . . . 72.55 111.967 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.75 1.94 13.56 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.734 -0.604 . . . . 65.5 111.836 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -64.69 -30.28 71.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.207 0.447 . . . . 62.03 112.207 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 14.5 m-20 -83.12 -32.5 26.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.875 0.369 . . . . 61.15 111.001 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.33 91.35 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.09 -0.505 . . . . 74.41 112.082 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -95.85 119.96 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.99 0.424 . . . . 74.22 111.723 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.6 m -96.09 116.43 28.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.938 0.399 . . . . 64.23 111.616 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 23' ' ' LEU . 49.3 t -74.6 142.03 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 116.005 -0.543 . . . . 75.13 111.096 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -142.83 -175.84 4.65 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.389 0.614 . . . . 74.25 111.61 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.22 104.39 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.756 -0.656 . . . . 71.11 111.972 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.74 32.2 2.14 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.197 -0.525 . . . . 44.13 113.818 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.74 138.1 48.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.328 0.585 . . . . 71.4 112.315 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -95.66 104.52 16.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.651 -0.704 . . . . 62.04 111.49 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -109.02 98.37 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.622 0.725 . . . . 75.44 110.404 175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -72.94 99.54 2.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.731 0.777 . . . . 74.24 112.628 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -85.01 143.71 28.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.151 170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.536 0.439 0 CA-C-O 121.284 0.564 . . . . 71.45 111.771 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.916 0.389 . . . . 75.42 111.313 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.78 126.41 37.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.309 -0.405 . . . . 73.54 111.122 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.36 134.92 50.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.937 0.399 . . . . 61.04 111.373 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -94.6 99.35 11.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.959 0.409 . . . . 72.1 111.004 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -100.19 124.21 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.965 0.412 . . . . 72.25 111.464 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 55.6 m-80 54.87 43.22 30.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.115 0.483 . . . . 73.22 111.371 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.69 12.83 62.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.872 -0.603 . . . . 73.41 113.872 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -126.89 125.31 24.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 122.596 -0.355 . . . . 74.31 110.917 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.0 142.18 19.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.684 2.256 . . . . 63.51 113.819 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.9 t -137.86 125.88 22.78 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.027 -0.533 . . . . 74.13 110.628 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -87.33 94.27 9.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.003 0.43 . . . . 72.02 111.536 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -94.78 95.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.491 0.662 . . . . 74.0 111.322 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.74 159.66 30.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.119 0.485 . . . . 64.4 111.373 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.78 -52.34 2.62 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.097 -0.573 . . . . 73.42 111.693 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.61 123.36 23.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.724 0.297 . . . . 31.33 110.569 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.06 -48.02 3.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.264 0.554 . . . . 70.13 111.423 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -157.64 106.6 2.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.224 -0.444 . . . . 72.02 110.632 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.02 151.81 50.27 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.346 -0.388 . . . . 74.1 111.29 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 20.4 p-10 -74.49 157.22 35.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.136 -0.32 . . . . 71.4 110.136 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 60.7 t -51.01 -37.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.86 0.319 . . . . 72.43 111.86 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -53.62 -51.75 62.07 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.821 0.343 . . . . 73.42 111.597 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 52.2 mm-40 -71.18 -29.2 64.88 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 122.246 -0.284 . . . . 61.4 111.756 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.646 HD11 HG11 ' A' ' 60' ' ' VAL . 7.6 tt -60.39 -45.3 94.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.527 -0.546 . . . . 74.14 109.527 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 78.0 mt -63.88 -41.02 97.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 70.45 110.206 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 37.0 t -60.47 -27.78 67.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.673 -0.694 . . . . 72.21 112.002 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -42.32 93.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.058 0.456 . . . . 73.12 111.314 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -88.68 -0.75 57.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.165 0.507 . . . . 72.41 110.465 174.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt 57.71 48.91 13.19 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.75 0.786 . . . . 70.44 111.101 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 56.3 t -81.54 88.51 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.853 -0.612 . . . . 52.4 110.259 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.92 -27.94 33.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.838 -0.619 . . . . 53.52 112.368 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 11.7 mm100 -83.92 45.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.282 -0.417 . . . . 74.51 112.024 -176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -36.99 74.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.474 0.546 . . . . 72.12 112.474 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.44 -7.64 56.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 75.2 111.449 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 5.8 m-85 -104.42 -50.61 3.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.276 -0.42 . . . . 74.22 111.455 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.46 136.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.195 0.521 . . . . 61.4 112.323 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.2 m -112.06 140.41 46.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.109 -0.496 . . . . 73.04 111.053 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.7 m -133.8 151.39 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.678 0.275 . . . . 71.22 110.842 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.56 126.12 51.29 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.709 0.766 . . . . 65.44 111.818 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.48 120.7 34.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.581 -0.736 . . . . 65.2 110.197 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.51 26.36 10.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.988 0.423 . . . . 63.02 111.779 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 12.92 68.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.092 -0.575 . . . . 45.14 113.226 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.79 124.88 53.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.654 0.382 . . . . 72.11 110.438 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.01 128.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.199 0.523 . . . . 73.34 111.945 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.15 139.99 35.03 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.428 -0.351 . . . . 64.32 111.179 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -68.94 160.77 30.18 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.351 -0.386 . . . . 53.05 110.771 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.09 -36.14 65.34 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.023 0.44 . . . . 71.34 111.726 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.78 -39.21 80.31 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.246 0.545 . . . . 62.44 111.416 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.3 63.77 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.538 0.57 . . . . 52.43 112.538 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -63.43 -33.48 75.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.985 0.422 . . . . 73.41 111.685 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.79 -32.26 59.8 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.37 -0.377 . . . . 71.3 111.46 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.95 6.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.329 0.492 . . . . 54.45 112.329 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -57.59 115.64 2.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.352 0.501 . . . . 44.52 112.352 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 73.8 p -99.37 119.63 38.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.049 0.452 . . . . 62.15 111.44 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -96.22 140.52 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.172 -0.467 . . . . 60.25 111.09 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.26 -172.34 2.82 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.663 0.616 . . . . 73.43 112.663 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.14 132.04 50.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.778 -0.646 . . . . 75.4 112.258 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.05 42.28 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.004 -0.544 . . . . 73.34 113.467 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -119.16 150.06 40.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.425 -0.456 . . . . 73.45 110.714 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.33 83.71 2.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.129 0.49 . . . . 55.1 112.185 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 23' ' ' LEU . 3.6 p -88.31 91.71 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.357 0.598 . . . . 65.12 110.343 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 33.8 tt0 -71.35 92.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.526 0.679 . . . . 73.02 110.859 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 37' ' ' VAL . 71.6 t80 -73.25 110.19 7.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.284 -0.871 . . . . 71.1 111.139 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.123 0.487 . . . . 65.14 110.766 178.478 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.674 0.273 . . . . 74.04 111.527 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -89.09 132.04 34.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.508 -0.315 . . . . 74.14 111.073 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.36 131.22 33.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.981 0.42 . . . . 64.33 111.377 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 89.3 m -81.85 89.47 6.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.288 0.566 . . . . 72.02 110.073 172.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.59 120.09 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 74.42 111.552 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 8' ' ' LYS . 6.2 t-20 62.43 22.62 13.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.118 0.485 . . . . 72.53 111.67 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.04 64.5 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.284 -0.484 . . . . 41.2 113.22 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 3.9 mppt? -113.91 127.07 27.23 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.667 -0.314 . . . . 64.31 111.427 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 90.3 Cg_endo -79.34 139.12 14.46 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.648 2.232 . . . . 75.32 113.543 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.1 t -149.75 159.36 44.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.748 0.309 . . . . 74.03 111.385 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -109.72 112.39 24.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.93 0.395 . . . . 74.41 111.362 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -112.01 119.49 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.953 0.406 . . . . 72.22 111.464 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.87 166.38 20.96 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.724 0.297 . . . . 72.32 110.517 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.51 4.01 73.63 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.933 -0.651 . . . . 73.43 112.524 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.4 108.34 11.57 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.862 0.363 . . . . 65.32 110.987 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -101.81 -60.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.387 0.613 . . . . 75.13 110.457 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -149.75 101.4 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.789 -0.642 . . . . 74.04 109.634 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 96.3 mt -125.03 133.06 53.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.145 0.424 . . . . 42.15 112.145 -170.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.0 p30 -63.59 149.67 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.597 -0.274 . . . . 60.31 110.452 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.83 -42.14 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.641 0.608 . . . . 70.11 112.641 -173.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -50.83 -48.51 59.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.824 0.345 . . . . 60.12 111.795 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 25.4 mm-40 -65.04 -32.77 74.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.336 . . . . 61.21 111.25 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 60' ' ' VAL . 6.9 tt -61.68 -50.04 74.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.937 0.398 . . . . 63.33 109.967 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 HG11 ' A' ' 29' ' ' VAL . 3.9 mm? -63.21 -33.66 75.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.861 0.362 . . . . 73.33 111.032 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -64.04 -41.34 97.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.15 111.365 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -33.23 70.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.155 0.502 . . . . 74.14 111.07 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 29' ' ' VAL . 5.6 tt -71.25 -35.07 71.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.015 -0.539 . . . . 60.5 110.368 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 60.17 73.45 0.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.518 0.675 . . . . 75.32 111.461 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.615 ' HB ' HD22 ' A' ' 27' ' ' LEU . 12.5 p -117.18 143.81 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.889 -0.596 . . . . 64.22 111.36 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.91 142.85 41.97 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 42.43 111.262 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 66.6 mt-30 71.12 37.58 1.21 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.852 -0.613 . . . . 74.51 112.124 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.24 75.16 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.946 0.403 . . . . 74.23 111.93 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -73.4 -3.27 26.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.14 0.495 . . . . 74.0 111.555 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 23.5 m-85 -119.76 -13.45 9.1 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.021 -0.425 . . . . 74.52 112.029 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.11 130.49 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 74.5 112.341 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -93.93 117.2 29.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.311 -0.404 . . . . 70.41 111.057 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.23 158.82 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 72.41 110.984 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 11.6 pt-20 -127.87 133.01 49.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.628 0.728 . . . . 54.2 111.981 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.55 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.9 tm? -91.52 104.04 16.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.338 -0.846 . . . . 71.43 109.689 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m120 55.18 46.21 24.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.098 0.475 . . . . 65.52 111.408 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.02 -3.79 74.38 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.474 -0.393 . . . . 60.45 113.946 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -96.59 111.38 23.54 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.567 -0.372 . . . . 61.21 111.112 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.25 125.34 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.206 0.527 . . . . 72.14 112.219 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 39' ' ' LEU . 1.4 mm? -97.76 152.1 19.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.003 0.43 . . . . 75.45 111.213 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.2 149.44 46.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.911 -0.774 . . . . 64.42 108.911 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -54.13 -38.11 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.56 -29.96 46.6 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.194 0.521 . . . . 74.34 111.193 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.35 -17.01 40.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.461 -0.336 . . . . 74.32 111.846 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.95 -32.55 66.13 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.181 0.515 . . . . 73.3 111.201 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.81 -24.85 35.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.094 -0.503 . . . . 75.41 111.431 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.13 -23.06 19.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.262 0.467 . . . . 60.21 112.262 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 106.65 18.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.144 -0.348 . . . . 74.22 111.56 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 76.3 p -85.57 115.6 23.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.01 0.433 . . . . 74.4 112.017 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.17 132.78 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.35 -0.386 . . . . 71.35 110.804 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -125.65 -177.32 3.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.149 0.5 . . . . 53.23 112.105 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.33 143.23 45.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 43.22 111.872 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.43 34.74 90.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 116.23 -0.441 . . . . 64.13 113.809 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.81 -177.12 3.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.022 0.411 . . . . 71.0 110.081 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.16 102.98 6.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.074 0.768 . . . . 51.11 113.074 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 23' ' ' LEU . 4.0 p -96.69 111.22 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.309 0.576 . . . . 74.32 110.394 173.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 42.2 mt-10 -101.25 105.23 16.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.593 0.711 . . . . 70.03 111.957 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -81.87 117.07 21.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.286 -0.87 . . . . 64.32 110.443 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 74.55 112.54 -175.476 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 3' ' ' LEU . 24.5 ptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.664 0.268 . . . . 70.01 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.24 118.67 26.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.66 -0.246 . . . . 75.32 110.528 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' SD ' ' A' ' 1' ' ' MET . 63.7 mt -127.93 169.7 13.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.178 0.513 . . . . 54.34 111.437 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -111.36 96.87 6.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.626 -0.509 . . . . 72.33 109.626 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 48.0 t -100.85 123.91 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 60.43 111.306 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.858 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 3.0 m-20 64.53 24.25 13.04 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.292 -0.413 . . . . 72.25 111.718 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.2 6.31 88.12 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.348 -0.453 . . . . 35.4 113.078 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -118.35 126.62 27.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 O-C-N 122.549 -0.383 . . . . 73.52 110.835 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.65 95.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.421 2.081 . . . . 71.05 112.43 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.1 m -113.5 118.04 33.35 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.077 -0.511 . . . . 64.21 111.093 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.4 m -96.99 114.35 25.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.877 0.37 . . . . 74.32 111.487 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -93.68 120.64 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.125 0.488 . . . . 65.01 110.562 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.61 154.78 30.0 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.032 -0.531 . . . . 54.45 112.022 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.19 -45.46 3.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.257 -0.497 . . . . 75.31 113.298 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.15 117.06 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.831 0.348 . . . . 70.33 111.906 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -107.23 -55.88 2.28 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.306 -0.407 . . . . 73.04 110.566 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -141.93 122.39 14.08 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.821 0.343 . . . . 72.22 111.853 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -157.72 160.58 38.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.264 -0.425 . . . . 61.3 111.021 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.7 p30 -86.73 168.86 13.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.917 0.389 . . . . 73.31 111.175 177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.1 -29.28 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.55 -0.295 . . . . 72.22 111.449 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.3 m -61.62 -42.17 98.51 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.742 0.306 . . . . 74.5 111.586 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.29 -47.91 77.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.796 0.331 . . . . 73.03 110.908 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.92 -43.6 77.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.022 0.439 . . . . 54.14 110.825 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.01 -43.39 98.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.982 -0.554 . . . . 53.3 110.6 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -74.68 -17.34 60.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.235 -0.438 . . . . 71.35 111.891 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.61 35.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.861 0.362 . . . . 61.3 111.315 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 28' ' ' LYS . 2.8 pp -87.76 -17.79 30.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.519 -0.309 . . . . 75.4 111.705 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' N ' HD12 ' A' ' 27' ' ' LEU . 57.4 mtmt 60.06 85.56 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 72.13 112.833 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.35 117.32 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.184 0.516 . . . . 75.04 110.959 176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.69 68.66 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.158 -0.473 . . . . 65.21 112.207 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -84.81 40.45 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.384 -0.371 . . . . 74.31 111.877 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.72 62.21 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.18 0.514 . . . . 74.12 112.131 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.65 -36.31 75.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.552 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -99.33 -17.16 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.554 0.576 . . . . 65.03 112.554 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.2 113.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.976 0.732 . . . . 75.02 112.976 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 m -94.69 107.47 19.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.988 -0.551 . . . . 71.13 111.297 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 62' ' ' PHE . 31.5 m -141.32 147.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.426 -0.352 . . . . 70.24 111.195 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.29 137.03 43.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.039 0.447 . . . . 73.43 111.746 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD23 HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -83.22 106.48 15.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.027 0.441 . . . . 54.41 110.621 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 61.6 11.02 3.62 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.377 0.671 . . . . 63.45 112.526 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.63 -10.26 7.61 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.992 -0.623 . . . . 44.53 113.914 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.54 114.94 29.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.294 -0.533 . . . . 75.31 111.639 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.56 148.89 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.109 0.48 . . . . 31.32 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 HD23 ' A' ' 39' ' ' LEU . 3.1 mm? -101.16 143.26 31.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.318 0.58 . . . . 64.25 112.259 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.94 156.79 16.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.777 -0.647 . . . . 71.54 109.304 170.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 46' ' ' ARG . 61.3 mtt85 -40.43 -54.63 2.42 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.573 0.583 . . . . 75.42 112.573 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -79.25 -14.28 59.14 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.319 0.489 . . . . 55.11 112.319 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.03 62.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 53.31 111.222 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.66 -37.23 73.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.895 0.379 . . . . 71.21 111.519 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.49 -36.59 52.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.97 0.414 . . . . 71.24 111.705 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.21 -56.99 4.34 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.268 0.47 . . . . 52.15 112.268 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.5 m -72.59 126.12 29.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.039 0.447 . . . . 54.2 112.045 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 75.6 p -105.95 138.3 42.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.203 0.525 . . . . 50.42 112.011 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 39' ' ' LEU . 43.9 t -95.22 129.79 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.086 -0.507 . . . . 73.32 110.895 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.77 -179.76 5.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.279 0.561 . . . . 73.41 111.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.98 102.82 0.09 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.974 -0.557 . . . . 64.23 112.267 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.53 4.42 8.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.313 -0.47 . . . . 65.05 113.838 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.44 145.04 25.24 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.42 0.629 . . . . 74.01 112.162 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.15 131.76 51.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.78 -0.645 . . . . 51.02 111.168 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -143.96 117.71 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.403 0.62 . . . . 72.35 111.435 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 28.6 tt0 -101.38 96.56 7.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.5 0.666 . . . . 73.15 111.896 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 37' ' ' VAL . 18.6 t80 -78.06 92.2 4.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.928 -0.578 . . . . 73.24 110.069 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 113.29 0.848 . . . . 73.23 113.29 -175.05 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 22.8 ptp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.793 0.33 . . . . 72.41 111.517 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -101.9 114.56 28.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.398 -0.365 . . . . 64.55 111.017 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.86 127.76 53.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.081 0.467 . . . . 72.34 111.411 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.2 m -82.4 97.7 8.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.462 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 31.5 t -85.72 110.83 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.918 0.389 . . . . 62.43 111.837 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.458 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 27.8 m120 57.74 25.62 12.07 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.164 0.586 . . . . 63.33 112.37 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.03 -11.55 58.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.212 -0.518 . . . . 65.55 113.086 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 9.9 mptt -102.48 114.62 65.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.672 -0.311 . . . . 74.21 110.93 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 25.6 Cg_exo -63.32 116.45 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.8 2.333 . . . . 71.24 113.148 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -114.01 158.74 20.78 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.348 -0.387 . . . . 63.15 110.558 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -126.31 110.28 13.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.894 0.378 . . . . 64.51 111.868 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 m -98.81 102.08 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.451 0.644 . . . . 72.34 110.666 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.04 136.22 37.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.758 -0.655 . . . . 73.22 111.534 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.65 59.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.18 -0.533 . . . . 51.12 113.001 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -103.04 101.74 11.73 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.592 -0.358 . . . . 73.43 111.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.82 88.12 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.932 0.396 . . . . 73.12 111.181 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m 49.29 91.96 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.752 -0.658 . . . . 52.31 112.454 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.4 pp -129.0 153.83 47.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.062 0.458 . . . . 71.4 111.611 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 27.7 m-20 -72.34 160.73 31.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.469 -0.332 . . . . 75.22 110.828 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 t -56.38 -36.65 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.968 0.413 . . . . 74.21 110.568 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -56.36 -52.03 66.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.96 0.41 . . . . 62.35 110.999 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 41.7 mt-10 -63.83 -34.45 77.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.305 -0.407 . . . . 71.13 111.44 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.3 -45.93 80.02 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.919 0.39 . . . . 75.14 110.434 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -56.25 -32.93 64.95 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.983 0.42 . . . . 71.24 111.499 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.4 t -77.97 -32.82 51.57 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.122 -0.49 . . . . 70.13 111.291 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.59 -46.38 63.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.082 0.468 . . . . 74.22 111.417 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.52 -30.42 65.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.909 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.89 87.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.58 0.752 . . . . 70.12 112.575 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.11 148.53 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.792 -0.64 . . . . 73.04 110.936 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.99 171.81 14.52 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.87 0.367 . . . . 64.41 111.867 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 57.17 39.07 29.13 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.057 0.455 . . . . 71.52 111.729 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -33.27 71.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.459 . . . . 42.14 111.961 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.72 -13.34 62.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.984 0.365 . . . . 74.25 111.984 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.17 4.7 5.82 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.458 0.54 . . . . 64.2 112.458 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG22 HG13 ' A' ' 37' ' ' VAL . 14.6 p -70.71 132.06 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.551 0.691 . . . . 73.2 112.338 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.9 m -95.26 98.89 10.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.221 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 35' ' ' VAL . 29.7 m -133.15 163.34 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.265 0.555 . . . . 75.35 112.08 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.39 154.71 32.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.983 -0.553 . . . . 62.0 111.298 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 39' ' ' LEU . 3.4 pp -123.17 137.95 54.77 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.531 -0.304 . . . . 44.43 111.286 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 59.21 16.08 4.66 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 116.358 -0.383 . . . . 71.03 112.024 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.27 15.41 53.65 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.347 -0.454 . . . . 55.34 113.825 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.15 118.3 28.33 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.3 -0.529 . . . . 73.01 111.368 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.68 135.13 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.11 0.481 . . . . 72.45 111.927 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.0 mm? -109.67 150.72 27.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.131 0.491 . . . . 60.43 112.092 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 mp0 -69.36 162.18 27.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.146 -0.479 . . . . 72.43 110.76 170.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -57.02 -39.43 74.74 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.714 0.292 . . . . 62.41 111.32 178.443 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.56 -35.94 68.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.153 0.501 . . . . 73.31 111.038 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -22.41 66.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.333 -0.394 . . . . 74.31 111.369 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 46' ' ' ARG . 17.5 m-30 -57.57 -39.33 76.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.646 0.26 . . . . 74.33 111.558 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 22.2 t70 -83.34 -35.51 25.11 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.241 0.543 . . . . 73.13 110.82 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.36 -23.57 67.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.258 -0.428 . . . . 74.01 112.09 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -103.77 115.78 31.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.787 0.327 . . . . 64.22 111.565 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 88.6 m -94.73 110.19 22.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.23 0.538 . . . . 41.12 111.801 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.48 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.901 -0.591 . . . . 65.1 111.24 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -130.07 -167.12 1.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.183 0.516 . . . . 72.34 111.929 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 2.8 t0 -78.97 42.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.931 0.396 . . . . 73.45 112.045 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.59 52.92 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.406 -0.902 . . . . 64.23 113.426 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.12 123.7 38.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.237 0.541 . . . . 74.44 110.956 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.82 82.96 3.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.267 -0.424 . . . . 53.44 111.577 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.7 p -83.47 104.93 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.529 0.68 . . . . 74.42 111.561 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 41.3 mt-10 -85.84 100.61 12.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.442 0.639 . . . . 73.31 111.167 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -101.71 110.9 22.99 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.291 -0.868 . . . . 73.52 110.676 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.2 pt? . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.444 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 26.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.846 0.355 . . . . 62.54 111.914 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -91.22 126.8 36.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.44 -0.345 . . . . 72.53 111.543 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 58' ' ' ASP . 74.7 mt -125.31 130.65 52.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.824 0.345 . . . . 71.14 110.889 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.7 m -94.58 86.08 4.7 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 73.51 111.151 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.1 122.44 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.43 . . . . 64.54 111.181 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.69 23.42 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.762 0.315 . . . . 73.04 111.568 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.5 79.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.827 -0.701 . . . . 63.2 112.464 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -113.23 131.58 22.82 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 122.78 0.432 . . . . 63.05 110.821 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.73 96.3 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.414 2.076 . . . . 72.15 112.961 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -98.76 102.15 13.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.098 0.475 . . . . 71.22 111.25 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.3 m -82.54 94.2 7.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 74.32 110.767 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.9 m -93.63 102.99 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.539 0.685 . . . . 72.04 111.401 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -89.0 151.79 22.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.306 -0.407 . . . . 64.43 110.559 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.07 18.53 53.67 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.555 -0.618 . . . . 65.04 111.555 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.46 116.2 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.119 0.568 . . . . 72.24 110.527 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -91.23 -62.65 1.4 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.416 0.626 . . . . 61.34 111.213 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 33.2 p -171.53 104.21 0.2 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.305 -0.861 . . . . 34.32 110.061 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -131.88 162.08 31.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.488 0.551 . . . . 63.03 112.488 -170.425 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -64.1 156.2 29.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.407 -0.36 . . . . 72.41 110.936 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 46.2 t -56.5 -35.6 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.001 0.429 . . . . 75.44 110.437 176.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -59.03 -49.07 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.143 -0.48 . . . . 61.51 110.992 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 44.0 mt-10 -61.44 -35.81 78.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.275 -0.42 . . . . 75.43 110.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 60' ' ' VAL . 61.7 tp -60.53 -45.92 92.08 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.897 0.38 . . . . 63.02 110.815 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 85.5 mt -60.07 -34.78 73.92 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 44.21 110.821 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -67.9 -41.75 82.24 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.19 -0.459 . . . . 62.23 111.119 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.69 90.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.261 -0.427 . . . . 41.42 111.709 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.49 -11.36 59.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.991 0.425 . . . . 75.24 111.081 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 58.91 64.66 1.37 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 74.34 111.914 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.49 114.05 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.811 -0.632 . . . . 74.44 110.784 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.46 80.42 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.13 0.419 . . . . 62.32 112.13 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 78.8 mt-30 -95.79 83.13 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.802 0.335 . . . . 74.53 111.649 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.83 -37.43 22.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.654 0.74 . . . . 75.24 110.421 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -67.36 -20.25 65.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.098 -0.955 . . . . 74.43 111.692 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -123.52 11.74 9.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.773 0.657 . . . . 74.14 112.773 -173.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 37' ' ' VAL . 14.8 p -83.7 131.94 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 75.12 112.19 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -95.11 102.14 13.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.412 -0.358 . . . . 60.41 110.897 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 35' ' ' VAL . 35.3 m -122.95 139.96 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.827 0.346 . . . . 51.34 111.621 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.34 110.68 11.7 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.409 0.623 . . . . 74.05 111.555 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 10.0 mp -77.37 129.82 36.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.243 -0.435 . . . . 62.24 111.273 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.06 21.23 9.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.979 0.419 . . . . 70.42 111.549 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.76 19.82 49.92 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.311 -0.471 . . . . 73.13 113.343 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -133.79 125.58 28.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.952 0.376 . . . . 70.41 111.129 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.22 144.49 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 120.985 0.421 . . . . 70.13 112.021 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 49' ' ' PHE . 9.9 mp -104.82 -179.78 4.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.419 0.628 . . . . 60.13 112.294 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -107.77 149.18 28.51 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.702 -0.681 . . . . 64.4 110.578 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 2.1 ptm180 -47.16 -52.98 14.15 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.71 1.004 . . . . 72.3 113.71 -171.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 19.5 tt0 -95.39 -6.49 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.452 0.644 . . . . 42.34 110.753 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.86 63.97 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.9 -0.591 . . . . 74.51 110.539 171.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.405 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 m-30 -51.14 -42.08 60.51 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.225 0.536 . . . . 73.11 110.893 174.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.16 -34.62 78.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.712 -0.676 . . . . 73.22 111.561 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.95 -5.57 50.43 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.751 0.648 . . . . 64.3 112.751 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -104.81 116.18 31.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 122.286 -0.258 . . . . 75.22 111.437 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.1 p -95.59 113.18 24.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.699 0.629 . . . . 74.0 112.699 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD21 ' A' ' 39' ' ' LEU . 65.0 t -79.11 133.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.133 -0.485 . . . . 62.13 110.798 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' HB2' ' A' ' 17' ' ' SER . 43.9 mtmt -131.92 -171.84 2.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.263 0.554 . . . . 74.51 112.024 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.9 t70 -66.17 124.53 22.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 72.43 111.632 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 30.16 11.45 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.276 -0.488 . . . . 54.11 113.317 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.5 t70 -93.54 176.96 6.18 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.756 -0.261 . . . . 65.55 110.344 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.22 42.46 1.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.829 0.347 . . . . 63.4 111.918 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 3.7 p -56.2 102.2 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.671 0.748 . . . . 74.04 111.846 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.75 116.78 28.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.054 -0.521 . . . . 64.32 111.957 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -88.93 135.75 33.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.052 -0.522 . . . . 72.32 111.292 173.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-N 116.469 -0.332 . . . . 75.51 111.253 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 3' ' ' LEU . 21.5 ptp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.039 0.447 . . . . 62.1 111.728 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -85.18 108.66 17.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.495 -0.32 . . . . 65.32 110.825 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 1' ' ' MET . 70.5 mt -118.83 113.89 21.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.997 0.427 . . . . 63.34 111.762 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.7 m -75.69 99.04 4.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.317 -0.401 . . . . 70.14 110.577 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.51 121.64 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.207 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 64.35 27.14 13.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.924 0.49 . . . . 73.12 110.715 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.62 0.03 88.04 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.859 -0.686 . . . . 23.44 113.595 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -104.39 110.05 63.64 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 117.298 0.549 . . . . 73.12 111.326 178.37 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 37.1 Cg_exo -61.33 103.92 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.848 2.365 . . . . 60.51 112.216 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -109.97 110.35 21.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.988 0.423 . . . . 65.02 111.842 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -82.67 96.97 8.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.882 0.373 . . . . 72.4 111.383 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -93.74 104.72 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.733 0.778 . . . . 72.01 110.844 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -72.81 147.59 45.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.251 -0.886 . . . . 71.05 111.407 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.14 -12.83 65.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.467 -0.397 . . . . 63.33 113.772 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -108.92 119.36 39.33 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.433 -0.451 . . . . 42.5 112.027 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.5 -73.8 0.33 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.207 -0.451 . . . . 73.51 112.194 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.513 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 87.0 p -163.07 135.56 5.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.652 -0.249 . . . . 42.33 110.707 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -148.67 157.04 43.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.944 0.402 . . . . 73.4 111.944 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -72.31 170.02 15.02 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.708 -0.224 . . . . 61.12 110.852 177.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 49' ' ' PHE . 58.8 t -62.16 -40.94 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 109.973 -0.38 . . . . 74.24 109.973 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.0 m -53.94 -52.85 59.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.196 0.522 . . . . 74.11 110.597 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 8.5 mm-40 -61.5 -33.78 74.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.028 -0.533 . . . . 74.12 112.006 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.52 -56.36 18.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.979 0.418 . . . . 75.45 111.139 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.52 -30.75 71.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.785 0.326 . . . . 75.21 110.961 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.7 t -66.57 -37.51 85.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.027 0.441 . . . . 72.13 111.274 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.86 80.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.33 -0.395 . . . . 71.11 111.204 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.51 -29.08 62.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.299 -0.41 . . . . 73.4 111.085 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 67.26 16.07 10.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.174 0.59 . . . . 64.11 112.145 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 31' ' ' GLN . 11.4 p -72.5 140.01 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.064 0.459 . . . . 74.0 111.438 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.58 -14.83 57.87 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.885 0.698 . . . . 74.44 112.885 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.07 30.77 1.8 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.281 -0.262 . . . . 54.13 111.39 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.87 79.74 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.424 0.528 . . . . 71.51 112.424 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.07 -10.79 59.93 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.156 0.503 . . . . 75.12 111.376 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.19 21.94 11.57 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.208 0.447 . . . . 71.22 112.208 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.4 p -110.88 133.57 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.166 0.507 . . . . 71.05 112.068 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.8 m -74.76 84.36 2.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.278 0.561 . . . . 74.33 110.936 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -99.11 110.33 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.971 -0.559 . . . . 74.21 110.31 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 10.5 pt-20 -118.2 119.65 35.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.734 0.778 . . . . 73.44 112.128 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.0 tm? -73.29 107.67 5.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.412 -0.813 . . . . 71.52 110.417 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.53 15.84 3.85 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.044 -0.525 . . . . 73.44 111.818 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 15.83 11.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.996 -0.621 . . . . 43.43 113.886 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -132.11 110.55 10.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 117.396 0.598 . . . . 74.31 110.899 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 12.4 p -64.58 141.88 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.787 0.662 . . . . 63.22 112.787 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.8 mm? -94.02 143.74 26.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.407 0.622 . . . . 74.12 112.485 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -77.4 154.43 32.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.717 -0.674 . . . . 50.44 110.536 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -48.26 -41.03 26.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.147 0.425 . . . . 65.34 112.147 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.32 -40.73 85.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.183 0.516 . . . . 74.11 111.485 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -24.15 63.51 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.311 0.486 . . . . 65.1 112.311 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 7.7 m-85 -49.48 -42.0 42.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.914 0.388 . . . . 75.53 111.728 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.77 -29.85 29.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.908 0.385 . . . . 73.01 111.648 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 -15.77 46.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.942 0.719 . . . . 73.14 112.942 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -104.18 123.08 46.67 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.073 -0.392 . . . . 60.11 111.483 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 89.5 m -111.14 110.81 21.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.201 0.524 . . . . 65.03 111.726 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.6 123.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.853 -0.612 . . . . 61.44 110.447 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -133.51 -175.37 3.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.977 0.417 . . . . 70.44 111.851 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.05 129.6 42.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.045 0.45 . . . . 74.11 111.715 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 42.49 12.81 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.378 -0.439 . . . . 15.02 112.733 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -119.6 -173.15 2.47 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.699 -0.482 . . . . 61.12 109.699 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 102.65 4.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 71.13 110.972 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.16 100.11 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.57 0.7 . . . . 73.32 110.557 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 5.1 mm-40 -76.86 105.99 8.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.839 0.828 . . . . 74.32 111.214 -176.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 35' ' ' VAL . 12.1 t80 -119.11 99.32 6.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.47 -1.241 . . . . 73.01 109.395 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.116 0.784 . . . . 72.51 113.116 -168.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 55' ' ' LYS . 24.8 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.086 0.47 . . . . 72.44 111.895 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -90.75 117.12 29.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.921 -0.582 . . . . 74.45 111.307 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 58' ' ' ASP . 24.0 mt -116.82 179.14 4.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 110.309 -0.256 . . . . 62.0 110.309 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 26.6 m -146.84 134.58 21.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.697 0.284 . . . . 64.51 111.006 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.7 113.36 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 122.259 -0.276 . . . . 70.41 110.778 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.586 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 4.0 m-20 63.27 38.28 10.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.894 0.378 . . . . 75.11 111.203 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.08 -2.91 67.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.887 -0.673 . . . . 52.21 113.791 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.99 113.99 65.46 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.075 0.438 . . . . 73.32 111.094 176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.52 151.11 77.64 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.848 2.366 . . . . 71.42 112.922 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -151.3 109.73 3.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.277 0.561 . . . . 54.44 111.3 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.0 m -85.24 107.35 17.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.908 -0.587 . . . . 65.24 111.245 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.6 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.047 0.451 . . . . 71.52 112.091 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.07 149.84 40.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.899 0.381 . . . . 70.44 111.143 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.99 32.28 2.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.32 -0.4 . . . . 64.32 113.111 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.96 123.24 13.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.567 -0.372 . . . . 70.31 111.013 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.22 83.4 1.89 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.068 0.395 . . . . 72.22 112.068 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m 49.45 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.975 0.732 . . . . 74.24 112.975 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -135.17 154.49 51.6 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.19 0.441 . . . . 60.3 112.19 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p30 -71.73 167.8 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.037 0.446 . . . . 72.13 111.904 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.21 -42.21 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.288 -0.414 . . . . 62.12 111.939 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HB1' ' A' ' 32' ' ' ALA . 92.7 m -59.86 -44.44 94.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.671 0.272 . . . . 74.0 111.538 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 36.5 mt-10 -66.91 -37.17 83.84 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.245 -0.285 . . . . 60.22 111.271 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 54' ' ' VAL . 56.4 tp -56.01 -56.55 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.084 0.469 . . . . 63.12 111.341 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD22 HG11 ' A' ' 35' ' ' VAL . 4.5 pp -68.09 -26.4 65.81 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.918 0.389 . . . . 73.12 111.53 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -65.77 -36.69 84.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.882 0.372 . . . . 64.21 111.015 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.34 67.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 73.0 111.165 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -85.31 -3.06 58.71 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.279 0.561 . . . . 64.15 109.925 175.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 65.74 28.2 11.04 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.189 0.596 . . . . 64.21 112.018 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 27' ' ' LEU . 58.3 t -73.2 113.03 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.526 -0.306 . . . . 64.32 111.007 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.69 158.04 19.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.488 -0.324 . . . . 53.34 111.287 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 41.3 mt-30 60.69 72.44 0.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.492 0.663 . . . . 73.05 110.769 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' HG23 ' A' ' 21' ' ' THR . . . -67.82 -16.24 64.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.07 0.767 . . . . 45.04 113.07 -171.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -41.58 3.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.62 -0.264 . . . . 60.12 111.465 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 22.5 m-85 -60.41 -21.18 61.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.037 0.384 . . . . 74.43 112.037 -177.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.582 HG11 HD22 ' A' ' 24' ' ' LEU . 10.1 p -60.26 149.61 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.092 0.472 . . . . 74.15 111.306 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -116.04 113.81 23.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.745 0.307 . . . . 72.44 111.024 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.38 149.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.959 0.409 . . . . 74.5 111.176 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 9.2 pt-20 -128.91 125.99 38.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.002 0.43 . . . . 61.12 111.597 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.619 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.68 110.36 17.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.223 -0.444 . . . . 65.22 110.797 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m120 63.03 29.63 16.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.204 0.526 . . . . 73.02 110.912 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.51 85.42 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.043 -0.598 . . . . 73.12 113.456 -175.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.79 111.32 23.78 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.644 -0.327 . . . . 65.33 110.92 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.28 138.03 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.409 0.522 . . . . 65.05 112.409 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -109.65 161.48 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.037 0.446 . . . . 75.12 111.103 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.71 155.17 19.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.145 -0.48 . . . . 74.44 109.892 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 2.3 mpt_? -53.99 -38.28 64.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.654 0.613 . . . . 71.24 112.654 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.35 -31.1 69.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.219 0.533 . . . . 73.01 110.804 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.52 -24.0 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.848 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -55.83 -41.1 73.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.403 0.621 . . . . 74.54 110.869 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -70.19 -37.86 75.21 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.202 -0.908 . . . . 51.41 111.869 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.66 -33.75 60.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.191 0.441 . . . . 73.0 112.191 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -82.05 104.61 12.52 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.788 0.327 . . . . 72.52 111.046 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 74.0 p -94.39 110.74 22.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.198 0.523 . . . . 72.12 111.781 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 97.1 t -74.14 127.46 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.718 -0.674 . . . . 42.21 111.454 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 19.6 ptmt -167.99 87.99 0.25 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.146 -0.479 . . . . 74.43 111.684 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.9 t70 66.02 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.14 -0.482 . . . . 44.5 112.241 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.12 40.13 83.1 Favored Glycine 0 N--CA 1.464 0.532 0 C-N-CA 120.899 -0.667 . . . . 63.53 112.245 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.2 t70 -106.83 164.18 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.905 0.482 . . . . 74.03 111.957 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -151.52 72.55 1.04 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.838 -0.619 . . . . 72.21 110.699 175.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.3 p -83.32 95.95 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.801 0.81 . . . . 71.54 112.012 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 2.4 mp0 -73.7 103.7 4.36 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.189 0.518 . . . . 63.34 112.104 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 24' ' ' LEU . 11.7 m-85 -87.03 134.12 33.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.942 -0.572 . . . . 72.31 110.47 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.471 ' N ' HD23 ' A' ' 63' ' ' LEU . 2.1 pt? . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 112.625 0.602 . . . . 72.11 112.625 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.045 0.45 . . . . 70.41 112.01 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 2.3 m-20 -98.2 134.4 41.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.962 0.505 . . . . 73.44 110.803 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.521 ' HB3' HG12 ' A' ' 60' ' ' VAL . 2.7 mm? -126.48 134.9 50.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.773 0.321 . . . . 74.1 111.354 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -84.19 77.86 9.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.209 0.528 . . . . 74.11 110.357 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -80.82 121.89 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.023 0.44 . . . . 63.44 111.923 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 61.04 18.54 9.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.34 -0.391 . . . . 72.44 111.683 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.94 -3.15 64.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.28 -0.486 . . . . 33.05 113.091 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 10.3 mptt -108.29 132.87 20.8 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.819 0.31 . . . . 64.55 110.917 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 97.75 1.15 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.501 2.134 . . . . 53.5 113.61 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.1 t -98.47 179.42 4.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.035 -0.53 . . . . 44.24 111.096 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 93.9 m -149.73 121.41 8.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.106 0.41 . . . . 73.21 112.106 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' VAL . 34.9 m -100.26 109.03 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.564 0.697 . . . . 74.32 110.488 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.42 151.46 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.788 -176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.7 -43.06 3.14 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.293 -0.48 . . . . 74.35 113.314 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.9 153.9 21.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.295 0.48 . . . . 72.33 112.295 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.91 -72.26 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.344 -0.389 . . . . 72.13 111.496 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -110.25 96.01 5.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.884 0.373 . . . . 74.41 111.38 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 83.6 mt -127.36 152.03 48.01 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.728 0.299 . . . . 74.12 111.637 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -76.47 166.7 23.05 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.494 0.188 . . . . 54.23 110.613 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.42 -38.35 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.079 0.466 . . . . 73.22 110.352 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -59.62 -40.72 88.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.177 0.513 . . . . 73.03 110.776 172.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 6.0 mm-40 -69.58 -26.0 64.25 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.409 -0.36 . . . . 65.4 111.803 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 39.1 mt -63.71 -41.46 98.09 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.927 -0.397 . . . . 71.32 109.927 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.88 -41.08 90.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.281 -0.418 . . . . 61.44 110.408 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 m -59.36 -54.17 49.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.04 -0.527 . . . . 62.51 111.409 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.02 68.52 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.158 0.429 . . . . 21.11 112.158 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.6 mt -75.63 -6.22 49.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.503 -0.317 . . . . 64.44 111.715 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt 54.72 51.91 13.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.44 111.065 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.7 t -87.13 119.49 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 74.03 111.1 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.56 -28.86 65.22 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.934 0.397 . . . . 71.23 111.519 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.46 87.94 6.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.856 0.36 . . . . 64.41 111.513 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.75 -13.92 21.12 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.744 0.783 . . . . 75.42 110.624 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.26 -48.82 3.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.822 -1.081 . . . . 63.2 110.117 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.64 44.78 1.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.448 -0.796 . . . . 74.54 111.577 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.12 149.04 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 112.673 0.62 . . . . 64.41 112.673 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 m -145.41 112.44 6.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.056 -0.52 . . . . 61.41 111.027 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 62' ' ' PHE . 35.7 m -144.46 160.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.422 0.289 . . . . 63.3 111.427 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.604 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -133.62 147.86 51.5 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.561 0.696 . . . . 73.33 111.249 172.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.6 tm? -108.54 105.09 14.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.724 -0.671 . . . . 63.23 110.233 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.2 35.58 25.97 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.795 0.331 . . . . 71.44 111.434 -175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.43 -17.56 57.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 121.127 -0.558 . . . . 51.04 113.617 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.58 100.34 11.35 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.447 -0.443 . . . . 74.14 111.121 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.46 140.42 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.363 . . . . 74.45 111.387 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -99.72 136.53 39.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.921 0.391 . . . . 55.24 111.552 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.75 146.5 37.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.436 -0.347 . . . . 72.31 110.499 172.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -53.02 -21.82 4.98 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.1 0.476 . . . . 74.54 111.893 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.81 -27.67 24.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.558 0.577 . . . . 73.03 112.558 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.18 11.19 37.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.589 0.959 . . . . 65.2 113.589 -169.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 18.4 m-85 -59.68 -49.17 78.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.245 0.461 . . . . 65.2 112.245 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.12 -23.86 54.89 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.074 0.464 . . . . 64.03 111.202 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.97 -17.12 57.53 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.11 0.411 . . . . 34.44 112.11 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.8 m -103.64 120.87 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.725 0.298 . . . . 63.31 111.377 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.4 p -89.9 150.14 22.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.424 0.63 . . . . 75.02 112.146 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 23' ' ' LEU . 46.4 t -115.81 142.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.633 -0.712 . . . . 70.44 110.724 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -137.47 176.35 8.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.442 . . . . 73.21 112.005 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.46 145.85 50.69 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.026 0.441 . . . . 73.34 111.975 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.56 30.71 78.06 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.062 -0.517 . . . . 71.11 113.063 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -109.56 142.52 40.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.821 0.343 . . . . 72.05 111.121 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.0 85.57 5.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.88 0.696 . . . . 62.24 112.88 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 3' ' ' LEU . 5.6 p -86.94 107.96 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.492 0.663 . . . . 71.03 110.461 173.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.604 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 34.1 mt-10 -94.21 97.62 10.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.383 0.611 . . . . 74.14 111.247 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . 42.5 t80 -89.56 115.9 27.31 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.528 -0.76 . . . . 72.33 111.22 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.87 0.367 . . . . 73.42 111.5 -179.365 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.771 0.319 . . . . 64.3 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -75.47 130.12 38.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.126 0.417 . . . . 62.01 112.126 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -141.73 118.19 10.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.198 -0.456 . . . . 53.03 111.475 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' LYS . 67.2 m -76.19 97.82 4.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.182 0.515 . . . . 70.32 110.985 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 46.5 t -93.05 107.84 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.288 -0.414 . . . . 74.25 111.21 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.03 35.51 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.939 0.4 . . . . 53.12 112.031 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.42 76.23 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.048 -0.596 . . . . 65.44 113.645 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' THR . 28.5 mtpp -91.96 113.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 122.438 -0.448 . . . . 73.13 111.272 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.62 65.41 4.73 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.554 2.17 . . . . 74.12 112.182 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t -102.83 176.74 5.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.455 0.645 . . . . 71.15 111.661 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -148.95 134.42 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.887 -0.597 . . . . 74.4 111.234 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.63 119.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.276 -0.42 . . . . 71.14 110.004 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.76 111.05 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.155 0.502 . . . . 72.53 111.796 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.47 2.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.908 -0.587 . . . . 42.41 112.936 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.84 92.53 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.3 0.571 . . . . 73.4 111.827 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -79.91 84.33 5.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.15 0.5 . . . . 74.15 110.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.6 p 61.63 114.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.176 0.99 . . . . 50.53 112.598 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.4 mt -130.61 131.59 45.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.413 -0.358 . . . . 74.44 110.994 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.5 p-10 -80.46 171.86 14.5 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.198 -0.314 . . . . 75.23 110.363 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.2 t -56.5 -37.98 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.717 0.294 . . . . 74.21 111.156 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.0 m -55.73 -46.65 77.74 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.891 0.377 . . . . 71.23 111.116 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -67.38 -29.95 69.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.175 0.435 . . . . 52.05 112.175 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.01 -37.37 81.33 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.095 0.474 . . . . 61.21 110.329 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 35' ' ' VAL . 91.0 mt -63.75 -37.86 88.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.161 -0.472 . . . . 75.24 111.298 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -76.54 -38.19 55.46 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.434 -0.348 . . . . 64.04 111.117 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.03 90.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.036 0.446 . . . . 54.33 111.397 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -80.26 -17.99 50.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.274 0.559 . . . . 70.23 110.478 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 tptt 67.02 82.52 0.18 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.212 -0.904 . . . . 73.42 112.753 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.85 142.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.967 -0.56 . . . . 64.13 110.77 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -42.84 15.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.794 0.33 . . . . 60.05 111.729 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -87.94 76.58 8.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.099 0.476 . . . . 54.01 111.064 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.38 -23.9 67.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.271 0.471 . . . . 61.12 112.271 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -93.26 -8.8 41.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.257 0.466 . . . . 51.43 112.257 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.43 4.71 6.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 71.22 112.031 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 24' ' ' LEU . 7.2 p -68.62 130.35 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.452 0.644 . . . . 71.33 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -112.96 112.06 23.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.062 -0.517 . . . . 70.24 111.016 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 62' ' ' PHE . 29.8 m -139.33 158.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.35 -0.386 . . . . 73.05 111.402 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 3.5 pm0 -132.26 169.62 16.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.194 0.521 . . . . 71.05 110.945 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 39' ' ' LEU . 2.4 pp -133.98 124.59 26.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.669 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 56.47 18.87 3.75 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.206 -0.452 . . . . 74.54 111.531 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.62 2.18 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.324 -0.465 . . . . 60.22 113.744 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.19 120.57 15.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.925 0.363 . . . . 64.21 111.195 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.79 143.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.918 0.39 . . . . 72.11 111.71 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -91.59 139.3 30.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.076 0.465 . . . . 74.12 111.732 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.47 163.61 24.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.058 -0.519 . . . . 75.32 111.009 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 46' ' ' ARG . 9.1 ptp85 -47.74 -24.04 0.85 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.355 0.872 . . . . 62.42 113.355 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -119.92 7.11 10.88 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.482 0.549 . . . . 52.53 112.482 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -12.11 34.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.102 0.408 . . . . 75.42 112.102 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 62.7 m-85 -62.17 -38.84 90.57 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.065 0.395 . . . . 73.15 112.065 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' HD22 ' A' ' 19' ' ' ASN . 26.1 m-20 -72.77 -56.2 5.6 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.422 0.527 . . . . 71.32 112.422 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.69 88.21 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.886 0.698 . . . . 61.52 112.886 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.458 HG21 HD21 ' A' ' 39' ' ' LEU . 99.7 m -74.32 98.15 3.17 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.236 0.541 . . . . 75.12 112.04 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 62.6 p -84.81 127.72 34.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.926 -0.579 . . . . 71.44 111.341 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.02 151.67 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.103 0.478 . . . . 64.32 110.881 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.08 -170.02 2.78 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.979 0.418 . . . . 73.04 111.916 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 136.68 56.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.437 -0.347 . . . . 75.41 111.487 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 50.43 5.25 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.168 -0.539 . . . . 53.14 113.366 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.57 -178.78 5.67 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.629 -0.336 . . . . 65.45 110.523 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.64 107.74 6.75 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.29 0.478 . . . . 73.04 112.29 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.6 p -103.11 116.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.441 0.638 . . . . 72.04 111.129 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 46.9 mt-10 -96.45 110.47 22.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.209 0.528 . . . . 71.33 111.08 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' VAL . 56.5 t80 -100.57 114.7 28.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.863 -0.608 . . . . 74.3 111.032 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.6 mt -88.09 137.31 32.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.951 0.405 . . . . 74.15 111.687 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -105.76 24.68 11.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.155 0.502 . . . . 73.05 111.033 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -52.49 157.46 1.5 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.415 0.894 . . . . 71.1 113.415 -174.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.482 ' HG3' ' H ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 69.2 167.16 0.28 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.331 -0.85 . . . . 73.02 111.925 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 66' ' ' MET . . . 179.36 -96.68 0.1 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.065 -0.588 . . . . 64.43 112.275 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.02 134.64 2.58 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.02 -0.609 . . . . 62.33 112.813 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.33 7.35 72.07 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.098 -0.573 . . . . 44.4 113.789 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -167.05 103.73 0.55 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.187 0.493 . . . . 74.22 111.171 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.4 16.7 5.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.306 -0.406 . . . . 73.42 111.44 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -68.75 110.97 4.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.932 0.716 . . . . 63.02 112.932 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -141.46 -47.76 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.648 -0.705 . . . . 62.04 109.971 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 65.6 121.33 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.405 0.621 . . . . 74.32 112.437 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -81.59 43.5 0.75 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.868 -0.605 . . . . 65.54 111.883 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -85.05 129.22 34.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.139 0.495 . . . . 52.21 111.61 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -150.38 143.69 24.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.929 -0.578 . . . . 64.55 110.325 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.738 -0.649 . . . . 63.13 111.852 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.256 0.551 . . . . 73.32 111.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.5 121.06 29.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.381 -0.372 . . . . 62.21 111.625 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.22 114.03 18.44 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.809 0.338 . . . . 75.04 111.25 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 28.5 m -76.05 77.5 2.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.558 0.694 . . . . 75.41 110.917 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.7 t -74.22 114.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.018 -0.537 . . . . 53.01 111.886 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 62.09 19.83 11.16 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.411 -0.359 . . . . 43.22 111.771 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.67 55.71 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.923 -0.656 . . . . 63.32 113.52 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.98 115.65 65.67 Favored Pre-proline 0 N--CA 1.471 0.596 0 O-C-N 122.3 -0.529 . . . . 75.44 111.236 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.85 96.15 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.868 2.379 . . . . 73.05 112.303 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 m -97.47 100.86 12.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.141 0.496 . . . . 72.34 111.243 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.6 m -73.96 84.09 1.74 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.346 -0.388 . . . . 53.04 111.083 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -97.33 113.43 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 73.45 111.057 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.87 -179.82 3.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.94 -0.475 . . . . 72.42 111.151 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.4 84.77 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.058 -0.592 . . . . 73.34 112.318 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.36 98.01 2.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.043 0.449 . . . . 74.15 110.225 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.38 82.17 2.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.306 -0.407 . . . . 74.24 112.025 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p 64.51 143.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 74.52 113.545 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.6 pp -156.34 175.43 14.02 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.807 -0.633 . . . . 74.14 111.268 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -97.85 172.24 7.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.739 0.304 . . . . 64.23 110.972 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.02 -36.58 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.882 0.372 . . . . 71.14 111.757 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -56.3 -45.78 80.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.189 0.518 . . . . 34.44 111.264 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 12.0 mm-40 -64.13 -41.36 97.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.978 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.77 -51.39 56.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.204 -0.453 . . . . 75.01 111.319 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.481 HD11 HG21 ' A' ' 35' ' ' VAL . 4.5 mm? -55.33 -44.72 76.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.901 0.382 . . . . 42.43 111.481 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 t -67.58 -27.96 67.37 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.791 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.71 -41.71 44.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.968 0.414 . . . . 75.3 111.578 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.55 -6.99 59.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.045 0.387 . . . . 71.55 112.045 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.788 0.435 . . . . 52.15 111.78 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.69 120.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.057 0.456 . . . . 71.01 111.737 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.03 36.38 0.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.955 0.502 . . . . 75.32 112.204 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.95 35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.216 0.451 . . . . 72.25 112.216 -174.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.64 50.29 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.132 0.419 . . . . 64.15 112.132 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.08 -24.54 28.04 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.117 0.484 . . . . 74.12 111.928 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -107.56 -4.45 18.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.739 0.304 . . . . 64.12 111.76 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 37' ' ' VAL . 7.4 p -68.27 89.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.868 0.842 . . . . 72.41 113.058 -172.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -82.18 93.42 7.06 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.907 -0.588 . . . . 71.04 110.941 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 62' ' ' PHE . 17.2 m -110.8 141.14 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.099 0.476 . . . . 64.14 111.63 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.77 119.85 27.9 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.573 0.702 . . . . 71.25 111.751 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -82.11 115.76 21.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.704 -0.68 . . . . 71.03 110.849 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 27.51 17.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.802 0.334 . . . . 75.12 111.697 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.61 5.26 66.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.343 -0.455 . . . . 72.43 113.633 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -114.54 117.85 32.07 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.529 -0.395 . . . . 73.4 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -74.27 139.72 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.956 0.408 . . . . 62.32 111.74 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 39' ' ' LEU . 3.3 mm? -101.35 153.69 19.44 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.264 0.554 . . . . 63.25 112.261 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 157.25 30.13 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.571 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -60.18 -33.01 71.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.961 0.41 . . . . 73.44 111.567 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -70.92 -32.65 69.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.393 0.616 . . . . 74.23 110.528 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HA ' ' HB3' ' A' ' 51' ' ' ALA . . . -71.99 -13.75 61.7 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.093 -0.503 . . . . 63.41 112.191 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -56.71 -45.6 81.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.021 0.439 . . . . 71.0 111.034 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.5 -21.31 35.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.113 -0.494 . . . . 64.21 111.281 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . . . -97.76 21.82 9.96 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.389 0.514 . . . . 61.22 112.389 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.8 m -133.82 113.69 12.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.81 0.338 . . . . 75.33 111.169 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.3 p -81.66 126.83 32.25 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.11 0.481 . . . . 63.53 111.837 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.52 113.65 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.622 -0.717 . . . . 75.02 109.538 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -144.74 -161.46 1.3 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.934 0.397 . . . . 74.21 111.597 -170.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.11 93.35 0.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.937 -0.477 . . . . 75.14 112.119 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.0 10.88 1.69 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.114 -0.565 . . . . 41.5 114.488 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.06 130.19 40.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.154 0.977 . . . . 41.12 112.108 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -85.93 66.14 9.46 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.399 0.619 . . . . 64.33 110.428 175.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.1 p -73.69 99.71 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.718 0.771 . . . . 42.12 112.009 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.49 78.57 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.304 0.573 . . . . 60.54 110.954 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' VAL . 36.0 t80 -73.77 96.37 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.102 -0.703 . . . . 75.5 109.102 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.8 mt -72.0 137.84 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.037 0.755 . . . . 72.3 113.037 -170.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -79.31 0.71 27.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.759 -0.655 . . . . 74.21 110.641 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 63.15 22.2 13.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.881 -0.599 . . . . 63.53 111.669 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.41 22.42 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.323 0.49 . . . . 72.21 112.323 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.02 -13.19 20.42 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.764 -0.534 . . . . 64.21 111.764 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 132.31 11.49 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.529 -0.367 . . . . 53.41 112.767 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.61 74.84 1.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.278 -0.487 . . . . 73.51 114.107 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -81.35 129.92 34.82 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.123 0.487 . . . . 72.44 110.901 174.563 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.09 138.43 54.18 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.068 -0.395 . . . . 70.14 111.963 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -65.05 129.92 41.45 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.507 -0.553 . . . . 64.11 109.507 171.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -67.59 -24.46 65.5 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.183 0.438 . . . . 64.0 112.183 -170.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.1 m80 58.88 19.92 7.54 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.329 0.863 . . . . 64.42 113.329 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -69.23 117.65 11.14 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.014 -0.429 . . . . 55.31 110.775 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -62.56 129.23 39.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.03 0.443 . . . . 74.14 111.422 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -153.35 141.42 20.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.113 -0.494 . . . . 75.43 111.437 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.986 -0.53 . . . . 73.53 111.569 179.12 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 111.659 0.244 . . . . 74.44 111.659 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -99.64 127.81 45.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.824 0.345 . . . . 75.41 111.246 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.55 140.85 49.86 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.975 0.417 . . . . 73.25 111.519 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -91.2 76.7 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.437 0.637 . . . . 61.2 110.133 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 39.5 t -74.0 110.01 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.892 -0.595 . . . . 74.12 111.827 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.3 m120 58.95 26.02 14.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.824 0.45 . . . . 72.4 111.559 -176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.28 -4.77 74.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.94 -0.647 . . . . 42.5 113.243 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.6 mptt -101.28 139.16 20.22 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.366 -0.49 . . . . 65.51 110.894 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.66 121.97 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.509 2.139 . . . . 74.11 113.0 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.2 t -133.65 156.54 47.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.008 -0.542 . . . . 73.3 110.539 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -135.85 113.91 11.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.204 -0.31 . . . . 75.12 111.524 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.3 m -91.57 108.55 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.334 0.588 . . . . 55.1 110.919 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.92 143.22 30.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.943 -0.571 . . . . 51.34 111.113 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.96 21.96 31.8 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.406 -0.426 . . . . 55.33 112.836 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.03 136.42 4.12 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.197 0.443 . . . . 72.21 112.197 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.06 -40.94 7.37 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.19 -0.459 . . . . 65.3 110.766 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.0 p -164.32 112.38 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 75.22 111.267 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.76 160.31 32.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.218 -0.446 . . . . 61.43 110.536 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -72.86 162.54 29.36 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.654 0.264 . . . . 71.01 110.319 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.4 t -59.33 -34.83 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 122.152 -0.343 . . . . 45.54 111.433 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -60.29 -53.72 54.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.76 0.314 . . . . 75.11 111.819 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.81 0.338 . . . . 72.24 111.192 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.5 -45.95 91.91 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.804 -0.443 . . . . 51.31 109.804 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 95.0 mt -59.3 -39.73 83.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.947 0.403 . . . . 72.44 111.136 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -69.97 -32.18 70.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.084 0.469 . . . . 75.21 111.441 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.05 -47.35 58.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.909 0.385 . . . . 51.32 111.477 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.59 -20.43 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.276 -0.42 . . . . 73.22 111.331 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 65.78 76.49 0.32 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.697 0.761 . . . . 65.43 111.541 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.67 146.2 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.581 -0.736 . . . . 73.4 110.915 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.18 3.18 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.174 0.435 . . . . 72.42 112.174 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.38 98.98 10.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.939 0.399 . . . . 74.11 111.8 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -86.52 -29.51 22.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.166 0.507 . . . . 52.24 111.311 177.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -79.41 -23.54 43.15 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.013 -0.54 . . . . 74.41 111.536 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -112.43 11.57 19.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 72.44 112.116 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 37' ' ' VAL . 7.3 p -75.73 88.91 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.838 0.828 . . . . 50.04 112.147 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -76.54 95.94 4.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.812 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 35' ' ' VAL . 35.4 m -120.3 158.42 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.428 -0.351 . . . . 60.34 110.975 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.6 134.45 43.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.78 0.8 . . . . 74.14 112.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD13 ' OD1' ' A' ' 40' ' ' ASN . 1.0 OUTLIER -78.24 103.23 8.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.968 -1.015 . . . . 73.22 110.757 -176.177 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.411 ' OD1' HD13 ' A' ' 39' ' ' LEU . 2.4 m-20 58.14 24.41 11.27 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.875 0.369 . . . . 74.31 111.728 178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.82 40.63 4.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.941 -0.647 . . . . 63.54 112.608 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.32 105.66 3.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.788 0.435 . . . . 75.11 110.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.66 138.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.641 0.608 . . . . 75.11 112.641 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -89.86 153.77 20.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.357 0.599 . . . . 73.51 111.72 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.19 160.5 26.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.399 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 38.0 ptt180 -37.07 -48.04 0.77 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.013 1.116 . . . . 74.44 114.013 -176.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 13.8 pt-20 -107.41 0.52 22.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.278 0.473 . . . . 74.41 112.278 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.71 65.28 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.945 0.402 . . . . 74.04 111.279 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -58.83 -41.24 86.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.133 -0.485 . . . . 62.22 111.44 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -82.02 -32.17 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.134 -0.484 . . . . 74.11 110.963 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.81 46.08 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.821 0.674 . . . . 74.31 112.821 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.3 m -96.47 122.2 39.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.871 0.367 . . . . 74.14 111.606 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 m -91.64 106.94 18.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.418 -0.355 . . . . 74.25 111.226 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.42 115.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.953 0.406 . . . . 64.1 110.997 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -112.0 -167.43 1.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.854 0.359 . . . . 75.22 111.648 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.39 133.83 37.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.872 0.368 . . . . 74.11 111.887 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.99 43.62 8.1 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.353 -0.451 . . . . 43.42 113.669 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -116.08 140.72 49.0 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.556 -0.379 . . . . 74.05 110.808 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.86 74.12 2.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.234 0.54 . . . . 61.11 111.643 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 34.6 m -82.4 125.39 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.407 0.622 . . . . 73.32 111.365 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -92.04 101.42 13.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.384 0.612 . . . . 70.55 111.157 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 37' ' ' VAL . 5.2 t80 -103.92 99.9 9.67 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.471 -0.786 . . . . 71.12 109.553 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.6 pt? -125.67 136.3 53.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -167.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 69.1 11.69 8.34 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.12 0.785 . . . . 65.24 113.12 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -130.92 147.52 52.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.289 0.566 . . . . 70.14 111.828 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -164.56 -170.46 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.678 -0.692 . . . . 64.31 110.401 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.95 -72.18 0.03 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.474 -0.87 . . . . 62.11 113.666 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.69 -45.27 2.9 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.285 -0.483 . . . . 64.14 113.136 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.61 93.97 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.528 -0.368 . . . . 73.04 113.457 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -115.63 148.6 39.47 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.226 0.536 . . . . 61.23 112.149 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.3 pt? -150.57 -165.33 2.24 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.643 -0.708 . . . . 72.12 110.289 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.22 133.67 39.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.492 -0.13 . . . . 75.25 110.859 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -57.14 135.02 56.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.59 0.234 . . . . 75.54 111.123 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -56.19 93.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.583 0.706 . . . . 74.25 112.738 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -76.95 -168.68 1.11 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 74.3 110.92 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -60.27 134.56 57.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.877 0.37 . . . . 73.33 110.804 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -144.38 143.27 30.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.252 -0.431 . . . . 75.45 110.89 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 119.33 -0.367 . . . . 72.32 111.812 178.036 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.819 0.343 . . . . 62.31 111.584 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.35 127.2 34.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.407 -0.36 . . . . 72.2 110.88 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -133.33 176.01 8.9 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.117 0.484 . . . . 75.43 111.109 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 m -141.04 132.23 26.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.374 -0.375 . . . . 73.33 111.185 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.53 121.12 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.74 0.305 . . . . 54.31 111.376 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 61' ' ' GLU . 15.9 m120 65.72 14.36 9.49 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.01 0.374 . . . . 73.2 112.01 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.73 -2.41 72.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.238 -0.506 . . . . 44.11 112.087 -172.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -97.7 110.78 56.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.379 0.671 . . . . 70.22 110.655 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.8 123.54 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.189 2.593 . . . . 74.24 113.724 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -136.51 100.86 4.47 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.216 0.531 . . . . 75.31 111.314 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.8 m -80.65 95.57 6.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.036 0.446 . . . . 75.42 111.66 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 12' ' ' VAL . 16.9 m -81.96 79.6 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.967 0.889 . . . . 65.51 110.463 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.54 170.69 14.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.945 -0.571 . . . . 73.11 111.168 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 25.3 68.31 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.581 -0.819 . . . . 75.41 111.533 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.29 123.2 10.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.728 0.411 . . . . 63.34 110.698 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -74.54 -68.73 0.51 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.205 0.526 . . . . 72.33 111.785 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -167.26 132.96 2.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.393 -0.821 . . . . 71.41 109.274 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 1.2 pp -149.99 163.07 39.09 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.039 0.755 . . . . 73.4 113.039 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.05 159.16 20.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.047 -0.524 . . . . 43.33 111.102 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 50.6 t -57.33 -43.74 82.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.015 0.435 . . . . 72.53 110.485 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.1 m -60.34 -45.65 92.68 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.42 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -59.72 -36.99 77.69 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.035 0.445 . . . . 54.44 110.632 176.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.94 -44.18 97.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.191 0.52 . . . . 73.32 110.385 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 89.1 mt -58.64 -34.72 71.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.01 -0.541 . . . . 65.11 110.759 174.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.9 t -68.19 -43.02 79.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.58 . . . . 54.22 111.406 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -46.29 76.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.261 0.467 . . . . 64.41 112.261 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 mm? -94.11 -6.89 43.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.662 -0.244 . . . . 61.32 111.626 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? 57.49 89.02 0.05 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.395 0.617 . . . . 65.11 111.649 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.826 -0.624 . . . . 64.32 111.686 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.85 -49.13 18.86 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.041 0.448 . . . . 63.41 111.517 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -123.15 142.38 50.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.964 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -110.71 -40.2 4.64 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.294 0.568 . . . . 54.31 111.974 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -80.63 -30.4 36.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 70.33 111.118 175.545 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -91.23 -7.15 52.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.403 0.52 . . . . 73.14 112.403 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 32' ' ' ALA . 9.7 p -58.7 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 122.007 0.908 . . . . 52.41 112.211 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -84.52 92.21 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.758 -0.655 . . . . 74.33 110.949 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 35' ' ' VAL . 28.7 m -125.0 141.95 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.953 -0.567 . . . . 74.31 110.999 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.8 pt-20 -118.26 122.16 42.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.686 0.755 . . . . 74.52 111.818 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -81.22 107.22 13.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.585 -0.734 . . . . 73.31 109.89 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 64.24 38.46 8.04 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.0 0.428 . . . . 64.52 111.282 -177.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.85 29.67 58.85 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.206 -0.521 . . . . 62.45 113.665 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 38' ' ' GLU . 41.4 tt0 -148.91 115.75 5.99 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.466 -0.432 . . . . 64.51 110.798 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 14.7 p -77.37 147.44 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 113.069 0.766 . . . . 73.12 113.069 -173.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -106.37 157.79 17.36 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.059 -0.519 . . . . 74.25 111.008 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.571 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 tt0 -76.4 159.59 30.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.858 0.361 . . . . 74.31 111.437 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -49.65 -49.24 48.01 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 73.41 113.936 -169.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -80.78 -23.14 39.52 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.564 -0.71 . . . . 75.04 111.689 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.13 49.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.285 0.476 . . . . 70.12 112.285 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.99 -30.53 70.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.778 0.323 . . . . 73.42 111.719 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.96 -21.48 27.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.795 0.331 . . . . 73.53 111.479 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.02 1.96 56.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.095 0.406 . . . . 75.23 112.095 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -116.1 116.45 27.89 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.582 0.229 . . . . 54.43 111.471 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -89.4 109.83 20.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.116 0.484 . . . . 71.35 111.65 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.35 137.32 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 74.2 110.521 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -135.67 176.08 9.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.232 0.539 . . . . 71.14 111.771 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.65 105.61 0.32 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.023 -0.535 . . . . 73.13 112.095 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.81 7.89 12.67 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.483 -0.389 . . . . 65.13 113.343 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.94 153.47 21.56 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.52 . . . . 65.24 111.764 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.85 107.65 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 75.42 111.631 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.27 110.85 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.792 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 6' ' ' ASN . 39.0 mt-10 -98.89 111.65 23.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.387 0.613 . . . . 63.42 112.339 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -80.77 130.92 35.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.383 -0.826 . . . . 74.51 111.468 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? -141.81 168.26 20.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.083 -0.386 . . . . 64.4 112.011 177.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 73.91 -37.08 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.644 0.778 . . . . 73.22 112.298 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -72.13 -13.04 61.46 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.57 0.582 . . . . 74.22 112.57 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 -178.9 6.14 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.802 0.334 . . . . 71.1 111.701 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.53 79.74 0.32 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.684 -0.566 . . . . 72.12 111.684 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.95 0.65 30.15 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.186 -0.531 . . . . 63.11 114.393 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.21 27.16 67.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.989 -0.624 . . . . 53.24 113.836 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -99.42 101.13 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.516 -0.403 . . . . 65.32 110.718 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.8 mp 52.27 23.87 2.59 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.81 0.814 . . . . 75.15 110.121 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -88.33 19.95 3.53 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.093 -0.958 . . . . 74.2 111.742 -167.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -75.27 92.68 2.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.905 0.384 . . . . 74.24 110.325 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -132.01 123.44 27.3 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.432 -0.349 . . . . 74.3 111.192 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -63.67 115.08 4.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.986 0.422 . . . . 72.15 110.895 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -81.5 152.38 27.35 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.069 0.461 . . . . 74.0 112.18 -173.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -79.19 -179.96 7.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.228 -0.442 . . . . 74.11 111.725 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 119.308 -0.377 . . . . 55.33 111.692 178.207 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HD21 ' A' ' 3' ' ' LEU . 23.1 ptp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.679 0.276 . . . . 75.11 111.641 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -99.29 124.39 44.34 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.407 -0.36 . . . . 71.12 111.001 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.7 mm? -119.5 129.06 54.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.734 0.302 . . . . 75.51 111.155 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -78.69 73.02 5.25 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.414 0.626 . . . . 75.34 110.185 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -70.81 110.4 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.332 0.586 . . . . 75.42 112.099 -173.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.4 m120 59.71 21.48 10.23 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.134 -0.485 . . . . 54.25 111.879 -177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.1 -4.29 62.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.869 -0.681 . . . . 75.41 113.035 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 mptp? -102.53 136.51 19.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.377 0.271 . . . . 71.44 110.685 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.37 104.55 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.264 1.976 . . . . 72.52 113.178 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 t -114.0 153.53 29.19 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.148 -0.345 . . . . 71.54 110.655 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -135.51 114.34 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.096 0.406 . . . . 62.1 112.096 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.69 112.08 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.508 0.67 . . . . 71.25 110.104 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.72 148.55 50.22 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.633 -0.712 . . . . 71.43 112.367 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.77 -58.35 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.498 -0.382 . . . . 63.53 113.44 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.38 110.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.175 0.435 . . . . 72.33 112.175 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' HE2' ' A' ' 1' ' ' MET . 42.8 mt-10 -94.18 -55.46 3.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 74.54 111.494 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 p -143.4 115.86 8.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.391 -0.368 . . . . 61.44 111.44 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -157.63 165.35 35.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.371 -0.377 . . . . 74.33 111.855 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 40.3 m-20 -66.37 160.95 23.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.605 0.241 . . . . 61.34 111.27 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 56.3 t -56.17 -41.9 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.014 0.435 . . . . 71.24 110.6 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 m -59.03 -47.21 86.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.083 0.468 . . . . 74.04 111.346 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 51.7 mt-10 -65.73 -31.6 72.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.955 0.407 . . . . 74.41 111.102 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.5 -46.74 78.5 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.856 -0.424 . . . . 72.21 109.856 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 90.6 mt -56.8 -36.21 69.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.161 -0.472 . . . . 63.34 111.047 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.6 t -64.52 -55.81 18.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 71.14 111.328 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.89 78.47 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 64.24 112.378 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 tp -79.6 -22.85 43.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.843 0.354 . . . . 60.24 111.42 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? 63.1 81.65 0.2 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.321 0.581 . . . . 73.42 109.731 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 31' ' ' GLN . 12.5 p -93.62 151.42 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.977 -0.556 . . . . 33.51 111.737 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.41 70.27 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.005 0.372 . . . . 52.13 112.005 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.542 ' H ' HG22 ' A' ' 29' ' ' VAL . 61.8 mm-40 -127.03 134.85 50.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.612 -0.267 . . . . 52.21 110.683 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.83 9.3 8.82 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.397 0.618 . . . . 63.12 111.48 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -32.45 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.524 -0.762 . . . . 74.32 111.305 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.48 -19.74 29.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.787 0.327 . . . . 72.03 111.54 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 37' ' ' VAL . 7.1 p -68.56 126.15 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.789 0.663 . . . . 72.03 112.789 -173.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -102.52 98.84 8.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.713 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 HG22 ' A' ' 35' ' ' VAL . 14.6 m -103.57 95.87 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.463 0.649 . . . . 72.32 111.283 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 10.1 pt-20 -95.48 94.35 7.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.482 0.658 . . . . 73.44 111.314 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -68.41 114.95 7.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.359 0.599 . . . . 64.14 112.025 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 59.09 39.49 23.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.901 -0.59 . . . . 50.51 111.748 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.82 48.66 40.31 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.032 -0.604 . . . . 75.02 113.194 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.06 108.58 3.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.957 0.408 . . . . 62.42 110.657 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.84 136.4 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.579 0.585 . . . . 54.25 112.579 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.7 mm? -101.74 152.35 20.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.033 -0.531 . . . . 74.13 110.824 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' N ' ' HB3' ' A' ' 48' ' ' ALA . 45.4 mt-10 -68.56 169.35 11.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.282 0.563 . . . . 74.54 111.969 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -58.85 -35.68 73.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.867 -0.606 . . . . 72.15 110.451 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.54 -42.12 22.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.43 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' A' ' 45' ' ' GLU . . . -56.66 -20.85 23.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.09 0.774 . . . . 63.32 113.09 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -56.03 -34.25 65.69 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.042 0.449 . . . . 63.21 111.136 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -81.62 -32.6 31.91 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.364 -0.38 . . . . 73.03 111.17 175.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.39 59.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.629 0.603 . . . . 75.41 112.629 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -113.11 119.24 37.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.756 0.313 . . . . 75.21 111.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 83.4 m -96.16 124.69 40.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.335 0.588 . . . . 71.34 112.328 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.64 151.77 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.889 -0.596 . . . . 74.43 110.897 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -147.76 -178.19 6.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.875 0.369 . . . . 74.35 111.624 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 26.2 t70 -58.46 119.01 6.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.163 0.506 . . . . 73.3 112.359 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.38 54.22 1.1 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.188 -0.46 . . . . 62.24 113.662 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.04 154.71 48.25 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.884 0.342 . . . . 64.34 111.035 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.82 1.83 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 39' ' ' LEU . 30.2 m -82.18 107.87 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.41 111.182 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 44.1 mt-10 -77.46 93.33 4.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.519 0.675 . . . . 73.13 110.804 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -80.08 92.11 5.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.365 -0.834 . . . . 73.5 110.431 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.32 127.64 33.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.172 0.511 . . . . 71.33 112.225 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -91.19 19.38 5.92 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.141 -0.481 . . . . 74.04 111.797 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -54.99 -17.22 3.47 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.174 0.805 . . . . 71.41 113.174 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.7 mmt -64.38 -31.29 72.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.045 0.45 . . . . 64.25 111.375 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.15 59.3 0.24 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 116.353 -0.385 . . . . 62.32 112.249 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.78 152.75 23.73 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.168 -0.539 . . . . 75.42 112.904 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.93 18.65 0.66 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.882 -0.675 . . . . 53.01 113.78 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -67.47 94.77 0.42 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.238 0.519 . . . . 74.34 109.9 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.13 110.84 13.33 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.189 0.518 . . . . 64.23 111.899 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.17 178.52 5.97 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.536 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -56.58 126.22 25.68 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.254 -0.43 . . . . 74.45 110.389 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 10.7 t60 -63.42 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.623 -0.262 . . . . 73.23 111.195 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 74' ' ' HIS . 62.8 m170 72.84 162.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.577 0.751 . . . . 53.31 111.865 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -73.11 105.67 4.65 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.26 -0.427 . . . . 72.45 111.947 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -120.77 -160.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.06 0.457 . . . . 60.12 110.299 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 118.678 -0.677 . . . . 74.4 110.13 170.391 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 20.4 ptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.91 0.386 . . . . 71.11 111.847 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -75.89 129.91 37.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.087 -0.506 . . . . 64.21 111.788 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.8 mt -139.12 153.07 47.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.947 0.404 . . . . 70.34 111.661 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.5 m -109.18 126.47 53.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.934 0.397 . . . . 74.33 111.34 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 62' ' ' PHE . 4.7 p -133.83 124.08 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.5 -0.318 . . . . 32.42 110.95 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 62.53 26.39 15.68 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.143 0.497 . . . . 74.14 111.163 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.28 16.8 80.41 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.24 -0.505 . . . . 72.02 112.74 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -103.35 117.98 58.87 Favored Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 122.761 -0.258 . . . . 64.13 110.793 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.21 116.44 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.447 2.098 . . . . 73.1 111.528 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 t -141.77 -173.95 3.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.933 0.397 . . . . 75.13 111.448 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -159.55 126.68 4.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 72.24 111.734 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 12' ' ' VAL . 18.9 m -96.05 99.09 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.595 0.712 . . . . 54.24 110.437 175.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.45 137.71 33.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.993 -0.549 . . . . 74.12 110.875 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.5 56.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.28 -0.486 . . . . 41.13 113.207 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.01 97.57 8.41 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.412 -0.464 . . . . 75.4 111.517 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -77.45 76.73 3.99 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.317 0.579 . . . . 70.45 111.669 -177.485 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.2 m 53.48 71.19 0.52 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.952 -0.567 . . . . 73.35 111.463 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 80.5 mt -93.3 145.75 24.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.272 0.558 . . . . 62.11 112.106 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 18.2 m-20 -70.51 163.98 25.71 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.857 -0.611 . . . . 75.14 110.037 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.5 -41.53 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.818 0.342 . . . . 71.33 110.608 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -61.69 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.926 0.393 . . . . 75.52 111.842 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 43.0 mt-10 -68.4 -43.75 76.56 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.11 0.481 . . . . 71.34 111.131 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.28 -37.66 86.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.311 0.577 . . . . 75.32 109.968 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.13 -34.95 70.79 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.699 -0.682 . . . . 64.34 110.833 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -74.66 -33.59 62.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.369 -0.378 . . . . 72.31 111.327 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.77 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.157 0.504 . . . . 61.31 111.6 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.0 mt -90.44 -29.77 17.77 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.286 0.565 . . . . 72.54 110.216 171.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 57.51 86.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.057 -0.974 . . . . 74.12 112.565 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.2 159.42 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.558 -0.746 . . . . 53.12 110.538 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.73 -63.77 1.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.054 0.454 . . . . 65.1 111.773 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -102.3 136.96 41.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.551 -0.295 . . . . 75.34 110.676 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.26 -55.52 2.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 75.41 111.545 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -63.02 -11.72 21.08 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.826 -0.625 . . . . 62.1 112.301 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.81 3.02 36.26 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.322 0.49 . . . . 75.14 112.322 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG12 HG13 ' A' ' 37' ' ' VAL . 81.3 t -74.39 138.19 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.321 0.581 . . . . 71.02 112.341 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.512 ' HB ' ' CE1' ' A' ' 65' ' ' PHE . 89.4 m -115.83 108.54 16.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.128 -0.487 . . . . 72.35 110.575 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.0 m -134.04 162.23 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.19 0.519 . . . . 71.14 111.891 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.09 169.61 17.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.577 -0.738 . . . . 74.15 110.563 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 39' ' ' LEU . 2.0 pt? -143.92 129.09 18.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 72.03 111.078 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.75 21.08 11.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.173 0.511 . . . . 55.21 111.005 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 55.78 2.98 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.04 -0.527 . . . . 74.4 113.374 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 126.15 2.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.914 0.357 . . . . 73.41 110.651 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.76 136.04 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.21 0.528 . . . . 74.31 112.352 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.58 166.78 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.667 0.746 . . . . 73.03 112.547 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.06 149.46 33.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.5 -0.773 . . . . 65.21 110.964 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 9.1 mpt_? -64.34 -41.31 96.84 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.185 -0.322 . . . . 72.43 111.864 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.25 -29.76 69.48 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.19 0.519 . . . . 74.3 111.058 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.28 65.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.279 -0.419 . . . . 73.44 111.585 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -62.13 -30.63 71.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.697 0.284 . . . . 74.3 111.508 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.7 -35.82 72.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.873 0.368 . . . . 70.43 111.54 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.87 -29.81 24.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.203 0.446 . . . . 73.31 112.203 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 m -82.03 113.69 20.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.758 0.314 . . . . 63.45 111.832 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.0 m -96.87 140.61 31.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.229 0.538 . . . . 73.04 111.881 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 55' ' ' LYS . 17.4 t -90.44 160.64 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.116 -0.493 . . . . 62.51 111.112 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.9 pttm -141.38 169.94 16.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.979 0.418 . . . . 72.13 111.805 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 27.8 t70 -70.88 111.45 6.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.133 0.492 . . . . 63.34 110.97 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.71 39.77 3.79 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.175 -0.466 . . . . 52.21 112.096 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -122.82 175.32 6.61 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 110.006 -0.368 . . . . 71.32 110.006 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.67 143.77 43.3 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.245 0.545 . . . . 53.24 112.459 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 5' ' ' VAL . 24.0 m -130.5 71.06 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.805 0.812 . . . . 75.24 109.677 172.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.21 83.11 0.73 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.763 0.792 . . . . 62.22 111.568 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.6 m-85 -77.4 92.26 3.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.09 -0.959 . . . . 73.45 111.767 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -82.53 87.68 6.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.346 0.593 . . . . 73.24 112.027 -177.299 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 70.96 -19.72 0.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.096 1.147 . . . . 73.52 114.096 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 36' ' ' THR . 78.7 m-85 -72.67 74.69 1.1 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.817 -0.552 . . . . 70.41 111.079 174.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.1 mtt -121.0 -34.05 3.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.295 -0.412 . . . . 73.13 112.017 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 -31.63 4.68 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.269 -0.491 . . . . 60.13 112.027 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.58 -84.58 0.76 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.378 -0.439 . . . . 63.52 114.024 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.8 49.38 4.23 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 114.379 0.512 . . . . 71.42 114.379 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.21 145.76 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.107 0.454 . . . . 64.21 110.734 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.58 112.29 5.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.708 0.289 . . . . 73.52 111.362 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.08 154.69 27.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.884 0.373 . . . . 43.01 111.429 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -55.23 124.12 15.95 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.919 0.39 . . . . 74.44 111.849 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -122.47 80.76 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.196 0.522 . . . . 72.43 110.875 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -120.23 152.18 38.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.13 -0.486 . . . . 74.05 110.929 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -72.54 139.69 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.111 0.481 . . . . 74.11 111.593 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -77.2 132.65 38.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.356 0.502 . . . . 72.01 112.356 -173.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 m170 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.866 -0.588 . . . . 53.2 111.814 177.869 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HG3' HD21 ' A' ' 3' ' ' LEU . 21.1 ptp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.693 0.282 . . . . 63.32 111.272 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.6 m-20 -95.46 119.98 34.92 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.803 0.335 . . . . 74.25 111.166 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.558 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.3 mm? -114.2 124.06 51.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.688 0.28 . . . . 75.31 111.201 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.4 m -78.06 79.46 4.52 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 74.24 110.343 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.28 122.09 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.085 -0.507 . . . . 63.45 112.334 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 39.7 m-80 56.93 23.02 7.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.099 -0.5 . . . . 72.52 112.081 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.4 64.63 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.329 -0.462 . . . . 52.33 113.474 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.2 mptp? -116.72 122.02 32.17 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 122.235 -0.567 . . . . 74.23 110.859 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.49 125.65 19.21 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.931 2.421 . . . . 75.12 113.816 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' HD21 ' A' ' 71' ' ' LEU . 40.7 t -135.23 173.32 11.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.958 -0.565 . . . . 75.24 109.946 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 4.6 t -157.28 129.47 7.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.22 108.22 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.537 0.684 . . . . 64.21 110.465 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.56 123.35 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.857 -0.61 . . . . 74.14 111.673 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.82 -33.48 4.75 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.24 -0.505 . . . . 73.5 113.161 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -74.48 127.64 33.56 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.726 0.298 . . . . 71.51 111.671 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -137.79 108.71 6.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.201 0.524 . . . . 65.54 111.647 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 m 62.66 25.07 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.268 0.84 . . . . 64.53 113.268 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.7 159.49 27.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.193 0.521 . . . . 75.23 111.853 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.5 p-10 -84.06 156.43 22.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.389 -0.369 . . . . 70.44 111.6 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.8 -36.94 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.683 0.623 . . . . 73.42 112.683 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -52.92 -43.7 66.45 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.035 0.445 . . . . 52.35 111.568 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.42 -32.03 29.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.474 -0.33 . . . . 63.21 111.826 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.79 -44.83 82.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.361 -0.607 . . . . 72.15 109.361 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 32' ' ' ALA . 26.7 tp -60.94 -44.49 97.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.635 -0.711 . . . . 61.15 110.661 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -63.79 -27.92 69.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.807 -0.633 . . . . 64.03 111.905 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.74 84.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.956 0.407 . . . . 73.31 111.585 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.12 -2.53 48.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.301 -0.409 . . . . 62.51 110.931 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.6 tttt 64.0 25.72 13.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.996 -0.547 . . . . 73.03 111.51 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.52 130.61 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.357 -0.383 . . . . 75.31 111.537 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.57 80.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.368 0.507 . . . . 73.55 112.368 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -96.04 167.65 11.1 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.116 0.484 . . . . 73.41 111.557 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -146.05 -62.16 0.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.214 0.53 . . . . 33.43 110.803 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -55.53 -31.74 62.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.592 -0.731 . . . . 75.41 112.049 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -83.34 -16.49 45.89 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.67 0.618 . . . . 64.43 112.67 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 37' ' ' VAL . 6.1 t -81.46 80.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.237 0.541 . . . . 52.41 111.621 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.6 m -70.87 84.14 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.083 -0.508 . . . . 75.45 111.442 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 35' ' ' VAL . 32.8 m -86.45 147.94 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.122 0.487 . . . . 64.33 111.464 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 13.2 pt-20 -136.44 127.14 27.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.25 0.547 . . . . 73.4 110.981 174.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -99.47 134.95 41.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 71.34 111.169 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 60.66 18.92 8.93 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.067 0.461 . . . . 75.03 111.403 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.2 20.28 57.5 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.311 -0.471 . . . . 64.31 113.616 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -124.77 112.47 16.75 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.122 0.486 . . . . 74.14 111.105 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 8.9 p -70.6 144.41 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.371 0.878 . . . . 62.43 113.371 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.569 HD21 ' HG ' ' A' ' 39' ' ' LEU . 3.2 mm? -99.49 166.26 11.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.22 0.533 . . . . 74.02 111.667 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.38 155.18 20.7 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.049 -0.523 . . . . 73.51 110.743 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.51 -22.73 5.18 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.116 0.784 . . . . 63.13 113.116 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.86 26.84 5.51 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.115 0.483 . . . . 54.44 111.771 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.24 5.37 42.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.286 -0.415 . . . . 71.44 111.376 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.23 -27.77 59.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.809 0.338 . . . . 73.45 111.527 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.46 -38.79 65.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 75.33 111.065 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.17 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.168 -0.469 . . . . 60.51 112.055 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.0 m -75.32 107.55 7.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.999 0.428 . . . . 35.24 111.986 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 63.8 p -92.85 130.25 38.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.185 -0.461 . . . . 72.0 111.388 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.6 147.41 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.356 -0.383 . . . . 73.15 111.116 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.07 -174.75 3.52 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.241 0.543 . . . . 74.13 111.349 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.26 111.36 3.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.045 -0.525 . . . . 72.54 111.243 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.35 66.9 0.74 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.045 -0.597 . . . . 61.33 113.958 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -149.71 162.08 40.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 110.147 -0.316 . . . . 75.45 110.147 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.42 99.32 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.511 0.56 . . . . 53.2 112.511 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -95.96 131.25 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.002 0.43 . . . . 75.2 111.097 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 40.8 mt-10 -109.03 121.2 44.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.262 0.553 . . . . 72.31 112.282 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -99.66 132.14 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.78 -0.645 . . . . 74.33 111.522 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -126.07 112.24 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.098 0.475 . . . . 73.42 112.092 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 68.05 -3.28 1.26 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.247 0.832 . . . . 73.15 113.247 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.2 119.8 27.82 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.996 -0.44 . . . . 60.13 111.838 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.0 mmm -83.93 146.04 28.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.896 -0.593 . . . . 72.31 111.815 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.89 -45.21 0.17 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.539 -0.755 . . . . 43.32 111.47 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.19 109.23 0.78 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.217 0.447 . . . . 42.55 114.217 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.9 63.0 1.86 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.872 -0.891 . . . . 71.21 110.872 171.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.09 104.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.947 0.721 . . . . 74.31 112.947 -171.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD21 ' OG ' ' A' ' 10' ' ' SER . 91.8 mt -88.51 -174.93 4.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.0 -0.545 . . . . 74.14 110.516 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 62.95 92.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.288 0.566 . . . . 71.25 111.753 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -135.01 168.27 19.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.475 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -60.65 116.44 4.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.24 -0.437 . . . . 65.0 110.135 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -54.79 110.27 0.63 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.469 . . . . 74.52 112.091 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -68.83 134.75 50.11 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.002 -0.545 . . . . 71.11 111.589 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -155.55 146.73 22.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.858 0.361 . . . . 72.34 111.059 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.851 -0.595 . . . . 55.25 111.415 176.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 23.0 ptp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.941 0.4 . . . . 71.1 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -101.6 106.24 17.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.978 0.418 . . . . 72.35 110.724 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 58' ' ' ASP . 82.4 mt -100.25 176.45 5.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 63.15 111.536 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.3 m -130.68 110.84 11.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.852 0.358 . . . . 54.03 110.979 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 29.8 m -105.11 118.39 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.956 0.407 . . . . 71.41 111.577 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 62.12 22.26 13.0 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.865 0.364 . . . . 74.25 111.943 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.11 -0.87 64.44 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.161 -0.543 . . . . 63.23 113.36 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.23 141.7 24.44 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 122.526 -0.396 . . . . 65.15 111.273 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 119.79 6.03 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.411 2.074 . . . . 60.53 112.978 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -120.4 113.24 20.05 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.983 0.42 . . . . 64.32 111.49 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.8 m -95.12 110.25 22.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.253 -0.431 . . . . 63.15 111.444 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.66 124.64 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.131 0.491 . . . . 72.4 110.968 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.78 144.6 41.31 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.089 -0.505 . . . . 62.24 111.921 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.69 -49.59 4.22 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.192 -0.458 . . . . 70.12 113.756 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 105.74 0.42 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.779 . . . . 45.45 113.102 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.1 -44.37 5.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.298 -0.41 . . . . 75.02 111.148 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.6 m -141.46 126.33 18.15 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.71 0.29 . . . . 73.23 110.86 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.96 169.63 16.2 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.728 0.299 . . . . 63.04 111.521 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -103.02 160.6 14.48 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.45 -0.204 . . . . 75.53 110.45 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 58.1 t -48.07 -40.82 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 112.917 0.71 . . . . 62.55 112.917 -172.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.6 m -48.0 -47.47 33.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.142 0.496 . . . . 65.3 111.581 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.44 -33.02 64.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.052 0.454 . . . . 74.03 111.203 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.05 -41.69 98.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.451 . . . . 73.53 110.239 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 91.8 mt -56.7 -28.66 61.32 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.132 -0.486 . . . . 74.12 111.507 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.7 t -80.17 -48.34 13.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.409 -0.36 . . . . 74.21 111.391 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.78 90.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.058 0.456 . . . . 74.21 111.864 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.14 -30.62 60.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.148 -0.478 . . . . 71.1 110.915 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 69.25 88.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.463 0.649 . . . . 63.14 111.332 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.472 HG11 HD22 ' A' ' 24' ' ' LEU . 8.0 p -102.15 149.52 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.773 -0.649 . . . . 74.33 111.91 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.58 126.9 35.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.72 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 58.88 67.57 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.234 0.54 . . . . 73.14 111.507 -174.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -63.85 -30.69 71.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.217 -0.447 . . . . 60.43 112.015 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.939 0.399 . . . . 73.11 111.491 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -129.93 12.36 5.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.53 -0.304 . . . . 71.44 111.64 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 37' ' ' VAL . 7.6 p -68.0 118.71 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.452 0.644 . . . . 70.44 112.508 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.1 m -92.97 108.58 20.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.03 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.465 HG13 HG22 ' A' ' 35' ' ' VAL . 18.0 m -140.92 146.35 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.164 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.2 pm0 -123.54 132.48 53.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.899 0.381 . . . . 74.44 111.745 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 HD11 ' A' ' 44' ' ' LEU . 2.1 pt? -97.02 124.53 41.03 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.932 -0.395 . . . . 71.31 109.932 175.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.18 22.62 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.98 0.419 . . . . 52.24 111.798 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -20.44 32.02 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.275 0.47 . . . . 74.55 114.275 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -95.45 122.47 38.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.677 0.739 . . . . 72.14 111.464 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.9 p -78.23 138.89 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 65.32 112.003 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -92.72 121.65 34.33 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.101 -0.5 . . . . 72.41 111.335 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.12 152.39 45.22 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.383 -0.371 . . . . 70.45 111.632 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 39.0 ptt180 -48.72 -36.81 17.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.635 0.605 . . . . 70.41 112.635 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -81.27 -24.62 37.16 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.214 0.53 . . . . 75.12 111.754 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.07 -16.65 57.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.054 0.761 . . . . 71.32 113.054 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 22.2 m-85 -53.06 -39.53 63.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.857 0.688 . . . . 72.51 112.857 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.81 -23.09 31.57 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.06 -0.4 . . . . 74.11 111.678 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.21 -2.21 52.86 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.621 0.6 . . . . 74.12 112.621 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.0 m -105.29 118.02 35.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.184 -0.323 . . . . 43.31 111.671 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.7 m -89.22 138.58 31.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.097 0.475 . . . . 74.15 112.017 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.49 147.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.942 0.497 . . . . 73.22 110.961 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.01 -168.47 2.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.123 0.487 . . . . 74.0 111.63 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 36.3 t70 -70.22 79.31 0.52 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.149 0.499 . . . . 62.13 111.5 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.84 65.31 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.154 -0.546 . . . . 75.11 113.52 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-20 -131.51 131.81 43.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.421 -0.458 . . . . 71.23 110.657 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -93.19 66.98 4.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.995 0.368 . . . . 74.12 111.995 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.2 p -82.83 114.77 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.285 0.564 . . . . 60.13 111.466 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -88.75 114.82 25.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.045 0.387 . . . . 75.24 112.045 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.462 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-85 -101.32 118.45 37.0 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 63.33 111.647 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.449 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.8 pt? -134.77 132.38 38.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.402 -0.363 . . . . 71.21 111.521 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 67.06 -3.28 0.99 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.168 0.803 . . . . 73.54 113.168 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.65 27.87 8.29 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.139 -0.351 . . . . 61.43 111.252 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.2 mtp 72.63 103.81 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.206 0.602 . . . . 70.44 112.11 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.81 35.71 1.9 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.23 -0.509 . . . . 61.23 113.26 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -115.33 72.85 0.25 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.357 -0.449 . . . . 35.35 113.355 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.53 44.52 3.34 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.92 -0.657 . . . . 65.04 113.603 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -145.62 -178.21 5.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 60.24 112.08 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' N ' HD23 ' A' ' 71' ' ' LEU . 1.9 pt? -147.28 134.75 20.82 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.975 -1.011 . . . . 61.11 109.06 171.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.53 118.46 11.59 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.247 0.546 . . . . 61.41 111.55 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -96.62 113.02 24.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.028 -0.533 . . . . 65.21 111.27 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -62.86 87.32 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.749 0.785 . . . . 75.45 110.822 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -101.53 139.64 36.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.609 -0.723 . . . . 74.33 111.815 -175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 65.63 128.21 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.383 0.611 . . . . 71.25 112.111 -175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -87.53 169.71 11.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.256 0.55 . . . . 73.34 112.191 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.0 p80 . . . . . 0 C--O 1.25 1.129 0 CA-C-N 115.754 -0.657 . . . . 71.23 111.747 -178.491 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.607 ' HE3' HD11 ' A' ' 3' ' ' LEU . 25.4 ptt? . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.764 0.316 . . . . 63.41 111.505 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -80.49 118.88 22.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.937 0.398 . . . . 74.4 111.359 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.607 HD11 ' HE3' ' A' ' 1' ' ' MET . 68.0 mt -123.34 148.4 46.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.156 0.503 . . . . 74.15 112.079 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 16.7 m -85.0 82.67 8.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.122 0.487 . . . . 75.24 110.431 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.36 134.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.431 -0.349 . . . . 71.43 110.973 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.1 8.26 6.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.556 0.342 . . . . 73.02 111.298 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.67 68.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.98 -0.629 . . . . 52.43 111.868 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 5.6 mtpm? -124.15 154.4 68.42 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.311 0.644 . . . . 74.44 110.768 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.78 115.86 4.29 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.294 1.996 . . . . 63.1 113.212 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -142.17 -176.79 4.95 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.579 0.352 . . . . 52.43 110.708 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -162.85 137.99 6.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.39 0.515 . . . . 52.22 112.39 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.33 86.84 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.358 0.599 . . . . 75.1 111.095 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.2 t70 59.71 174.5 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.505 -0.77 . . . . 75.42 112.455 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.13 -4.83 69.25 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.292 -0.48 . . . . 63.52 113.144 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 126.42 8.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.826 0.451 . . . . 73.54 111.95 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.53 -66.04 0.6 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 62.42 112.521 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -133.05 124.17 27.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.643 0.259 . . . . 73.41 111.329 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 91.3 mt -132.38 142.6 49.37 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.741 0.305 . . . . 74.21 111.257 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.26 162.8 5.6 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.575 -0.284 . . . . 74.21 110.818 175.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 39.7 t -61.09 -40.15 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.981 -0.449 . . . . 64.53 110.298 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -59.78 -47.75 84.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.256 -0.429 . . . . 74.14 111.167 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 2.5 mm-40 -58.47 -38.03 76.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.0 0.428 . . . . 73.23 111.256 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.69 -45.44 92.09 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.049 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.489 HD13 ' HB1' ' A' ' 32' ' ' ALA . 72.4 mt -56.91 -39.34 74.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.181 0.515 . . . . 62.54 111.262 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -78.05 -29.19 49.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.161 -0.472 . . . . 55.15 112.121 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -47.21 20.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.164 0.507 . . . . 54.15 111.754 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 27' ' ' LEU . 7.2 tt -76.79 -16.43 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.615 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 66.77 74.04 0.34 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.352 0.596 . . . . 45.23 110.501 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 HD22 ' A' ' 27' ' ' LEU . 53.5 t -104.21 130.91 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.691 0.626 . . . . 72.25 112.691 -174.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.69 146.0 30.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.32 -0.4 . . . . 73.42 110.209 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 62.07 33.23 17.22 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.925 0.393 . . . . 54.22 110.79 -172.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' HD13 ' A' ' 24' ' ' LEU . . . -53.39 -51.9 61.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.281 0.474 . . . . 34.54 112.281 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.03 -12.45 61.61 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.191 0.519 . . . . 65.34 111.813 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.06 2.69 12.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.479 0.548 . . . . 74.25 112.479 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.8 p -73.09 146.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 65.21 111.875 -176.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.5 m -100.3 108.85 21.01 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.471 -0.331 . . . . 74.04 110.456 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 62' ' ' PHE . 26.8 m -133.17 134.0 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.217 0.532 . . . . 74.35 111.698 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.7 pm0 -104.88 125.3 50.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.308 0.575 . . . . 54.33 111.508 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.667 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.14 106.43 7.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.836 -0.62 . . . . 62.41 110.216 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.8 m120 53.08 26.96 5.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.84 0.456 . . . . 64.24 112.05 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.13 4.38 41.39 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.304 -0.474 . . . . 72.01 113.947 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.88 108.07 13.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.278 0.539 . . . . 71.22 111.418 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 8.8 p -60.27 137.51 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.318 0.488 . . . . 64.43 112.318 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.1 mm? -94.2 151.81 19.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.145 0.497 . . . . 73.1 111.807 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -71.99 160.91 31.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.114 -0.494 . . . . 75.42 110.946 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -51.37 -46.73 62.85 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.321 0.489 . . . . 71.15 112.321 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.19 -6.48 55.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.417 0.525 . . . . 74.44 112.417 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.75 -27.49 66.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.769 0.319 . . . . 54.31 111.364 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -50.68 -38.03 44.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.198 -0.455 . . . . 71.23 111.544 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.54 -42.88 61.12 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.914 -0.584 . . . . 63.41 111.573 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.89 -4.78 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.084 0.772 . . . . 75.41 113.084 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -101.82 116.96 33.86 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.709 0.29 . . . . 72.21 111.561 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 65.2 p -100.5 116.96 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.16 0.43 . . . . 74.24 112.16 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.88 152.52 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.824 -0.625 . . . . 73.55 110.903 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -139.89 175.89 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.878 0.371 . . . . 74.05 111.42 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.14 137.63 58.29 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.117 0.484 . . . . 75.32 111.391 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.36 33.94 24.37 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.147 -0.479 . . . . 35.32 113.164 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' HD22 ' A' ' 3' ' ' LEU . 12.7 t70 -109.88 177.45 4.72 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 122.684 -0.303 . . . . 70.14 110.867 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -139.99 92.13 2.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.429 0.529 . . . . 52.21 112.429 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.1 p -98.17 115.76 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.344 0.592 . . . . 73.14 111.219 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 44.0 mt-10 -84.15 93.45 8.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.217 0.532 . . . . 72.23 112.414 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' VAL . 12.8 m-85 -78.9 120.27 23.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.941 -0.572 . . . . 75.13 110.875 169.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.3 mt -124.03 136.1 54.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.633 0.254 . . . . 61.54 110.807 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 34.66 0.22 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.528 0.566 . . . . 62.2 112.528 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 66.41 149.5 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.119 0.785 . . . . 73.24 113.119 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.99 76.64 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.234 0.54 . . . . 71.43 110.486 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -151.65 -14.77 0.07 OUTLIER Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.151 -0.547 . . . . 72.42 113.666 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.8 -61.54 3.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.331 -0.462 . . . . 63.2 113.746 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 41.67 10.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.987 -0.625 . . . . 75.41 112.84 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 66.44 158.33 0.12 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.498 0.666 . . . . 74.45 112.477 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 74' ' ' HIS . 1.4 tt -78.27 90.47 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.124 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -37.69 48.63 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.586 0.958 . . . . 70.22 113.586 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -170.99 -54.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.033 -0.358 . . . . 70.24 110.033 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.467 ' HA ' HD21 ' A' ' 71' ' ' LEU . 9.2 t60 -179.97 66.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.145 -0.479 . . . . 72.43 111.013 173.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -67.77 127.89 34.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 120.929 0.395 . . . . 74.42 111.284 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -67.25 11.18 0.12 Allowed 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 113.678 0.992 . . . . 71.2 113.678 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -158.47 -175.97 5.62 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.77 -0.581 . . . . 73.53 110.963 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 55.5 m80 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.15 -0.929 . . . . 74.03 110.231 174.353 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.568 ' HB3' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.22 0.452 . . . . 75.33 112.22 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -94.89 124.15 38.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.157 -0.474 . . . . 50.15 111.505 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 1' ' ' MET . 2.9 mm? -120.99 174.42 6.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.068 0.461 . . . . 55.42 111.103 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 m -129.04 95.29 4.03 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.072 0.463 . . . . 71.14 110.692 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG22 HG13 ' A' ' 60' ' ' VAL . 61.8 t -88.13 113.97 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.436 -0.347 . . . . 73.12 111.774 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.404 ' OD1' HG12 ' A' ' 5' ' ' VAL . 29.9 m120 57.91 29.68 17.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.005 0.522 . . . . 64.24 112.001 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.88 75.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.89 -0.671 . . . . 71.11 113.301 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -114.11 122.07 35.31 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.625 -0.338 . . . . 74.31 110.975 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.83 119.45 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.739 2.293 . . . . 74.31 112.997 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.8 p -130.08 127.74 40.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.155 0.502 . . . . 53.14 111.258 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.4 m -102.7 117.18 34.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.159 -0.338 . . . . 65.04 111.51 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' SD ' ' A' ' 1' ' ' MET . 19.6 m -89.56 131.8 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.892 0.377 . . . . 71.43 110.373 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.3 155.03 20.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.446 0.536 . . . . 71.33 112.446 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.49 -72.04 1.77 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.986 -0.552 . . . . 63.45 113.77 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.97 12.95 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.416 0.524 . . . . 72.13 112.416 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 10.0 pt-20 -129.06 -31.93 2.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 74.33 112.177 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -140.08 130.64 25.58 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.003 0.43 . . . . 73.14 112.122 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -170.72 165.45 8.09 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.967 -0.56 . . . . 72.45 111.5 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.754 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 48.7 m-20 -61.84 155.82 22.22 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.753 0.311 . . . . 73.53 111.376 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.88 -38.77 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.071 0.462 . . . . 74.33 110.56 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.4 m -59.33 -41.92 90.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.082 -0.508 . . . . 71.41 111.783 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 15.3 mm-40 -63.58 -48.57 76.86 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.069 0.461 . . . . 74.51 110.527 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.53 -46.3 84.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.136 -0.484 . . . . 75.03 111.068 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.03 -44.02 91.68 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.103 0.478 . . . . 72.42 111.043 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -66.76 -30.42 70.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.021 0.439 . . . . 74.41 111.161 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.93 77.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 73.42 111.013 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.14 -32.56 63.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.122 -0.49 . . . . 65.41 111.844 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 64.95 85.54 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.387 0.613 . . . . 75.44 110.881 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.6 149.7 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 75.25 112.106 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.88 121.84 20.65 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.451 -0.34 . . . . 70.44 110.98 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 21.6 mt-30 61.99 80.46 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.262 0.553 . . . . 64.43 110.759 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -55.31 -35.92 65.64 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.671 0.989 . . . . 55.15 113.671 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.45 -22.72 43.78 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.216 0.451 . . . . 61.22 112.216 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 31' ' ' GLN . 9.4 m-85 -86.98 -11.85 49.25 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.512 0.56 . . . . 72.14 112.512 -171.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 32' ' ' ALA . 7.9 p -79.42 131.7 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.235 0.54 . . . . 64.54 111.366 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -115.89 128.3 55.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.503 -0.317 . . . . 70.44 111.457 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 62' ' ' PHE . 34.9 m -137.67 140.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.106 0.479 . . . . 74.3 111.274 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -111.09 113.25 25.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.458 0.647 . . . . 74.31 110.088 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -75.23 104.96 6.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.009 -0.541 . . . . 74.35 112.195 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.62 28.35 17.76 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.861 -0.609 . . . . 71.25 111.789 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.47 -20.04 14.06 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.362 -0.447 . . . . 61.23 113.727 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.84 135.8 45.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.044 0.422 . . . . 74.33 111.376 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.23 134.82 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.934 0.397 . . . . 74.42 111.728 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.65 141.98 43.15 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.313 0.578 . . . . 71.4 111.832 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -79.84 167.67 20.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.021 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -57.15 -35.02 69.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.73 0.641 . . . . 73.0 112.73 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -96.55 -4.91 40.47 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.07 0.396 . . . . 71.32 112.07 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.53 56.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.254 0.464 . . . . 50.22 112.254 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.35 -24.74 63.62 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.056 0.455 . . . . 73.0 111.957 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.78 -29.11 44.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.32 -0.4 . . . . 64.14 111.847 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.54 12.36 7.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.155 0.798 . . . . 70.32 113.155 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.1 m -141.69 120.24 12.47 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.726 -0.609 . . . . 72.33 111.782 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.7 m -92.96 106.89 18.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.097 -0.501 . . . . 75.04 111.158 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.5 148.14 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.363 -0.38 . . . . 73.14 110.893 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 17.0 ptpt -144.11 -173.18 3.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.839 0.352 . . . . 65.34 111.665 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 10.2 t70 -66.94 112.74 4.49 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 55.51 111.463 -176.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.66 63.42 0.66 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.105 -0.498 . . . . 75.23 113.042 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -154.2 172.58 17.37 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.895 -0.409 . . . . 75.35 109.895 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.23 94.56 4.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.811 0.671 . . . . 62.11 112.811 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG13 HG22 ' A' ' 5' ' ' VAL . 4.8 p -88.94 95.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.491 0.662 . . . . 63.23 110.809 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -79.88 103.16 9.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.376 0.608 . . . . 73.15 111.42 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 37' ' ' VAL . 45.0 t80 -91.69 109.49 20.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.809 -0.632 . . . . 74.3 110.911 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.76 149.8 43.37 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.066 0.46 . . . . 73.14 112.202 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -104.62 21.7 16.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.331 0.493 . . . . 65.13 112.331 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -59.26 148.33 32.35 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.275 0.56 . . . . 71.44 112.47 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 mtt -74.37 115.13 13.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.102 -0.499 . . . . 74.21 111.239 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -129.37 24.76 4.64 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.254 -0.498 . . . . 50.03 112.908 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.63 -36.47 6.87 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.042 -0.599 . . . . 73.25 113.476 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.09 -61.4 4.67 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.292 -0.48 . . . . 62.24 113.009 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -70.7 118.38 13.42 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.874 0.368 . . . . 71.31 111.62 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.9 tp -109.91 112.61 24.74 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.016 0.436 . . . . 63.42 110.538 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.4 18.3 10.56 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.645 0.609 . . . . 62.22 112.645 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.82 162.68 0.09 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.16 0.505 . . . . 74.13 111.307 -170.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -133.48 -58.49 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.762 -0.586 . . . . 70.14 112.316 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -160.17 149.61 17.71 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.762 0.653 . . . . 63.43 112.762 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -106.81 150.34 26.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.197 0.522 . . . . 71.24 112.189 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -111.67 176.55 4.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.681 -0.69 . . . . 75.22 110.353 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 119.228 -0.415 . . . . 70.31 111.977 -178.502 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 3' ' ' LEU . 24.9 ptp . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.742 0.306 . . . . 73.2 111.072 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -98.04 114.44 26.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.464 -0.334 . . . . 65.44 110.86 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 1' ' ' MET . 91.3 mt -121.94 131.16 53.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.938 0.399 . . . . 74.11 111.715 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 39.6 m -85.78 85.45 7.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.04 0.448 . . . . 72.31 111.001 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.3 p -82.44 117.03 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.024 0.44 . . . . 71.53 111.615 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 59.29 15.04 4.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.615 0.598 . . . . 72.13 112.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.22 -4.43 33.46 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.319 -0.467 . . . . 74.54 113.218 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.62 106.57 58.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 122.584 -0.362 . . . . 73.44 111.545 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 20.4 Cg_exo -65.82 99.5 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.798 2.332 . . . . 72.31 112.877 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 t -112.79 139.14 48.67 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 63.42 111.556 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.0 m -89.3 99.97 12.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.38 . . . . 74.33 111.355 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.89 111.04 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.22 0.533 . . . . 71.53 110.198 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.55 161.09 18.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.233 0.539 . . . . 74.42 112.211 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.75 84.51 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.971 -0.559 . . . . 71.23 112.869 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.91 102.72 4.48 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.641 -0.329 . . . . 71.53 111.474 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.79 -29.94 13.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.732 0.301 . . . . 75.11 111.731 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -160.62 106.4 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.564 -0.289 . . . . 71.04 111.156 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.5 pp -143.79 156.53 44.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.163 0.506 . . . . 73.53 111.649 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 49' ' ' PHE . 4.6 p-10 -83.09 164.27 20.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.359 -0.382 . . . . 73.3 110.973 177.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.408 HG21 ' CD2' ' A' ' 44' ' ' LEU . 46.1 t -53.84 -33.93 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.749 0.648 . . . . 71.02 112.749 -172.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 m -52.03 -54.67 27.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.274 0.559 . . . . 71.01 111.403 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.56 -33.0 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.985 -0.552 . . . . 53.12 111.592 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.92 -44.68 78.51 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.035 0.445 . . . . 64.54 110.333 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.15 -32.62 72.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.929 0.395 . . . . 60.12 111.252 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.6 t -66.34 -35.46 80.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.291 -0.413 . . . . 65.11 111.29 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.95 92.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.112 0.482 . . . . 52.22 111.639 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 27' ' ' LEU . 6.5 mp -82.48 -24.48 34.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.174 0.511 . . . . 71.53 110.777 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 tttm 63.04 84.8 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.7 0.8 . . . . 71.21 111.961 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.14 145.89 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.701 -0.681 . . . . 72.25 110.691 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.08 -55.32 8.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.023 0.439 . . . . 74.43 111.324 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 22.8 mp0 -91.73 78.44 5.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.407 -0.36 . . . . 72.02 110.822 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -64.93 -44.56 89.07 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.175 0.512 . . . . 72.12 111.356 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -63.58 -33.42 75.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.036 -0.529 . . . . 64.03 111.916 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 26.1 m-85 -109.11 9.1 26.26 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.763 0.653 . . . . 74.44 112.763 -167.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 32' ' ' ALA . 8.7 p -86.44 124.74 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.982 0.42 . . . . 70.53 110.998 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -85.09 109.52 18.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.17 0.51 . . . . 41.2 111.231 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.68 145.55 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.915 -0.584 . . . . 61.52 111.105 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -136.57 147.7 47.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.911 0.386 . . . . 75.31 111.068 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.6 mp -112.49 131.27 55.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.815 0.302 . . . . 61.42 111.815 -178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 m120 56.23 27.32 11.54 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.598 0.592 . . . . 73.23 112.598 171.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.26 18.57 57.17 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.481 -0.39 . . . . 71.23 113.721 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -131.98 131.69 42.81 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.364 -0.492 . . . . 51.32 110.199 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.66 127.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.366 0.603 . . . . 74.21 112.286 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' CD2' HG21 ' A' ' 20' ' ' VAL . 10.5 mp -94.39 136.79 34.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.523 0.677 . . . . 71.44 112.317 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 9.3 tp10 -66.25 142.2 57.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.56 -0.745 . . . . 74.5 110.711 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -52.25 -45.95 65.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.219 0.533 . . . . 74.15 111.177 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 40.4 mt-10 -77.92 9.66 3.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.037 -0.529 . . . . 62.32 112.112 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.59 -10.21 15.72 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.186 -0.322 . . . . 71.03 111.376 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 22.5 m-30 -60.93 -24.75 66.28 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.159 0.429 . . . . 71.21 112.159 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 3.6 p30 -84.34 -29.75 26.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.848 0.356 . . . . 73.44 111.663 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.19 -53.14 6.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.331 -0.395 . . . . 74.12 111.861 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.406 HG21 HD21 ' A' ' 44' ' ' LEU . 62.4 m -63.2 98.74 0.15 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.831 0.348 . . . . 73.25 111.124 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.2 m -85.2 108.59 17.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.882 0.373 . . . . 71.01 111.21 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.45 133.67 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.977 0.418 . . . . 64.32 111.377 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -128.86 -177.65 4.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.451 0.643 . . . . 71.0 112.063 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.62 122.57 15.61 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.593 -0.73 . . . . 72.34 111.884 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.29 31.58 7.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.353 -0.385 . . . . 23.33 113.603 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.96 160.62 15.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 117.04 0.42 . . . . 72.14 110.54 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.17 99.11 6.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.053 0.454 . . . . 74.52 111.701 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -95.64 131.19 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.227 0.537 . . . . 63.11 111.739 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.93 109.62 21.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.376 0.607 . . . . 65.41 110.829 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -113.05 108.88 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.703 -0.68 . . . . 73.24 110.54 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 mt -87.36 128.42 35.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.052 0.453 . . . . 73.43 111.841 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -81.63 33.94 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.304 0.483 . . . . 74.4 112.304 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -77.19 134.7 38.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.06 0.457 . . . . 55.51 111.733 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.8 mtp -127.59 132.04 49.87 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.315 -0.402 . . . . 72.13 110.863 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -142.06 39.73 1.36 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.214 -0.517 . . . . 62.02 112.662 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.72 23.11 22.67 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.433 -0.413 . . . . 54.41 113.41 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.83 -101.08 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.285 -0.483 . . . . 62.53 113.227 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 66.58 116.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.619 0.723 . . . . 73.42 112.284 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 3.6 pp -81.56 157.85 24.62 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.706 0.632 . . . . 74.11 112.706 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -107.82 146.71 31.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.999 -0.546 . . . . 74.32 111.191 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -175.11 122.59 0.22 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.506 0.193 . . . . 70.24 111.314 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -119.59 114.59 22.47 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.927 0.394 . . . . 72.0 112.019 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -69.78 155.11 41.03 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.334 -0.393 . . . . 61.43 111.534 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -103.15 146.78 27.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.219 0.533 . . . . 62.54 111.695 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -114.79 139.71 49.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.018 -0.537 . . . . 72.45 111.267 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.4 m80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.484 -0.77 . . . . 70.44 111.081 178.519 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HG3' HD11 ' A' ' 3' ' ' LEU . 19.7 ptp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.719 0.295 . . . . 71.02 111.403 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -101.81 133.28 46.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.624 0.37 . . . . 65.21 110.652 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 1' ' ' MET . 1.6 mp -133.95 157.17 46.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.132 -0.355 . . . . 71.52 111.338 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 36.7 m -107.54 105.7 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.888 -0.412 . . . . 73.44 109.888 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 60' ' ' VAL . 31.8 m -119.5 136.83 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.197 -0.456 . . . . 71.14 111.163 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 59.17 30.06 19.75 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.486 0.315 . . . . 73.02 111.443 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.28 21.0 79.5 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.923 -0.656 . . . . 75.21 113.372 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -128.86 142.89 46.59 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.568 0.347 . . . . 65.24 111.717 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.96 143.47 32.89 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.256 1.971 . . . . 74.23 111.859 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.7 p -146.1 162.81 37.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.183 -0.323 . . . . 61.21 111.406 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -142.42 107.64 4.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.738 0.304 . . . . 71.23 111.508 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -103.59 128.28 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.994 0.426 . . . . 52.13 111.21 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.39 157.26 29.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.067 0.461 . . . . 73.44 111.818 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.78 -64.4 4.31 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.475 -0.393 . . . . 63.41 113.378 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.23 107.03 1.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.185 0.439 . . . . 73.41 112.185 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.04 -45.11 8.07 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.404 -0.362 . . . . 74.52 111.582 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -153.68 129.41 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.851 0.357 . . . . 62.23 111.194 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.2 pp -158.05 152.5 24.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 50' ' ' ASP . 12.2 p-10 -61.35 154.68 23.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.321 -0.399 . . . . 73.44 111.457 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.1 t -53.38 -33.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.886 0.374 . . . . 45.52 111.518 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -53.84 -49.47 68.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.381 -0.372 . . . . 73.15 111.545 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -68.96 -35.85 77.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.565 0.221 . . . . 71.51 111.454 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' VAL . 64.8 tp -54.39 -50.82 66.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.095 0.474 . . . . 75.31 110.908 174.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -57.73 -41.56 82.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.164 0.507 . . . . 72.25 110.871 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 t -68.36 -29.5 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.817 -0.628 . . . . 71.4 111.597 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.75 77.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.027 0.441 . . . . 74.43 111.189 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.84 -21.51 57.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.082 0.468 . . . . 71.45 110.501 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 tttp 65.57 36.95 6.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.359 -0.837 . . . . 73.21 111.579 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.01 129.73 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.134 -0.484 . . . . 70.14 111.401 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.49 81.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.275 0.472 . . . . 64.52 112.275 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -101.44 89.67 3.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.932 0.396 . . . . 71.35 111.422 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -92.42 -45.87 7.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.314 0.578 . . . . 64.0 110.635 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.66 -25.66 40.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.676 -0.693 . . . . 75.53 111.719 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -122.41 28.16 7.55 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.093 0.405 . . . . 72.25 112.093 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' ALA . 11.7 p -89.5 139.46 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.306 0.574 . . . . 71.22 111.971 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -97.95 99.82 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.351 -0.386 . . . . 73.54 110.444 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.27 136.59 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.852 0.358 . . . . 73.24 111.579 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.0 pt-20 -122.24 131.88 54.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.155 0.502 . . . . 71.43 111.377 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 44' ' ' LEU . 2.4 tm? -88.35 99.9 12.6 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.208 -0.451 . . . . 72.15 110.413 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 63.89 1.34 1.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.133 0.79 . . . . 72.25 113.133 176.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.32 -6.85 0.82 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.403 -0.904 . . . . 74.43 114.856 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.85 128.77 41.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.86 0.83 . . . . 74.04 112.102 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.7 p -66.34 139.54 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.129 0.49 . . . . 75.04 112.304 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 39' ' ' LEU . 6.0 mp -92.5 147.16 23.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.445 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.87 149.77 37.75 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.098 -0.501 . . . . 63.13 110.336 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -48.33 -55.68 10.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.591 0.589 . . . . 61.33 112.591 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -81.98 23.93 0.67 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.326 0.584 . . . . 72.55 111.967 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.75 1.94 13.56 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.734 -0.604 . . . . 65.5 111.836 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -64.69 -30.28 71.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.207 0.447 . . . . 62.03 112.207 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 14.5 m-20 -83.12 -32.5 26.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.875 0.369 . . . . 61.15 111.001 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.33 91.35 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.09 -0.505 . . . . 74.41 112.082 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -95.85 119.96 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.99 0.424 . . . . 74.22 111.723 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.6 m -96.09 116.43 28.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.938 0.399 . . . . 64.23 111.616 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 23' ' ' LEU . 49.3 t -74.6 142.03 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 116.005 -0.543 . . . . 75.13 111.096 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -142.83 -175.84 4.65 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.389 0.614 . . . . 74.25 111.61 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.22 104.39 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.756 -0.656 . . . . 71.11 111.972 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.74 32.2 2.14 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.197 -0.525 . . . . 44.13 113.818 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.74 138.1 48.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.328 0.585 . . . . 71.4 112.315 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -95.66 104.52 16.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.651 -0.704 . . . . 62.04 111.49 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -109.02 98.37 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.622 0.725 . . . . 75.44 110.404 175.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -72.94 99.54 2.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.731 0.777 . . . . 74.24 112.628 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -85.01 143.71 28.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.151 170.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.3 pt? -148.52 114.59 5.8 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.284 0.564 . . . . 71.45 111.771 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 64.64 22.4 12.61 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.774 -0.648 . . . . 73.21 112.087 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -112.98 121.35 44.38 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.756 0.313 . . . . 63.55 110.947 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 85.1 mtp -138.71 -174.21 3.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.9 0.381 . . . . 65.34 111.674 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.18 42.99 0.06 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.083 -0.579 . . . . 61.12 112.961 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.16 -107.71 2.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.415 -0.422 . . . . 70.31 113.658 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.78 -57.24 4.79 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.26 -0.495 . . . . 54.32 113.653 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? 67.99 113.12 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.394 0.616 . . . . 74.11 112.092 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.0 tp -76.95 96.79 4.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.298 0.57 . . . . 74.01 110.805 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -80.48 115.6 20.08 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.177 -0.465 . . . . 42.42 111.866 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -148.27 102.29 3.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.919 0.39 . . . . 74.21 110.934 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -86.95 147.18 25.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.673 0.389 . . . . 62.21 111.422 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -92.53 130.78 38.08 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.91 0.386 . . . . 62.21 111.433 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -68.53 -41.72 79.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.405 -0.361 . . . . 72.42 111.554 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -129.88 159.44 36.59 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.676 0.274 . . . . 61.31 110.788 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.775 -0.631 . . . . 70.23 111.394 178.63 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.916 0.389 . . . . 75.42 111.313 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.78 126.41 37.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.309 -0.405 . . . . 73.54 111.122 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.36 134.92 50.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.937 0.399 . . . . 61.04 111.373 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -94.6 99.35 11.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.959 0.409 . . . . 72.1 111.004 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -100.19 124.21 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.965 0.412 . . . . 72.25 111.464 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 55.6 m-80 54.87 43.22 30.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.115 0.483 . . . . 73.22 111.371 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.69 12.83 62.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.872 -0.603 . . . . 73.41 113.872 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -126.89 125.31 24.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 122.596 -0.355 . . . . 74.31 110.917 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.0 142.18 19.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.684 2.256 . . . . 63.51 113.819 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.9 t -137.86 125.88 22.78 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.027 -0.533 . . . . 74.13 110.628 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -87.33 94.27 9.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.003 0.43 . . . . 72.02 111.536 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -94.78 95.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.491 0.662 . . . . 74.0 111.322 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.74 159.66 30.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.119 0.485 . . . . 64.4 111.373 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.78 -52.34 2.62 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.097 -0.573 . . . . 73.42 111.693 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.61 123.36 23.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.724 0.297 . . . . 31.33 110.569 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.06 -48.02 3.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.264 0.554 . . . . 70.13 111.423 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -157.64 106.6 2.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.224 -0.444 . . . . 72.02 110.632 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.02 151.81 50.27 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.346 -0.388 . . . . 74.1 111.29 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 20.4 p-10 -74.49 157.22 35.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.136 -0.32 . . . . 71.4 110.136 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 60.7 t -51.01 -37.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.86 0.319 . . . . 72.43 111.86 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -53.62 -51.75 62.07 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.821 0.343 . . . . 73.42 111.597 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 52.2 mm-40 -71.18 -29.2 64.88 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 122.246 -0.284 . . . . 61.4 111.756 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.646 HD11 HG11 ' A' ' 60' ' ' VAL . 7.6 tt -60.39 -45.3 94.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.527 -0.546 . . . . 74.14 109.527 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 78.0 mt -63.88 -41.02 97.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 70.45 110.206 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 37.0 t -60.47 -27.78 67.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.673 -0.694 . . . . 72.21 112.002 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -42.32 93.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.058 0.456 . . . . 73.12 111.314 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -88.68 -0.75 57.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.165 0.507 . . . . 72.41 110.465 174.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt 57.71 48.91 13.19 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.75 0.786 . . . . 70.44 111.101 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 56.3 t -81.54 88.51 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.853 -0.612 . . . . 52.4 110.259 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.92 -27.94 33.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.838 -0.619 . . . . 53.52 112.368 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 11.7 mm100 -83.92 45.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.282 -0.417 . . . . 74.51 112.024 -176.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -36.99 74.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.474 0.546 . . . . 72.12 112.474 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.44 -7.64 56.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 75.2 111.449 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 5.8 m-85 -104.42 -50.61 3.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.276 -0.42 . . . . 74.22 111.455 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.5 p -70.46 136.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.195 0.521 . . . . 61.4 112.323 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.2 m -112.06 140.41 46.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.109 -0.496 . . . . 73.04 111.053 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.7 m -133.8 151.39 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.678 0.275 . . . . 71.22 110.842 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.56 126.12 51.29 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.709 0.766 . . . . 65.44 111.818 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.48 120.7 34.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.581 -0.736 . . . . 65.2 110.197 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 56.51 26.36 10.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.988 0.423 . . . . 63.02 111.779 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 12.92 68.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.092 -0.575 . . . . 45.14 113.226 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.79 124.88 53.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.654 0.382 . . . . 72.11 110.438 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.01 128.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.199 0.523 . . . . 73.34 111.945 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.15 139.99 35.03 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.428 -0.351 . . . . 64.32 111.179 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -68.94 160.77 30.18 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.351 -0.386 . . . . 53.05 110.771 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.09 -36.14 65.34 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.023 0.44 . . . . 71.34 111.726 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.78 -39.21 80.31 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.246 0.545 . . . . 62.44 111.416 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.3 63.77 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.538 0.57 . . . . 52.43 112.538 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -63.43 -33.48 75.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.985 0.422 . . . . 73.41 111.685 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.79 -32.26 59.8 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.37 -0.377 . . . . 71.3 111.46 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.95 6.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.329 0.492 . . . . 54.45 112.329 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -57.59 115.64 2.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.352 0.501 . . . . 44.52 112.352 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 73.8 p -99.37 119.63 38.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.049 0.452 . . . . 62.15 111.44 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -96.22 140.52 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.172 -0.467 . . . . 60.25 111.09 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.26 -172.34 2.82 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.663 0.616 . . . . 73.43 112.663 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.14 132.04 50.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.778 -0.646 . . . . 75.4 112.258 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.05 42.28 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.004 -0.544 . . . . 73.34 113.467 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -119.16 150.06 40.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.425 -0.456 . . . . 73.45 110.714 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.33 83.71 2.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.129 0.49 . . . . 55.1 112.185 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 23' ' ' LEU . 3.6 p -88.31 91.71 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.357 0.598 . . . . 65.12 110.343 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 33.8 tt0 -71.35 92.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.526 0.679 . . . . 73.02 110.859 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 37' ' ' VAL . 71.6 t80 -73.25 110.19 7.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.284 -0.871 . . . . 71.1 111.139 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.7 mt -74.31 152.84 39.55 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.123 0.487 . . . . 65.14 110.766 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.0 46.78 1.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.323 0.582 . . . . 54.52 112.441 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.532 ' HB2' HG23 ' A' ' 35' ' ' VAL . 56.0 m-85 -61.26 -9.06 4.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.325 -0.398 . . . . 71.44 112.063 172.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.7 mtm -81.16 101.54 9.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.934 0.397 . . . . 73.34 111.108 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.9 -6.16 28.51 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 116.294 -0.412 . . . . 71.21 112.189 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.26 142.43 44.5 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.596 -0.335 . . . . 71.3 113.129 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 -42.77 53.91 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.029 -0.605 . . . . 74.11 113.444 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 66.92 118.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.173 0.589 . . . . 74.33 111.166 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.4 pt? -48.75 -25.37 1.79 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 74.25 114.783 -170.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.41 -45.56 11.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.22 0.452 . . . . 62.31 112.22 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 63.14 -174.11 0.16 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.199 0.524 . . . . 72.32 112.164 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -113.96 20.94 15.33 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 120.998 0.428 . . . . 75.52 111.547 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -62.86 130.4 44.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.507 -0.315 . . . . 75.11 111.013 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -134.13 170.08 16.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.601 0.715 . . . . 54.34 112.654 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.67 152.1 45.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.293 -0.867 . . . . 41.45 110.189 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.91 -0.567 . . . . 54.52 111.316 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.674 0.273 . . . . 74.04 111.527 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -89.09 132.04 34.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.508 -0.315 . . . . 74.14 111.073 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.36 131.22 33.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.981 0.42 . . . . 64.33 111.377 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 89.3 m -81.85 89.47 6.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.288 0.566 . . . . 72.02 110.073 172.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.59 120.09 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 74.42 111.552 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 8' ' ' LYS . 6.2 t-20 62.43 22.62 13.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.118 0.485 . . . . 72.53 111.67 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.04 64.5 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.284 -0.484 . . . . 41.2 113.22 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 3.9 mppt? -113.91 127.07 27.23 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.667 -0.314 . . . . 64.31 111.427 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 90.3 Cg_endo -79.34 139.12 14.46 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.648 2.232 . . . . 75.32 113.543 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.1 t -149.75 159.36 44.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.748 0.309 . . . . 74.03 111.385 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -109.72 112.39 24.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.93 0.395 . . . . 74.41 111.362 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -112.01 119.49 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.953 0.406 . . . . 72.22 111.464 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.87 166.38 20.96 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.724 0.297 . . . . 72.32 110.517 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.51 4.01 73.63 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.933 -0.651 . . . . 73.43 112.524 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.4 108.34 11.57 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.862 0.363 . . . . 65.32 110.987 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -101.81 -60.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.387 0.613 . . . . 75.13 110.457 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -149.75 101.4 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.789 -0.642 . . . . 74.04 109.634 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 96.3 mt -125.03 133.06 53.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.145 0.424 . . . . 42.15 112.145 -170.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 4.0 p30 -63.59 149.67 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.597 -0.274 . . . . 60.31 110.452 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.83 -42.14 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.641 0.608 . . . . 70.11 112.641 -173.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.6 m -50.83 -48.51 59.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.824 0.345 . . . . 60.12 111.795 177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 25.4 mm-40 -65.04 -32.77 74.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.336 . . . . 61.21 111.25 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 60' ' ' VAL . 6.9 tt -61.68 -50.04 74.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.937 0.398 . . . . 63.33 109.967 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 HG11 ' A' ' 29' ' ' VAL . 3.9 mm? -63.21 -33.66 75.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.861 0.362 . . . . 73.33 111.032 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -64.04 -41.34 97.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.15 111.365 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -33.23 70.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.155 0.502 . . . . 74.14 111.07 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 29' ' ' VAL . 5.6 tt -71.25 -35.07 71.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.015 -0.539 . . . . 60.5 110.368 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 60.17 73.45 0.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.518 0.675 . . . . 75.32 111.461 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.615 ' HB ' HD22 ' A' ' 27' ' ' LEU . 12.5 p -117.18 143.81 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.889 -0.596 . . . . 64.22 111.36 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.555 ' HB3' ' HA2' ' A' ' 68' ' ' GLY . . . -75.91 142.85 41.97 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 42.43 111.262 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 66.6 mt-30 71.12 37.58 1.21 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.852 -0.613 . . . . 74.51 112.124 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.24 75.16 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.946 0.403 . . . . 74.23 111.93 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -73.4 -3.27 26.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.14 0.495 . . . . 74.0 111.555 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 23.5 m-85 -119.76 -13.45 9.1 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.021 -0.425 . . . . 74.52 112.029 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.5 p -86.11 130.49 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 74.5 112.341 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.425 ' HB ' ' CE1' ' A' ' 65' ' ' PHE . 70.3 m -93.93 117.2 29.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.311 -0.404 . . . . 70.41 111.057 175.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.23 158.82 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 72.41 110.984 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 11.6 pt-20 -127.87 133.01 49.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.628 0.728 . . . . 54.2 111.981 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.55 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.9 tm? -91.52 104.04 16.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.338 -0.846 . . . . 71.43 109.689 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.3 m120 55.18 46.21 24.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.098 0.475 . . . . 65.52 111.408 -173.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.02 -3.79 74.38 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.474 -0.393 . . . . 60.45 113.946 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -96.59 111.38 23.54 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.567 -0.372 . . . . 61.21 111.112 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.25 125.34 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.206 0.527 . . . . 72.14 112.219 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 39' ' ' LEU . 1.4 mm? -97.76 152.1 19.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.003 0.43 . . . . 75.45 111.213 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.2 149.44 46.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.911 -0.774 . . . . 64.42 108.911 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -54.13 -38.11 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.56 -29.96 46.6 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.194 0.521 . . . . 74.34 111.193 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.35 -17.01 40.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.461 -0.336 . . . . 74.32 111.846 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.95 -32.55 66.13 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.181 0.515 . . . . 73.3 111.201 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.81 -24.85 35.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.094 -0.503 . . . . 75.41 111.431 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.13 -23.06 19.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.262 0.467 . . . . 60.21 112.262 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 106.65 18.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.144 -0.348 . . . . 74.22 111.56 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 76.3 p -85.57 115.6 23.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.01 0.433 . . . . 74.4 112.017 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.17 132.78 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.35 -0.386 . . . . 71.35 110.804 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -125.65 -177.32 3.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.149 0.5 . . . . 53.23 112.105 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.33 143.23 45.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 43.22 111.872 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.43 34.74 90.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 116.23 -0.441 . . . . 64.13 113.809 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.81 -177.12 3.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.022 0.411 . . . . 71.0 110.081 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.16 102.98 6.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.074 0.768 . . . . 51.11 113.074 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 23' ' ' LEU . 4.0 p -96.69 111.22 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.309 0.576 . . . . 74.32 110.394 173.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 42.2 mt-10 -101.25 105.23 16.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.593 0.711 . . . . 70.03 111.957 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -81.87 117.07 21.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.286 -0.87 . . . . 64.32 110.443 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.1 -176.9 5.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 74.55 112.54 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -56.56 -2.26 0.07 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.975 1.472 . . . . 73.25 114.975 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.65 ' HB2' HG23 ' A' ' 35' ' ' VAL . 84.7 m-85 -69.1 94.32 0.65 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.473 0.579 . . . . 61.03 111.695 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.9 ttm -147.23 153.15 39.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.396 -0.366 . . . . 54.43 110.912 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.27 -21.02 2.96 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.005 -0.617 . . . . 54.12 113.305 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 30' ' ' ALA . . . 76.93 -58.14 3.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.227 -0.511 . . . . 52.43 113.469 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.4 -52.07 4.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.196 -0.526 . . . . 64.22 112.904 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -81.12 75.24 8.1 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.841 0.353 . . . . 62.14 111.031 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 74' ' ' HIS . 43.3 tp 31.07 90.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.13 1.159 . . . . 74.42 114.13 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -101.22 -25.06 14.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.759 0.314 . . . . 75.5 111.405 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -142.33 126.28 17.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.219 0.451 . . . . 72.41 112.219 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' HIS . . . . . 0.485 ' HB2' HD11 ' A' ' 71' ' ' LEU . 59.0 t-80 -124.36 120.81 33.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.71 -0.478 . . . . 75.53 109.71 171.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -95.12 146.34 24.37 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.06 0.457 . . . . 63.15 112.111 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -88.05 105.69 17.65 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.36 -0.382 . . . . 71.03 110.387 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -144.47 146.52 32.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.808 0.337 . . . . 73.12 111.256 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 119.412 -0.327 . . . . 74.25 111.593 176.611 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 3' ' ' LEU . 24.5 ptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.664 0.268 . . . . 70.01 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.24 118.67 26.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.66 -0.246 . . . . 75.32 110.528 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' SD ' ' A' ' 1' ' ' MET . 63.7 mt -127.93 169.7 13.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.178 0.513 . . . . 54.34 111.437 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -111.36 96.87 6.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.626 -0.509 . . . . 72.33 109.626 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 48.0 t -100.85 123.91 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 60.43 111.306 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.858 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 3.0 m-20 64.53 24.25 13.04 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.292 -0.413 . . . . 72.25 111.718 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.2 6.31 88.12 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.348 -0.453 . . . . 35.4 113.078 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -118.35 126.62 27.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 O-C-N 122.549 -0.383 . . . . 73.52 110.835 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.65 95.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.421 2.081 . . . . 71.05 112.43 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.1 m -113.5 118.04 33.35 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.077 -0.511 . . . . 64.21 111.093 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.4 m -96.99 114.35 25.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.877 0.37 . . . . 74.32 111.487 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -93.68 120.64 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.125 0.488 . . . . 65.01 110.562 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.61 154.78 30.0 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.032 -0.531 . . . . 54.45 112.022 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.19 -45.46 3.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.257 -0.497 . . . . 75.31 113.298 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.15 117.06 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.831 0.348 . . . . 70.33 111.906 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -107.23 -55.88 2.28 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.306 -0.407 . . . . 73.04 110.566 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -141.93 122.39 14.08 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.821 0.343 . . . . 72.22 111.853 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -157.72 160.58 38.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.264 -0.425 . . . . 61.3 111.021 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.7 p30 -86.73 168.86 13.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.917 0.389 . . . . 73.31 111.175 177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.1 -29.28 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.55 -0.295 . . . . 72.22 111.449 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.3 m -61.62 -42.17 98.51 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.742 0.306 . . . . 74.5 111.586 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.29 -47.91 77.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.796 0.331 . . . . 73.03 110.908 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.92 -43.6 77.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.022 0.439 . . . . 54.14 110.825 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.01 -43.39 98.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.982 -0.554 . . . . 53.3 110.6 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -74.68 -17.34 60.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.235 -0.438 . . . . 71.35 111.891 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.61 35.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.861 0.362 . . . . 61.3 111.315 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 28' ' ' LYS . 2.8 pp -87.76 -17.79 30.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.519 -0.309 . . . . 75.4 111.705 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' N ' HD12 ' A' ' 27' ' ' LEU . 57.4 mtmt 60.06 85.56 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 72.13 112.833 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.35 117.32 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.184 0.516 . . . . 75.04 110.959 176.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.69 68.66 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.158 -0.473 . . . . 65.21 112.207 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 66' ' ' MET . 23.4 mp0 -84.81 40.45 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.384 -0.371 . . . . 74.31 111.877 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.72 62.21 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.18 0.514 . . . . 74.12 112.131 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.65 -36.31 75.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.552 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -99.33 -17.16 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.554 0.576 . . . . 65.03 112.554 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.2 113.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.976 0.732 . . . . 75.02 112.976 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 m -94.69 107.47 19.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.988 -0.551 . . . . 71.13 111.297 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 62' ' ' PHE . 31.5 m -141.32 147.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.426 -0.352 . . . . 70.24 111.195 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.29 137.03 43.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.039 0.447 . . . . 73.43 111.746 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD23 HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -83.22 106.48 15.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.027 0.441 . . . . 54.41 110.621 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 61.6 11.02 3.62 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.377 0.671 . . . . 63.45 112.526 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.63 -10.26 7.61 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.992 -0.623 . . . . 44.53 113.914 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.54 114.94 29.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.294 -0.533 . . . . 75.31 111.639 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.56 148.89 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.109 0.48 . . . . 31.32 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 HD23 ' A' ' 39' ' ' LEU . 3.1 mm? -101.16 143.26 31.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.318 0.58 . . . . 64.25 112.259 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.94 156.79 16.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.777 -0.647 . . . . 71.54 109.304 170.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 46' ' ' ARG . 61.3 mtt85 -40.43 -54.63 2.42 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.573 0.583 . . . . 75.42 112.573 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -79.25 -14.28 59.14 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.319 0.489 . . . . 55.11 112.319 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.03 62.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 53.31 111.222 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.66 -37.23 73.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.895 0.379 . . . . 71.21 111.519 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.49 -36.59 52.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.97 0.414 . . . . 71.24 111.705 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.21 -56.99 4.34 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.268 0.47 . . . . 52.15 112.268 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.5 m -72.59 126.12 29.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.039 0.447 . . . . 54.2 112.045 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 75.6 p -105.95 138.3 42.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.203 0.525 . . . . 50.42 112.011 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 39' ' ' LEU . 43.9 t -95.22 129.79 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.086 -0.507 . . . . 73.32 110.895 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.77 -179.76 5.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.279 0.561 . . . . 73.41 111.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.98 102.82 0.09 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.974 -0.557 . . . . 64.23 112.267 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.53 4.42 8.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.313 -0.47 . . . . 65.05 113.838 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.44 145.04 25.24 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.42 0.629 . . . . 74.01 112.162 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.15 131.76 51.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.78 -0.645 . . . . 51.02 111.168 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -143.96 117.71 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.403 0.62 . . . . 72.35 111.435 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 28.6 tt0 -101.38 96.56 7.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.5 0.666 . . . . 73.15 111.896 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 37' ' ' VAL . 18.6 t80 -78.06 92.2 4.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.928 -0.578 . . . . 73.24 110.069 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.78 135.5 56.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.29 0.848 . . . . 73.23 113.29 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -83.37 18.98 1.63 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 52.33 111.88 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -54.74 -31.51 58.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.027 0.441 . . . . 75.43 111.816 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.685 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 18.0 tpt -102.32 117.91 35.74 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.115 -0.493 . . . . 65.15 111.189 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.7 13.6 2.48 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.077 -0.583 . . . . 43.51 113.347 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.58 -18.47 4.62 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.213 -0.518 . . . . 73.43 114.142 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.89 81.67 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.328 -0.463 . . . . 64.13 113.88 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -90.57 88.76 7.26 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.349 -0.501 . . . . 72.33 112.114 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.0 mp -106.34 155.23 19.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.576 -0.528 . . . . 71.42 109.576 170.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.37 95.47 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.055 0.455 . . . . 74.23 111.755 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -88.2 119.75 28.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.377 -0.374 . . . . 75.03 110.426 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -73.86 -43.05 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.467 0.543 . . . . 74.33 112.467 -173.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 68.35 164.59 0.23 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.517 0.327 . . . . 73.44 110.845 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -107.73 147.77 30.35 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.707 -0.621 . . . . 60.4 112.505 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -150.63 111.37 4.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.621 -0.718 . . . . 75.53 109.761 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.785 -0.626 . . . . 71.24 111.997 -173.249 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 22.8 ptp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.793 0.33 . . . . 72.41 111.517 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -101.9 114.56 28.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.398 -0.365 . . . . 64.55 111.017 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.86 127.76 53.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.081 0.467 . . . . 72.34 111.411 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.2 m -82.4 97.7 8.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.462 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 31.5 t -85.72 110.83 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.918 0.389 . . . . 62.43 111.837 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.458 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 27.8 m120 57.74 25.62 12.07 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.164 0.586 . . . . 63.33 112.37 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.03 -11.55 58.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.212 -0.518 . . . . 65.55 113.086 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 9.9 mptt -102.48 114.62 65.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.672 -0.311 . . . . 74.21 110.93 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 25.6 Cg_exo -63.32 116.45 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.8 2.333 . . . . 71.24 113.148 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -114.01 158.74 20.78 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.348 -0.387 . . . . 63.15 110.558 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -126.31 110.28 13.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.894 0.378 . . . . 64.51 111.868 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 m -98.81 102.08 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.451 0.644 . . . . 72.34 110.666 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.04 136.22 37.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.758 -0.655 . . . . 73.22 111.534 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.65 59.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.18 -0.533 . . . . 51.12 113.001 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -103.04 101.74 11.73 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.592 -0.358 . . . . 73.43 111.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.82 88.12 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.932 0.396 . . . . 73.12 111.181 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m 49.29 91.96 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.752 -0.658 . . . . 52.31 112.454 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.4 pp -129.0 153.83 47.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.062 0.458 . . . . 71.4 111.611 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 27.7 m-20 -72.34 160.73 31.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.469 -0.332 . . . . 75.22 110.828 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 t -56.38 -36.65 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.968 0.413 . . . . 74.21 110.568 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -56.36 -52.03 66.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.96 0.41 . . . . 62.35 110.999 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 41.7 mt-10 -63.83 -34.45 77.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.305 -0.407 . . . . 71.13 111.44 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.3 -45.93 80.02 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.919 0.39 . . . . 75.14 110.434 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -56.25 -32.93 64.95 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.983 0.42 . . . . 71.24 111.499 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.4 t -77.97 -32.82 51.57 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.122 -0.49 . . . . 70.13 111.291 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.59 -46.38 63.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.082 0.468 . . . . 74.22 111.417 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.52 -30.42 65.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.909 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.89 87.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.58 0.752 . . . . 70.12 112.575 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.11 148.53 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.792 -0.64 . . . . 73.04 110.936 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.99 171.81 14.52 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.87 0.367 . . . . 64.41 111.867 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 57.17 39.07 29.13 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.057 0.455 . . . . 71.52 111.729 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -33.27 71.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.459 . . . . 42.14 111.961 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.72 -13.34 62.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.984 0.365 . . . . 74.25 111.984 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.17 4.7 5.82 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.458 0.54 . . . . 64.2 112.458 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG22 HG13 ' A' ' 37' ' ' VAL . 14.6 p -70.71 132.06 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.551 0.691 . . . . 73.2 112.338 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.9 m -95.26 98.89 10.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.221 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 35' ' ' VAL . 29.7 m -133.15 163.34 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.265 0.555 . . . . 75.35 112.08 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.39 154.71 32.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.983 -0.553 . . . . 62.0 111.298 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.544 HD12 ' O ' ' A' ' 39' ' ' LEU . 3.4 pp -123.17 137.95 54.77 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.531 -0.304 . . . . 44.43 111.286 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 59.21 16.08 4.66 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 116.358 -0.383 . . . . 71.03 112.024 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.27 15.41 53.65 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.347 -0.454 . . . . 55.34 113.825 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.15 118.3 28.33 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.3 -0.529 . . . . 73.01 111.368 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.68 135.13 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.11 0.481 . . . . 72.45 111.927 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.0 mm? -109.67 150.72 27.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.131 0.491 . . . . 60.43 112.092 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 mp0 -69.36 162.18 27.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.146 -0.479 . . . . 72.43 110.76 170.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -57.02 -39.43 74.74 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.714 0.292 . . . . 62.41 111.32 178.443 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.56 -35.94 68.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.153 0.501 . . . . 73.31 111.038 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -22.41 66.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.333 -0.394 . . . . 74.31 111.369 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 46' ' ' ARG . 17.5 m-30 -57.57 -39.33 76.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.646 0.26 . . . . 74.33 111.558 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 22.2 t70 -83.34 -35.51 25.11 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.241 0.543 . . . . 73.13 110.82 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.36 -23.57 67.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.258 -0.428 . . . . 74.01 112.09 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -103.77 115.78 31.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.787 0.327 . . . . 64.22 111.565 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 88.6 m -94.73 110.19 22.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.23 0.538 . . . . 41.12 111.801 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.48 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.901 -0.591 . . . . 65.1 111.24 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -130.07 -167.12 1.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.183 0.516 . . . . 72.34 111.929 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 2.8 t0 -78.97 42.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.931 0.396 . . . . 73.45 112.045 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.59 52.92 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.406 -0.902 . . . . 64.23 113.426 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.12 123.7 38.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.237 0.541 . . . . 74.44 110.956 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.82 82.96 3.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.267 -0.424 . . . . 53.44 111.577 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.7 p -83.47 104.93 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.529 0.68 . . . . 74.42 111.561 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 41.3 mt-10 -85.84 100.61 12.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.442 0.639 . . . . 73.31 111.167 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -101.71 110.9 22.99 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.291 -0.868 . . . . 73.52 110.676 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.2 pt? -137.54 155.06 49.67 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 65.24 9.11 5.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.764 1.024 . . . . 75.32 113.764 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -131.61 26.33 4.73 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.991 0.424 . . . . 74.44 111.505 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' A' ' 66' ' ' MET . 1.5 mpt? -57.83 140.73 51.12 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.946 0.403 . . . . 64.04 111.617 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.68 -35.72 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.28 -0.486 . . . . 53.31 113.475 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.79 -117.35 5.1 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.173 -0.537 . . . . 74.35 113.151 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.04 33.6 69.96 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.305 -0.474 . . . . 53.44 113.053 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.89 126.05 55.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.329 0.585 . . . . 73.53 112.503 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 pp -88.91 178.66 6.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.985 -0.552 . . . . 60.41 110.397 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -148.06 132.22 17.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.837 0.351 . . . . 75.21 111.903 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -86.07 124.65 32.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.067 0.461 . . . . 72.31 111.488 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -58.47 120.74 9.35 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.845 -0.616 . . . . 74.11 111.962 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -84.73 140.4 31.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.466 -0.334 . . . . 71.54 111.014 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.5 t60 62.8 111.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.302 0.572 . . . . 63.25 112.157 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -139.12 -166.58 2.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.235 -0.438 . . . . 73.32 111.169 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 119.483 -0.294 . . . . 74.21 111.541 175.782 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 26.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.846 0.355 . . . . 62.54 111.914 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -91.22 126.8 36.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.44 -0.345 . . . . 72.53 111.543 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 58' ' ' ASP . 74.7 mt -125.31 130.65 52.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.824 0.345 . . . . 71.14 110.889 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.7 m -94.58 86.08 4.7 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 73.51 111.151 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.1 122.44 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.43 . . . . 64.54 111.181 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.69 23.42 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.762 0.315 . . . . 73.04 111.568 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.5 79.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.827 -0.701 . . . . 63.2 112.464 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -113.23 131.58 22.82 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 122.78 0.432 . . . . 63.05 110.821 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.73 96.3 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.414 2.076 . . . . 72.15 112.961 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -98.76 102.15 13.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.098 0.475 . . . . 71.22 111.25 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.3 m -82.54 94.2 7.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 74.32 110.767 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.9 m -93.63 102.99 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.539 0.685 . . . . 72.04 111.401 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -89.0 151.79 22.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.306 -0.407 . . . . 64.43 110.559 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.07 18.53 53.67 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.555 -0.618 . . . . 65.04 111.555 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.46 116.2 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.119 0.568 . . . . 72.24 110.527 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -91.23 -62.65 1.4 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.416 0.626 . . . . 61.34 111.213 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 33.2 p -171.53 104.21 0.2 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.305 -0.861 . . . . 34.32 110.061 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -131.88 162.08 31.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.488 0.551 . . . . 63.03 112.488 -170.425 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -64.1 156.2 29.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.407 -0.36 . . . . 72.41 110.936 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 46.2 t -56.5 -35.6 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.001 0.429 . . . . 75.44 110.437 176.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -59.03 -49.07 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.143 -0.48 . . . . 61.51 110.992 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 44.0 mt-10 -61.44 -35.81 78.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.275 -0.42 . . . . 75.43 110.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 60' ' ' VAL . 61.7 tp -60.53 -45.92 92.08 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.897 0.38 . . . . 63.02 110.815 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 85.5 mt -60.07 -34.78 73.92 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 44.21 110.821 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -67.9 -41.75 82.24 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.19 -0.459 . . . . 62.23 111.119 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.69 90.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.261 -0.427 . . . . 41.42 111.709 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.49 -11.36 59.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.991 0.425 . . . . 75.24 111.081 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 58.91 64.66 1.37 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 74.34 111.914 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.49 114.05 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.811 -0.632 . . . . 74.44 110.784 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.46 80.42 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.13 0.419 . . . . 62.32 112.13 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 78.8 mt-30 -95.79 83.13 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.802 0.335 . . . . 74.53 111.649 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.83 -37.43 22.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.654 0.74 . . . . 75.24 110.421 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -67.36 -20.25 65.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.098 -0.955 . . . . 74.43 111.692 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -123.52 11.74 9.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.773 0.657 . . . . 74.14 112.773 -173.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 37' ' ' VAL . 14.8 p -83.7 131.94 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 75.12 112.19 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -95.11 102.14 13.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.412 -0.358 . . . . 60.41 110.897 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 35' ' ' VAL . 35.3 m -122.95 139.96 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.827 0.346 . . . . 51.34 111.621 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.34 110.68 11.7 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.409 0.623 . . . . 74.05 111.555 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 10.0 mp -77.37 129.82 36.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.243 -0.435 . . . . 62.24 111.273 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.06 21.23 9.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.979 0.419 . . . . 70.42 111.549 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.76 19.82 49.92 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.311 -0.471 . . . . 73.13 113.343 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -133.79 125.58 28.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.952 0.376 . . . . 70.41 111.129 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.22 144.49 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 120.985 0.421 . . . . 70.13 112.021 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 49' ' ' PHE . 9.9 mp -104.82 -179.78 4.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.419 0.628 . . . . 60.13 112.294 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -107.77 149.18 28.51 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.702 -0.681 . . . . 64.4 110.578 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 2.1 ptm180 -47.16 -52.98 14.15 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.71 1.004 . . . . 72.3 113.71 -171.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 19.5 tt0 -95.39 -6.49 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.452 0.644 . . . . 42.34 110.753 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.86 63.97 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.9 -0.591 . . . . 74.51 110.539 171.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.405 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 m-30 -51.14 -42.08 60.51 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.225 0.536 . . . . 73.11 110.893 174.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.16 -34.62 78.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.712 -0.676 . . . . 73.22 111.561 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.95 -5.57 50.43 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.751 0.648 . . . . 64.3 112.751 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -104.81 116.18 31.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 122.286 -0.258 . . . . 75.22 111.437 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.1 p -95.59 113.18 24.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.699 0.629 . . . . 74.0 112.699 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD21 ' A' ' 39' ' ' LEU . 65.0 t -79.11 133.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.133 -0.485 . . . . 62.13 110.798 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' HB2' ' A' ' 17' ' ' SER . 43.9 mtmt -131.92 -171.84 2.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.263 0.554 . . . . 74.51 112.024 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.9 t70 -66.17 124.53 22.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 72.43 111.632 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 30.16 11.45 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.276 -0.488 . . . . 54.11 113.317 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.5 t70 -93.54 176.96 6.18 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.756 -0.261 . . . . 65.55 110.344 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.22 42.46 1.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.829 0.347 . . . . 63.4 111.918 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 3.7 p -56.2 102.2 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.671 0.748 . . . . 74.04 111.846 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.75 116.78 28.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.054 -0.521 . . . . 64.32 111.957 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -88.93 135.75 33.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.052 -0.522 . . . . 72.32 111.292 173.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -137.83 133.5 34.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.469 -0.332 . . . . 75.51 111.253 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 70.36 -19.61 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.347 0.869 . . . . 70.33 113.347 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.68 80.66 1.81 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.891 -0.506 . . . . 74.51 111.863 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 65.9 mtt -145.38 120.99 10.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.107 -0.497 . . . . 61.31 111.319 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.71 -45.05 0.57 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.346 -0.454 . . . . 32.1 112.404 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.44 -25.25 28.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.355 -0.45 . . . . 74.11 113.315 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.12 -78.16 0.81 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.389 -0.434 . . . . 64.24 112.723 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 59.1 pttt -89.0 104.03 16.6 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.322 0.582 . . . . 63.11 111.467 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.3 mp -78.0 102.14 7.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 73.11 110.903 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 57.03 -163.74 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.206 0.527 . . . . 73.0 111.883 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -123.72 -38.86 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.61 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.4 t60 67.59 123.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.482 0.658 . . . . 71.34 111.334 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -79.77 134.44 36.36 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.571 0.582 . . . . 65.23 112.571 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -113.22 157.51 21.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.022 -0.535 . . . . 72.41 110.036 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -137.04 -177.29 4.69 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.249 0.547 . . . . 73.5 112.274 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.817 -0.611 . . . . 74.41 111.302 -176.744 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 3' ' ' LEU . 21.5 ptp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.039 0.447 . . . . 62.1 111.728 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -85.18 108.66 17.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.495 -0.32 . . . . 65.32 110.825 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 1' ' ' MET . 70.5 mt -118.83 113.89 21.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.997 0.427 . . . . 63.34 111.762 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.7 m -75.69 99.04 4.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.317 -0.401 . . . . 70.14 110.577 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.51 121.64 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.207 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 64.35 27.14 13.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.924 0.49 . . . . 73.12 110.715 -179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.62 0.03 88.04 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.859 -0.686 . . . . 23.44 113.595 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -104.39 110.05 63.64 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 117.298 0.549 . . . . 73.12 111.326 178.37 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 37.1 Cg_exo -61.33 103.92 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.848 2.365 . . . . 60.51 112.216 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -109.97 110.35 21.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.988 0.423 . . . . 65.02 111.842 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -82.67 96.97 8.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.882 0.373 . . . . 72.4 111.383 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -93.74 104.72 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.733 0.778 . . . . 72.01 110.844 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -72.81 147.59 45.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.251 -0.886 . . . . 71.05 111.407 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.14 -12.83 65.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.467 -0.397 . . . . 63.33 113.772 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -108.92 119.36 39.33 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.433 -0.451 . . . . 42.5 112.027 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.5 -73.8 0.33 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.207 -0.451 . . . . 73.51 112.194 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.513 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 87.0 p -163.07 135.56 5.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.652 -0.249 . . . . 42.33 110.707 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -148.67 157.04 43.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.944 0.402 . . . . 73.4 111.944 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -72.31 170.02 15.02 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.708 -0.224 . . . . 61.12 110.852 177.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 49' ' ' PHE . 58.8 t -62.16 -40.94 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 109.973 -0.38 . . . . 74.24 109.973 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.0 m -53.94 -52.85 59.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.196 0.522 . . . . 74.11 110.597 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 8.5 mm-40 -61.5 -33.78 74.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.028 -0.533 . . . . 74.12 112.006 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.52 -56.36 18.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.979 0.418 . . . . 75.45 111.139 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.52 -30.75 71.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.785 0.326 . . . . 75.21 110.961 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.7 t -66.57 -37.51 85.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.027 0.441 . . . . 72.13 111.274 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.86 80.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.33 -0.395 . . . . 71.11 111.204 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.51 -29.08 62.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.299 -0.41 . . . . 73.4 111.085 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 67.26 16.07 10.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.174 0.59 . . . . 64.11 112.145 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 31' ' ' GLN . 11.4 p -72.5 140.01 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.064 0.459 . . . . 74.0 111.438 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.58 -14.83 57.87 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.885 0.698 . . . . 74.44 112.885 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.07 30.77 1.8 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.281 -0.262 . . . . 54.13 111.39 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.87 79.74 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.424 0.528 . . . . 71.51 112.424 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.07 -10.79 59.93 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.156 0.503 . . . . 75.12 111.376 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.19 21.94 11.57 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.208 0.447 . . . . 71.22 112.208 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.4 p -110.88 133.57 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.166 0.507 . . . . 71.05 112.068 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.8 m -74.76 84.36 2.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.278 0.561 . . . . 74.33 110.936 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -99.11 110.33 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.971 -0.559 . . . . 74.21 110.31 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 10.5 pt-20 -118.2 119.65 35.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.734 0.778 . . . . 73.44 112.128 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.0 tm? -73.29 107.67 5.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.412 -0.813 . . . . 71.52 110.417 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 58.53 15.84 3.85 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.044 -0.525 . . . . 73.44 111.818 -178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 15.83 11.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.996 -0.621 . . . . 43.43 113.886 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -132.11 110.55 10.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 117.396 0.598 . . . . 74.31 110.899 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 12.4 p -64.58 141.88 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.787 0.662 . . . . 63.22 112.787 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.8 mm? -94.02 143.74 26.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.407 0.622 . . . . 74.12 112.485 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -77.4 154.43 32.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.717 -0.674 . . . . 50.44 110.536 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -48.26 -41.03 26.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.147 0.425 . . . . 65.34 112.147 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.32 -40.73 85.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.183 0.516 . . . . 74.11 111.485 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -24.15 63.51 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.311 0.486 . . . . 65.1 112.311 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 7.7 m-85 -49.48 -42.0 42.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.914 0.388 . . . . 75.53 111.728 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.77 -29.85 29.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.908 0.385 . . . . 73.01 111.648 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 -15.77 46.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.942 0.719 . . . . 73.14 112.942 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -104.18 123.08 46.67 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.073 -0.392 . . . . 60.11 111.483 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 89.5 m -111.14 110.81 21.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.201 0.524 . . . . 65.03 111.726 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.6 123.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.853 -0.612 . . . . 61.44 110.447 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -133.51 -175.37 3.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.977 0.417 . . . . 70.44 111.851 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.05 129.6 42.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.045 0.45 . . . . 74.11 111.715 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 42.49 12.81 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.378 -0.439 . . . . 15.02 112.733 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -119.6 -173.15 2.47 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.699 -0.482 . . . . 61.12 109.699 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 102.65 4.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 71.13 110.972 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.16 100.11 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.57 0.7 . . . . 73.32 110.557 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 5.1 mm-40 -76.86 105.99 8.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.839 0.828 . . . . 74.32 111.214 -176.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.434 ' CE2' HG21 ' A' ' 35' ' ' VAL . 12.1 t80 -119.11 99.32 6.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.47 -1.241 . . . . 73.01 109.395 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.482 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? -134.5 143.04 47.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.116 0.784 . . . . 72.51 113.116 -168.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 67.33 12.29 8.84 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.271 0.841 . . . . 71.41 113.271 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.29 164.82 22.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.296 0.57 . . . . 60.4 112.275 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 27.3 ttt -73.23 124.39 25.57 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.5 -0.773 . . . . 60.5 112.055 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 -54.33 0.03 OUTLIER Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.347 -0.454 . . . . 53.25 113.038 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.42 -157.12 24.53 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.156 -0.545 . . . . 53.42 113.0 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 101.24 0.88 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.056 -0.593 . . . . 71.1 113.031 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -121.69 144.83 48.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.047 0.451 . . . . 53.21 111.575 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 71' ' ' LEU . 3.1 mm? -96.56 54.85 1.38 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 61.11 109.803 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.34 71.55 3.03 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 75.1 112.474 -172.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 38.95 58.07 1.83 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.539 0.736 . . . . 73.42 112.422 174.288 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -73.49 155.49 39.17 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 74.52 112.084 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.65 113.26 2.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.838 -0.619 . . . . 71.0 111.272 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -81.21 141.23 34.36 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.767 0.318 . . . . 75.42 111.687 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -178.06 138.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.723 0.409 . . . . 75.24 110.958 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 p80 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 119.292 -0.385 . . . . 73.41 111.172 178.097 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 55' ' ' LYS . 24.8 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.086 0.47 . . . . 72.44 111.895 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -90.75 117.12 29.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.921 -0.582 . . . . 74.45 111.307 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 58' ' ' ASP . 24.0 mt -116.82 179.14 4.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 110.309 -0.256 . . . . 62.0 110.309 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 26.6 m -146.84 134.58 21.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.697 0.284 . . . . 64.51 111.006 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.7 113.36 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 122.259 -0.276 . . . . 70.41 110.778 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.586 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 4.0 m-20 63.27 38.28 10.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.894 0.378 . . . . 75.11 111.203 179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.08 -2.91 67.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.887 -0.673 . . . . 52.21 113.791 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.99 113.99 65.46 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.075 0.438 . . . . 73.32 111.094 176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.52 151.11 77.64 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.848 2.366 . . . . 71.42 112.922 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -151.3 109.73 3.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.277 0.561 . . . . 54.44 111.3 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.0 m -85.24 107.35 17.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.908 -0.587 . . . . 65.24 111.245 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.6 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.047 0.451 . . . . 71.52 112.091 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.07 149.84 40.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.899 0.381 . . . . 70.44 111.143 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.99 32.28 2.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.32 -0.4 . . . . 64.32 113.111 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.96 123.24 13.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.567 -0.372 . . . . 70.31 111.013 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.22 83.4 1.89 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.068 0.395 . . . . 72.22 112.068 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m 49.45 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.975 0.732 . . . . 74.24 112.975 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -135.17 154.49 51.6 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.19 0.441 . . . . 60.3 112.19 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p30 -71.73 167.8 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.037 0.446 . . . . 72.13 111.904 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.21 -42.21 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.288 -0.414 . . . . 62.12 111.939 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HB1' ' A' ' 32' ' ' ALA . 92.7 m -59.86 -44.44 94.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.671 0.272 . . . . 74.0 111.538 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 36.5 mt-10 -66.91 -37.17 83.84 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.245 -0.285 . . . . 60.22 111.271 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 54' ' ' VAL . 56.4 tp -56.01 -56.55 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.084 0.469 . . . . 63.12 111.341 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD22 HG11 ' A' ' 35' ' ' VAL . 4.5 pp -68.09 -26.4 65.81 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.918 0.389 . . . . 73.12 111.53 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -65.77 -36.69 84.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.882 0.372 . . . . 64.21 111.015 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.34 67.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 73.0 111.165 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -85.31 -3.06 58.71 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.279 0.561 . . . . 64.15 109.925 175.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 65.74 28.2 11.04 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.189 0.596 . . . . 64.21 112.018 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 27' ' ' LEU . 58.3 t -73.2 113.03 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.526 -0.306 . . . . 64.32 111.007 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.69 158.04 19.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.488 -0.324 . . . . 53.34 111.287 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 41.3 mt-30 60.69 72.44 0.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.492 0.663 . . . . 73.05 110.769 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' HG23 ' A' ' 21' ' ' THR . . . -67.82 -16.24 64.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.07 0.767 . . . . 45.04 113.07 -171.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -41.58 3.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.62 -0.264 . . . . 60.12 111.465 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 22.5 m-85 -60.41 -21.18 61.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.037 0.384 . . . . 74.43 112.037 -177.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.582 HG11 HD22 ' A' ' 24' ' ' LEU . 10.1 p -60.26 149.61 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.092 0.472 . . . . 74.15 111.306 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -116.04 113.81 23.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.745 0.307 . . . . 72.44 111.024 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.38 149.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.959 0.409 . . . . 74.5 111.176 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 9.2 pt-20 -128.91 125.99 38.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.002 0.43 . . . . 61.12 111.597 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.619 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.68 110.36 17.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.223 -0.444 . . . . 65.22 110.797 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 24.3 m120 63.03 29.63 16.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.204 0.526 . . . . 73.02 110.912 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.51 85.42 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.043 -0.598 . . . . 73.12 113.456 -175.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.79 111.32 23.78 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.644 -0.327 . . . . 65.33 110.92 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.28 138.03 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.409 0.522 . . . . 65.05 112.409 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -109.65 161.48 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.037 0.446 . . . . 75.12 111.103 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.71 155.17 19.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.145 -0.48 . . . . 74.44 109.892 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 2.3 mpt_? -53.99 -38.28 64.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.654 0.613 . . . . 71.24 112.654 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.35 -31.1 69.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.219 0.533 . . . . 73.01 110.804 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.52 -24.0 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.848 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -55.83 -41.1 73.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.403 0.621 . . . . 74.54 110.869 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -70.19 -37.86 75.21 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.202 -0.908 . . . . 51.41 111.869 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.66 -33.75 60.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.191 0.441 . . . . 73.0 112.191 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -82.05 104.61 12.52 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.788 0.327 . . . . 72.52 111.046 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 74.0 p -94.39 110.74 22.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.198 0.523 . . . . 72.12 111.781 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 97.1 t -74.14 127.46 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.718 -0.674 . . . . 42.21 111.454 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 19.6 ptmt -167.99 87.99 0.25 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.146 -0.479 . . . . 74.43 111.684 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.9 t70 66.02 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.14 -0.482 . . . . 44.5 112.241 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.12 40.13 83.1 Favored Glycine 0 N--CA 1.464 0.532 0 C-N-CA 120.899 -0.667 . . . . 63.53 112.245 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.2 t70 -106.83 164.18 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.905 0.482 . . . . 74.03 111.957 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -151.52 72.55 1.04 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.838 -0.619 . . . . 72.21 110.699 175.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.3 p -83.32 95.95 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.801 0.81 . . . . 71.54 112.012 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 2.4 mp0 -73.7 103.7 4.36 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.189 0.518 . . . . 63.34 112.104 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 24' ' ' LEU . 11.7 m-85 -87.03 134.12 33.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.942 -0.572 . . . . 72.31 110.47 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 63' ' ' LEU . 2.1 pt? -148.06 130.33 15.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.625 0.602 . . . . 72.11 112.625 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 73.31 -31.39 0.22 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.253 1.205 . . . . 71.45 114.253 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -84.39 53.2 2.57 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.837 -0.539 . . . . 63.21 112.382 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -155.01 139.19 16.55 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.52 -0.309 . . . . 61.53 110.708 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.495 ' N ' ' SD ' ' A' ' 66' ' ' MET . . . 174.99 -27.2 0.08 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.209 -0.519 . . . . 61.52 113.402 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.6 122.9 25.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.341 -0.457 . . . . 30.21 113.558 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.97 -22.72 3.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.367 -0.444 . . . . 51.31 113.562 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.8 tttm 67.8 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.474 0.654 . . . . 75.31 112.3 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.35 134.69 34.09 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.148 0.499 . . . . 63.22 111.166 174.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.39 -52.12 66.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.772 -0.649 . . . . 72.42 112.152 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -119.04 -77.65 0.58 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.883 0.327 . . . . 64.21 111.883 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -171.28 151.69 3.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.016 0.376 . . . . 64.12 112.016 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -87.72 -58.58 2.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.729 0.3 . . . . 72.42 111.053 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 67.11 104.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.993 -0.549 . . . . 65.05 110.919 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -153.74 132.92 12.62 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.043 0.449 . . . . 73.03 111.936 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.6 m80 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.846 -0.597 . . . . 61.34 110.919 172.707 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.045 0.45 . . . . 70.41 112.01 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 2.3 m-20 -98.2 134.4 41.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.962 0.505 . . . . 73.44 110.803 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.521 ' HB3' HG12 ' A' ' 60' ' ' VAL . 2.7 mm? -126.48 134.9 50.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.773 0.321 . . . . 74.1 111.354 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -84.19 77.86 9.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.209 0.528 . . . . 74.11 110.357 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -80.82 121.89 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.023 0.44 . . . . 63.44 111.923 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 61.04 18.54 9.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.34 -0.391 . . . . 72.44 111.683 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.94 -3.15 64.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.28 -0.486 . . . . 33.05 113.091 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 10.3 mptt -108.29 132.87 20.8 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.819 0.31 . . . . 64.55 110.917 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 97.75 1.15 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.501 2.134 . . . . 53.5 113.61 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.1 t -98.47 179.42 4.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.035 -0.53 . . . . 44.24 111.096 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 93.9 m -149.73 121.41 8.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.106 0.41 . . . . 73.21 112.106 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' VAL . 34.9 m -100.26 109.03 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.564 0.697 . . . . 74.32 110.488 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.42 151.46 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.788 -176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.7 -43.06 3.14 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.293 -0.48 . . . . 74.35 113.314 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.9 153.9 21.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.295 0.48 . . . . 72.33 112.295 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.91 -72.26 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.344 -0.389 . . . . 72.13 111.496 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -110.25 96.01 5.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.884 0.373 . . . . 74.41 111.38 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 83.6 mt -127.36 152.03 48.01 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.728 0.299 . . . . 74.12 111.637 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -76.47 166.7 23.05 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.494 0.188 . . . . 54.23 110.613 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.42 -38.35 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.079 0.466 . . . . 73.22 110.352 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -59.62 -40.72 88.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.177 0.513 . . . . 73.03 110.776 172.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 6.0 mm-40 -69.58 -26.0 64.25 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.409 -0.36 . . . . 65.4 111.803 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 39.1 mt -63.71 -41.46 98.09 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.927 -0.397 . . . . 71.32 109.927 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.88 -41.08 90.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.281 -0.418 . . . . 61.44 110.408 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 m -59.36 -54.17 49.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.04 -0.527 . . . . 62.51 111.409 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.02 68.52 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.158 0.429 . . . . 21.11 112.158 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.6 mt -75.63 -6.22 49.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.503 -0.317 . . . . 64.44 111.715 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt 54.72 51.91 13.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.44 111.065 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.7 t -87.13 119.49 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 74.03 111.1 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.56 -28.86 65.22 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.934 0.397 . . . . 71.23 111.519 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.46 87.94 6.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.856 0.36 . . . . 64.41 111.513 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.75 -13.92 21.12 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.744 0.783 . . . . 75.42 110.624 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.26 -48.82 3.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.822 -1.081 . . . . 63.2 110.117 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.64 44.78 1.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.448 -0.796 . . . . 74.54 111.577 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.12 149.04 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 112.673 0.62 . . . . 64.41 112.673 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 m -145.41 112.44 6.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.056 -0.52 . . . . 61.41 111.027 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 62' ' ' PHE . 35.7 m -144.46 160.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.422 0.289 . . . . 63.3 111.427 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.604 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -133.62 147.86 51.5 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.561 0.696 . . . . 73.33 111.249 172.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.493 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.6 tm? -108.54 105.09 14.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.724 -0.671 . . . . 63.23 110.233 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.2 35.58 25.97 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.795 0.331 . . . . 71.44 111.434 -175.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.43 -17.56 57.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 121.127 -0.558 . . . . 51.04 113.617 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.58 100.34 11.35 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.447 -0.443 . . . . 74.14 111.121 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.46 140.42 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.363 . . . . 74.45 111.387 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -99.72 136.53 39.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.921 0.391 . . . . 55.24 111.552 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.75 146.5 37.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.436 -0.347 . . . . 72.31 110.499 172.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -53.02 -21.82 4.98 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.1 0.476 . . . . 74.54 111.893 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.81 -27.67 24.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.558 0.577 . . . . 73.03 112.558 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.18 11.19 37.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.589 0.959 . . . . 65.2 113.589 -169.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 18.4 m-85 -59.68 -49.17 78.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.245 0.461 . . . . 65.2 112.245 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.12 -23.86 54.89 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.074 0.464 . . . . 64.03 111.202 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.97 -17.12 57.53 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.11 0.411 . . . . 34.44 112.11 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.8 m -103.64 120.87 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.725 0.298 . . . . 63.31 111.377 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.4 p -89.9 150.14 22.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.424 0.63 . . . . 75.02 112.146 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 23' ' ' LEU . 46.4 t -115.81 142.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.633 -0.712 . . . . 70.44 110.724 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -137.47 176.35 8.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.442 . . . . 73.21 112.005 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.46 145.85 50.69 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.026 0.441 . . . . 73.34 111.975 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.56 30.71 78.06 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.062 -0.517 . . . . 71.11 113.063 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -109.56 142.52 40.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.821 0.343 . . . . 72.05 111.121 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.0 85.57 5.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.88 0.696 . . . . 62.24 112.88 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 3' ' ' LEU . 5.6 p -86.94 107.96 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.492 0.663 . . . . 71.03 110.461 173.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.604 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 34.1 mt-10 -94.21 97.62 10.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.383 0.611 . . . . 74.14 111.247 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . 42.5 t80 -89.56 115.9 27.31 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.528 -0.76 . . . . 72.33 111.22 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.0 mt -91.8 125.16 36.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.87 0.367 . . . . 73.42 111.5 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -81.27 22.63 0.65 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.902 0.334 . . . . 75.14 111.902 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 61.28 29.96 18.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.966 0.506 . . . . 74.52 111.729 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 66' ' ' MET . 0.0 OUTLIER 54.98 88.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.151 0.501 . . . . 71.14 111.179 -176.446 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.25 18.01 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.102 -0.57 . . . . 75.23 113.321 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.42 -22.24 17.35 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.085 -0.579 . . . . 53.51 113.159 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 -84.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.497 -0.383 . . . . 70.21 112.827 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.2 30.09 3.63 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.766 0.427 . . . . 64.42 110.842 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.2 mt 66.78 -172.55 0.19 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.054 -0.521 . . . . 64.31 111.714 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.63 115.38 8.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.064 0.459 . . . . 64.24 111.404 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -128.98 78.31 1.85 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.219 0.533 . . . . 74.35 111.512 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -87.54 -47.98 8.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 64.53 110.051 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 t60 65.15 153.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.077 -0.511 . . . . 73.44 111.626 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -55.48 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.002 -0.436 . . . . 72.24 111.599 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -133.34 140.16 47.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.864 0.364 . . . . 74.41 111.139 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.252 1.186 0 CA-C-N 116.279 -0.419 . . . . 72.02 111.449 178.487 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.771 0.319 . . . . 64.3 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -75.47 130.12 38.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.126 0.417 . . . . 62.01 112.126 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -141.73 118.19 10.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.198 -0.456 . . . . 53.03 111.475 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' LYS . 67.2 m -76.19 97.82 4.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.182 0.515 . . . . 70.32 110.985 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 46.5 t -93.05 107.84 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.288 -0.414 . . . . 74.25 111.21 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.03 35.51 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.939 0.4 . . . . 53.12 112.031 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.42 76.23 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.048 -0.596 . . . . 65.44 113.645 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' THR . 28.5 mtpp -91.96 113.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 122.438 -0.448 . . . . 73.13 111.272 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.62 65.41 4.73 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.554 2.17 . . . . 74.12 112.182 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t -102.83 176.74 5.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.455 0.645 . . . . 71.15 111.661 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -148.95 134.42 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.887 -0.597 . . . . 74.4 111.234 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.63 119.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.276 -0.42 . . . . 71.14 110.004 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.76 111.05 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.155 0.502 . . . . 72.53 111.796 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.47 2.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.908 -0.587 . . . . 42.41 112.936 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.84 92.53 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.3 0.571 . . . . 73.4 111.827 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -79.91 84.33 5.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.15 0.5 . . . . 74.15 110.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.6 p 61.63 114.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.176 0.99 . . . . 50.53 112.598 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.4 mt -130.61 131.59 45.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.413 -0.358 . . . . 74.44 110.994 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.5 p-10 -80.46 171.86 14.5 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.198 -0.314 . . . . 75.23 110.363 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.2 t -56.5 -37.98 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.717 0.294 . . . . 74.21 111.156 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.0 m -55.73 -46.65 77.74 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.891 0.377 . . . . 71.23 111.116 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -67.38 -29.95 69.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.175 0.435 . . . . 52.05 112.175 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.01 -37.37 81.33 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.095 0.474 . . . . 61.21 110.329 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 35' ' ' VAL . 91.0 mt -63.75 -37.86 88.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.161 -0.472 . . . . 75.24 111.298 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -76.54 -38.19 55.46 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.434 -0.348 . . . . 64.04 111.117 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.03 90.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.036 0.446 . . . . 54.33 111.397 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -80.26 -17.99 50.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.274 0.559 . . . . 70.23 110.478 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 tptt 67.02 82.52 0.18 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.212 -0.904 . . . . 73.42 112.753 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.85 142.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.967 -0.56 . . . . 64.13 110.77 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -42.84 15.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.794 0.33 . . . . 60.05 111.729 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -87.94 76.58 8.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.099 0.476 . . . . 54.01 111.064 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.38 -23.9 67.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.271 0.471 . . . . 61.12 112.271 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -93.26 -8.8 41.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.257 0.466 . . . . 51.43 112.257 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.43 4.71 6.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 71.22 112.031 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 24' ' ' LEU . 7.2 p -68.62 130.35 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.452 0.644 . . . . 71.33 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -112.96 112.06 23.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.062 -0.517 . . . . 70.24 111.016 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 62' ' ' PHE . 29.8 m -139.33 158.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.35 -0.386 . . . . 73.05 111.402 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 3.5 pm0 -132.26 169.62 16.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.194 0.521 . . . . 71.05 110.945 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 39' ' ' LEU . 2.4 pp -133.98 124.59 26.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.669 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 56.47 18.87 3.75 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.206 -0.452 . . . . 74.54 111.531 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.62 2.18 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.324 -0.465 . . . . 60.22 113.744 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.19 120.57 15.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.925 0.363 . . . . 64.21 111.195 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.79 143.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.918 0.39 . . . . 72.11 111.71 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -91.59 139.3 30.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.076 0.465 . . . . 74.12 111.732 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.47 163.61 24.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.058 -0.519 . . . . 75.32 111.009 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 46' ' ' ARG . 9.1 ptp85 -47.74 -24.04 0.85 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.355 0.872 . . . . 62.42 113.355 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -119.92 7.11 10.88 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.482 0.549 . . . . 52.53 112.482 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -12.11 34.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.102 0.408 . . . . 75.42 112.102 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 62.7 m-85 -62.17 -38.84 90.57 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.065 0.395 . . . . 73.15 112.065 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' HD22 ' A' ' 19' ' ' ASN . 26.1 m-20 -72.77 -56.2 5.6 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.422 0.527 . . . . 71.32 112.422 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.69 88.21 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.886 0.698 . . . . 61.52 112.886 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.458 HG21 HD21 ' A' ' 39' ' ' LEU . 99.7 m -74.32 98.15 3.17 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.236 0.541 . . . . 75.12 112.04 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 62.6 p -84.81 127.72 34.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.926 -0.579 . . . . 71.44 111.341 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.02 151.67 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.103 0.478 . . . . 64.32 110.881 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.08 -170.02 2.78 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.979 0.418 . . . . 73.04 111.916 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 136.68 56.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.437 -0.347 . . . . 75.41 111.487 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 50.43 5.25 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.168 -0.539 . . . . 53.14 113.366 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.57 -178.78 5.67 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.629 -0.336 . . . . 65.45 110.523 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.64 107.74 6.75 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.29 0.478 . . . . 73.04 112.29 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.6 p -103.11 116.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.441 0.638 . . . . 72.04 111.129 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 46.9 mt-10 -96.45 110.47 22.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.209 0.528 . . . . 71.33 111.08 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' VAL . 56.5 t80 -100.57 114.7 28.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.863 -0.608 . . . . 74.3 111.032 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.6 mt . . . . . 0 CA--C 1.542 0.661 0 CA-C-O 120.951 0.405 . . . . 74.15 111.687 -178.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.256 0.551 . . . . 73.32 111.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.5 121.06 29.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.381 -0.372 . . . . 62.21 111.625 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.22 114.03 18.44 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.809 0.338 . . . . 75.04 111.25 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 28.5 m -76.05 77.5 2.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.558 0.694 . . . . 75.41 110.917 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.7 t -74.22 114.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.018 -0.537 . . . . 53.01 111.886 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.566 HD22 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.09 19.83 11.16 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.411 -0.359 . . . . 43.22 111.771 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.67 55.71 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.923 -0.656 . . . . 63.32 113.52 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.98 115.65 65.67 Favored Pre-proline 0 N--CA 1.471 0.596 0 O-C-N 122.3 -0.529 . . . . 75.44 111.236 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.85 96.15 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.868 2.379 . . . . 73.05 112.303 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 m -97.47 100.86 12.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.141 0.496 . . . . 72.34 111.243 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.6 m -73.96 84.09 1.74 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.346 -0.388 . . . . 53.04 111.083 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -97.33 113.43 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 73.45 111.057 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.87 -179.82 3.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.94 -0.475 . . . . 72.42 111.151 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.4 84.77 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.058 -0.592 . . . . 73.34 112.318 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.36 98.01 2.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.043 0.449 . . . . 74.15 110.225 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.38 82.17 2.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.306 -0.407 . . . . 74.24 112.025 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p 64.51 143.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 74.52 113.545 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.6 pp -156.34 175.43 14.02 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.807 -0.633 . . . . 74.14 111.268 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -97.85 172.24 7.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.739 0.304 . . . . 64.23 110.972 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.02 -36.58 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.882 0.372 . . . . 71.14 111.757 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -56.3 -45.78 80.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.189 0.518 . . . . 34.44 111.264 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 12.0 mm-40 -64.13 -41.36 97.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.978 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.77 -51.39 56.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.204 -0.453 . . . . 75.01 111.319 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.481 HD11 HG21 ' A' ' 35' ' ' VAL . 4.5 mm? -55.33 -44.72 76.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.901 0.382 . . . . 42.43 111.481 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 t -67.58 -27.96 67.37 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.791 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.71 -41.71 44.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.968 0.414 . . . . 75.3 111.578 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.55 -6.99 59.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.045 0.387 . . . . 71.55 112.045 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.788 0.435 . . . . 52.15 111.78 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.69 120.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.057 0.456 . . . . 71.01 111.737 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.03 36.38 0.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.955 0.502 . . . . 75.32 112.204 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.95 35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.216 0.451 . . . . 72.25 112.216 -174.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.64 50.29 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.132 0.419 . . . . 64.15 112.132 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.08 -24.54 28.04 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.117 0.484 . . . . 74.12 111.928 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -107.56 -4.45 18.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.739 0.304 . . . . 64.12 111.76 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 37' ' ' VAL . 7.4 p -68.27 89.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.868 0.842 . . . . 72.41 113.058 -172.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -82.18 93.42 7.06 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.907 -0.588 . . . . 71.04 110.941 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 62' ' ' PHE . 17.2 m -110.8 141.14 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.099 0.476 . . . . 64.14 111.63 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.77 119.85 27.9 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.573 0.702 . . . . 71.25 111.751 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -82.11 115.76 21.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.704 -0.68 . . . . 71.03 110.849 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 27.51 17.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.802 0.334 . . . . 75.12 111.697 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.61 5.26 66.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.343 -0.455 . . . . 72.43 113.633 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -114.54 117.85 32.07 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.529 -0.395 . . . . 73.4 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -74.27 139.72 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.956 0.408 . . . . 62.32 111.74 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 39' ' ' LEU . 3.3 mm? -101.35 153.69 19.44 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.264 0.554 . . . . 63.25 112.261 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 157.25 30.13 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.571 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -60.18 -33.01 71.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.961 0.41 . . . . 73.44 111.567 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -70.92 -32.65 69.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.393 0.616 . . . . 74.23 110.528 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HA ' ' HB3' ' A' ' 51' ' ' ALA . . . -71.99 -13.75 61.7 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.093 -0.503 . . . . 63.41 112.191 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -56.71 -45.6 81.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.021 0.439 . . . . 71.0 111.034 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.5 -21.31 35.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.113 -0.494 . . . . 64.21 111.281 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . . . -97.76 21.82 9.96 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.389 0.514 . . . . 61.22 112.389 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.8 m -133.82 113.69 12.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.81 0.338 . . . . 75.33 111.169 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.3 p -81.66 126.83 32.25 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.11 0.481 . . . . 63.53 111.837 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.52 113.65 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.622 -0.717 . . . . 75.02 109.538 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -144.74 -161.46 1.3 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.934 0.397 . . . . 74.21 111.597 -170.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.11 93.35 0.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.937 -0.477 . . . . 75.14 112.119 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.0 10.88 1.69 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.114 -0.565 . . . . 41.5 114.488 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.06 130.19 40.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.154 0.977 . . . . 41.12 112.108 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -85.93 66.14 9.46 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.399 0.619 . . . . 64.33 110.428 175.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.1 p -73.69 99.71 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.718 0.771 . . . . 42.12 112.009 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.49 78.57 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.304 0.573 . . . . 60.54 110.954 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' VAL . 36.0 t80 -73.77 96.37 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.102 -0.703 . . . . 75.5 109.102 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 113.037 0.755 . . . . 72.3 113.037 -170.684 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 111.659 0.244 . . . . 74.44 111.659 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.64 127.81 45.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.824 0.345 . . . . 75.41 111.246 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.55 140.85 49.86 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.975 0.417 . . . . 73.25 111.519 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -91.2 76.7 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.437 0.637 . . . . 61.2 110.133 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.625 HG12 HD22 ' A' ' 6' ' ' ASN . 39.5 t -74.0 110.01 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.892 -0.595 . . . . 74.12 111.827 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.625 HD22 HG12 ' A' ' 5' ' ' VAL . 47.6 m-80 58.95 26.02 14.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.824 0.45 . . . . 72.4 111.559 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.28 -4.77 74.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.94 -0.647 . . . . 42.5 113.243 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.6 mptt -101.28 139.16 20.22 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.366 -0.49 . . . . 65.51 110.894 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.66 121.97 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.509 2.139 . . . . 74.11 113.0 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.2 t -133.65 156.54 47.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.008 -0.542 . . . . 73.3 110.539 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -135.85 113.91 11.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.204 -0.31 . . . . 75.12 111.524 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.3 m -91.57 108.55 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.334 0.588 . . . . 55.1 110.919 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.92 143.22 30.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.943 -0.571 . . . . 51.34 111.113 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.96 21.96 31.8 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.406 -0.426 . . . . 55.33 112.836 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.03 136.42 4.12 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.197 0.443 . . . . 72.21 112.197 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.06 -40.94 7.37 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.19 -0.459 . . . . 65.3 110.766 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.0 p -164.32 112.38 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 75.22 111.267 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.76 160.31 32.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.218 -0.446 . . . . 61.43 110.536 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -72.86 162.54 29.36 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.654 0.264 . . . . 71.01 110.319 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.4 t -59.33 -34.83 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 122.152 -0.343 . . . . 45.54 111.433 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -60.29 -53.72 54.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.76 0.314 . . . . 75.11 111.819 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.81 0.338 . . . . 72.24 111.192 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.5 -45.95 91.91 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.804 -0.443 . . . . 51.31 109.804 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 95.0 mt -59.3 -39.73 83.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.947 0.403 . . . . 72.44 111.136 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -69.97 -32.18 70.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.084 0.469 . . . . 75.21 111.441 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.05 -47.35 58.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.909 0.385 . . . . 51.32 111.477 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.59 -20.43 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.276 -0.42 . . . . 73.22 111.331 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 65.78 76.49 0.32 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.697 0.761 . . . . 65.43 111.541 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.67 146.2 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.581 -0.736 . . . . 73.4 110.915 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.18 3.18 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.174 0.435 . . . . 72.42 112.174 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.38 98.98 10.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.939 0.399 . . . . 74.11 111.8 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -86.52 -29.51 22.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.166 0.507 . . . . 52.24 111.311 177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -79.41 -23.54 43.15 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.013 -0.54 . . . . 74.41 111.536 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -112.43 11.57 19.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 72.44 112.116 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 37' ' ' VAL . 7.3 p -75.73 88.91 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.838 0.828 . . . . 50.04 112.147 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -76.54 95.94 4.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.812 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 35' ' ' VAL . 35.4 m -120.3 158.42 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.428 -0.351 . . . . 60.34 110.975 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.6 134.45 43.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.78 0.8 . . . . 74.14 112.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.554 HD13 ' ND2' ' A' ' 40' ' ' ASN . 1.0 OUTLIER -78.24 103.23 8.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.968 -1.015 . . . . 73.22 110.757 -176.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.611 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.7 OUTLIER 58.14 24.41 11.27 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.875 0.369 . . . . 74.31 111.728 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.82 40.63 4.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.941 -0.647 . . . . 63.54 112.608 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.32 105.66 3.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.788 0.435 . . . . 75.11 110.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.66 138.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.641 0.608 . . . . 75.11 112.641 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -89.86 153.77 20.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.357 0.599 . . . . 73.51 111.72 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.19 160.5 26.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.399 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 38.0 ptt180 -37.07 -48.04 0.77 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.013 1.116 . . . . 74.44 114.013 -176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 13.8 pt-20 -107.41 0.52 22.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.278 0.473 . . . . 74.41 112.278 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.71 65.28 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.945 0.402 . . . . 74.04 111.279 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -58.83 -41.24 86.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.133 -0.485 . . . . 62.22 111.44 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -82.02 -32.17 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.134 -0.484 . . . . 74.11 110.963 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.81 46.08 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.821 0.674 . . . . 74.31 112.821 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.3 m -96.47 122.2 39.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.871 0.367 . . . . 74.14 111.606 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 m -91.64 106.94 18.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.418 -0.355 . . . . 74.25 111.226 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.42 115.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.953 0.406 . . . . 64.1 110.997 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -112.0 -167.43 1.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.854 0.359 . . . . 75.22 111.648 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.39 133.83 37.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.872 0.368 . . . . 74.11 111.887 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.99 43.62 8.1 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.353 -0.451 . . . . 43.42 113.669 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -116.08 140.72 49.0 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.556 -0.379 . . . . 74.05 110.808 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.86 74.12 2.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.234 0.54 . . . . 61.11 111.643 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 34.6 m -82.4 125.39 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.407 0.622 . . . . 73.32 111.365 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -92.04 101.42 13.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.384 0.612 . . . . 70.55 111.157 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 37' ' ' VAL . 5.2 t80 -103.92 99.9 9.67 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.471 -0.786 . . . . 71.12 109.553 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.6 pt? . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.819 0.343 . . . . 62.31 111.584 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.35 127.2 34.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.407 -0.36 . . . . 72.2 110.88 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -133.33 176.01 8.9 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.117 0.484 . . . . 75.43 111.109 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 m -141.04 132.23 26.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.374 -0.375 . . . . 73.33 111.185 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.53 121.12 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.74 0.305 . . . . 54.31 111.376 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 61' ' ' GLU . 15.9 m120 65.72 14.36 9.49 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.01 0.374 . . . . 73.2 112.01 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.73 -2.41 72.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.238 -0.506 . . . . 44.11 112.087 -172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -97.7 110.78 56.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.379 0.671 . . . . 70.22 110.655 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.8 123.54 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.189 2.593 . . . . 74.24 113.724 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -136.51 100.86 4.47 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.216 0.531 . . . . 75.31 111.314 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.8 m -80.65 95.57 6.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.036 0.446 . . . . 75.42 111.66 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 12' ' ' VAL . 16.9 m -81.96 79.6 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.967 0.889 . . . . 65.51 110.463 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.54 170.69 14.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.945 -0.571 . . . . 73.11 111.168 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 25.3 68.31 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.581 -0.819 . . . . 75.41 111.533 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.29 123.2 10.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.728 0.411 . . . . 63.34 110.698 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -74.54 -68.73 0.51 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.205 0.526 . . . . 72.33 111.785 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -167.26 132.96 2.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.393 -0.821 . . . . 71.41 109.274 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 1.2 pp -149.99 163.07 39.09 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.039 0.755 . . . . 73.4 113.039 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.05 159.16 20.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.047 -0.524 . . . . 43.33 111.102 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 50.6 t -57.33 -43.74 82.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.015 0.435 . . . . 72.53 110.485 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.1 m -60.34 -45.65 92.68 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.42 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -59.72 -36.99 77.69 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.035 0.445 . . . . 54.44 110.632 176.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.94 -44.18 97.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.191 0.52 . . . . 73.32 110.385 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 89.1 mt -58.64 -34.72 71.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.01 -0.541 . . . . 65.11 110.759 174.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.9 t -68.19 -43.02 79.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.58 . . . . 54.22 111.406 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -46.29 76.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.261 0.467 . . . . 64.41 112.261 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 mm? -94.11 -6.89 43.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.662 -0.244 . . . . 61.32 111.626 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? 57.49 89.02 0.05 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.395 0.617 . . . . 65.11 111.649 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.826 -0.624 . . . . 64.32 111.686 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.85 -49.13 18.86 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.041 0.448 . . . . 63.41 111.517 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -123.15 142.38 50.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.964 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -110.71 -40.2 4.64 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.294 0.568 . . . . 54.31 111.974 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -80.63 -30.4 36.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 70.33 111.118 175.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -91.23 -7.15 52.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.403 0.52 . . . . 73.14 112.403 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 32' ' ' ALA . 9.7 p -58.7 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 122.007 0.908 . . . . 52.41 112.211 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -84.52 92.21 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.758 -0.655 . . . . 74.33 110.949 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 35' ' ' VAL . 28.7 m -125.0 141.95 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.953 -0.567 . . . . 74.31 110.999 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.8 pt-20 -118.26 122.16 42.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.686 0.755 . . . . 74.52 111.818 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.467 HD13 ' ND2' ' A' ' 40' ' ' ASN . 1.6 tm? -81.22 107.22 13.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.585 -0.734 . . . . 73.31 109.89 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.9 OUTLIER 64.24 38.46 8.04 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.0 0.428 . . . . 64.52 111.282 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.85 29.67 58.85 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.206 -0.521 . . . . 62.45 113.665 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 38' ' ' GLU . 41.4 tt0 -148.91 115.75 5.99 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.466 -0.432 . . . . 64.51 110.798 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 14.7 p -77.37 147.44 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 113.069 0.766 . . . . 73.12 113.069 -173.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -106.37 157.79 17.36 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.059 -0.519 . . . . 74.25 111.008 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.571 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 tt0 -76.4 159.59 30.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.858 0.361 . . . . 74.31 111.437 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -49.65 -49.24 48.01 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 73.41 113.936 -169.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -80.78 -23.14 39.52 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.564 -0.71 . . . . 75.04 111.689 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.13 49.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.285 0.476 . . . . 70.12 112.285 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.99 -30.53 70.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.778 0.323 . . . . 73.42 111.719 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.96 -21.48 27.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.795 0.331 . . . . 73.53 111.479 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.02 1.96 56.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.095 0.406 . . . . 75.23 112.095 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -116.1 116.45 27.89 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.582 0.229 . . . . 54.43 111.471 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -89.4 109.83 20.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.116 0.484 . . . . 71.35 111.65 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.35 137.32 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 74.2 110.521 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -135.67 176.08 9.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.232 0.539 . . . . 71.14 111.771 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.65 105.61 0.32 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.023 -0.535 . . . . 73.13 112.095 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.81 7.89 12.67 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.483 -0.389 . . . . 65.13 113.343 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.94 153.47 21.56 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.52 . . . . 65.24 111.764 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.85 107.65 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 75.42 111.631 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.27 110.85 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.792 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 6' ' ' ASN . 39.0 mt-10 -98.89 111.65 23.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.387 0.613 . . . . 63.42 112.339 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -80.77 130.92 35.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.383 -0.826 . . . . 74.51 111.468 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.47 0.561 0 O-C-N 122.083 -0.386 . . . . 64.4 112.011 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HD21 ' A' ' 3' ' ' LEU . 23.1 ptp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.679 0.276 . . . . 75.11 111.641 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -99.29 124.39 44.34 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.407 -0.36 . . . . 71.12 111.001 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.7 mm? -119.5 129.06 54.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.734 0.302 . . . . 75.51 111.155 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -78.69 73.02 5.25 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.414 0.626 . . . . 75.34 110.185 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.644 HG22 HD22 ' A' ' 6' ' ' ASN . 7.1 p -70.81 110.4 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.332 0.586 . . . . 75.42 112.099 -173.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.644 HD22 HG22 ' A' ' 5' ' ' VAL . 48.7 m-80 59.71 21.48 10.23 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.134 -0.485 . . . . 54.25 111.879 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.1 -4.29 62.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.869 -0.681 . . . . 75.41 113.035 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 mptp? -102.53 136.51 19.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.377 0.271 . . . . 71.44 110.685 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.37 104.55 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.264 1.976 . . . . 72.52 113.178 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 t -114.0 153.53 29.19 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.148 -0.345 . . . . 71.54 110.655 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -135.51 114.34 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.096 0.406 . . . . 62.1 112.096 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.69 112.08 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.508 0.67 . . . . 71.25 110.104 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.72 148.55 50.22 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.633 -0.712 . . . . 71.43 112.367 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.77 -58.35 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.498 -0.382 . . . . 63.53 113.44 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.38 110.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.175 0.435 . . . . 72.33 112.175 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' HE2' ' A' ' 1' ' ' MET . 42.8 mt-10 -94.18 -55.46 3.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 74.54 111.494 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 p -143.4 115.86 8.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.391 -0.368 . . . . 61.44 111.44 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -157.63 165.35 35.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.371 -0.377 . . . . 74.33 111.855 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 40.3 m-20 -66.37 160.95 23.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.605 0.241 . . . . 61.34 111.27 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 56.3 t -56.17 -41.9 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.014 0.435 . . . . 71.24 110.6 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 m -59.03 -47.21 86.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.083 0.468 . . . . 74.04 111.346 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 51.7 mt-10 -65.73 -31.6 72.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.955 0.407 . . . . 74.41 111.102 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.5 -46.74 78.5 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.856 -0.424 . . . . 72.21 109.856 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 90.6 mt -56.8 -36.21 69.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.161 -0.472 . . . . 63.34 111.047 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.6 t -64.52 -55.81 18.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 71.14 111.328 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.89 78.47 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 64.24 112.378 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 tp -79.6 -22.85 43.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.843 0.354 . . . . 60.24 111.42 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? 63.1 81.65 0.2 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.321 0.581 . . . . 73.42 109.731 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 31' ' ' GLN . 12.5 p -93.62 151.42 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.977 -0.556 . . . . 33.51 111.737 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.41 70.27 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.005 0.372 . . . . 52.13 112.005 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.542 ' H ' HG22 ' A' ' 29' ' ' VAL . 61.8 mm-40 -127.03 134.85 50.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.612 -0.267 . . . . 52.21 110.683 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.83 9.3 8.82 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.397 0.618 . . . . 63.12 111.48 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -32.45 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.524 -0.762 . . . . 74.32 111.305 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.48 -19.74 29.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.787 0.327 . . . . 72.03 111.54 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 37' ' ' VAL . 7.1 p -68.56 126.15 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.789 0.663 . . . . 72.03 112.789 -173.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -102.52 98.84 8.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.713 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 HG22 ' A' ' 35' ' ' VAL . 14.6 m -103.57 95.87 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.463 0.649 . . . . 72.32 111.283 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 10.1 pt-20 -95.48 94.35 7.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.482 0.658 . . . . 73.44 111.314 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -68.41 114.95 7.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.359 0.599 . . . . 64.14 112.025 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 59.09 39.49 23.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.901 -0.59 . . . . 50.51 111.748 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.82 48.66 40.31 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.032 -0.604 . . . . 75.02 113.194 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.06 108.58 3.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.957 0.408 . . . . 62.42 110.657 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.84 136.4 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.579 0.585 . . . . 54.25 112.579 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.7 mm? -101.74 152.35 20.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.033 -0.531 . . . . 74.13 110.824 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.458 ' N ' ' HB3' ' A' ' 48' ' ' ALA . 45.4 mt-10 -68.56 169.35 11.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.282 0.563 . . . . 74.54 111.969 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -58.85 -35.68 73.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.867 -0.606 . . . . 72.15 110.451 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.54 -42.12 22.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.43 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' A' ' 45' ' ' GLU . . . -56.66 -20.85 23.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.09 0.774 . . . . 63.32 113.09 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -56.03 -34.25 65.69 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.042 0.449 . . . . 63.21 111.136 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -81.62 -32.6 31.91 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.364 -0.38 . . . . 73.03 111.17 175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.39 59.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.629 0.603 . . . . 75.41 112.629 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -113.11 119.24 37.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.756 0.313 . . . . 75.21 111.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 83.4 m -96.16 124.69 40.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.335 0.588 . . . . 71.34 112.328 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.64 151.77 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.889 -0.596 . . . . 74.43 110.897 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -147.76 -178.19 6.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.875 0.369 . . . . 74.35 111.624 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 26.2 t70 -58.46 119.01 6.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.163 0.506 . . . . 73.3 112.359 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.38 54.22 1.1 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.188 -0.46 . . . . 62.24 113.662 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.04 154.71 48.25 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.884 0.342 . . . . 64.34 111.035 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.82 1.83 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 39' ' ' LEU . 30.2 m -82.18 107.87 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.41 111.182 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 44.1 mt-10 -77.46 93.33 4.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.519 0.675 . . . . 73.13 110.804 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -80.08 92.11 5.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.365 -0.834 . . . . 73.5 110.431 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 CA--C 1.542 0.653 0 CA-C-O 121.172 0.511 . . . . 71.33 112.225 -176.236 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 20.4 ptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.91 0.386 . . . . 71.11 111.847 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -75.89 129.91 37.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.087 -0.506 . . . . 64.21 111.788 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.8 mt -139.12 153.07 47.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.947 0.404 . . . . 70.34 111.661 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.5 m -109.18 126.47 53.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.934 0.397 . . . . 74.33 111.34 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 62' ' ' PHE . 4.7 p -133.83 124.08 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.5 -0.318 . . . . 32.42 110.95 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.547 HD22 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.53 26.39 15.68 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.143 0.497 . . . . 74.14 111.163 -179.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.28 16.8 80.41 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.24 -0.505 . . . . 72.02 112.74 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -103.35 117.98 58.87 Favored Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 122.761 -0.258 . . . . 64.13 110.793 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.21 116.44 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.447 2.098 . . . . 73.1 111.528 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 t -141.77 -173.95 3.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.933 0.397 . . . . 75.13 111.448 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -159.55 126.68 4.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 72.24 111.734 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 12' ' ' VAL . 18.9 m -96.05 99.09 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.595 0.712 . . . . 54.24 110.437 175.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.45 137.71 33.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.993 -0.549 . . . . 74.12 110.875 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.5 56.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.28 -0.486 . . . . 41.13 113.207 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.01 97.57 8.41 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.412 -0.464 . . . . 75.4 111.517 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -77.45 76.73 3.99 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.317 0.579 . . . . 70.45 111.669 -177.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.2 m 53.48 71.19 0.52 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.952 -0.567 . . . . 73.35 111.463 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 80.5 mt -93.3 145.75 24.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.272 0.558 . . . . 62.11 112.106 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 18.2 m-20 -70.51 163.98 25.71 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.857 -0.611 . . . . 75.14 110.037 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.5 -41.53 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.818 0.342 . . . . 71.33 110.608 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -61.69 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.926 0.393 . . . . 75.52 111.842 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 43.0 mt-10 -68.4 -43.75 76.56 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.11 0.481 . . . . 71.34 111.131 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.28 -37.66 86.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.311 0.577 . . . . 75.32 109.968 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.13 -34.95 70.79 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.699 -0.682 . . . . 64.34 110.833 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -74.66 -33.59 62.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.369 -0.378 . . . . 72.31 111.327 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.77 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.157 0.504 . . . . 61.31 111.6 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.0 mt -90.44 -29.77 17.77 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.286 0.565 . . . . 72.54 110.216 171.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 57.51 86.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.057 -0.974 . . . . 74.12 112.565 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.2 159.42 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.558 -0.746 . . . . 53.12 110.538 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.73 -63.77 1.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.054 0.454 . . . . 65.1 111.773 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -102.3 136.96 41.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.551 -0.295 . . . . 75.34 110.676 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.26 -55.52 2.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 75.41 111.545 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -63.02 -11.72 21.08 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.826 -0.625 . . . . 62.1 112.301 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.81 3.02 36.26 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.322 0.49 . . . . 75.14 112.322 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.423 HG12 HG13 ' A' ' 37' ' ' VAL . 81.3 t -74.39 138.19 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.321 0.581 . . . . 71.02 112.341 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.4 m -115.83 108.54 16.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.128 -0.487 . . . . 72.35 110.575 174.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.0 m -134.04 162.23 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.19 0.519 . . . . 71.14 111.891 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.09 169.61 17.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.577 -0.738 . . . . 74.15 110.563 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 39' ' ' LEU . 2.0 pt? -143.92 129.09 18.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 72.03 111.078 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.75 21.08 11.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.173 0.511 . . . . 55.21 111.005 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 55.78 2.98 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.04 -0.527 . . . . 74.4 113.374 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 126.15 2.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.914 0.357 . . . . 73.41 110.651 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.76 136.04 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.21 0.528 . . . . 74.31 112.352 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.58 166.78 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.667 0.746 . . . . 73.03 112.547 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.06 149.46 33.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.5 -0.773 . . . . 65.21 110.964 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 9.1 mpt_? -64.34 -41.31 96.84 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.185 -0.322 . . . . 72.43 111.864 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.25 -29.76 69.48 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.19 0.519 . . . . 74.3 111.058 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.28 65.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.279 -0.419 . . . . 73.44 111.585 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -62.13 -30.63 71.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.697 0.284 . . . . 74.3 111.508 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.7 -35.82 72.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.873 0.368 . . . . 70.43 111.54 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.87 -29.81 24.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.203 0.446 . . . . 73.31 112.203 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 m -82.03 113.69 20.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.758 0.314 . . . . 63.45 111.832 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.0 m -96.87 140.61 31.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.229 0.538 . . . . 73.04 111.881 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 55' ' ' LYS . 17.4 t -90.44 160.64 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.116 -0.493 . . . . 62.51 111.112 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.9 pttm -141.38 169.94 16.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.979 0.418 . . . . 72.13 111.805 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 27.8 t70 -70.88 111.45 6.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.133 0.492 . . . . 63.34 110.97 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.71 39.77 3.79 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.175 -0.466 . . . . 52.21 112.096 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -122.82 175.32 6.61 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 110.006 -0.368 . . . . 71.32 110.006 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.67 143.77 43.3 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.245 0.545 . . . . 53.24 112.459 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 5' ' ' VAL . 24.0 m -130.5 71.06 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.805 0.812 . . . . 75.24 109.677 172.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.21 83.11 0.73 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.763 0.792 . . . . 62.22 111.568 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.513 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.6 m-85 -77.4 92.26 3.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.09 -0.959 . . . . 73.45 111.767 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.534 0 CA-C-O 121.346 0.593 . . . . 73.24 112.027 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.558 ' HG3' HD21 ' A' ' 3' ' ' LEU . 21.1 ptp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.693 0.282 . . . . 63.32 111.272 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.6 m-20 -95.46 119.98 34.92 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.803 0.335 . . . . 74.25 111.166 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.558 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.3 mm? -114.2 124.06 51.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.688 0.28 . . . . 75.31 111.201 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.4 m -78.06 79.46 4.52 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 74.24 110.343 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.28 122.09 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.085 -0.507 . . . . 63.45 112.334 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 17.9 m120 56.93 23.02 7.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.099 -0.5 . . . . 72.52 112.081 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.4 64.63 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.329 -0.462 . . . . 52.33 113.474 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.2 mptp? -116.72 122.02 32.17 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 122.235 -0.567 . . . . 74.23 110.859 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.49 125.65 19.21 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.931 2.421 . . . . 75.12 113.816 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 40.7 t -135.23 173.32 11.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.958 -0.565 . . . . 75.24 109.946 174.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 4.6 t -157.28 129.47 7.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.22 108.22 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.537 0.684 . . . . 64.21 110.465 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.56 123.35 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.857 -0.61 . . . . 74.14 111.673 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.82 -33.48 4.75 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.24 -0.505 . . . . 73.5 113.161 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -74.48 127.64 33.56 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.726 0.298 . . . . 71.51 111.671 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -137.79 108.71 6.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.201 0.524 . . . . 65.54 111.647 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 m 62.66 25.07 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.268 0.84 . . . . 64.53 113.268 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.7 159.49 27.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.193 0.521 . . . . 75.23 111.853 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.5 p-10 -84.06 156.43 22.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.389 -0.369 . . . . 70.44 111.6 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.8 -36.94 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.683 0.623 . . . . 73.42 112.683 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -52.92 -43.7 66.45 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.035 0.445 . . . . 52.35 111.568 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.42 -32.03 29.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.474 -0.33 . . . . 63.21 111.826 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.79 -44.83 82.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.361 -0.607 . . . . 72.15 109.361 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 32' ' ' ALA . 26.7 tp -60.94 -44.49 97.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.635 -0.711 . . . . 61.15 110.661 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -63.79 -27.92 69.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.807 -0.633 . . . . 64.03 111.905 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.74 84.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.956 0.407 . . . . 73.31 111.585 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.12 -2.53 48.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.301 -0.409 . . . . 62.51 110.931 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.6 tttt 64.0 25.72 13.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.996 -0.547 . . . . 73.03 111.51 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.52 130.61 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.357 -0.383 . . . . 75.31 111.537 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.57 80.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.368 0.507 . . . . 73.55 112.368 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -96.04 167.65 11.1 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.116 0.484 . . . . 73.41 111.557 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -146.05 -62.16 0.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.214 0.53 . . . . 33.43 110.803 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -55.53 -31.74 62.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.592 -0.731 . . . . 75.41 112.049 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -83.34 -16.49 45.89 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.67 0.618 . . . . 64.43 112.67 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 37' ' ' VAL . 6.1 t -81.46 80.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.237 0.541 . . . . 52.41 111.621 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.6 m -70.87 84.14 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.083 -0.508 . . . . 75.45 111.442 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 35' ' ' VAL . 32.8 m -86.45 147.94 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.122 0.487 . . . . 64.33 111.464 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 13.2 pt-20 -136.44 127.14 27.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.25 0.547 . . . . 73.4 110.981 174.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -99.47 134.95 41.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 71.34 111.169 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.685 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.5 OUTLIER 60.66 18.92 8.93 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.067 0.461 . . . . 75.03 111.403 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.2 20.28 57.5 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.311 -0.471 . . . . 64.31 113.616 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -124.77 112.47 16.75 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.122 0.486 . . . . 74.14 111.105 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 8.9 p -70.6 144.41 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.371 0.878 . . . . 62.43 113.371 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.569 HD21 ' HG ' ' A' ' 39' ' ' LEU . 3.2 mm? -99.49 166.26 11.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.22 0.533 . . . . 74.02 111.667 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.38 155.18 20.7 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.049 -0.523 . . . . 73.51 110.743 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.51 -22.73 5.18 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.116 0.784 . . . . 63.13 113.116 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.86 26.84 5.51 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.115 0.483 . . . . 54.44 111.771 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.24 5.37 42.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.286 -0.415 . . . . 71.44 111.376 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.23 -27.77 59.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.809 0.338 . . . . 73.45 111.527 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.46 -38.79 65.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 75.33 111.065 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.17 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.168 -0.469 . . . . 60.51 112.055 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.0 m -75.32 107.55 7.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.999 0.428 . . . . 35.24 111.986 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 63.8 p -92.85 130.25 38.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.185 -0.461 . . . . 72.0 111.388 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.6 147.41 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.356 -0.383 . . . . 73.15 111.116 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.07 -174.75 3.52 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.241 0.543 . . . . 74.13 111.349 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.26 111.36 3.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.045 -0.525 . . . . 72.54 111.243 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.35 66.9 0.74 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.045 -0.597 . . . . 61.33 113.958 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -149.71 162.08 40.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 110.147 -0.316 . . . . 75.45 110.147 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.42 99.32 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.511 0.56 . . . . 53.2 112.511 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -95.96 131.25 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.002 0.43 . . . . 75.2 111.097 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 40.8 mt-10 -109.03 121.2 44.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.262 0.553 . . . . 72.31 112.282 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -99.66 132.14 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.78 -0.645 . . . . 74.33 111.522 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.542 0.667 0 CA-C-O 121.098 0.475 . . . . 73.42 112.092 178.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.487 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 23.0 ptp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.941 0.4 . . . . 71.1 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -101.6 106.24 17.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.978 0.418 . . . . 72.35 110.724 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 58' ' ' ASP . 82.4 mt -100.25 176.45 5.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 63.15 111.536 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.3 m -130.68 110.84 11.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.852 0.358 . . . . 54.03 110.979 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 29.8 m -105.11 118.39 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.956 0.407 . . . . 71.41 111.577 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 62.12 22.26 13.0 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.865 0.364 . . . . 74.25 111.943 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.11 -0.87 64.44 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.161 -0.543 . . . . 63.23 113.36 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.23 141.7 24.44 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 122.526 -0.396 . . . . 65.15 111.273 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 119.79 6.03 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.411 2.074 . . . . 60.53 112.978 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -120.4 113.24 20.05 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.983 0.42 . . . . 64.32 111.49 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.8 m -95.12 110.25 22.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.253 -0.431 . . . . 63.15 111.444 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.66 124.64 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.131 0.491 . . . . 72.4 110.968 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.78 144.6 41.31 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.089 -0.505 . . . . 62.24 111.921 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.69 -49.59 4.22 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.192 -0.458 . . . . 70.12 113.756 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 105.74 0.42 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.779 . . . . 45.45 113.102 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.1 -44.37 5.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.298 -0.41 . . . . 75.02 111.148 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.6 m -141.46 126.33 18.15 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.71 0.29 . . . . 73.23 110.86 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.96 169.63 16.2 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.728 0.299 . . . . 63.04 111.521 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -103.02 160.6 14.48 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.45 -0.204 . . . . 75.53 110.45 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 58.1 t -48.07 -40.82 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 112.917 0.71 . . . . 62.55 112.917 -172.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.6 m -48.0 -47.47 33.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.142 0.496 . . . . 65.3 111.581 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.44 -33.02 64.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.052 0.454 . . . . 74.03 111.203 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.05 -41.69 98.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.451 . . . . 73.53 110.239 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 91.8 mt -56.7 -28.66 61.32 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.132 -0.486 . . . . 74.12 111.507 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.7 t -80.17 -48.34 13.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.409 -0.36 . . . . 74.21 111.391 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.78 90.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.058 0.456 . . . . 74.21 111.864 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.14 -30.62 60.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.148 -0.478 . . . . 71.1 110.915 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 69.25 88.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.463 0.649 . . . . 63.14 111.332 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.472 HG11 HD22 ' A' ' 24' ' ' LEU . 8.0 p -102.15 149.52 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.773 -0.649 . . . . 74.33 111.91 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.58 126.9 35.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.72 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 58.88 67.57 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.234 0.54 . . . . 73.14 111.507 -174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -63.85 -30.69 71.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.217 -0.447 . . . . 60.43 112.015 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.939 0.399 . . . . 73.11 111.491 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -129.93 12.36 5.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.53 -0.304 . . . . 71.44 111.64 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 37' ' ' VAL . 7.6 p -68.0 118.71 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.452 0.644 . . . . 70.44 112.508 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.1 m -92.97 108.58 20.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.03 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.465 HG13 HG22 ' A' ' 35' ' ' VAL . 18.0 m -140.92 146.35 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.164 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.2 pm0 -123.54 132.48 53.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.899 0.381 . . . . 74.44 111.745 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 HD11 ' A' ' 44' ' ' LEU . 2.1 pt? -97.02 124.53 41.03 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.932 -0.395 . . . . 71.31 109.932 175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.18 22.62 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.98 0.419 . . . . 52.24 111.798 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -20.44 32.02 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.275 0.47 . . . . 74.55 114.275 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -95.45 122.47 38.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.677 0.739 . . . . 72.14 111.464 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.9 p -78.23 138.89 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 65.32 112.003 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -92.72 121.65 34.33 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.101 -0.5 . . . . 72.41 111.335 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.12 152.39 45.22 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.383 -0.371 . . . . 70.45 111.632 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 39.0 ptt180 -48.72 -36.81 17.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.635 0.605 . . . . 70.41 112.635 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -81.27 -24.62 37.16 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.214 0.53 . . . . 75.12 111.754 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.07 -16.65 57.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.054 0.761 . . . . 71.32 113.054 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 22.2 m-85 -53.06 -39.53 63.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.857 0.688 . . . . 72.51 112.857 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.81 -23.09 31.57 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.06 -0.4 . . . . 74.11 111.678 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.21 -2.21 52.86 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.621 0.6 . . . . 74.12 112.621 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.0 m -105.29 118.02 35.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.184 -0.323 . . . . 43.31 111.671 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.7 m -89.22 138.58 31.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.097 0.475 . . . . 74.15 112.017 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.49 147.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.942 0.497 . . . . 73.22 110.961 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.01 -168.47 2.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.123 0.487 . . . . 74.0 111.63 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 36.3 t70 -70.22 79.31 0.52 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.149 0.499 . . . . 62.13 111.5 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.84 65.31 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.154 -0.546 . . . . 75.11 113.52 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-20 -131.51 131.81 43.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.421 -0.458 . . . . 71.23 110.657 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -93.19 66.98 4.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.995 0.368 . . . . 74.12 111.995 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.2 p -82.83 114.77 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.285 0.564 . . . . 60.13 111.466 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -88.75 114.82 25.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.045 0.387 . . . . 75.24 112.045 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.462 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-85 -101.32 118.45 37.0 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 63.33 111.647 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.449 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.8 pt? . . . . . 0 CA--C 1.539 0.539 0 CA-C-N 116.402 -0.363 . . . . 71.21 111.521 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.607 ' HE3' HD11 ' A' ' 3' ' ' LEU . 25.4 ptt? . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.764 0.316 . . . . 63.41 111.505 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -80.49 118.88 22.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.937 0.398 . . . . 74.4 111.359 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.607 HD11 ' HE3' ' A' ' 1' ' ' MET . 68.0 mt -123.34 148.4 46.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.156 0.503 . . . . 74.15 112.079 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 16.7 m -85.0 82.67 8.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.122 0.487 . . . . 75.24 110.431 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.36 134.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.431 -0.349 . . . . 71.43 110.973 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.1 8.26 6.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.556 0.342 . . . . 73.02 111.298 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.67 68.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.98 -0.629 . . . . 52.43 111.868 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 5.6 mtpm? -124.15 154.4 68.42 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.311 0.644 . . . . 74.44 110.768 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.78 115.86 4.29 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.294 1.996 . . . . 63.1 113.212 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -142.17 -176.79 4.95 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.579 0.352 . . . . 52.43 110.708 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -162.85 137.99 6.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.39 0.515 . . . . 52.22 112.39 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.33 86.84 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.358 0.599 . . . . 75.1 111.095 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.2 t70 59.71 174.5 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.505 -0.77 . . . . 75.42 112.455 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.13 -4.83 69.25 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.292 -0.48 . . . . 63.52 113.144 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 126.42 8.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.826 0.451 . . . . 73.54 111.95 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.53 -66.04 0.6 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 62.42 112.521 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -133.05 124.17 27.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.643 0.259 . . . . 73.41 111.329 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 91.3 mt -132.38 142.6 49.37 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.741 0.305 . . . . 74.21 111.257 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.26 162.8 5.6 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.575 -0.284 . . . . 74.21 110.818 175.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 39.7 t -61.09 -40.15 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.981 -0.449 . . . . 64.53 110.298 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -59.78 -47.75 84.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.256 -0.429 . . . . 74.14 111.167 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 2.5 mm-40 -58.47 -38.03 76.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.0 0.428 . . . . 73.23 111.256 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.69 -45.44 92.09 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.049 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.489 HD13 ' HB1' ' A' ' 32' ' ' ALA . 72.4 mt -56.91 -39.34 74.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.181 0.515 . . . . 62.54 111.262 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -78.05 -29.19 49.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.161 -0.472 . . . . 55.15 112.121 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -47.21 20.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.164 0.507 . . . . 54.15 111.754 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 27' ' ' LEU . 7.2 tt -76.79 -16.43 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.615 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 66.77 74.04 0.34 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.352 0.596 . . . . 45.23 110.501 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 HD22 ' A' ' 27' ' ' LEU . 53.5 t -104.21 130.91 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.691 0.626 . . . . 72.25 112.691 -174.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.69 146.0 30.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.32 -0.4 . . . . 73.42 110.209 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 62.07 33.23 17.22 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.925 0.393 . . . . 54.22 110.79 -172.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' HD13 ' A' ' 24' ' ' LEU . . . -53.39 -51.9 61.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.281 0.474 . . . . 34.54 112.281 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.03 -12.45 61.61 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.191 0.519 . . . . 65.34 111.813 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.06 2.69 12.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.479 0.548 . . . . 74.25 112.479 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.8 p -73.09 146.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 65.21 111.875 -176.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.5 m -100.3 108.85 21.01 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.471 -0.331 . . . . 74.04 110.456 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 62' ' ' PHE . 26.8 m -133.17 134.0 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.217 0.532 . . . . 74.35 111.698 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.7 pm0 -104.88 125.3 50.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.308 0.575 . . . . 54.33 111.508 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.667 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.14 106.43 7.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.836 -0.62 . . . . 62.41 110.216 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 53.08 26.96 5.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.84 0.456 . . . . 64.24 112.05 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.13 4.38 41.39 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.304 -0.474 . . . . 72.01 113.947 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.88 108.07 13.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.278 0.539 . . . . 71.22 111.418 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 8.8 p -60.27 137.51 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.318 0.488 . . . . 64.43 112.318 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.1 mm? -94.2 151.81 19.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.145 0.497 . . . . 73.1 111.807 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -71.99 160.91 31.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.114 -0.494 . . . . 75.42 110.946 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -51.37 -46.73 62.85 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.321 0.489 . . . . 71.15 112.321 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.19 -6.48 55.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.417 0.525 . . . . 74.44 112.417 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.75 -27.49 66.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.769 0.319 . . . . 54.31 111.364 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -50.68 -38.03 44.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.198 -0.455 . . . . 71.23 111.544 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.54 -42.88 61.12 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.914 -0.584 . . . . 63.41 111.573 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.89 -4.78 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.084 0.772 . . . . 75.41 113.084 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -101.82 116.96 33.86 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.709 0.29 . . . . 72.21 111.561 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 65.2 p -100.5 116.96 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.16 0.43 . . . . 74.24 112.16 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.88 152.52 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.824 -0.625 . . . . 73.55 110.903 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -139.89 175.89 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.878 0.371 . . . . 74.05 111.42 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.14 137.63 58.29 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.117 0.484 . . . . 75.32 111.391 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.36 33.94 24.37 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.147 -0.479 . . . . 35.32 113.164 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' HD22 ' A' ' 3' ' ' LEU . 12.7 t70 -109.88 177.45 4.72 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 122.684 -0.303 . . . . 70.14 110.867 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -139.99 92.13 2.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.429 0.529 . . . . 52.21 112.429 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.1 p -98.17 115.76 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.344 0.592 . . . . 73.14 111.219 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 44.0 mt-10 -84.15 93.45 8.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.217 0.532 . . . . 72.23 112.414 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' VAL . 12.8 m-85 -78.9 120.27 23.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.941 -0.572 . . . . 75.13 110.875 169.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.3 mt . . . . . 0 N--CA 1.469 0.508 0 CA-C-O 120.633 0.254 . . . . 61.54 110.807 176.8 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.568 ' HB3' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.22 0.452 . . . . 75.33 112.22 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -94.89 124.15 38.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.157 -0.474 . . . . 50.15 111.505 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 1' ' ' MET . 2.9 mm? -120.99 174.42 6.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.068 0.461 . . . . 55.42 111.103 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 m -129.04 95.29 4.03 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.072 0.463 . . . . 71.14 110.692 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.647 HG12 HD22 ' A' ' 6' ' ' ASN . 61.8 t -88.13 113.97 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.436 -0.347 . . . . 73.12 111.774 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.647 HD22 HG12 ' A' ' 5' ' ' VAL . 53.8 m-80 57.91 29.68 17.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.005 0.522 . . . . 64.24 112.001 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.88 75.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.89 -0.671 . . . . 71.11 113.301 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -114.11 122.07 35.31 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.625 -0.338 . . . . 74.31 110.975 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.83 119.45 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.739 2.293 . . . . 74.31 112.997 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.8 p -130.08 127.74 40.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.155 0.502 . . . . 53.14 111.258 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.4 m -102.7 117.18 34.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.159 -0.338 . . . . 65.04 111.51 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' SD ' ' A' ' 1' ' ' MET . 19.6 m -89.56 131.8 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.892 0.377 . . . . 71.43 110.373 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.3 155.03 20.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.446 0.536 . . . . 71.33 112.446 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.49 -72.04 1.77 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.986 -0.552 . . . . 63.45 113.77 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.97 12.95 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.416 0.524 . . . . 72.13 112.416 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 10.0 pt-20 -129.06 -31.93 2.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 74.33 112.177 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -140.08 130.64 25.58 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.003 0.43 . . . . 73.14 112.122 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -170.72 165.45 8.09 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.967 -0.56 . . . . 72.45 111.5 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.754 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 48.7 m-20 -61.84 155.82 22.22 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.753 0.311 . . . . 73.53 111.376 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.88 -38.77 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.071 0.462 . . . . 74.33 110.56 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.4 m -59.33 -41.92 90.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.082 -0.508 . . . . 71.41 111.783 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 15.3 mm-40 -63.58 -48.57 76.86 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.069 0.461 . . . . 74.51 110.527 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.53 -46.3 84.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.136 -0.484 . . . . 75.03 111.068 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.03 -44.02 91.68 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.103 0.478 . . . . 72.42 111.043 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -66.76 -30.42 70.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.021 0.439 . . . . 74.41 111.161 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.93 77.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 73.42 111.013 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.14 -32.56 63.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.122 -0.49 . . . . 65.41 111.844 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 64.95 85.54 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.387 0.613 . . . . 75.44 110.881 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.6 149.7 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 75.25 112.106 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.88 121.84 20.65 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.451 -0.34 . . . . 70.44 110.98 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 21.6 mt-30 61.99 80.46 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.262 0.553 . . . . 64.43 110.759 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -55.31 -35.92 65.64 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.671 0.989 . . . . 55.15 113.671 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.45 -22.72 43.78 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.216 0.451 . . . . 61.22 112.216 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 31' ' ' GLN . 9.4 m-85 -86.98 -11.85 49.25 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.512 0.56 . . . . 72.14 112.512 -171.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 32' ' ' ALA . 7.9 p -79.42 131.7 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.235 0.54 . . . . 64.54 111.366 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -115.89 128.3 55.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.503 -0.317 . . . . 70.44 111.457 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 62' ' ' PHE . 34.9 m -137.67 140.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.106 0.479 . . . . 74.3 111.274 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -111.09 113.25 25.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.458 0.647 . . . . 74.31 110.088 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -75.23 104.96 6.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.009 -0.541 . . . . 74.35 112.195 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.62 28.35 17.76 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.861 -0.609 . . . . 71.25 111.789 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.47 -20.04 14.06 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.362 -0.447 . . . . 61.23 113.727 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.84 135.8 45.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.044 0.422 . . . . 74.33 111.376 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.23 134.82 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.934 0.397 . . . . 74.42 111.728 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.65 141.98 43.15 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.313 0.578 . . . . 71.4 111.832 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -79.84 167.67 20.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.021 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -57.15 -35.02 69.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.73 0.641 . . . . 73.0 112.73 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -96.55 -4.91 40.47 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.07 0.396 . . . . 71.32 112.07 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.53 56.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.254 0.464 . . . . 50.22 112.254 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.35 -24.74 63.62 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.056 0.455 . . . . 73.0 111.957 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.78 -29.11 44.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.32 -0.4 . . . . 64.14 111.847 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.54 12.36 7.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.155 0.798 . . . . 70.32 113.155 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.1 m -141.69 120.24 12.47 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.726 -0.609 . . . . 72.33 111.782 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.7 m -92.96 106.89 18.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.097 -0.501 . . . . 75.04 111.158 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.5 148.14 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.363 -0.38 . . . . 73.14 110.893 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 17.0 ptpt -144.11 -173.18 3.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.839 0.352 . . . . 65.34 111.665 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 10.2 t70 -66.94 112.74 4.49 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 55.51 111.463 -176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.66 63.42 0.66 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.105 -0.498 . . . . 75.23 113.042 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -154.2 172.58 17.37 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.895 -0.409 . . . . 75.35 109.895 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.23 94.56 4.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.811 0.671 . . . . 62.11 112.811 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG13 HG22 ' A' ' 5' ' ' VAL . 4.8 p -88.94 95.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.491 0.662 . . . . 63.23 110.809 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -79.88 103.16 9.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.376 0.608 . . . . 73.15 111.42 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 37' ' ' VAL . 45.0 t80 -91.69 109.49 20.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.809 -0.632 . . . . 74.3 110.911 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 121.066 0.46 . . . . 73.14 112.202 -177.046 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 3' ' ' LEU . 24.9 ptp . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.742 0.306 . . . . 73.2 111.072 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -98.04 114.44 26.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.464 -0.334 . . . . 65.44 110.86 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 1' ' ' MET . 91.3 mt -121.94 131.16 53.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.938 0.399 . . . . 74.11 111.715 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 39.6 m -85.78 85.45 7.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.04 0.448 . . . . 72.31 111.001 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.3 p -82.44 117.03 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.024 0.44 . . . . 71.53 111.615 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 59.29 15.04 4.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.615 0.598 . . . . 72.13 112.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.22 -4.43 33.46 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.319 -0.467 . . . . 74.54 113.218 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.62 106.57 58.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 122.584 -0.362 . . . . 73.44 111.545 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 20.4 Cg_exo -65.82 99.5 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.798 2.332 . . . . 72.31 112.877 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 t -112.79 139.14 48.67 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 63.42 111.556 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.0 m -89.3 99.97 12.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.38 . . . . 74.33 111.355 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.89 111.04 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.22 0.533 . . . . 71.53 110.198 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.55 161.09 18.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.233 0.539 . . . . 74.42 112.211 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.75 84.51 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.971 -0.559 . . . . 71.23 112.869 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.91 102.72 4.48 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.641 -0.329 . . . . 71.53 111.474 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.79 -29.94 13.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.732 0.301 . . . . 75.11 111.731 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -160.62 106.4 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.564 -0.289 . . . . 71.04 111.156 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.5 pp -143.79 156.53 44.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.163 0.506 . . . . 73.53 111.649 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 49' ' ' PHE . 4.6 p-10 -83.09 164.27 20.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.359 -0.382 . . . . 73.3 110.973 177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.408 HG21 ' CD2' ' A' ' 44' ' ' LEU . 46.1 t -53.84 -33.93 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.749 0.648 . . . . 71.02 112.749 -172.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 m -52.03 -54.67 27.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.274 0.559 . . . . 71.01 111.403 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.56 -33.0 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.985 -0.552 . . . . 53.12 111.592 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.92 -44.68 78.51 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.035 0.445 . . . . 64.54 110.333 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.15 -32.62 72.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.929 0.395 . . . . 60.12 111.252 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.6 t -66.34 -35.46 80.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.291 -0.413 . . . . 65.11 111.29 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.95 92.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.112 0.482 . . . . 52.22 111.639 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 27' ' ' LEU . 6.5 mp -82.48 -24.48 34.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.174 0.511 . . . . 71.53 110.777 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 tttm 63.04 84.8 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.7 0.8 . . . . 71.21 111.961 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.14 145.89 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.701 -0.681 . . . . 72.25 110.691 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.08 -55.32 8.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.023 0.439 . . . . 74.43 111.324 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 22.8 mp0 -91.73 78.44 5.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.407 -0.36 . . . . 72.02 110.822 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.424 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -64.93 -44.56 89.07 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.175 0.512 . . . . 72.12 111.356 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -63.58 -33.42 75.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.036 -0.529 . . . . 64.03 111.916 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 26.1 m-85 -109.11 9.1 26.26 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.763 0.653 . . . . 74.44 112.763 -167.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 32' ' ' ALA . 8.7 p -86.44 124.74 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.982 0.42 . . . . 70.53 110.998 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -85.09 109.52 18.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.17 0.51 . . . . 41.2 111.231 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.68 145.55 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.915 -0.584 . . . . 61.52 111.105 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -136.57 147.7 47.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.911 0.386 . . . . 75.31 111.068 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.556 ' HB3' HD22 ' A' ' 40' ' ' ASN . 10.6 mp -112.49 131.27 55.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.815 0.302 . . . . 61.42 111.815 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.556 HD22 ' HB3' ' A' ' 39' ' ' LEU . 32.7 m-80 56.23 27.32 11.54 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.598 0.592 . . . . 73.23 112.598 171.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.26 18.57 57.17 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.481 -0.39 . . . . 71.23 113.721 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -131.98 131.69 42.81 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.364 -0.492 . . . . 51.32 110.199 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.66 127.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.366 0.603 . . . . 74.21 112.286 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.408 ' CD2' HG21 ' A' ' 20' ' ' VAL . 10.5 mp -94.39 136.79 34.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.523 0.677 . . . . 71.44 112.317 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 9.3 tp10 -66.25 142.2 57.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.56 -0.745 . . . . 74.5 110.711 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -52.25 -45.95 65.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.219 0.533 . . . . 74.15 111.177 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 40.4 mt-10 -77.92 9.66 3.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.037 -0.529 . . . . 62.32 112.112 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.59 -10.21 15.72 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.186 -0.322 . . . . 71.03 111.376 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 22.5 m-30 -60.93 -24.75 66.28 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.159 0.429 . . . . 71.21 112.159 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 3.6 p30 -84.34 -29.75 26.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.848 0.356 . . . . 73.44 111.663 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.19 -53.14 6.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.331 -0.395 . . . . 74.12 111.861 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.406 HG21 HD21 ' A' ' 44' ' ' LEU . 62.4 m -63.2 98.74 0.15 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.831 0.348 . . . . 73.25 111.124 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.2 m -85.2 108.59 17.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.882 0.373 . . . . 71.01 111.21 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.45 133.67 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.977 0.418 . . . . 64.32 111.377 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -128.86 -177.65 4.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.451 0.643 . . . . 71.0 112.063 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.62 122.57 15.61 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.593 -0.73 . . . . 72.34 111.884 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.29 31.58 7.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.353 -0.385 . . . . 23.33 113.603 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.96 160.62 15.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 117.04 0.42 . . . . 72.14 110.54 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.17 99.11 6.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.053 0.454 . . . . 74.52 111.701 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -95.64 131.19 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.227 0.537 . . . . 63.11 111.739 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.93 109.62 21.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.376 0.607 . . . . 65.41 110.829 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -113.05 108.88 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.703 -0.68 . . . . 73.24 110.54 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 mt . . . . . 0 CA--C 1.542 0.642 0 CA-C-O 121.052 0.453 . . . . 73.43 111.841 -176.646 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.57 ' HG3' HD11 ' A' ' 3' ' ' LEU . 19.7 ptp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.719 0.295 . . . . 71.02 111.403 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -101.81 133.28 46.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.624 0.37 . . . . 65.21 110.652 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 1' ' ' MET . 1.6 mp -133.95 157.17 46.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.132 -0.355 . . . . 71.52 111.338 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 36.7 m -107.54 105.7 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.888 -0.412 . . . . 73.44 109.888 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 60' ' ' VAL . 31.8 m -119.5 136.83 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.197 -0.456 . . . . 71.14 111.163 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.17 30.06 19.75 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.486 0.315 . . . . 73.02 111.443 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.28 21.0 79.5 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.923 -0.656 . . . . 75.21 113.372 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -128.86 142.89 46.59 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.568 0.347 . . . . 65.24 111.717 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.96 143.47 32.89 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.256 1.971 . . . . 74.23 111.859 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.7 p -146.1 162.81 37.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.183 -0.323 . . . . 61.21 111.406 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -142.42 107.64 4.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.738 0.304 . . . . 71.23 111.508 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -103.59 128.28 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.994 0.426 . . . . 52.13 111.21 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.39 157.26 29.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.067 0.461 . . . . 73.44 111.818 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.78 -64.4 4.31 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.475 -0.393 . . . . 63.41 113.378 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.23 107.03 1.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.185 0.439 . . . . 73.41 112.185 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.04 -45.11 8.07 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.404 -0.362 . . . . 74.52 111.582 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -153.68 129.41 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.851 0.357 . . . . 62.23 111.194 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.2 pp -158.05 152.5 24.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 50' ' ' ASP . 12.2 p-10 -61.35 154.68 23.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.321 -0.399 . . . . 73.44 111.457 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.1 t -53.38 -33.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.886 0.374 . . . . 45.52 111.518 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -53.84 -49.47 68.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.381 -0.372 . . . . 73.15 111.545 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -68.96 -35.85 77.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.565 0.221 . . . . 71.51 111.454 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' VAL . 64.8 tp -54.39 -50.82 66.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.095 0.474 . . . . 75.31 110.908 174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -57.73 -41.56 82.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.164 0.507 . . . . 72.25 110.871 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 t -68.36 -29.5 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.817 -0.628 . . . . 71.4 111.597 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.75 77.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.027 0.441 . . . . 74.43 111.189 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.84 -21.51 57.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.082 0.468 . . . . 71.45 110.501 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 tttp 65.57 36.95 6.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.359 -0.837 . . . . 73.21 111.579 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.01 129.73 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.134 -0.484 . . . . 70.14 111.401 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.49 81.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.275 0.472 . . . . 64.52 112.275 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -101.44 89.67 3.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.932 0.396 . . . . 71.35 111.422 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -92.42 -45.87 7.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.314 0.578 . . . . 64.0 110.635 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.66 -25.66 40.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.676 -0.693 . . . . 75.53 111.719 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -122.41 28.16 7.55 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.093 0.405 . . . . 72.25 112.093 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' ALA . 11.7 p -89.5 139.46 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.306 0.574 . . . . 71.22 111.971 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -97.95 99.82 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.351 -0.386 . . . . 73.54 110.444 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.27 136.59 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.852 0.358 . . . . 73.24 111.579 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.0 pt-20 -122.24 131.88 54.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.155 0.502 . . . . 71.43 111.377 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 44' ' ' LEU . 2.4 tm? -88.35 99.9 12.6 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.208 -0.451 . . . . 72.15 110.413 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 63.89 1.34 1.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.133 0.79 . . . . 72.25 113.133 176.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.32 -6.85 0.82 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.403 -0.904 . . . . 74.43 114.856 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.85 128.77 41.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.86 0.83 . . . . 74.04 112.102 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.7 p -66.34 139.54 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.129 0.49 . . . . 75.04 112.304 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 39' ' ' LEU . 6.0 mp -92.5 147.16 23.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.445 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.87 149.77 37.75 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.098 -0.501 . . . . 63.13 110.336 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -48.33 -55.68 10.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.591 0.589 . . . . 61.33 112.591 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -81.98 23.93 0.67 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.326 0.584 . . . . 72.55 111.967 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.75 1.94 13.56 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.734 -0.604 . . . . 65.5 111.836 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -64.69 -30.28 71.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.207 0.447 . . . . 62.03 112.207 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 14.5 m-20 -83.12 -32.5 26.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.875 0.369 . . . . 61.15 111.001 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.33 91.35 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.09 -0.505 . . . . 74.41 112.082 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -95.85 119.96 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.99 0.424 . . . . 74.22 111.723 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.6 m -96.09 116.43 28.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.938 0.399 . . . . 64.23 111.616 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 23' ' ' LEU . 49.3 t -74.6 142.03 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 116.005 -0.543 . . . . 75.13 111.096 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -142.83 -175.84 4.65 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.389 0.614 . . . . 74.25 111.61 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.22 104.39 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.756 -0.656 . . . . 71.11 111.972 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.74 32.2 2.14 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.197 -0.525 . . . . 44.13 113.818 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.74 138.1 48.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.328 0.585 . . . . 71.4 112.315 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -95.66 104.52 16.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.651 -0.704 . . . . 62.04 111.49 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -109.02 98.37 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.622 0.725 . . . . 75.44 110.404 175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -72.94 99.54 2.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.731 0.777 . . . . 74.24 112.628 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -85.01 143.71 28.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.151 170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.3 pt? . . . . . 0 CA--C 1.536 0.439 0 CA-C-O 121.284 0.564 . . . . 71.45 111.771 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.916 0.389 . . . . 75.42 111.313 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.78 126.41 37.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.309 -0.405 . . . . 73.54 111.122 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.36 134.92 50.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.937 0.399 . . . . 61.04 111.373 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -94.6 99.35 11.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.959 0.409 . . . . 72.1 111.004 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -100.19 124.21 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.965 0.412 . . . . 72.25 111.464 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 55.6 m-80 54.87 43.22 30.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.115 0.483 . . . . 73.22 111.371 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.69 12.83 62.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.872 -0.603 . . . . 73.41 113.872 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -126.89 125.31 24.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 122.596 -0.355 . . . . 74.31 110.917 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.0 142.18 19.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.684 2.256 . . . . 63.51 113.819 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.9 t -137.86 125.88 22.78 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.027 -0.533 . . . . 74.13 110.628 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -87.33 94.27 9.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.003 0.43 . . . . 72.02 111.536 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -94.78 95.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.491 0.662 . . . . 74.0 111.322 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.74 159.66 30.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.119 0.485 . . . . 64.4 111.373 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.78 -52.34 2.62 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.097 -0.573 . . . . 73.42 111.693 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.61 123.36 23.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.724 0.297 . . . . 31.33 110.569 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.06 -48.02 3.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.264 0.554 . . . . 70.13 111.423 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -157.64 106.6 2.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.224 -0.444 . . . . 72.02 110.632 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.02 151.81 50.27 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.346 -0.388 . . . . 74.1 111.29 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 20.4 p-10 -74.49 157.22 35.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.136 -0.32 . . . . 71.4 110.136 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 60.7 t -51.01 -37.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.86 0.319 . . . . 72.43 111.86 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -53.62 -51.75 62.07 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.821 0.343 . . . . 73.42 111.597 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 52.2 mm-40 -71.18 -29.2 64.88 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 122.246 -0.284 . . . . 61.4 111.756 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.646 HD11 HG11 ' A' ' 60' ' ' VAL . 7.6 tt -60.39 -45.3 94.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.527 -0.546 . . . . 74.14 109.527 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 78.0 mt -63.88 -41.02 97.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 70.45 110.206 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 37.0 t -60.47 -27.78 67.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.673 -0.694 . . . . 72.21 112.002 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -42.32 93.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.058 0.456 . . . . 73.12 111.314 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -88.68 -0.75 57.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.165 0.507 . . . . 72.41 110.465 174.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt 57.71 48.91 13.19 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.75 0.786 . . . . 70.44 111.101 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 56.3 t -81.54 88.51 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.853 -0.612 . . . . 52.4 110.259 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.92 -27.94 33.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.838 -0.619 . . . . 53.52 112.368 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 11.7 mm100 -83.92 45.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.282 -0.417 . . . . 74.51 112.024 -176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -36.99 74.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.474 0.546 . . . . 72.12 112.474 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.44 -7.64 56.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 75.2 111.449 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 5.8 m-85 -104.42 -50.61 3.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.276 -0.42 . . . . 74.22 111.455 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -70.46 136.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.195 0.521 . . . . 61.4 112.323 -175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.2 m -112.06 140.41 46.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.109 -0.496 . . . . 73.04 111.053 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.7 m -133.8 151.39 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.678 0.275 . . . . 71.22 110.842 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.56 126.12 51.29 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.709 0.766 . . . . 65.44 111.818 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.48 120.7 34.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.581 -0.736 . . . . 65.2 110.197 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.51 26.36 10.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.988 0.423 . . . . 63.02 111.779 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 12.92 68.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.092 -0.575 . . . . 45.14 113.226 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.79 124.88 53.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.654 0.382 . . . . 72.11 110.438 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.01 128.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.199 0.523 . . . . 73.34 111.945 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.15 139.99 35.03 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.428 -0.351 . . . . 64.32 111.179 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -68.94 160.77 30.18 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.351 -0.386 . . . . 53.05 110.771 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.09 -36.14 65.34 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.023 0.44 . . . . 71.34 111.726 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.78 -39.21 80.31 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.246 0.545 . . . . 62.44 111.416 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.3 63.77 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.538 0.57 . . . . 52.43 112.538 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -63.43 -33.48 75.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.985 0.422 . . . . 73.41 111.685 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.79 -32.26 59.8 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.37 -0.377 . . . . 71.3 111.46 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.95 6.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.329 0.492 . . . . 54.45 112.329 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -57.59 115.64 2.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.352 0.501 . . . . 44.52 112.352 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 73.8 p -99.37 119.63 38.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.049 0.452 . . . . 62.15 111.44 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -96.22 140.52 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.172 -0.467 . . . . 60.25 111.09 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.26 -172.34 2.82 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.663 0.616 . . . . 73.43 112.663 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.14 132.04 50.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.778 -0.646 . . . . 75.4 112.258 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.05 42.28 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.004 -0.544 . . . . 73.34 113.467 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -119.16 150.06 40.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.425 -0.456 . . . . 73.45 110.714 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.33 83.71 2.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.129 0.49 . . . . 55.1 112.185 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 23' ' ' LEU . 3.6 p -88.31 91.71 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.357 0.598 . . . . 65.12 110.343 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 33.8 tt0 -71.35 92.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.526 0.679 . . . . 73.02 110.859 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 37' ' ' VAL . 71.6 t80 -73.25 110.19 7.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.284 -0.871 . . . . 71.1 111.139 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.123 0.487 . . . . 65.14 110.766 178.478 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.674 0.273 . . . . 74.04 111.527 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -89.09 132.04 34.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.508 -0.315 . . . . 74.14 111.073 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.36 131.22 33.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.981 0.42 . . . . 64.33 111.377 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 89.3 m -81.85 89.47 6.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.288 0.566 . . . . 72.02 110.073 172.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.59 120.09 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 74.42 111.552 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 8' ' ' LYS . 6.2 t-20 62.43 22.62 13.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.118 0.485 . . . . 72.53 111.67 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.04 64.5 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.284 -0.484 . . . . 41.2 113.22 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 3.9 mppt? -113.91 127.07 27.23 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.667 -0.314 . . . . 64.31 111.427 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 90.3 Cg_endo -79.34 139.12 14.46 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.648 2.232 . . . . 75.32 113.543 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.1 t -149.75 159.36 44.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.748 0.309 . . . . 74.03 111.385 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -109.72 112.39 24.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.93 0.395 . . . . 74.41 111.362 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -112.01 119.49 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.953 0.406 . . . . 72.22 111.464 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.87 166.38 20.96 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.724 0.297 . . . . 72.32 110.517 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.51 4.01 73.63 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.933 -0.651 . . . . 73.43 112.524 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.4 108.34 11.57 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.862 0.363 . . . . 65.32 110.987 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -101.81 -60.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.387 0.613 . . . . 75.13 110.457 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -149.75 101.4 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.789 -0.642 . . . . 74.04 109.634 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 96.3 mt -125.03 133.06 53.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.145 0.424 . . . . 42.15 112.145 -170.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.7 p-10 -63.59 149.67 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.597 -0.274 . . . . 60.31 110.452 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.83 -42.14 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.641 0.608 . . . . 70.11 112.641 -173.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.431 ' HB ' ' ND2' ' A' ' 19' ' ' ASN . 86.6 m -50.83 -48.51 59.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.824 0.345 . . . . 60.12 111.795 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 25.4 mm-40 -65.04 -32.77 74.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.336 . . . . 61.21 111.25 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 60' ' ' VAL . 6.9 tt -61.68 -50.04 74.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.937 0.398 . . . . 63.33 109.967 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 HG11 ' A' ' 29' ' ' VAL . 3.9 mm? -63.21 -33.66 75.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.861 0.362 . . . . 73.33 111.032 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -64.04 -41.34 97.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.15 111.365 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -33.23 70.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.155 0.502 . . . . 74.14 111.07 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 29' ' ' VAL . 5.6 tt -71.25 -35.07 71.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.015 -0.539 . . . . 60.5 110.368 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 60.17 73.45 0.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.518 0.675 . . . . 75.32 111.461 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.615 ' HB ' HD22 ' A' ' 27' ' ' LEU . 12.5 p -117.18 143.81 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.889 -0.596 . . . . 64.22 111.36 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.91 142.85 41.97 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 42.43 111.262 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 66.6 mt-30 71.12 37.58 1.21 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.852 -0.613 . . . . 74.51 112.124 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.24 75.16 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.946 0.403 . . . . 74.23 111.93 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -73.4 -3.27 26.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.14 0.495 . . . . 74.0 111.555 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 23.5 m-85 -119.76 -13.45 9.1 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.021 -0.425 . . . . 74.52 112.029 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.11 130.49 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 74.5 112.341 -176.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -93.93 117.2 29.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.311 -0.404 . . . . 70.41 111.057 175.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.23 158.82 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 72.41 110.984 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 11.6 pt-20 -127.87 133.01 49.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.628 0.728 . . . . 54.2 111.981 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.55 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.9 tm? -91.52 104.04 16.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.338 -0.846 . . . . 71.43 109.689 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.543 HD22 HD13 ' A' ' 39' ' ' LEU . 32.4 m-80 55.18 46.21 24.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.098 0.475 . . . . 65.52 111.408 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.02 -3.79 74.38 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.474 -0.393 . . . . 60.45 113.946 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -96.59 111.38 23.54 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.567 -0.372 . . . . 61.21 111.112 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.25 125.34 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.206 0.527 . . . . 72.14 112.219 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 39' ' ' LEU . 1.4 mm? -97.76 152.1 19.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.003 0.43 . . . . 75.45 111.213 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.2 149.44 46.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.911 -0.774 . . . . 64.42 108.911 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -54.13 -38.11 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.56 -29.96 46.6 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.194 0.521 . . . . 74.34 111.193 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.35 -17.01 40.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.461 -0.336 . . . . 74.32 111.846 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.95 -32.55 66.13 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.181 0.515 . . . . 73.3 111.201 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.81 -24.85 35.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.094 -0.503 . . . . 75.41 111.431 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.13 -23.06 19.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.262 0.467 . . . . 60.21 112.262 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 106.65 18.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.144 -0.348 . . . . 74.22 111.56 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 76.3 p -85.57 115.6 23.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.01 0.433 . . . . 74.4 112.017 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.17 132.78 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.35 -0.386 . . . . 71.35 110.804 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -125.65 -177.32 3.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.149 0.5 . . . . 53.23 112.105 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.33 143.23 45.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 43.22 111.872 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.43 34.74 90.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 116.23 -0.441 . . . . 64.13 113.809 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.81 -177.12 3.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.022 0.411 . . . . 71.0 110.081 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.16 102.98 6.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.074 0.768 . . . . 51.11 113.074 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 23' ' ' LEU . 4.0 p -96.69 111.22 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.309 0.576 . . . . 74.32 110.394 173.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 42.2 mt-10 -101.25 105.23 16.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.593 0.711 . . . . 70.03 111.957 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -81.87 117.07 21.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.286 -0.87 . . . . 64.32 110.443 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.5 mt . . . . . 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 74.55 112.54 -175.476 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 3' ' ' LEU . 24.5 ptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.664 0.268 . . . . 70.01 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.24 118.67 26.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.66 -0.246 . . . . 75.32 110.528 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' SD ' ' A' ' 1' ' ' MET . 63.7 mt -127.93 169.7 13.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.178 0.513 . . . . 54.34 111.437 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -111.36 96.87 6.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.626 -0.509 . . . . 72.33 109.626 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 48.0 t -100.85 123.91 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 60.43 111.306 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.858 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.8 OUTLIER 64.53 24.25 13.04 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.292 -0.413 . . . . 72.25 111.718 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.2 6.31 88.12 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.348 -0.453 . . . . 35.4 113.078 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -118.35 126.62 27.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 O-C-N 122.549 -0.383 . . . . 73.52 110.835 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.65 95.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.421 2.081 . . . . 71.05 112.43 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.1 m -113.5 118.04 33.35 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.077 -0.511 . . . . 64.21 111.093 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.4 m -96.99 114.35 25.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.877 0.37 . . . . 74.32 111.487 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -93.68 120.64 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.125 0.488 . . . . 65.01 110.562 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.61 154.78 30.0 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.032 -0.531 . . . . 54.45 112.022 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.19 -45.46 3.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.257 -0.497 . . . . 75.31 113.298 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.15 117.06 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.831 0.348 . . . . 70.33 111.906 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -107.23 -55.88 2.28 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.306 -0.407 . . . . 73.04 110.566 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -141.93 122.39 14.08 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.821 0.343 . . . . 72.22 111.853 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -157.72 160.58 38.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.264 -0.425 . . . . 61.3 111.021 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.7 p30 -86.73 168.86 13.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.917 0.389 . . . . 73.31 111.175 177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.1 -29.28 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.55 -0.295 . . . . 72.22 111.449 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.3 m -61.62 -42.17 98.51 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.742 0.306 . . . . 74.5 111.586 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.29 -47.91 77.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.796 0.331 . . . . 73.03 110.908 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.92 -43.6 77.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.022 0.439 . . . . 54.14 110.825 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.01 -43.39 98.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.982 -0.554 . . . . 53.3 110.6 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -74.68 -17.34 60.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.235 -0.438 . . . . 71.35 111.891 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.61 35.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.861 0.362 . . . . 61.3 111.315 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 28' ' ' LYS . 2.8 pp -87.76 -17.79 30.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.519 -0.309 . . . . 75.4 111.705 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.43 ' N ' HD12 ' A' ' 27' ' ' LEU . 57.4 mtmt 60.06 85.56 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 72.13 112.833 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.35 117.32 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.184 0.516 . . . . 75.04 110.959 176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.69 68.66 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.158 -0.473 . . . . 65.21 112.207 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -84.81 40.45 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.384 -0.371 . . . . 74.31 111.877 -176.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.72 62.21 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.18 0.514 . . . . 74.12 112.131 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.65 -36.31 75.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.552 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -99.33 -17.16 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.554 0.576 . . . . 65.03 112.554 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.2 113.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.976 0.732 . . . . 75.02 112.976 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 m -94.69 107.47 19.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.988 -0.551 . . . . 71.13 111.297 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 62' ' ' PHE . 31.5 m -141.32 147.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.426 -0.352 . . . . 70.24 111.195 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.29 137.03 43.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.039 0.447 . . . . 73.43 111.746 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.691 HD23 HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -83.22 106.48 15.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.027 0.441 . . . . 54.41 110.621 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 61.6 11.02 3.62 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.377 0.671 . . . . 63.45 112.526 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.63 -10.26 7.61 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.992 -0.623 . . . . 44.53 113.914 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.54 114.94 29.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.294 -0.533 . . . . 75.31 111.639 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.56 148.89 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.109 0.48 . . . . 31.32 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 HD23 ' A' ' 39' ' ' LEU . 3.1 mm? -101.16 143.26 31.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.318 0.58 . . . . 64.25 112.259 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.94 156.79 16.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.777 -0.647 . . . . 71.54 109.304 170.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 46' ' ' ARG . 61.3 mtt85 -40.43 -54.63 2.42 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.573 0.583 . . . . 75.42 112.573 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -79.25 -14.28 59.14 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.319 0.489 . . . . 55.11 112.319 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.03 62.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 53.31 111.222 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.66 -37.23 73.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.895 0.379 . . . . 71.21 111.519 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.49 -36.59 52.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.97 0.414 . . . . 71.24 111.705 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.21 -56.99 4.34 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.268 0.47 . . . . 52.15 112.268 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.5 m -72.59 126.12 29.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.039 0.447 . . . . 54.2 112.045 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 75.6 p -105.95 138.3 42.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.203 0.525 . . . . 50.42 112.011 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 39' ' ' LEU . 43.9 t -95.22 129.79 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.086 -0.507 . . . . 73.32 110.895 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.77 -179.76 5.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.279 0.561 . . . . 73.41 111.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.98 102.82 0.09 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.974 -0.557 . . . . 64.23 112.267 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.53 4.42 8.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.313 -0.47 . . . . 65.05 113.838 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.44 145.04 25.24 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.42 0.629 . . . . 74.01 112.162 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.15 131.76 51.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.78 -0.645 . . . . 51.02 111.168 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -143.96 117.71 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.403 0.62 . . . . 72.35 111.435 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 28.6 tt0 -101.38 96.56 7.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.5 0.666 . . . . 73.15 111.896 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 37' ' ' VAL . 18.6 t80 -78.06 92.2 4.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.928 -0.578 . . . . 73.24 110.069 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt . . . . . 0 CA--C 1.542 0.642 0 N-CA-C 113.29 0.848 . . . . 73.23 113.29 -175.05 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 22.8 ptp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.793 0.33 . . . . 72.41 111.517 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -101.9 114.56 28.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.398 -0.365 . . . . 64.55 111.017 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.86 127.76 53.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.081 0.467 . . . . 72.34 111.411 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.2 m -82.4 97.7 8.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.462 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.637 HG12 HD22 ' A' ' 6' ' ' ASN . 31.5 t -85.72 110.83 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.918 0.389 . . . . 62.43 111.837 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.637 HD22 HG12 ' A' ' 5' ' ' VAL . 52.2 m-80 57.74 25.62 12.07 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.164 0.586 . . . . 63.33 112.37 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.03 -11.55 58.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.212 -0.518 . . . . 65.55 113.086 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 9.9 mptt -102.48 114.62 65.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.672 -0.311 . . . . 74.21 110.93 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 25.6 Cg_exo -63.32 116.45 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.8 2.333 . . . . 71.24 113.148 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -114.01 158.74 20.78 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.348 -0.387 . . . . 63.15 110.558 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -126.31 110.28 13.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.894 0.378 . . . . 64.51 111.868 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 m -98.81 102.08 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.451 0.644 . . . . 72.34 110.666 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.04 136.22 37.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.758 -0.655 . . . . 73.22 111.534 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.65 59.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.18 -0.533 . . . . 51.12 113.001 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -103.04 101.74 11.73 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.592 -0.358 . . . . 73.43 111.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.82 88.12 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.932 0.396 . . . . 73.12 111.181 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m 49.29 91.96 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.752 -0.658 . . . . 52.31 112.454 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.4 pp -129.0 153.83 47.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.062 0.458 . . . . 71.4 111.611 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 27.7 m-20 -72.34 160.73 31.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.469 -0.332 . . . . 75.22 110.828 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 t -56.38 -36.65 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.968 0.413 . . . . 74.21 110.568 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -56.36 -52.03 66.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.96 0.41 . . . . 62.35 110.999 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 41.7 mt-10 -63.83 -34.45 77.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.305 -0.407 . . . . 71.13 111.44 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.3 -45.93 80.02 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.919 0.39 . . . . 75.14 110.434 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -56.25 -32.93 64.95 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.983 0.42 . . . . 71.24 111.499 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.4 t -77.97 -32.82 51.57 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.122 -0.49 . . . . 70.13 111.291 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.59 -46.38 63.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.082 0.468 . . . . 74.22 111.417 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.52 -30.42 65.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.909 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.89 87.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.58 0.752 . . . . 70.12 112.575 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.11 148.53 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.792 -0.64 . . . . 73.04 110.936 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.99 171.81 14.52 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.87 0.367 . . . . 64.41 111.867 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 57.17 39.07 29.13 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.057 0.455 . . . . 71.52 111.729 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -33.27 71.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.459 . . . . 42.14 111.961 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.72 -13.34 62.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.984 0.365 . . . . 74.25 111.984 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.17 4.7 5.82 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.458 0.54 . . . . 64.2 112.458 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.508 HG22 HG13 ' A' ' 37' ' ' VAL . 14.6 p -70.71 132.06 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.551 0.691 . . . . 73.2 112.338 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.9 m -95.26 98.89 10.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.221 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 35' ' ' VAL . 29.7 m -133.15 163.34 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.265 0.555 . . . . 75.35 112.08 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.39 154.71 32.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.983 -0.553 . . . . 62.0 111.298 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.544 ' O ' HD12 ' A' ' 39' ' ' LEU . 3.4 pp -123.17 137.95 54.77 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.531 -0.304 . . . . 44.43 111.286 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 59.21 16.08 4.66 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 116.358 -0.383 . . . . 71.03 112.024 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.27 15.41 53.65 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.347 -0.454 . . . . 55.34 113.825 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.15 118.3 28.33 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.3 -0.529 . . . . 73.01 111.368 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.68 135.13 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.11 0.481 . . . . 72.45 111.927 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.0 mm? -109.67 150.72 27.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.131 0.491 . . . . 60.43 112.092 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 mp0 -69.36 162.18 27.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.146 -0.479 . . . . 72.43 110.76 170.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -57.02 -39.43 74.74 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.714 0.292 . . . . 62.41 111.32 178.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.56 -35.94 68.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.153 0.501 . . . . 73.31 111.038 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -22.41 66.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.333 -0.394 . . . . 74.31 111.369 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 46' ' ' ARG . 17.5 m-30 -57.57 -39.33 76.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.646 0.26 . . . . 74.33 111.558 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 22.2 t70 -83.34 -35.51 25.11 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.241 0.543 . . . . 73.13 110.82 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.36 -23.57 67.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.258 -0.428 . . . . 74.01 112.09 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -103.77 115.78 31.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.787 0.327 . . . . 64.22 111.565 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 88.6 m -94.73 110.19 22.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.23 0.538 . . . . 41.12 111.801 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.48 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.901 -0.591 . . . . 65.1 111.24 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -130.07 -167.12 1.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.183 0.516 . . . . 72.34 111.929 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 2.8 t0 -78.97 42.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.931 0.396 . . . . 73.45 112.045 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.59 52.92 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.406 -0.902 . . . . 64.23 113.426 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.12 123.7 38.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.237 0.541 . . . . 74.44 110.956 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.82 82.96 3.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.267 -0.424 . . . . 53.44 111.577 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.7 p -83.47 104.93 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.529 0.68 . . . . 74.42 111.561 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 41.3 mt-10 -85.84 100.61 12.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.442 0.639 . . . . 73.31 111.167 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -101.71 110.9 22.99 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.291 -0.868 . . . . 73.52 110.676 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.2 pt? . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.444 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 26.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.846 0.355 . . . . 62.54 111.914 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.22 126.8 36.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.44 -0.345 . . . . 72.53 111.543 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 58' ' ' ASP . 74.7 mt -125.31 130.65 52.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.824 0.345 . . . . 71.14 110.889 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.7 m -94.58 86.08 4.7 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 73.51 111.151 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.1 122.44 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.43 . . . . 64.54 111.181 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.69 23.42 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.762 0.315 . . . . 73.04 111.568 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.5 79.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.827 -0.701 . . . . 63.2 112.464 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -113.23 131.58 22.82 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 122.78 0.432 . . . . 63.05 110.821 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.73 96.3 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.414 2.076 . . . . 72.15 112.961 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -98.76 102.15 13.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.098 0.475 . . . . 71.22 111.25 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.3 m -82.54 94.2 7.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 74.32 110.767 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.9 m -93.63 102.99 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.539 0.685 . . . . 72.04 111.401 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -89.0 151.79 22.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.306 -0.407 . . . . 64.43 110.559 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.07 18.53 53.67 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.555 -0.618 . . . . 65.04 111.555 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.46 116.2 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.119 0.568 . . . . 72.24 110.527 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -91.23 -62.65 1.4 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.416 0.626 . . . . 61.34 111.213 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 33.2 p -171.53 104.21 0.2 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.305 -0.861 . . . . 34.32 110.061 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -131.88 162.08 31.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.488 0.551 . . . . 63.03 112.488 -170.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -64.1 156.2 29.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.407 -0.36 . . . . 72.41 110.936 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 46.2 t -56.5 -35.6 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.001 0.429 . . . . 75.44 110.437 176.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -59.03 -49.07 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.143 -0.48 . . . . 61.51 110.992 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 44.0 mt-10 -61.44 -35.81 78.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.275 -0.42 . . . . 75.43 110.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 60' ' ' VAL . 61.7 tp -60.53 -45.92 92.08 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.897 0.38 . . . . 63.02 110.815 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 85.5 mt -60.07 -34.78 73.92 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 44.21 110.821 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -67.9 -41.75 82.24 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.19 -0.459 . . . . 62.23 111.119 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.69 90.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.261 -0.427 . . . . 41.42 111.709 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.49 -11.36 59.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.991 0.425 . . . . 75.24 111.081 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 58.91 64.66 1.37 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 74.34 111.914 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.49 114.05 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.811 -0.632 . . . . 74.44 110.784 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.46 80.42 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.13 0.419 . . . . 62.32 112.13 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 78.8 mt-30 -95.79 83.13 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.802 0.335 . . . . 74.53 111.649 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.83 -37.43 22.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.654 0.74 . . . . 75.24 110.421 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -67.36 -20.25 65.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.098 -0.955 . . . . 74.43 111.692 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -123.52 11.74 9.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.773 0.657 . . . . 74.14 112.773 -173.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 37' ' ' VAL . 14.8 p -83.7 131.94 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 75.12 112.19 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -95.11 102.14 13.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.412 -0.358 . . . . 60.41 110.897 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 35' ' ' VAL . 35.3 m -122.95 139.96 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.827 0.346 . . . . 51.34 111.621 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.34 110.68 11.7 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.409 0.623 . . . . 74.05 111.555 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 10.0 mp -77.37 129.82 36.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.243 -0.435 . . . . 62.24 111.273 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.06 21.23 9.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.979 0.419 . . . . 70.42 111.549 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.76 19.82 49.92 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.311 -0.471 . . . . 73.13 113.343 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -133.79 125.58 28.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.952 0.376 . . . . 70.41 111.129 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.22 144.49 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 120.985 0.421 . . . . 70.13 112.021 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 49' ' ' PHE . 9.9 mp -104.82 -179.78 4.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.419 0.628 . . . . 60.13 112.294 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -107.77 149.18 28.51 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.702 -0.681 . . . . 64.4 110.578 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 2.1 ptm180 -47.16 -52.98 14.15 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.71 1.004 . . . . 72.3 113.71 -171.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.545 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 19.5 tt0 -95.39 -6.49 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.452 0.644 . . . . 42.34 110.753 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.86 63.97 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.9 -0.591 . . . . 74.51 110.539 171.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.405 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 m-30 -51.14 -42.08 60.51 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.225 0.536 . . . . 73.11 110.893 174.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.16 -34.62 78.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.712 -0.676 . . . . 73.22 111.561 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.95 -5.57 50.43 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.751 0.648 . . . . 64.3 112.751 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -104.81 116.18 31.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 122.286 -0.258 . . . . 75.22 111.437 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.1 p -95.59 113.18 24.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.699 0.629 . . . . 74.0 112.699 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD21 ' A' ' 39' ' ' LEU . 65.0 t -79.11 133.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.133 -0.485 . . . . 62.13 110.798 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' HB2' ' A' ' 17' ' ' SER . 43.9 mtmt -131.92 -171.84 2.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.263 0.554 . . . . 74.51 112.024 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.9 t70 -66.17 124.53 22.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 72.43 111.632 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 30.16 11.45 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.276 -0.488 . . . . 54.11 113.317 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.5 t70 -93.54 176.96 6.18 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.756 -0.261 . . . . 65.55 110.344 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.22 42.46 1.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.829 0.347 . . . . 63.4 111.918 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 3.7 p -56.2 102.2 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.671 0.748 . . . . 74.04 111.846 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.75 116.78 28.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.054 -0.521 . . . . 64.32 111.957 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -88.93 135.75 33.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.052 -0.522 . . . . 72.32 111.292 173.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER . . . . . 0 CA--C 1.537 0.454 0 CA-C-N 116.469 -0.332 . . . . 75.51 111.253 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 3' ' ' LEU . 21.5 ptp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.039 0.447 . . . . 62.1 111.728 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -85.18 108.66 17.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.495 -0.32 . . . . 65.32 110.825 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 1' ' ' MET . 70.5 mt -118.83 113.89 21.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.997 0.427 . . . . 63.34 111.762 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.7 m -75.69 99.04 4.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.317 -0.401 . . . . 70.14 110.577 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.51 121.64 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.207 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.461 HD21 ' C ' ' A' ' 62' ' ' PHE . 7.8 m120 64.35 27.14 13.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.924 0.49 . . . . 73.12 110.715 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.62 0.03 88.04 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.859 -0.686 . . . . 23.44 113.595 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -104.39 110.05 63.64 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 117.298 0.549 . . . . 73.12 111.326 178.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 37.1 Cg_exo -61.33 103.92 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.848 2.365 . . . . 60.51 112.216 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -109.97 110.35 21.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.988 0.423 . . . . 65.02 111.842 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -82.67 96.97 8.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.882 0.373 . . . . 72.4 111.383 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -93.74 104.72 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.733 0.778 . . . . 72.01 110.844 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -72.81 147.59 45.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.251 -0.886 . . . . 71.05 111.407 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.14 -12.83 65.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.467 -0.397 . . . . 63.33 113.772 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -108.92 119.36 39.33 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.433 -0.451 . . . . 42.5 112.027 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.5 -73.8 0.33 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.207 -0.451 . . . . 73.51 112.194 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.513 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 87.0 p -163.07 135.56 5.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.652 -0.249 . . . . 42.33 110.707 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -148.67 157.04 43.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.944 0.402 . . . . 73.4 111.944 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -72.31 170.02 15.02 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.708 -0.224 . . . . 61.12 110.852 177.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 49' ' ' PHE . 58.8 t -62.16 -40.94 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 109.973 -0.38 . . . . 74.24 109.973 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.0 m -53.94 -52.85 59.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.196 0.522 . . . . 74.11 110.597 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 8.5 mm-40 -61.5 -33.78 74.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.028 -0.533 . . . . 74.12 112.006 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.52 -56.36 18.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.979 0.418 . . . . 75.45 111.139 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.52 -30.75 71.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.785 0.326 . . . . 75.21 110.961 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.7 t -66.57 -37.51 85.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.027 0.441 . . . . 72.13 111.274 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.86 80.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.33 -0.395 . . . . 71.11 111.204 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.51 -29.08 62.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.299 -0.41 . . . . 73.4 111.085 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 67.26 16.07 10.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.174 0.59 . . . . 64.11 112.145 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 31' ' ' GLN . 11.4 p -72.5 140.01 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.064 0.459 . . . . 74.0 111.438 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.58 -14.83 57.87 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.885 0.698 . . . . 74.44 112.885 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.07 30.77 1.8 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.281 -0.262 . . . . 54.13 111.39 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.87 79.74 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.424 0.528 . . . . 71.51 112.424 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.07 -10.79 59.93 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.156 0.503 . . . . 75.12 111.376 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.19 21.94 11.57 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.208 0.447 . . . . 71.22 112.208 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.4 p -110.88 133.57 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.166 0.507 . . . . 71.05 112.068 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.8 m -74.76 84.36 2.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.278 0.561 . . . . 74.33 110.936 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -99.11 110.33 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.971 -0.559 . . . . 74.21 110.31 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 10.5 pt-20 -118.2 119.65 35.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.734 0.778 . . . . 73.44 112.128 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.0 tm? -73.29 107.67 5.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.412 -0.813 . . . . 71.52 110.417 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.537 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 58.53 15.84 3.85 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.044 -0.525 . . . . 73.44 111.818 -178.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 15.83 11.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.996 -0.621 . . . . 43.43 113.886 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -132.11 110.55 10.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 117.396 0.598 . . . . 74.31 110.899 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 12.4 p -64.58 141.88 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.787 0.662 . . . . 63.22 112.787 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.8 mm? -94.02 143.74 26.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.407 0.622 . . . . 74.12 112.485 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -77.4 154.43 32.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.717 -0.674 . . . . 50.44 110.536 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -48.26 -41.03 26.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.147 0.425 . . . . 65.34 112.147 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.32 -40.73 85.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.183 0.516 . . . . 74.11 111.485 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -24.15 63.51 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.311 0.486 . . . . 65.1 112.311 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 7.7 m-85 -49.48 -42.0 42.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.914 0.388 . . . . 75.53 111.728 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.77 -29.85 29.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.908 0.385 . . . . 73.01 111.648 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 -15.77 46.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.942 0.719 . . . . 73.14 112.942 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -104.18 123.08 46.67 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.073 -0.392 . . . . 60.11 111.483 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 89.5 m -111.14 110.81 21.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.201 0.524 . . . . 65.03 111.726 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.6 123.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.853 -0.612 . . . . 61.44 110.447 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -133.51 -175.37 3.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.977 0.417 . . . . 70.44 111.851 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.05 129.6 42.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.045 0.45 . . . . 74.11 111.715 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 42.49 12.81 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.378 -0.439 . . . . 15.02 112.733 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -119.6 -173.15 2.47 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.699 -0.482 . . . . 61.12 109.699 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 102.65 4.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 71.13 110.972 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.16 100.11 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.57 0.7 . . . . 73.32 110.557 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 5.1 mm-40 -76.86 105.99 8.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.839 0.828 . . . . 74.32 111.214 -176.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.461 ' C ' HD21 ' A' ' 6' ' ' ASN . 12.1 t80 -119.11 99.32 6.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.47 -1.241 . . . . 73.01 109.395 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 63' ' ' LEU . 1.7 pt? . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.116 0.784 . . . . 72.51 113.116 -168.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 55' ' ' LYS . 24.8 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.086 0.47 . . . . 72.44 111.895 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -90.75 117.12 29.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.921 -0.582 . . . . 74.45 111.307 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 58' ' ' ASP . 24.0 mt -116.82 179.14 4.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 110.309 -0.256 . . . . 62.0 110.309 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 26.6 m -146.84 134.58 21.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.697 0.284 . . . . 64.51 111.006 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.7 113.36 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 122.259 -0.276 . . . . 70.41 110.778 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.586 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.9 OUTLIER 63.27 38.28 10.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.894 0.378 . . . . 75.11 111.203 179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.08 -2.91 67.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.887 -0.673 . . . . 52.21 113.791 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.99 113.99 65.46 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.075 0.438 . . . . 73.32 111.094 176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.52 151.11 77.64 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.848 2.366 . . . . 71.42 112.922 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -151.3 109.73 3.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.277 0.561 . . . . 54.44 111.3 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.0 m -85.24 107.35 17.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.908 -0.587 . . . . 65.24 111.245 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.6 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.047 0.451 . . . . 71.52 112.091 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.07 149.84 40.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.899 0.381 . . . . 70.44 111.143 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.99 32.28 2.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.32 -0.4 . . . . 64.32 113.111 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.96 123.24 13.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.567 -0.372 . . . . 70.31 111.013 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.22 83.4 1.89 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.068 0.395 . . . . 72.22 112.068 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m 49.45 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.975 0.732 . . . . 74.24 112.975 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -135.17 154.49 51.6 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.19 0.441 . . . . 60.3 112.19 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p30 -71.73 167.8 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.037 0.446 . . . . 72.13 111.904 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.21 -42.21 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.288 -0.414 . . . . 62.12 111.939 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HB1' ' A' ' 32' ' ' ALA . 92.7 m -59.86 -44.44 94.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.671 0.272 . . . . 74.0 111.538 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 36.5 mt-10 -66.91 -37.17 83.84 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.245 -0.285 . . . . 60.22 111.271 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 54' ' ' VAL . 56.4 tp -56.01 -56.55 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.084 0.469 . . . . 63.12 111.341 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.582 HD22 HG11 ' A' ' 35' ' ' VAL . 4.5 pp -68.09 -26.4 65.81 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.918 0.389 . . . . 73.12 111.53 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -65.77 -36.69 84.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.882 0.372 . . . . 64.21 111.015 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.34 67.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 73.0 111.165 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -85.31 -3.06 58.71 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.279 0.561 . . . . 64.15 109.925 175.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 65.74 28.2 11.04 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.189 0.596 . . . . 64.21 112.018 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 27' ' ' LEU . 58.3 t -73.2 113.03 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.526 -0.306 . . . . 64.32 111.007 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.69 158.04 19.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.488 -0.324 . . . . 53.34 111.287 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 41.3 mt-30 60.69 72.44 0.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.492 0.663 . . . . 73.05 110.769 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' HG23 ' A' ' 21' ' ' THR . . . -67.82 -16.24 64.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.07 0.767 . . . . 45.04 113.07 -171.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -41.58 3.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.62 -0.264 . . . . 60.12 111.465 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 22.5 m-85 -60.41 -21.18 61.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.037 0.384 . . . . 74.43 112.037 -177.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.582 HG11 HD22 ' A' ' 24' ' ' LEU . 10.1 p -60.26 149.61 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.092 0.472 . . . . 74.15 111.306 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -116.04 113.81 23.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.745 0.307 . . . . 72.44 111.024 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.38 149.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.959 0.409 . . . . 74.5 111.176 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 9.2 pt-20 -128.91 125.99 38.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.002 0.43 . . . . 61.12 111.597 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.619 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.68 110.36 17.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.223 -0.444 . . . . 65.22 110.797 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 63.03 29.63 16.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.204 0.526 . . . . 73.02 110.912 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.51 85.42 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.043 -0.598 . . . . 73.12 113.456 -175.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.79 111.32 23.78 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.644 -0.327 . . . . 65.33 110.92 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.28 138.03 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.409 0.522 . . . . 65.05 112.409 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -109.65 161.48 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.037 0.446 . . . . 75.12 111.103 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.71 155.17 19.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.145 -0.48 . . . . 74.44 109.892 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 2.3 mpt_? -53.99 -38.28 64.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.654 0.613 . . . . 71.24 112.654 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.35 -31.1 69.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.219 0.533 . . . . 73.01 110.804 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.52 -24.0 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.848 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -55.83 -41.1 73.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.403 0.621 . . . . 74.54 110.869 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -70.19 -37.86 75.21 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.202 -0.908 . . . . 51.41 111.869 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.66 -33.75 60.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.191 0.441 . . . . 73.0 112.191 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -82.05 104.61 12.52 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.788 0.327 . . . . 72.52 111.046 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 74.0 p -94.39 110.74 22.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.198 0.523 . . . . 72.12 111.781 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 97.1 t -74.14 127.46 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.718 -0.674 . . . . 42.21 111.454 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 19.6 ptmt -167.99 87.99 0.25 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.146 -0.479 . . . . 74.43 111.684 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.9 t70 66.02 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.14 -0.482 . . . . 44.5 112.241 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.12 40.13 83.1 Favored Glycine 0 N--CA 1.464 0.532 0 C-N-CA 120.899 -0.667 . . . . 63.53 112.245 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.2 t70 -106.83 164.18 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.905 0.482 . . . . 74.03 111.957 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -151.52 72.55 1.04 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.838 -0.619 . . . . 72.21 110.699 175.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.3 p -83.32 95.95 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.801 0.81 . . . . 71.54 112.012 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 2.4 mp0 -73.7 103.7 4.36 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.189 0.518 . . . . 63.34 112.104 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 24' ' ' LEU . 11.7 m-85 -87.03 134.12 33.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.942 -0.572 . . . . 72.31 110.47 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 63' ' ' LEU . 2.1 pt? . . . . . 0 CA--C 1.544 0.719 0 N-CA-C 112.625 0.602 . . . . 72.11 112.625 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.045 0.45 . . . . 70.41 112.01 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 2.3 m-20 -98.2 134.4 41.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.962 0.505 . . . . 73.44 110.803 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.521 ' HB3' HG12 ' A' ' 60' ' ' VAL . 2.7 mm? -126.48 134.9 50.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.773 0.321 . . . . 74.1 111.354 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -84.19 77.86 9.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.209 0.528 . . . . 74.11 110.357 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -80.82 121.89 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.023 0.44 . . . . 63.44 111.923 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 61.04 18.54 9.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.34 -0.391 . . . . 72.44 111.683 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.94 -3.15 64.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.28 -0.486 . . . . 33.05 113.091 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 10.3 mptt -108.29 132.87 20.8 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.819 0.31 . . . . 64.55 110.917 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 97.75 1.15 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.501 2.134 . . . . 53.5 113.61 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.1 t -98.47 179.42 4.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.035 -0.53 . . . . 44.24 111.096 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 93.9 m -149.73 121.41 8.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.106 0.41 . . . . 73.21 112.106 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' VAL . 34.9 m -100.26 109.03 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.564 0.697 . . . . 74.32 110.488 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.42 151.46 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.788 -176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.7 -43.06 3.14 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.293 -0.48 . . . . 74.35 113.314 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.9 153.9 21.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.295 0.48 . . . . 72.33 112.295 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.91 -72.26 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.344 -0.389 . . . . 72.13 111.496 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -110.25 96.01 5.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.884 0.373 . . . . 74.41 111.38 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 83.6 mt -127.36 152.03 48.01 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.728 0.299 . . . . 74.12 111.637 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -76.47 166.7 23.05 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.494 0.188 . . . . 54.23 110.613 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.42 -38.35 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.079 0.466 . . . . 73.22 110.352 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -59.62 -40.72 88.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.177 0.513 . . . . 73.03 110.776 172.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 6.0 mm-40 -69.58 -26.0 64.25 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.409 -0.36 . . . . 65.4 111.803 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 39.1 mt -63.71 -41.46 98.09 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.927 -0.397 . . . . 71.32 109.927 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.88 -41.08 90.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.281 -0.418 . . . . 61.44 110.408 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 m -59.36 -54.17 49.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.04 -0.527 . . . . 62.51 111.409 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.02 68.52 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.158 0.429 . . . . 21.11 112.158 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.6 mt -75.63 -6.22 49.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.503 -0.317 . . . . 64.44 111.715 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt 54.72 51.91 13.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.44 111.065 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.7 t -87.13 119.49 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 74.03 111.1 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.56 -28.86 65.22 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.934 0.397 . . . . 71.23 111.519 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.46 87.94 6.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.856 0.36 . . . . 64.41 111.513 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.75 -13.92 21.12 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.744 0.783 . . . . 75.42 110.624 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.26 -48.82 3.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.822 -1.081 . . . . 63.2 110.117 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.64 44.78 1.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.448 -0.796 . . . . 74.54 111.577 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.12 149.04 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 112.673 0.62 . . . . 64.41 112.673 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 m -145.41 112.44 6.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.056 -0.52 . . . . 61.41 111.027 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 62' ' ' PHE . 35.7 m -144.46 160.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.422 0.289 . . . . 63.3 111.427 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.604 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -133.62 147.86 51.5 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.561 0.696 . . . . 73.33 111.249 172.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.497 HD13 HD22 ' A' ' 40' ' ' ASN . 2.6 tm? -108.54 105.09 14.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.724 -0.671 . . . . 63.23 110.233 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.497 HD22 HD13 ' A' ' 39' ' ' LEU . 33.3 m-80 56.2 35.58 25.97 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.795 0.331 . . . . 71.44 111.434 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.43 -17.56 57.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 121.127 -0.558 . . . . 51.04 113.617 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.58 100.34 11.35 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.447 -0.443 . . . . 74.14 111.121 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.46 140.42 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.363 . . . . 74.45 111.387 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -99.72 136.53 39.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.921 0.391 . . . . 55.24 111.552 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.75 146.5 37.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.436 -0.347 . . . . 72.31 110.499 172.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -53.02 -21.82 4.98 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.1 0.476 . . . . 74.54 111.893 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.81 -27.67 24.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.558 0.577 . . . . 73.03 112.558 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.18 11.19 37.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.589 0.959 . . . . 65.2 113.589 -169.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 18.4 m-85 -59.68 -49.17 78.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.245 0.461 . . . . 65.2 112.245 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.12 -23.86 54.89 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.074 0.464 . . . . 64.03 111.202 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.97 -17.12 57.53 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.11 0.411 . . . . 34.44 112.11 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.8 m -103.64 120.87 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.725 0.298 . . . . 63.31 111.377 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.4 p -89.9 150.14 22.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.424 0.63 . . . . 75.02 112.146 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 23' ' ' LEU . 46.4 t -115.81 142.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.633 -0.712 . . . . 70.44 110.724 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -137.47 176.35 8.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.442 . . . . 73.21 112.005 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.46 145.85 50.69 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.026 0.441 . . . . 73.34 111.975 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.56 30.71 78.06 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.062 -0.517 . . . . 71.11 113.063 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -109.56 142.52 40.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.821 0.343 . . . . 72.05 111.121 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.0 85.57 5.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.88 0.696 . . . . 62.24 112.88 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 3' ' ' LEU . 5.6 p -86.94 107.96 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.492 0.663 . . . . 71.03 110.461 173.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.604 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 34.1 mt-10 -94.21 97.62 10.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.383 0.611 . . . . 74.14 111.247 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . 42.5 t80 -89.56 115.9 27.31 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.528 -0.76 . . . . 72.33 111.22 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 120.87 0.367 . . . . 73.42 111.5 -179.365 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.771 0.319 . . . . 64.3 111.583 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.2 m-80 -75.47 130.12 38.39 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.126 0.417 . . . . 62.01 112.126 -176.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.8 mt -141.73 118.19 10.88 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.198 -0.456 . . . . 53.03 111.475 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' LYS . 67.2 m -76.19 97.82 4.24 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.182 0.515 . . . . 70.32 110.985 175.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 46.5 t -93.05 107.84 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 116.288 -0.414 . . . . 74.25 111.21 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 58.03 35.51 25.28 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 120.939 0.4 . . . . 53.12 112.031 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.55 2.42 76.23 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 121.048 -0.596 . . . . 65.44 113.645 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 4' ' ' THR . 28.5 mtpp -91.96 113.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.522 0 O-C-N 122.438 -0.448 . . . . 73.13 111.272 178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.62 65.41 4.73 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.554 2.17 . . . . 74.12 112.182 178.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t -102.83 176.74 5.06 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.455 0.645 . . . . 71.15 111.661 -175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.8 t -148.95 134.42 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.887 -0.597 . . . . 74.4 111.234 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.63 119.05 33.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.276 -0.42 . . . . 71.14 110.004 174.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -49.76 111.05 0.45 Allowed 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.155 0.502 . . . . 72.53 111.796 -175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.21 -107.47 2.18 Favored Glycine 0 CA--C 1.528 0.863 0 CA-C-N 115.908 -0.587 . . . . 42.41 112.936 -176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 62.84 92.53 0.06 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.3 0.571 . . . . 73.4 111.827 -177.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -79.91 84.33 5.69 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.15 0.5 . . . . 74.15 110.965 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.6 p 61.63 114.14 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.176 0.99 . . . . 50.53 112.598 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.4 mt -130.61 131.59 45.04 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 116.413 -0.358 . . . . 74.44 110.994 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.5 p-10 -80.46 171.86 14.5 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 122.198 -0.314 . . . . 75.23 110.363 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 42.2 t -56.5 -37.98 54.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.717 0.294 . . . . 74.21 111.156 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 78.0 m -55.73 -46.65 77.74 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.891 0.377 . . . . 71.23 111.116 174.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -67.38 -29.95 69.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.175 0.435 . . . . 52.05 112.175 177.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.01 -37.37 81.33 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.095 0.474 . . . . 61.21 110.329 174.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 35' ' ' VAL . 91.0 mt -63.75 -37.86 88.94 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.161 -0.472 . . . . 75.24 111.298 176.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -76.54 -38.19 55.46 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.434 -0.348 . . . . 64.04 111.117 177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.03 90.81 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 121.036 0.446 . . . . 54.33 111.397 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.7 mt -80.26 -17.99 50.64 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.274 0.559 . . . . 70.23 110.478 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 48.5 tptt 67.02 82.52 0.18 Allowed 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.212 -0.904 . . . . 73.42 112.753 174.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.6 p -94.85 142.4 13.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 CA-C-N 115.967 -0.56 . . . . 64.13 110.77 172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.46 -42.84 15.19 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.794 0.33 . . . . 60.05 111.729 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -87.94 76.58 8.63 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.099 0.476 . . . . 54.01 111.064 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.38 -23.9 67.09 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.271 0.471 . . . . 61.12 112.271 -176.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -93.26 -8.8 41.17 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.257 0.466 . . . . 51.43 112.257 -178.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -126.43 4.71 6.92 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.031 0.382 . . . . 71.22 112.031 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 24' ' ' LEU . 7.2 p -68.62 130.35 33.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 121.452 0.644 . . . . 71.33 112.31 -177.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 96.5 m -112.96 112.06 23.25 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.062 -0.517 . . . . 70.24 111.016 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 62' ' ' PHE . 29.8 m -139.33 158.94 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.35 -0.386 . . . . 73.05 111.402 178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.579 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 3.5 pm0 -132.26 169.62 16.2 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.194 0.521 . . . . 71.05 110.945 175.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.609 HD12 ' O ' ' A' ' 39' ' ' LEU . 2.4 pp -133.98 124.59 26.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.205 -0.452 . . . . 64.34 110.669 174.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 56.47 18.87 3.75 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 116.206 -0.452 . . . . 74.54 111.531 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.28 -41.62 2.18 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 121.324 -0.465 . . . . 60.22 113.744 -177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -69.19 120.57 15.23 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 116.925 0.363 . . . . 64.21 111.195 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.2 p -81.79 143.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 CA-C-O 120.918 0.39 . . . . 72.11 111.71 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.447 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -91.59 139.3 30.83 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.076 0.465 . . . . 74.12 111.732 -178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.47 163.61 24.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.058 -0.519 . . . . 75.32 111.009 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 46' ' ' ARG . 9.1 ptp85 -47.74 -24.04 0.85 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 113.355 0.872 . . . . 62.42 113.355 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -119.92 7.11 10.88 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.482 0.549 . . . . 52.53 112.482 -174.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -92.03 -12.11 34.09 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 112.102 0.408 . . . . 75.42 112.102 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 62.7 m-85 -62.17 -38.84 90.57 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.065 0.395 . . . . 73.15 112.065 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' HD22 ' A' ' 19' ' ' ASN . 26.1 m-20 -72.77 -56.2 5.6 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 112.422 0.527 . . . . 71.32 112.422 -176.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -63.1 -37.69 88.21 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 112.886 0.698 . . . . 61.52 112.886 -175.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.458 HG21 HD21 ' A' ' 39' ' ' LEU . 99.7 m -74.32 98.15 3.17 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.236 0.541 . . . . 75.12 112.04 -176.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 62.6 p -84.81 127.72 34.27 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.926 -0.579 . . . . 71.44 111.341 176.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.6 t -102.02 151.67 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.103 0.478 . . . . 64.32 110.881 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.4 ptmm? -139.08 -170.02 2.78 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.979 0.418 . . . . 73.04 111.916 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -66.41 136.68 56.08 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.437 -0.347 . . . . 75.41 111.487 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 80.79 50.43 5.25 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.168 -0.539 . . . . 53.14 113.366 177.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -140.57 -178.78 5.67 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 122.629 -0.336 . . . . 65.45 110.523 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -136.64 107.74 6.75 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.29 0.478 . . . . 73.04 112.29 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 3.6 p -103.11 116.58 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 121.441 0.638 . . . . 72.04 111.129 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.579 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 46.9 mt-10 -96.45 110.47 22.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.209 0.528 . . . . 71.33 111.08 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 37' ' ' VAL . 56.5 t80 -100.57 114.7 28.58 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.863 -0.608 . . . . 74.3 111.032 -177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.6 mt -88.09 137.31 32.45 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.951 0.405 . . . . 74.15 111.687 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -105.76 24.68 11.9 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.155 0.502 . . . . 73.05 111.033 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -52.49 157.46 1.5 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 113.415 0.894 . . . . 71.1 113.415 -174.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.482 ' HG3' ' H ' ' A' ' 67' ' ' GLY . 0.0 OUTLIER 69.2 167.16 0.28 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-N 115.331 -0.85 . . . . 73.02 111.925 175.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.482 ' H ' ' HG3' ' A' ' 66' ' ' MET . . . 179.36 -96.68 0.1 Allowed Glycine 0 CA--C 1.523 0.569 0 C-N-CA 121.065 -0.588 . . . . 64.43 112.275 177.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 147.02 134.64 2.58 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 121.02 -0.609 . . . . 62.33 112.813 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -94.33 7.35 72.07 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.098 -0.573 . . . . 44.4 113.789 -177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -167.05 103.73 0.55 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 117.187 0.493 . . . . 74.22 111.171 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.1 mt -130.4 16.7 5.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 116.306 -0.406 . . . . 73.42 111.44 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -68.75 110.97 4.57 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.932 0.716 . . . . 63.02 112.932 -176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 86.6 m-70 -141.46 -47.76 0.39 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.648 -0.705 . . . . 62.04 109.971 169.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 65.6 121.33 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.405 0.621 . . . . 74.32 112.437 175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -81.59 43.5 0.75 Allowed 'General case' 0 CA--C 1.546 0.803 0 CA-C-N 115.868 -0.605 . . . . 65.54 111.883 -174.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -85.05 129.22 34.84 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.139 0.495 . . . . 52.21 111.61 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -150.38 143.69 24.99 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.929 -0.578 . . . . 64.55 110.325 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 59.4 m-70 . . . . . 0 C--O 1.254 1.297 0 CA-C-O 118.738 -0.649 . . . . 63.13 111.852 -178.575 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.256 0.551 . . . . 73.32 111.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -87.5 121.06 29.45 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.381 -0.372 . . . . 62.21 111.625 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 96.5 mt -125.22 114.03 18.44 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.809 0.338 . . . . 75.04 111.25 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 28.5 m -76.05 77.5 2.9 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 121.558 0.694 . . . . 75.41 110.917 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 51.7 t -74.22 114.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.018 -0.537 . . . . 53.01 111.886 -175.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.566 HD22 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.09 19.83 11.16 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.411 -0.359 . . . . 43.22 111.771 179.239 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.95 -10.67 55.71 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 120.923 -0.656 . . . . 63.32 113.52 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.491 ' NZ ' ' HB2' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -98.98 115.65 65.67 Favored Pre-proline 0 N--CA 1.471 0.596 0 O-C-N 122.3 -0.529 . . . . 75.44 111.236 179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -60.85 96.15 0.11 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.868 2.379 . . . . 73.05 112.303 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 18.1 m -97.47 100.86 12.29 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.141 0.496 . . . . 72.34 111.243 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.6 m -73.96 84.09 1.74 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.346 -0.388 . . . . 53.04 111.083 178.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -97.33 113.43 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-O 121.188 0.518 . . . . 73.45 111.057 179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -117.87 -179.82 3.86 Favored 'General case' 0 CA--C 1.544 0.724 0 O-C-N 121.94 -0.475 . . . . 72.42 111.151 -177.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.44 7.4 84.77 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.058 -0.592 . . . . 73.34 112.318 -174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.36 98.01 2.61 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-O 121.043 0.449 . . . . 74.15 110.225 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.38 82.17 2.46 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.306 -0.407 . . . . 74.24 112.025 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 90.6 p 64.51 143.64 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.293 1.037 . . . . 74.52 113.545 173.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.6 pp -156.34 175.43 14.02 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.807 -0.633 . . . . 74.14 111.268 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 30.9 p30 -97.85 172.24 7.79 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.739 0.304 . . . . 64.23 110.972 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 48.7 t -60.02 -36.58 68.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 120.882 0.372 . . . . 71.14 111.757 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.7 m -56.3 -45.78 80.07 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.189 0.518 . . . . 34.44 111.264 176.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 12.0 mm-40 -64.13 -41.36 97.24 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 116.2 -0.454 . . . . 72.12 110.978 176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 41.7 tp -51.77 -51.39 56.64 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 116.204 -0.453 . . . . 75.01 111.319 176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.481 HD11 HG21 ' A' ' 35' ' ' VAL . 4.5 mm? -55.33 -44.72 76.13 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 120.901 0.382 . . . . 42.43 111.481 175.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.1 t -67.58 -27.96 67.37 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 116.271 -0.422 . . . . 72.44 111.791 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.71 -41.71 44.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 120.968 0.414 . . . . 75.3 111.578 178.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -81.55 -6.99 59.52 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.045 0.387 . . . . 71.55 112.045 179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.788 0.435 . . . . 52.15 111.78 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.4 t -90.69 120.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.057 0.456 . . . . 71.01 111.737 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.03 36.38 0.28 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.955 0.502 . . . . 75.32 112.204 -178.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -134.95 35.6 3.08 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 112.216 0.451 . . . . 72.25 112.216 -174.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.37 -25.64 50.29 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 112.132 0.419 . . . . 64.15 112.132 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.08 -24.54 28.04 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 121.117 0.484 . . . . 74.12 111.928 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -107.56 -4.45 18.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 120.739 0.304 . . . . 64.12 111.76 -175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.495 HG22 HG13 ' A' ' 37' ' ' VAL . 7.4 p -68.27 89.0 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 CA-C-O 121.868 0.842 . . . . 72.41 113.058 -172.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -82.18 93.42 7.06 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.907 -0.588 . . . . 71.04 110.941 174.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' HA ' ' A' ' 62' ' ' PHE . 17.2 m -110.8 141.14 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-O 121.099 0.476 . . . . 64.14 111.63 176.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -126.77 119.85 27.9 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.573 0.702 . . . . 71.25 111.751 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.449 ' HB2' HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -82.11 115.76 21.38 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.704 -0.68 . . . . 71.03 110.849 178.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 60.43 27.51 17.12 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-O 120.802 0.334 . . . . 75.12 111.697 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 91.61 5.26 66.99 Favored Glycine 0 CA--C 1.53 1.009 0 C-N-CA 121.343 -0.455 . . . . 72.43 113.633 -178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -114.54 117.85 32.07 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 122.529 -0.395 . . . . 73.4 111.239 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 p -74.27 139.72 18.8 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 120.956 0.408 . . . . 62.32 111.74 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.449 HD21 ' HB2' ' A' ' 39' ' ' LEU . 3.3 mm? -101.35 153.69 19.44 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.264 0.554 . . . . 63.25 112.261 -177.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -77.74 157.25 30.13 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.797 -0.638 . . . . 74.23 110.571 173.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -60.18 -33.01 71.62 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.961 0.41 . . . . 73.44 111.567 176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -70.92 -32.65 69.63 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.393 0.616 . . . . 74.23 110.528 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HA ' ' HB3' ' A' ' 51' ' ' ALA . . . -71.99 -13.75 61.7 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.093 -0.503 . . . . 63.41 112.191 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.0 m-30 -56.71 -45.6 81.76 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.021 0.439 . . . . 71.0 111.034 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.5 -21.31 35.52 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 116.113 -0.494 . . . . 64.21 111.281 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 48' ' ' ALA . . . -97.76 21.82 9.96 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 112.389 0.514 . . . . 61.22 112.389 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.8 m -133.82 113.69 12.54 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.81 0.338 . . . . 75.33 111.169 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 46.3 p -81.66 126.83 32.25 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.11 0.481 . . . . 63.53 111.837 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 45.8 t -109.52 113.65 44.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-N 115.622 -0.717 . . . . 75.02 109.538 178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.652 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -144.74 -161.46 1.3 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.934 0.397 . . . . 74.21 111.597 -170.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -68.11 93.35 0.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.937 -0.477 . . . . 75.14 112.119 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 134.0 10.88 1.69 Allowed Glycine 0 CA--C 1.531 1.075 0 C-N-CA 121.114 -0.565 . . . . 41.5 114.488 173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -94.06 130.19 40.3 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.154 0.977 . . . . 41.12 112.108 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -85.93 66.14 9.46 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.399 0.619 . . . . 64.33 110.428 175.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.1 p -73.69 99.71 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.718 0.771 . . . . 42.12 112.009 -176.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -76.49 78.57 3.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.304 0.573 . . . . 60.54 110.954 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.56 ' HA ' HG12 ' A' ' 37' ' ' VAL . 36.0 t80 -73.77 96.37 2.54 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 109.102 -0.703 . . . . 75.5 109.102 173.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 85.8 mt -72.0 137.84 47.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.037 0.755 . . . . 72.3 113.037 -170.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -79.31 0.71 27.79 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 115.759 -0.655 . . . . 74.21 110.641 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 63.15 22.2 13.27 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.881 -0.599 . . . . 63.53 111.669 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 mpp? 55.41 22.42 4.96 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.323 0.49 . . . . 72.21 112.323 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -108.02 -13.19 20.42 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.764 -0.534 . . . . 64.21 111.764 176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -78.72 132.31 11.49 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 121.529 -0.367 . . . . 53.41 112.767 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -76.61 74.84 1.71 Allowed Glycine 0 CA--C 1.529 0.927 0 C-N-CA 121.278 -0.487 . . . . 73.51 114.107 -175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.591 ' HD2' ' O ' ' A' ' 70' ' ' LYS . 0.0 OUTLIER -81.35 129.92 34.82 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.123 0.487 . . . . 72.44 110.901 174.563 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 72.7 mt -125.09 138.43 54.18 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 122.068 -0.395 . . . . 70.14 111.963 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -65.05 129.92 41.45 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 109.507 -0.553 . . . . 64.11 109.507 171.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.515 ' HD2' ' HB2' ' A' ' 75' ' ' HIS . 14.2 t60 -67.59 -24.46 65.5 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.183 0.438 . . . . 64.0 112.183 -170.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 43.1 m80 58.88 19.92 7.54 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 113.329 0.863 . . . . 64.42 113.329 174.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.515 ' HB2' ' HD2' ' A' ' 73' ' ' HIS . 82.3 t60 -69.23 117.65 11.14 Favored 'General case' 0 CA--C 1.538 0.481 0 O-C-N 122.014 -0.429 . . . . 55.31 110.775 178.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 32.7 m170 -62.56 129.23 39.65 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.03 0.443 . . . . 74.14 111.422 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -153.35 141.42 20.35 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.113 -0.494 . . . . 75.43 111.437 -174.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 35.1 m-70 . . . . . 0 C--O 1.252 1.192 0 CA-C-O 118.986 -0.53 . . . . 73.53 111.569 179.12 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 111.659 0.244 . . . . 74.44 111.659 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -99.64 127.81 45.74 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.824 0.345 . . . . 75.41 111.246 178.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -119.55 140.85 49.86 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.975 0.417 . . . . 73.25 111.519 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.3 m -91.2 76.7 6.04 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.437 0.637 . . . . 61.2 110.133 176.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.625 HG12 HD22 ' A' ' 6' ' ' ASN . 39.5 t -74.0 110.01 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 115.892 -0.595 . . . . 74.12 111.827 -172.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.625 HD22 HG12 ' A' ' 5' ' ' VAL . 47.6 m-80 58.95 26.02 14.48 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.824 0.45 . . . . 72.4 111.559 -176.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.28 -4.77 74.28 Favored Glycine 0 CA--C 1.529 0.924 0 C-N-CA 120.94 -0.647 . . . . 42.5 113.243 -177.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 11.6 mptt -101.28 139.16 20.22 Favored Pre-proline 0 N--CA 1.473 0.7 0 O-C-N 122.366 -0.49 . . . . 65.51 110.894 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.66 121.97 7.06 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.509 2.139 . . . . 74.11 113.0 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.2 t -133.65 156.54 47.7 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 116.008 -0.542 . . . . 73.3 110.539 178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.9 m -135.85 113.91 11.33 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.204 -0.31 . . . . 75.12 111.524 -177.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.3 m -91.57 108.55 20.1 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-O 121.334 0.588 . . . . 55.1 110.919 176.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -82.92 143.22 30.87 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.943 -0.571 . . . . 51.34 111.113 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.96 21.96 31.8 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.406 -0.426 . . . . 55.33 112.836 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.03 136.42 4.12 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.197 0.443 . . . . 72.21 112.197 -177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.06 -40.94 7.37 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 116.19 -0.459 . . . . 65.3 110.766 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.0 p -164.32 112.38 1.12 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.117 -0.492 . . . . 75.22 111.267 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.8 mt -128.76 160.31 32.94 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.218 -0.446 . . . . 61.43 110.536 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -72.86 162.54 29.36 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-O 120.654 0.264 . . . . 71.01 110.319 172.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.534 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.4 t -59.33 -34.83 55.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 O-C-N 122.152 -0.343 . . . . 45.54 111.433 -176.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 m -60.29 -53.72 54.32 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 120.76 0.314 . . . . 75.11 111.819 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -63.79 -33.14 75.01 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.81 0.338 . . . . 72.24 111.192 176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.3 tt -60.5 -45.95 91.91 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 109.804 -0.443 . . . . 51.31 109.804 175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 95.0 mt -59.3 -39.73 83.92 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.947 0.403 . . . . 72.44 111.136 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 46.2 t -69.97 -32.18 70.28 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.084 0.469 . . . . 75.21 111.441 178.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.05 -47.35 58.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.909 0.385 . . . . 51.32 111.477 178.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -78.59 -20.43 50.52 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 116.276 -0.42 . . . . 73.22 111.331 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 65.78 76.49 0.32 Allowed 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.697 0.761 . . . . 65.43 111.541 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 59.2 t -96.67 146.2 7.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 115.581 -0.736 . . . . 73.4 110.915 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -69.29 -59.18 3.18 Favored 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 112.174 0.435 . . . . 72.42 112.174 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -97.38 98.98 10.42 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.939 0.399 . . . . 74.11 111.8 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.428 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -86.52 -29.51 22.65 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.166 0.507 . . . . 52.24 111.311 177.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -79.41 -23.54 43.15 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 116.013 -0.54 . . . . 74.41 111.536 178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -112.43 11.57 19.93 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.116 0.413 . . . . 72.44 112.116 -175.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.524 HG22 HG13 ' A' ' 37' ' ' VAL . 7.3 p -75.73 88.91 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 CA-C-O 121.838 0.828 . . . . 50.04 112.147 -175.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.2 m -76.54 95.94 4.0 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.181 -0.463 . . . . 74.15 111.812 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG13 HG22 ' A' ' 35' ' ' VAL . 35.4 m -120.3 158.42 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 116.428 -0.351 . . . . 60.34 110.975 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -133.6 134.45 43.28 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.78 0.8 . . . . 74.14 112.617 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.554 HD13 ' ND2' ' A' ' 40' ' ' ASN . 1.0 OUTLIER -78.24 103.23 8.05 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.968 -1.015 . . . . 73.22 110.757 -176.177 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.611 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.7 OUTLIER 58.14 24.41 11.27 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 120.875 0.369 . . . . 74.31 111.728 178.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.82 40.63 4.32 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 120.941 -0.647 . . . . 63.54 112.608 -175.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.32 105.66 3.22 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 122.788 0.435 . . . . 75.11 110.437 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.66 138.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 112.641 0.608 . . . . 75.11 112.641 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.42 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -89.86 153.77 20.39 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.357 0.599 . . . . 73.51 111.72 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.19 160.5 26.91 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.091 -0.504 . . . . 74.34 111.399 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 38.0 ptt180 -37.07 -48.04 0.77 Allowed 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.013 1.116 . . . . 74.44 114.013 -176.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 13.8 pt-20 -107.41 0.52 22.98 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.278 0.473 . . . . 74.41 112.278 -174.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.73 -18.71 65.28 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.945 0.402 . . . . 74.04 111.279 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -58.83 -41.24 86.41 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.133 -0.485 . . . . 62.22 111.44 177.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -82.02 -32.17 30.64 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 116.134 -0.484 . . . . 74.11 110.963 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.87 -18.81 46.08 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 112.821 0.674 . . . . 74.31 112.821 -177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 82.3 m -96.47 122.2 39.12 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.871 0.367 . . . . 74.14 111.606 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.2 m -91.64 106.94 18.86 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.418 -0.355 . . . . 74.25 111.226 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 48.7 t -74.42 115.57 15.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 120.953 0.406 . . . . 64.1 110.997 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -112.0 -167.43 1.18 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.854 0.359 . . . . 75.22 111.648 -177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.39 133.83 37.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-O 120.872 0.368 . . . . 74.11 111.887 -178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 81.99 43.62 8.1 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 121.353 -0.451 . . . . 43.42 113.669 176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -116.08 140.72 49.0 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 122.556 -0.379 . . . . 74.05 110.808 178.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -96.86 74.12 2.64 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.234 0.54 . . . . 61.11 111.643 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 34.6 m -82.4 125.39 39.86 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.407 0.622 . . . . 73.32 111.365 178.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -92.04 101.42 13.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.384 0.612 . . . . 70.55 111.157 178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 37' ' ' VAL . 5.2 t80 -103.92 99.9 9.67 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 115.471 -0.786 . . . . 71.12 109.553 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 63' ' ' LEU . 1.6 pt? -125.67 136.3 53.08 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.105 0.78 . . . . 74.34 113.105 -167.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 69.1 11.69 8.34 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.12 0.785 . . . . 65.24 113.12 174.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -130.92 147.52 52.58 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.289 0.566 . . . . 70.14 111.828 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -164.56 -170.46 2.03 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.678 -0.692 . . . . 64.31 110.401 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.95 -72.18 0.03 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.474 -0.87 . . . . 62.11 113.666 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.69 -45.27 2.9 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 121.285 -0.483 . . . . 64.14 113.136 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.74 41.61 93.97 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.528 -0.368 . . . . 73.04 113.457 178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -115.63 148.6 39.47 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.226 0.536 . . . . 61.23 112.149 -175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.3 pt? -150.57 -165.33 2.24 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.643 -0.708 . . . . 72.12 110.289 -177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -53.22 133.67 39.4 Favored 'General case' 0 N--CA 1.471 0.612 0 O-C-N 122.492 -0.13 . . . . 75.25 110.859 175.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -57.14 135.02 56.36 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.59 0.234 . . . . 75.54 111.123 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 49.9 m80 -56.19 93.7 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.583 0.706 . . . . 74.25 112.738 -175.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -76.95 -168.68 1.11 Allowed 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.095 -0.957 . . . . 74.3 110.92 174.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -60.27 134.56 57.18 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.877 0.37 . . . . 73.33 110.804 176.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -144.38 143.27 30.86 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.252 -0.431 . . . . 75.45 110.89 -173.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 14.5 p80 . . . . . 0 C--O 1.247 0.972 0 CA-C-O 119.33 -0.367 . . . . 72.32 111.812 178.036 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.5 ptt? . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.819 0.343 . . . . 62.31 111.584 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -86.35 127.2 34.77 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 116.407 -0.36 . . . . 72.2 110.88 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.9 mt -133.33 176.01 8.9 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.117 0.484 . . . . 75.43 111.109 177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.0 m -141.04 132.23 26.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.374 -0.375 . . . . 73.33 111.185 178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.2 p -120.53 121.12 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 120.74 0.305 . . . . 54.31 111.376 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.411 ' H ' ' HG2' ' A' ' 61' ' ' GLU . 15.9 m120 65.72 14.36 9.49 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 112.01 0.374 . . . . 73.2 112.01 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.73 -2.41 72.99 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 121.238 -0.506 . . . . 44.11 112.087 -172.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -97.7 110.78 56.69 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 123.379 0.671 . . . . 70.22 110.655 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -56.8 123.54 14.11 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.189 2.593 . . . . 74.24 113.724 -176.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 74.8 m -136.51 100.86 4.47 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.216 0.531 . . . . 75.31 111.314 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.8 m -80.65 95.57 6.61 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.036 0.446 . . . . 75.42 111.66 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 12' ' ' VAL . 16.9 m -81.96 79.6 1.28 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.967 0.889 . . . . 65.51 110.463 173.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.54 170.69 14.93 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.945 -0.571 . . . . 73.11 111.168 -176.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.47 25.3 68.31 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 120.581 -0.819 . . . . 75.41 111.533 -169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -147.29 123.2 10.67 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 122.728 0.411 . . . . 63.34 110.698 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -74.54 -68.73 0.51 Allowed 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.205 0.526 . . . . 72.33 111.785 -176.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 80.2 p -167.26 132.96 2.1 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.393 -0.821 . . . . 71.41 109.274 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' GLU . 1.2 pp -149.99 163.07 39.09 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.039 0.755 . . . . 73.4 113.039 -171.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.05 159.16 20.81 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.047 -0.524 . . . . 43.33 111.102 177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.462 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 50.6 t -57.33 -43.74 82.82 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-O 121.015 0.435 . . . . 72.53 110.485 174.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.1 m -60.34 -45.65 92.68 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.203 -0.453 . . . . 71.25 111.42 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HB3' ' HB2' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -59.72 -36.99 77.69 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-O 121.035 0.445 . . . . 54.44 110.632 176.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 52.5 tp -61.94 -44.18 97.29 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.191 0.52 . . . . 73.32 110.385 173.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 89.1 mt -58.64 -34.72 71.49 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.01 -0.541 . . . . 65.11 110.759 174.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.9 t -68.19 -43.02 79.05 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.925 -0.58 . . . . 54.22 111.406 176.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.27 -46.29 76.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.261 0.467 . . . . 64.41 112.261 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.433 ' N ' HD22 ' A' ' 27' ' ' LEU . 3.0 mm? -94.11 -6.89 43.97 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.662 -0.244 . . . . 61.32 111.626 178.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? 57.49 89.02 0.05 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-O 121.395 0.617 . . . . 65.11 111.649 -175.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.1 161.38 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.826 -0.624 . . . . 64.32 111.686 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.85 -49.13 18.86 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.041 0.448 . . . . 63.41 111.517 176.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -123.15 142.38 50.96 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 116.199 -0.455 . . . . 74.34 110.964 -176.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.563 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -110.71 -40.2 4.64 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.294 0.568 . . . . 54.31 111.974 -175.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -80.63 -30.4 36.71 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.961 -0.563 . . . . 70.33 111.118 175.545 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -91.23 -7.15 52.09 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.403 0.52 . . . . 73.14 112.403 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.563 HG12 ' O ' ' A' ' 32' ' ' ALA . 9.7 p -58.7 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 CA-C-O 122.007 0.908 . . . . 52.41 112.211 -175.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 70.3 m -84.52 92.21 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.758 -0.655 . . . . 74.33 110.949 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG22 ' A' ' 35' ' ' VAL . 28.7 m -125.0 141.95 43.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.953 -0.567 . . . . 74.31 110.999 177.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 9.8 pt-20 -118.26 122.16 42.24 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.686 0.755 . . . . 74.52 111.818 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.467 HD13 ' ND2' ' A' ' 40' ' ' ASN . 1.6 tm? -81.22 107.22 13.83 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.585 -0.734 . . . . 73.31 109.89 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.9 OUTLIER 64.24 38.46 8.04 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-O 121.0 0.428 . . . . 64.52 111.282 -177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 75.85 29.67 58.85 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 121.206 -0.521 . . . . 62.45 113.665 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' N ' ' HB2' ' A' ' 38' ' ' GLU . 41.4 tt0 -148.91 115.75 5.99 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 122.466 -0.432 . . . . 64.51 110.798 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 14.7 p -77.37 147.44 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 113.069 0.766 . . . . 73.12 113.069 -173.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.443 HD22 ' N ' ' A' ' 44' ' ' LEU . 3.0 mm? -106.37 157.79 17.36 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.059 -0.519 . . . . 74.25 111.008 176.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.571 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 tt0 -76.4 159.59 30.34 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 120.858 0.361 . . . . 74.31 111.437 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -49.65 -49.24 48.01 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.936 1.087 . . . . 73.41 113.936 -169.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -80.78 -23.14 39.52 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.564 -0.71 . . . . 75.04 111.689 -179.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.13 49.7 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.285 0.476 . . . . 70.12 112.285 179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -60.99 -30.53 70.33 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 120.778 0.323 . . . . 73.42 111.719 177.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -85.96 -21.48 27.85 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.795 0.331 . . . . 73.53 111.479 173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.02 1.96 56.68 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.095 0.406 . . . . 75.23 112.095 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -116.1 116.45 27.89 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 120.582 0.229 . . . . 54.43 111.471 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 99.5 m -89.4 109.83 20.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.116 0.484 . . . . 71.35 111.65 178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.35 137.32 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 116.009 -0.541 . . . . 74.2 110.521 175.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -135.67 176.08 9.01 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.232 0.539 . . . . 71.14 111.771 -173.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -58.65 105.61 0.32 Allowed 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.023 -0.535 . . . . 73.13 112.095 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 116.81 7.89 12.67 Favored Glycine 0 CA--C 1.524 0.615 0 C-N-CA 121.483 -0.389 . . . . 65.13 113.343 174.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -86.94 153.47 21.56 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 121.193 0.52 . . . . 65.24 111.764 -177.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.85 107.65 12.97 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.368 -0.378 . . . . 75.42 111.631 -176.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.27 110.85 31.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.114 -0.494 . . . . 71.21 110.792 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.411 ' HG2' ' H ' ' A' ' 6' ' ' ASN . 39.0 mt-10 -98.89 111.65 23.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.387 0.613 . . . . 63.42 112.339 -175.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -80.77 130.92 35.33 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.383 -0.826 . . . . 74.51 111.468 174.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.517 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.7 pt? -141.81 168.26 20.18 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.083 -0.386 . . . . 64.4 112.011 177.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 73.91 -37.08 0.36 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.644 0.778 . . . . 73.22 112.298 -177.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -72.13 -13.04 61.46 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.57 0.582 . . . . 74.22 112.57 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.73 -178.9 6.14 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 120.802 0.334 . . . . 71.1 111.701 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.53 79.74 0.32 Allowed Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.684 -0.566 . . . . 72.12 111.684 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.95 0.65 30.15 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.186 -0.531 . . . . 63.11 114.393 -172.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.21 27.16 67.02 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 120.989 -0.624 . . . . 53.24 113.836 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -99.42 101.13 12.3 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.516 -0.403 . . . . 65.32 110.718 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.8 mp 52.27 23.87 2.59 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.81 0.814 . . . . 75.15 110.121 -174.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -88.33 19.95 3.53 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.093 -0.958 . . . . 74.2 111.742 -167.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.9 m-70 -75.27 92.68 2.77 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.905 0.384 . . . . 74.24 110.325 177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -132.01 123.44 27.3 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.432 -0.349 . . . . 74.3 111.192 -178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -63.67 115.08 4.41 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.986 0.422 . . . . 72.15 110.895 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -81.5 152.38 27.35 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.069 0.461 . . . . 74.0 112.18 -173.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -79.19 -179.96 7.03 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.228 -0.442 . . . . 74.11 111.725 -176.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 . . . . . 0 C--O 1.252 1.224 0 CA-C-O 119.308 -0.377 . . . . 55.33 111.692 178.207 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.536 ' HG3' HD21 ' A' ' 3' ' ' LEU . 23.1 ptp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.679 0.276 . . . . 75.11 111.641 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 57.3 m-20 -99.29 124.39 44.34 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 116.407 -0.36 . . . . 71.12 111.001 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.536 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.7 mm? -119.5 129.06 54.52 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.734 0.302 . . . . 75.51 111.155 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 20.2 m -78.69 73.02 5.25 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.414 0.626 . . . . 75.34 110.185 174.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.644 HG22 HD22 ' A' ' 6' ' ' ASN . 7.1 p -70.81 110.4 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.778 0 CA-C-O 121.332 0.586 . . . . 75.42 112.099 -173.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.644 HD22 HG22 ' A' ' 5' ' ' VAL . 48.7 m-80 59.71 21.48 10.23 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.134 -0.485 . . . . 54.25 111.879 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.1 -4.29 62.6 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 120.869 -0.681 . . . . 75.41 113.035 -176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.0 mptp? -102.53 136.51 19.34 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.377 0.271 . . . . 71.44 110.685 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.37 104.55 1.76 Allowed 'Trans proline' 0 CA--C 1.543 0.975 0 C-N-CA 122.264 1.976 . . . . 72.52 113.178 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.7 t -114.0 153.53 29.19 Favored 'General case' 0 N--CA 1.472 0.662 0 O-C-N 122.148 -0.345 . . . . 71.54 110.655 175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 92.4 m -135.51 114.34 11.99 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.096 0.406 . . . . 62.1 112.096 -175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.9 m -93.69 112.08 26.05 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-O 121.508 0.67 . . . . 71.25 110.104 171.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.72 148.55 50.22 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.633 -0.712 . . . . 71.43 112.367 -172.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.77 -58.35 4.98 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.498 -0.382 . . . . 63.53 113.44 178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.38 110.54 0.88 Allowed 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.175 0.435 . . . . 72.33 112.175 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.423 ' O ' ' HE2' ' A' ' 1' ' ' MET . 42.8 mt-10 -94.18 -55.46 3.19 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.955 0.407 . . . . 74.54 111.494 177.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.0 p -143.4 115.86 8.57 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.391 -0.368 . . . . 61.44 111.44 -177.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -157.63 165.35 35.72 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.371 -0.377 . . . . 74.33 111.855 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 40.3 m-20 -66.37 160.95 23.6 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.605 0.241 . . . . 61.34 111.27 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.447 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 56.3 t -56.17 -41.9 71.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-O 121.014 0.435 . . . . 71.24 110.6 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 m -59.03 -47.21 86.03 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.083 0.468 . . . . 74.04 111.346 175.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 51.7 mt-10 -65.73 -31.6 72.69 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.955 0.407 . . . . 74.41 111.102 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -65.5 -46.74 78.5 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.856 -0.424 . . . . 72.21 109.856 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 90.6 mt -56.8 -36.21 69.65 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.161 -0.472 . . . . 63.34 111.047 176.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.6 t -64.52 -55.81 18.16 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 116.034 -0.53 . . . . 71.14 111.328 175.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.12 -36.89 78.47 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.378 0.51 . . . . 64.24 112.378 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.1 tp -79.6 -22.85 43.18 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.843 0.354 . . . . 60.24 111.42 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? 63.1 81.65 0.2 Allowed 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.321 0.581 . . . . 73.42 109.731 -175.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 ' H ' ' A' ' 31' ' ' GLN . 12.5 p -93.62 151.42 3.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-N 115.977 -0.556 . . . . 33.51 111.737 -176.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.69 -35.41 70.27 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.005 0.372 . . . . 52.13 112.005 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.542 ' H ' HG22 ' A' ' 29' ' ' VAL . 61.8 mm-40 -127.03 134.85 50.23 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.612 -0.267 . . . . 52.21 110.683 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -123.83 9.3 8.82 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.397 0.618 . . . . 63.12 111.48 -178.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.86 -32.45 0.57 Allowed 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.524 -0.762 . . . . 74.32 111.305 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -86.48 -19.74 29.13 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.787 0.327 . . . . 72.03 111.54 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.459 HG22 HG13 ' A' ' 37' ' ' VAL . 7.1 p -68.56 126.15 27.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.789 0.663 . . . . 72.03 112.789 -173.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.9 m -102.52 98.84 8.86 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 116.172 -0.467 . . . . 74.31 110.713 174.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 HG22 ' A' ' 35' ' ' VAL . 14.6 m -103.57 95.87 4.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.463 0.649 . . . . 72.32 111.283 176.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 10.1 pt-20 -95.48 94.35 7.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.482 0.658 . . . . 73.44 111.314 -179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.476 ' HB3' HG12 ' A' ' 60' ' ' VAL . 0.5 OUTLIER -68.41 114.95 7.28 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.359 0.599 . . . . 64.14 112.025 -179.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 59.09 39.49 23.12 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.901 -0.59 . . . . 50.51 111.748 -179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 69.82 48.66 40.31 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 121.032 -0.604 . . . . 75.02 113.194 -178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -151.06 108.58 3.64 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 120.957 0.408 . . . . 62.42 110.657 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -85.84 136.4 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.579 0.585 . . . . 54.25 112.579 -173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.458 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.7 mm? -101.74 152.35 20.96 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.033 -0.531 . . . . 74.13 110.824 177.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.458 ' N ' ' HB3' ' A' ' 48' ' ' ALA . 45.4 mt-10 -68.56 169.35 11.15 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.282 0.563 . . . . 74.54 111.969 175.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.7 ttm180 -58.85 -35.68 73.33 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.867 -0.606 . . . . 72.15 110.451 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -80.54 -42.12 22.97 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.794 -0.639 . . . . 74.4 111.43 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' A' ' 45' ' ' GLU . . . -56.66 -20.85 23.59 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 113.09 0.774 . . . . 63.32 113.09 -175.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -56.03 -34.25 65.69 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.042 0.449 . . . . 63.21 111.136 175.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -81.62 -32.6 31.91 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.364 -0.38 . . . . 73.03 111.17 175.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.32 -9.39 59.74 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.629 0.603 . . . . 75.41 112.629 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 51.5 m -113.11 119.24 37.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 120.756 0.313 . . . . 75.21 111.802 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.553 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 83.4 m -96.16 124.69 40.26 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.335 0.588 . . . . 71.34 112.328 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.0 t -101.64 151.77 5.52 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 115.889 -0.596 . . . . 74.43 110.897 176.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -147.76 -178.19 6.13 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.875 0.369 . . . . 74.35 111.624 177.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.46 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 26.2 t70 -58.46 119.01 6.22 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.163 0.506 . . . . 73.3 112.359 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 99.38 54.22 1.1 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 116.188 -0.46 . . . . 62.24 113.662 176.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -139.04 154.71 48.25 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.884 0.342 . . . . 64.34 111.035 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.64 83.82 1.83 Allowed 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.336 0.495 . . . . 62.32 112.336 -176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.476 HG12 ' HB3' ' A' ' 39' ' ' LEU . 30.2 m -82.18 107.87 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-O 121.476 0.655 . . . . 72.41 111.182 175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 44.1 mt-10 -77.46 93.33 4.1 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-O 121.519 0.675 . . . . 73.13 110.804 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -80.08 92.11 5.59 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.365 -0.834 . . . . 73.5 110.431 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 70.0 mt -67.32 127.64 33.43 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-O 121.172 0.511 . . . . 71.33 112.225 -176.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -91.19 19.38 5.92 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.141 -0.481 . . . . 74.04 111.797 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -54.99 -17.22 3.47 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.174 0.805 . . . . 71.41 113.174 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.7 mmt -64.38 -31.29 72.44 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.045 0.45 . . . . 64.25 111.375 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 120.15 59.3 0.24 Allowed Glycine 0 CA--C 1.523 0.577 0 CA-C-N 116.353 -0.385 . . . . 62.32 112.249 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -141.78 152.75 23.73 Favored Glycine 0 CA--C 1.525 0.659 0 C-N-CA 121.168 -0.539 . . . . 75.42 112.904 -176.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 136.93 18.65 0.66 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 120.882 -0.675 . . . . 53.01 113.78 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -67.47 94.77 0.42 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 117.238 0.519 . . . . 74.34 109.9 176.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -127.13 110.84 13.33 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.189 0.518 . . . . 64.23 111.899 -175.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -127.17 178.52 5.97 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.2 -0.455 . . . . 72.4 110.536 173.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.0 p-80 -56.58 126.22 25.68 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.254 -0.43 . . . . 74.45 110.389 170.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.46 ' O ' ' HB2' ' A' ' 75' ' ' HIS . 10.7 t60 -63.42 86.54 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 116.623 -0.262 . . . . 73.23 111.195 -175.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 74' ' ' HIS . 62.8 m170 72.84 162.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.577 0.751 . . . . 53.31 111.865 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.9 t-80 -73.11 105.67 4.65 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.26 -0.427 . . . . 72.45 111.947 179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -120.77 -160.0 0.82 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.06 0.457 . . . . 60.12 110.299 175.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 . . . . . 0 C--O 1.254 1.296 0 CA-C-O 118.678 -0.677 . . . . 74.4 110.13 170.391 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 20.4 ptp . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.91 0.386 . . . . 71.11 111.847 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -75.89 129.91 37.7 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.087 -0.506 . . . . 64.21 111.788 -177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 91.8 mt -139.12 153.07 47.93 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 120.947 0.404 . . . . 70.34 111.661 -176.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.5 m -109.18 126.47 53.29 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.934 0.397 . . . . 74.33 111.34 175.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.513 HG23 ' H ' ' A' ' 62' ' ' PHE . 4.7 p -133.83 124.08 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 116.5 -0.318 . . . . 32.42 110.95 178.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.547 HD22 ' N ' ' A' ' 6' ' ' ASN . 0.8 OUTLIER 62.53 26.39 15.68 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.143 0.497 . . . . 74.14 111.163 -179.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.28 16.8 80.41 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 121.24 -0.505 . . . . 72.02 112.74 -175.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -103.35 117.98 58.87 Favored Pre-proline 0 CA--C 1.536 0.417 0 O-C-N 122.761 -0.258 . . . . 64.13 110.793 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.21 116.44 4.19 Favored 'Trans proline' 0 CA--C 1.539 0.747 0 C-N-CA 122.447 2.098 . . . . 73.1 111.528 173.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.9 t -141.77 -173.95 3.93 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.933 0.397 . . . . 75.13 111.448 -178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.9 t -159.55 126.68 4.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.183 0.516 . . . . 72.24 111.734 176.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 12' ' ' VAL . 18.9 m -96.05 99.09 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.595 0.712 . . . . 54.24 110.437 175.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -84.45 137.71 33.22 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.993 -0.549 . . . . 74.12 110.875 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.96 8.5 56.85 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.28 -0.486 . . . . 41.13 113.207 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.01 97.57 8.41 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.412 -0.464 . . . . 75.4 111.517 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.405 ' CD ' ' H ' ' A' ' 16' ' ' GLU . 0.7 OUTLIER -77.45 76.73 3.99 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.317 0.579 . . . . 70.45 111.669 -177.485 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.2 m 53.48 71.19 0.52 Allowed 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.952 -0.567 . . . . 73.35 111.463 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 80.5 mt -93.3 145.75 24.22 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.272 0.558 . . . . 62.11 112.106 -176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 18.2 m-20 -70.51 163.98 25.71 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 115.857 -0.611 . . . . 75.14 110.037 173.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.6 t -55.5 -41.53 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-O 120.818 0.342 . . . . 71.33 110.608 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.5 m -61.69 -42.22 98.64 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.926 0.393 . . . . 75.52 111.842 176.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 43.0 mt-10 -68.4 -43.75 76.56 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.11 0.481 . . . . 71.34 111.131 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.7 tt -62.28 -37.66 86.36 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.311 0.577 . . . . 75.32 109.968 175.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 48.1 tp -58.13 -34.95 70.79 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.699 -0.682 . . . . 64.34 110.833 174.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 47.9 t -74.66 -33.59 62.53 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.369 -0.378 . . . . 72.31 111.327 174.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.77 71.81 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-O 121.157 0.504 . . . . 61.31 111.6 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.0 mt -90.44 -29.77 17.77 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.286 0.565 . . . . 72.54 110.216 171.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.1 tttt 57.51 86.81 0.07 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.057 -0.974 . . . . 74.12 112.565 176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.9 t -95.2 159.42 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.558 -0.746 . . . . 53.12 110.538 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.73 -63.77 1.07 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.054 0.454 . . . . 65.1 111.773 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -102.3 136.96 41.21 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.551 -0.295 . . . . 75.34 110.676 175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -104.26 -55.52 2.35 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 75.41 111.545 -178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -63.02 -11.72 21.08 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 115.826 -0.625 . . . . 62.1 112.301 -179.876 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -102.81 3.02 36.26 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 112.322 0.49 . . . . 75.14 112.322 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.423 HG12 HG13 ' A' ' 37' ' ' VAL . 81.3 t -74.39 138.19 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.321 0.581 . . . . 71.02 112.341 -177.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.512 ' HB ' ' CE1' ' A' ' 65' ' ' PHE . 89.4 m -115.83 108.54 16.44 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.128 -0.487 . . . . 72.35 110.575 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.0 m -134.04 162.23 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 CA-C-O 121.19 0.519 . . . . 71.14 111.891 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -140.09 169.61 17.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.577 -0.738 . . . . 74.15 110.563 176.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 39' ' ' LEU . 2.0 pt? -143.92 129.09 18.72 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.86 0.362 . . . . 72.03 111.078 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 60.75 21.08 11.14 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.173 0.511 . . . . 55.21 111.005 178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 55.78 2.98 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-N 116.04 -0.527 . . . . 74.4 113.374 -176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -164.33 126.15 2.28 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 116.914 0.357 . . . . 73.41 110.651 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -95.76 136.04 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-O 121.21 0.528 . . . . 74.31 112.352 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -111.58 166.78 10.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 121.667 0.746 . . . . 73.03 112.547 -177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -78.06 149.46 33.95 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.5 -0.773 . . . . 65.21 110.964 175.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.54 ' N ' ' HD2' ' A' ' 46' ' ' ARG . 9.1 mpt_? -64.34 -41.31 96.84 Favored 'General case' 0 N--CA 1.474 0.767 0 O-C-N 122.185 -0.322 . . . . 72.43 111.864 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.25 -29.76 69.48 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.19 0.519 . . . . 74.3 111.058 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.07 -19.28 65.63 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.279 -0.419 . . . . 73.44 111.585 177.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -62.13 -30.63 71.16 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.697 0.284 . . . . 74.3 111.508 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.7 -35.82 72.95 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 120.873 0.368 . . . . 70.43 111.54 176.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.87 -29.81 24.95 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.203 0.446 . . . . 73.31 112.203 -178.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.4 m -82.03 113.69 20.09 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.758 0.314 . . . . 63.45 111.832 -176.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.588 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.0 m -96.87 140.61 31.17 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.229 0.538 . . . . 73.04 111.881 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 55' ' ' LYS . 17.4 t -90.44 160.64 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 116.116 -0.493 . . . . 62.51 111.112 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' N ' HG12 ' A' ' 54' ' ' VAL . 20.9 pttm -141.38 169.94 16.66 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.979 0.418 . . . . 72.13 111.805 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 27.8 t70 -70.88 111.45 6.3 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.133 0.492 . . . . 63.34 110.97 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 97.71 39.77 3.79 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-N 116.175 -0.466 . . . . 52.21 112.096 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -122.82 175.32 6.61 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 110.006 -0.368 . . . . 71.32 110.006 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.67 143.77 43.3 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.245 0.545 . . . . 53.24 112.459 -178.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.475 HG23 ' HB ' ' A' ' 5' ' ' VAL . 24.0 m -130.5 71.06 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.805 0.812 . . . . 75.24 109.677 172.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.21 83.11 0.73 Allowed 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.763 0.792 . . . . 62.22 111.568 -172.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' H ' HG23 ' A' ' 5' ' ' VAL . 2.6 m-85 -77.4 92.26 3.94 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.09 -0.959 . . . . 73.45 111.767 177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.454 ' H ' HD23 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -82.53 87.68 6.67 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 121.346 0.593 . . . . 73.24 112.027 -177.299 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 70.96 -19.72 0.23 Allowed 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.096 1.147 . . . . 73.52 114.096 173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 36' ' ' THR . 78.7 m-85 -72.67 74.69 1.1 Allowed 'General case' 0 N--CA 1.473 0.697 0 O-C-N 121.817 -0.552 . . . . 70.41 111.079 174.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 58.1 mtt -121.0 -34.05 3.61 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 116.295 -0.412 . . . . 73.13 112.017 -177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.93 -31.63 4.68 Favored Glycine 0 CA--C 1.523 0.534 0 C-N-CA 121.269 -0.491 . . . . 60.13 112.027 -177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 74.58 -84.58 0.76 Allowed Glycine 0 CA--C 1.526 0.766 0 C-N-CA 121.378 -0.439 . . . . 63.52 114.024 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -84.8 49.38 4.23 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 114.379 0.512 . . . . 71.42 114.379 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -78.21 145.76 35.36 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 117.107 0.454 . . . . 64.21 110.734 176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.7 mt -69.58 112.29 5.98 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.708 0.289 . . . . 73.52 111.362 -179.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -80.08 154.69 27.93 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.884 0.373 . . . . 43.01 111.429 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -55.23 124.12 15.95 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 120.919 0.39 . . . . 74.44 111.849 174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -122.47 80.76 1.77 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.196 0.522 . . . . 72.43 110.875 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -120.23 152.18 38.1 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.13 -0.486 . . . . 74.05 110.929 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -72.54 139.69 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 121.111 0.481 . . . . 74.11 111.593 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.4 t60 -77.2 132.65 38.86 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 112.356 0.502 . . . . 72.01 112.356 -173.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 12.2 m170 . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.866 -0.588 . . . . 53.2 111.814 177.869 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HG3' HD21 ' A' ' 3' ' ' LEU . 21.1 ptp . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.693 0.282 . . . . 63.32 111.272 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.468 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 3.6 m-20 -95.46 119.98 34.92 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.803 0.335 . . . . 74.25 111.166 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.558 HD21 ' HG3' ' A' ' 1' ' ' MET . 1.3 mm? -114.2 124.06 51.1 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.688 0.28 . . . . 75.31 111.201 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.4 m -78.06 79.46 4.52 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 121.377 0.608 . . . . 74.24 110.343 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.28 122.09 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 116.085 -0.507 . . . . 63.45 112.334 -173.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.507 ' HA ' ' HG2' ' A' ' 61' ' ' GLU . 17.9 m120 56.93 23.02 7.75 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 116.099 -0.5 . . . . 72.52 112.081 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.58 3.4 64.63 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.329 -0.462 . . . . 52.33 113.474 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 3.2 mptp? -116.72 122.02 32.17 Favored Pre-proline 0 CA--C 1.54 0.584 0 O-C-N 122.235 -0.567 . . . . 74.23 110.859 178.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -53.49 125.65 19.21 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.931 2.421 . . . . 75.12 113.816 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.478 ' OG ' HD21 ' A' ' 71' ' ' LEU . 40.7 t -135.23 173.32 11.86 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.958 -0.565 . . . . 75.24 109.946 174.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 4.6 t -157.28 129.47 7.27 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.313 0.857 . . . . 74.53 113.313 -176.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.22 108.22 24.8 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 CA-C-O 121.537 0.684 . . . . 64.21 110.465 172.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.56 123.35 25.33 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 115.857 -0.61 . . . . 74.14 111.673 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 118.82 -33.48 4.75 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 121.24 -0.505 . . . . 73.5 113.161 179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.461 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -74.48 127.64 33.56 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.726 0.298 . . . . 71.51 111.671 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -137.79 108.71 6.7 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.201 0.524 . . . . 65.54 111.647 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.6 m 62.66 25.07 14.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.268 0.84 . . . . 64.53 113.268 171.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.2 pp -78.7 159.49 27.95 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.193 0.521 . . . . 75.23 111.853 178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 5.5 p-10 -84.06 156.43 22.21 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.389 -0.369 . . . . 70.44 111.6 178.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 58.3 t -51.8 -36.94 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 N-CA-C 112.683 0.623 . . . . 73.42 112.683 -173.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 16.8 m -52.92 -43.7 66.45 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 121.035 0.445 . . . . 52.35 111.568 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -82.42 -32.03 29.25 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.474 -0.33 . . . . 63.21 111.826 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.5 tt -56.79 -44.83 82.26 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 109.361 -0.607 . . . . 72.15 109.361 171.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.429 HD21 ' HA ' ' A' ' 32' ' ' ALA . 26.7 tp -60.94 -44.49 97.19 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 115.635 -0.711 . . . . 61.15 110.661 175.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.4 t -63.79 -27.92 69.51 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.807 -0.633 . . . . 64.03 111.905 177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.84 -36.74 84.22 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.956 0.407 . . . . 73.31 111.585 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.12 -2.53 48.76 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.301 -0.409 . . . . 62.51 110.931 175.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 79.6 tttt 64.0 25.72 13.92 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.996 -0.547 . . . . 73.03 111.51 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.6 t -57.52 130.61 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 116.357 -0.383 . . . . 75.31 111.537 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -67.05 -35.57 80.15 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 112.368 0.507 . . . . 73.55 112.368 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -96.04 167.65 11.1 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.116 0.484 . . . . 73.41 111.557 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 24' ' ' LEU . . . -146.05 -62.16 0.32 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.214 0.53 . . . . 33.43 110.803 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -55.53 -31.74 62.35 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.592 -0.731 . . . . 75.41 112.049 177.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -83.34 -16.49 45.89 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.67 0.618 . . . . 64.43 112.67 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 37' ' ' VAL . 6.1 t -81.46 80.0 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.237 0.541 . . . . 52.41 111.621 -174.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.6 m -70.87 84.14 0.66 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.083 -0.508 . . . . 75.45 111.442 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG12 ' A' ' 35' ' ' VAL . 32.8 m -86.45 147.94 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.122 0.487 . . . . 64.33 111.464 177.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 43' ' ' VAL . 13.2 pt-20 -136.44 127.14 27.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.25 0.547 . . . . 73.4 110.981 174.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.569 ' HG ' HD21 ' A' ' 44' ' ' LEU . 0.9 OUTLIER -99.47 134.95 41.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.001 0.429 . . . . 71.34 111.169 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.685 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.5 OUTLIER 60.66 18.92 8.93 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-O 121.067 0.461 . . . . 75.03 111.403 178.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.2 20.28 57.5 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 121.311 -0.471 . . . . 64.31 113.616 -176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -124.77 112.47 16.75 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.122 0.486 . . . . 74.14 111.105 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.409 ' HA ' ' HB3' ' A' ' 38' ' ' GLU . 8.9 p -70.6 144.41 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.371 0.878 . . . . 62.43 113.371 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.569 HD21 ' HG ' ' A' ' 39' ' ' LEU . 3.2 mm? -99.49 166.26 11.24 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.22 0.533 . . . . 74.02 111.667 177.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.38 155.18 20.7 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 116.049 -0.523 . . . . 73.51 110.743 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -52.51 -22.73 5.18 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.116 0.784 . . . . 63.13 113.116 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -128.86 26.84 5.51 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.115 0.483 . . . . 54.44 111.771 -177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -101.24 5.37 42.49 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.286 -0.415 . . . . 71.44 111.376 177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 21.3 m-85 -75.23 -27.77 59.64 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.809 0.338 . . . . 73.45 111.527 -177.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -73.46 -38.79 65.35 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.981 0.419 . . . . 75.33 111.065 174.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.64 -43.17 63.55 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.168 -0.469 . . . . 60.51 112.055 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.0 m -75.32 107.55 7.51 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.999 0.428 . . . . 35.24 111.986 -177.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 63.8 p -92.85 130.25 38.51 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.185 -0.461 . . . . 72.0 111.388 176.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.4 t -103.6 147.41 9.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.356 -0.383 . . . . 73.15 111.116 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -132.07 -174.75 3.52 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.241 0.543 . . . . 74.13 111.349 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.26 111.36 3.93 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.045 -0.525 . . . . 72.54 111.243 178.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 103.35 66.9 0.74 Allowed Glycine 0 CA--C 1.528 0.903 0 C-N-CA 121.045 -0.597 . . . . 61.33 113.958 175.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -149.71 162.08 40.94 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 110.147 -0.316 . . . . 75.45 110.147 171.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -111.42 99.32 8.12 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.511 0.56 . . . . 53.2 112.511 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 p -95.96 131.25 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 121.002 0.43 . . . . 75.2 111.097 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 40.8 mt-10 -109.03 121.2 44.64 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.262 0.553 . . . . 72.31 112.282 -177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -99.66 132.14 45.19 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.78 -0.645 . . . . 74.33 111.522 173.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -126.07 112.24 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-O 121.098 0.475 . . . . 73.42 112.092 178.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 68.05 -3.28 1.26 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.247 0.832 . . . . 73.15 113.247 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -87.2 119.8 27.82 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 121.996 -0.44 . . . . 60.13 111.838 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 95.0 mmm -83.93 146.04 28.25 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.896 -0.593 . . . . 72.31 111.815 -177.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.89 -45.21 0.17 Allowed Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.539 -0.755 . . . . 43.32 111.47 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 86.19 109.23 0.78 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.217 0.447 . . . . 42.55 114.217 174.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -93.9 63.0 1.86 Allowed Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.872 -0.891 . . . . 71.21 110.872 171.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -51.09 104.25 0.07 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 112.947 0.721 . . . . 74.31 112.947 -171.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD21 ' OG ' ' A' ' 10' ' ' SER . 91.8 mt -88.51 -174.93 4.78 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.0 -0.545 . . . . 74.14 110.516 172.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 62.95 92.21 0.06 Allowed 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.288 0.566 . . . . 71.25 111.753 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 -135.01 168.27 19.42 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.175 -0.466 . . . . 72.42 111.475 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 46.5 t-80 -60.65 116.44 4.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 116.24 -0.437 . . . . 65.0 110.135 174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -54.79 110.27 0.63 Allowed 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 121.084 0.469 . . . . 74.52 112.091 -175.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -68.83 134.75 50.11 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.002 -0.545 . . . . 71.11 111.589 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -155.55 146.73 22.6 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 120.858 0.361 . . . . 72.34 111.059 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.851 -0.595 . . . . 55.25 111.415 176.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 23.0 ptp . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 120.941 0.4 . . . . 71.1 111.26 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -101.6 106.24 17.29 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.978 0.418 . . . . 72.35 110.724 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.432 HD22 ' HB2' ' A' ' 58' ' ' ASP . 82.4 mt -100.25 176.45 5.37 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.973 0.416 . . . . 63.15 111.536 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 93.3 m -130.68 110.84 11.67 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.852 0.358 . . . . 54.03 110.979 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 29.8 m -105.11 118.39 52.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 CA-C-O 120.956 0.407 . . . . 71.41 111.577 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 38.4 m-80 62.12 22.26 13.0 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 120.865 0.364 . . . . 74.25 111.943 178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.11 -0.87 64.44 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.161 -0.543 . . . . 63.23 113.36 -177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -110.23 141.7 24.44 Favored Pre-proline 0 N--CA 1.471 0.605 0 O-C-N 122.526 -0.396 . . . . 65.15 111.273 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -73.98 119.79 6.03 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.411 2.074 . . . . 60.53 112.978 -177.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 32.5 t -120.4 113.24 20.05 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.983 0.42 . . . . 64.32 111.49 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.8 m -95.12 110.25 22.22 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.253 -0.431 . . . . 63.15 111.444 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.9 m -93.66 124.64 46.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.131 0.491 . . . . 72.4 110.968 176.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -75.78 144.6 41.31 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.089 -0.505 . . . . 62.24 111.921 -174.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.69 -49.59 4.22 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-N 116.192 -0.458 . . . . 70.12 113.756 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.84 105.74 0.42 Allowed 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.102 0.779 . . . . 45.45 113.102 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -103.1 -44.37 5.23 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 116.298 -0.41 . . . . 75.02 111.148 173.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.6 m -141.46 126.33 18.15 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.71 0.29 . . . . 73.23 110.86 176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.8 pp -164.96 169.63 16.2 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.728 0.299 . . . . 63.04 111.521 177.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -103.02 160.6 14.48 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 110.45 -0.204 . . . . 75.53 110.45 173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 58.1 t -48.07 -40.82 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 N-CA-C 112.917 0.71 . . . . 62.55 112.917 -172.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.6 m -48.0 -47.47 33.15 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 121.142 0.496 . . . . 65.3 111.581 176.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -73.44 -33.02 64.7 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.052 0.454 . . . . 74.03 111.203 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -62.05 -41.69 98.4 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.046 0.451 . . . . 73.53 110.239 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 91.8 mt -56.7 -28.66 61.32 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.132 -0.486 . . . . 74.12 111.507 177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.7 t -80.17 -48.34 13.3 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.409 -0.36 . . . . 74.21 111.391 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.4 -45.78 90.54 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.058 0.456 . . . . 74.21 111.864 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 10.0 tt -75.14 -30.62 60.84 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.148 -0.478 . . . . 71.1 110.915 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 69.25 88.97 0.11 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.463 0.649 . . . . 63.14 111.332 -176.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.472 HG11 HD22 ' A' ' 24' ' ' LEU . 8.0 p -102.15 149.52 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 115.773 -0.649 . . . . 74.33 111.91 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.58 126.9 35.21 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.72 174.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 58.88 67.57 0.91 Allowed 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.234 0.54 . . . . 73.14 111.507 -174.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -63.85 -30.69 71.76 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.217 -0.447 . . . . 60.43 112.015 -177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -71.8 -12.96 61.55 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.939 0.399 . . . . 73.11 111.491 179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -129.93 12.36 5.69 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 116.53 -0.304 . . . . 71.44 111.64 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.465 HG22 HG13 ' A' ' 37' ' ' VAL . 7.6 p -68.0 118.71 12.39 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 121.452 0.644 . . . . 70.44 112.508 -175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.1 m -92.97 108.58 20.12 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.173 -0.467 . . . . 74.34 111.03 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.465 HG13 HG22 ' A' ' 35' ' ' VAL . 18.0 m -140.92 146.35 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-N 116.146 -0.479 . . . . 73.43 111.164 179.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.2 pm0 -123.54 132.48 53.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 120.899 0.381 . . . . 74.44 111.745 175.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.455 HD22 HD11 ' A' ' 44' ' ' LEU . 2.1 pt? -97.02 124.53 41.03 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.932 -0.395 . . . . 71.31 109.932 175.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.5 m120 56.18 22.62 6.24 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 120.98 0.419 . . . . 52.24 111.798 177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.62 -20.44 32.02 Favored Glycine 0 CA--C 1.532 1.097 0 N-CA-C 114.275 0.47 . . . . 74.55 114.275 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -95.45 122.47 38.21 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 117.677 0.739 . . . . 72.14 111.464 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.9 p -78.23 138.89 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 CA-C-O 121.146 0.498 . . . . 65.32 112.003 -177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' N ' HD12 ' A' ' 44' ' ' LEU . 5.0 mp -92.72 121.65 34.33 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.101 -0.5 . . . . 72.41 111.335 -178.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -69.12 152.39 45.22 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 116.383 -0.371 . . . . 70.45 111.632 178.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 39.0 ptt180 -48.72 -36.81 17.1 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 112.635 0.605 . . . . 70.41 112.635 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -81.27 -24.62 37.16 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.214 0.53 . . . . 75.12 111.754 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.07 -16.65 57.84 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 113.054 0.761 . . . . 71.32 113.054 -174.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.539 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 22.2 m-85 -53.06 -39.53 63.32 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 112.857 0.688 . . . . 72.51 112.857 -176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -83.81 -23.09 31.57 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 122.06 -0.4 . . . . 74.11 111.678 -176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -94.21 -2.21 52.86 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 112.621 0.6 . . . . 74.12 112.621 -176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.0 m -105.29 118.02 35.5 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 122.184 -0.323 . . . . 43.31 111.671 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.7 m -89.22 138.58 31.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.097 0.475 . . . . 74.15 112.017 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.4 t -114.49 147.09 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 122.942 0.497 . . . . 73.22 110.961 177.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -145.01 -168.47 2.95 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.123 0.487 . . . . 74.0 111.63 -177.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 36.3 t70 -70.22 79.31 0.52 Allowed 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 121.149 0.499 . . . . 62.13 111.5 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 133.84 65.31 0.07 OUTLIER Glycine 0 CA--C 1.53 0.974 0 C-N-CA 121.154 -0.546 . . . . 75.11 113.52 176.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD22 ' A' ' 3' ' ' LEU . 5.0 m-20 -131.51 131.81 43.71 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 122.421 -0.458 . . . . 71.23 110.657 175.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 39' ' ' LEU . . . -93.19 66.98 4.13 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 111.995 0.368 . . . . 74.12 111.995 -176.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.2 p -82.83 114.77 24.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 CA-C-O 121.285 0.564 . . . . 60.13 111.466 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -88.75 114.82 25.78 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 112.045 0.387 . . . . 75.24 112.045 -177.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.462 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-85 -101.32 118.45 37.0 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-O 120.887 0.375 . . . . 63.33 111.647 176.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 63' ' ' LEU . 1.8 pt? -134.77 132.38 38.66 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.402 -0.363 . . . . 71.21 111.521 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 67.06 -3.28 0.99 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.168 0.803 . . . . 73.54 113.168 177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -120.65 27.87 8.29 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 122.139 -0.351 . . . . 61.43 111.252 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.2 mtp 72.63 103.81 0.07 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.206 0.602 . . . . 70.44 112.11 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -139.81 35.71 1.9 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.23 -0.509 . . . . 61.23 113.26 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -115.33 72.85 0.25 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.357 -0.449 . . . . 35.35 113.355 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -86.53 44.52 3.34 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 120.92 -0.657 . . . . 65.04 113.603 -179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -145.62 -178.21 5.98 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.558 0.694 . . . . 60.24 112.08 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.498 ' N ' HD23 ' A' ' 71' ' ' LEU . 1.9 pt? -147.28 134.75 20.82 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 114.975 -1.011 . . . . 61.11 109.06 171.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.53 118.46 11.59 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 121.247 0.546 . . . . 61.41 111.55 -175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -96.62 113.02 24.55 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.028 -0.533 . . . . 65.21 111.27 -176.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -62.86 87.32 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 121.749 0.785 . . . . 75.45 110.822 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.523 ' H ' ' CD2' ' A' ' 75' ' ' HIS . 0.8 OUTLIER -101.53 139.64 36.91 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.609 -0.723 . . . . 74.33 111.815 -175.37 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 66.6 m-70 65.63 128.21 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.383 0.611 . . . . 71.25 112.111 -175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -87.53 169.71 11.96 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.256 0.55 . . . . 73.34 112.191 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 11.0 p80 . . . . . 0 C--O 1.25 1.129 0 CA-C-N 115.754 -0.657 . . . . 71.23 111.747 -178.491 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.607 ' HE3' HD11 ' A' ' 3' ' ' LEU . 25.4 ptt? . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.764 0.316 . . . . 63.41 111.505 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -80.49 118.88 22.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.937 0.398 . . . . 74.4 111.359 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.607 HD11 ' HE3' ' A' ' 1' ' ' MET . 68.0 mt -123.34 148.4 46.05 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.156 0.503 . . . . 74.15 112.079 -173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.409 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 16.7 m -85.0 82.67 8.35 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.122 0.487 . . . . 75.24 110.431 176.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -89.36 134.78 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-N 116.431 -0.349 . . . . 71.43 110.973 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 67.1 8.26 6.04 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.556 0.342 . . . . 73.02 111.298 -176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.21 16.67 68.76 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 120.98 -0.629 . . . . 52.43 111.868 -169.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.416 ' HB3' ' NZ ' ' A' ' 8' ' ' LYS . 5.6 mtpm? -124.15 154.4 68.42 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 123.311 0.644 . . . . 74.44 110.768 -177.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.78 115.86 4.29 Favored 'Trans proline' 0 CA--C 1.545 1.06 0 C-N-CA 122.294 1.996 . . . . 63.1 113.212 178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 46.9 t -142.17 -176.79 4.95 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.579 0.352 . . . . 52.43 110.708 178.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.3 t -162.85 137.99 6.75 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.39 0.515 . . . . 52.22 112.39 -178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.7 m -108.33 86.84 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.358 0.599 . . . . 75.1 111.095 175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.2 t70 59.71 174.5 0.08 Allowed 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.505 -0.77 . . . . 75.42 112.455 178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -74.13 -4.83 69.25 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 121.292 -0.48 . . . . 63.52 113.144 174.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -46.6 126.42 8.3 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 122.826 0.451 . . . . 73.54 111.95 177.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -66.53 -66.04 0.6 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 62.42 112.521 -172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.6 p -133.05 124.17 27.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.643 0.259 . . . . 73.41 111.329 -177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 91.3 mt -132.38 142.6 49.37 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.741 0.305 . . . . 74.21 111.257 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.575 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.26 162.8 5.6 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.575 -0.284 . . . . 74.21 110.818 175.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 39.7 t -61.09 -40.15 84.75 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 O-C-N 121.981 -0.449 . . . . 64.53 110.298 175.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.0 m -59.78 -47.75 84.45 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 116.256 -0.429 . . . . 74.14 111.167 173.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 18' ' ' LEU . 2.5 mm-40 -58.47 -38.03 76.73 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.0 0.428 . . . . 73.23 111.256 174.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.6 tt -59.69 -45.44 92.09 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.199 -0.455 . . . . 64.44 110.049 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.489 HD13 ' HB1' ' A' ' 32' ' ' ALA . 72.4 mt -56.91 -39.34 74.25 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.181 0.515 . . . . 62.54 111.262 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 57.9 m -78.05 -29.19 49.16 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.161 -0.472 . . . . 55.15 112.121 178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.26 -47.21 20.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.164 0.507 . . . . 54.15 111.754 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.579 ' O ' HD23 ' A' ' 27' ' ' LEU . 7.2 tt -76.79 -16.43 59.46 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 116.082 -0.508 . . . . 72.23 110.615 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp 66.77 74.04 0.34 Allowed 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 121.352 0.596 . . . . 45.23 110.501 -177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.405 HG22 HD22 ' A' ' 27' ' ' LEU . 53.5 t -104.21 130.91 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 112.691 0.626 . . . . 72.25 112.691 -174.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -81.69 146.0 30.24 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.32 -0.4 . . . . 73.42 110.209 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 62.07 33.23 17.22 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 120.925 0.393 . . . . 54.22 110.79 -172.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' HB1' HD13 ' A' ' 24' ' ' LEU . . . -53.39 -51.9 61.04 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.281 0.474 . . . . 34.54 112.281 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -70.03 -12.45 61.61 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-O 121.191 0.519 . . . . 65.34 111.813 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -118.06 2.69 12.08 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.479 0.548 . . . . 74.25 112.479 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG12 ' O ' ' A' ' 32' ' ' ALA . 10.8 p -73.09 146.3 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 65.21 111.875 -176.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.5 m -100.3 108.85 21.01 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.471 -0.331 . . . . 74.04 110.456 174.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG12 ' HA ' ' A' ' 62' ' ' PHE . 26.8 m -133.17 134.0 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-O 121.217 0.532 . . . . 74.35 111.698 178.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 1.7 pm0 -104.88 125.3 50.76 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 121.308 0.575 . . . . 54.33 111.508 174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.667 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -76.14 106.43 7.75 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.836 -0.62 . . . . 62.41 110.216 179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 53.08 26.96 5.28 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.84 0.456 . . . . 64.24 112.05 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.13 4.38 41.39 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.304 -0.474 . . . . 72.01 113.947 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -119.88 108.07 13.91 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 117.278 0.539 . . . . 71.22 111.418 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 8.8 p -60.27 137.51 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 N-CA-C 112.318 0.488 . . . . 64.43 112.318 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.1 mm? -94.2 151.81 19.19 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.145 0.497 . . . . 73.1 111.807 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -71.99 160.91 31.7 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.114 -0.494 . . . . 75.42 110.946 173.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -51.37 -46.73 62.85 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.321 0.489 . . . . 71.15 112.321 -174.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.19 -6.48 55.25 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.417 0.525 . . . . 74.44 112.417 -179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.75 -27.49 66.82 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.769 0.319 . . . . 54.31 111.364 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -50.68 -38.03 44.41 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 116.198 -0.455 . . . . 71.23 111.544 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -73.54 -42.88 61.12 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.914 -0.584 . . . . 63.41 111.573 -178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -86.89 -4.78 59.21 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 113.084 0.772 . . . . 75.41 113.084 -173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.8 m -101.82 116.96 33.86 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.709 0.29 . . . . 72.21 111.561 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.575 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 65.2 p -100.5 116.96 33.66 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 112.16 0.43 . . . . 74.24 112.16 -177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.88 152.52 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-N 115.824 -0.625 . . . . 73.55 110.903 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -139.89 175.89 9.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.878 0.371 . . . . 74.05 111.42 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -63.14 137.63 58.29 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-O 121.117 0.484 . . . . 75.32 111.391 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.36 33.94 24.37 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 116.147 -0.479 . . . . 35.32 113.164 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.474 ' HB3' HD22 ' A' ' 3' ' ' LEU . 12.7 t70 -109.88 177.45 4.72 Favored 'General case' 0 CA--C 1.547 0.859 0 O-C-N 122.684 -0.303 . . . . 70.14 110.867 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -139.99 92.13 2.52 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 112.429 0.529 . . . . 52.21 112.429 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.1 p -98.17 115.76 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.344 0.592 . . . . 73.14 111.219 176.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.563 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 44.0 mt-10 -84.15 93.45 8.15 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.217 0.532 . . . . 72.23 112.414 -177.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' A' ' 37' ' ' VAL . 12.8 m-85 -78.9 120.27 23.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.941 -0.572 . . . . 75.13 110.875 169.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 74.3 mt -124.03 136.1 54.04 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.633 0.254 . . . . 61.54 110.807 176.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.51 34.66 0.22 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 112.528 0.566 . . . . 62.2 112.528 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 66.41 149.5 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.119 0.785 . . . . 73.24 113.119 174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 66.3 mtt -70.99 76.64 0.65 Allowed 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.234 0.54 . . . . 71.43 110.486 174.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -151.65 -14.77 0.07 OUTLIER Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.151 -0.547 . . . . 72.42 113.666 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 76.8 -61.54 3.3 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 121.331 -0.462 . . . . 63.2 113.746 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.06 41.67 10.18 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 120.987 -0.625 . . . . 75.41 112.84 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 66.44 158.33 0.12 Allowed 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.498 0.666 . . . . 74.45 112.477 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 74' ' ' HIS . 1.4 tt -78.27 90.47 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.144 -0.48 . . . . 74.32 110.124 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.27 -37.69 48.63 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.586 0.958 . . . . 70.22 113.586 -175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -170.99 -54.3 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.033 -0.358 . . . . 70.24 110.033 177.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.467 ' HA ' HD21 ' A' ' 71' ' ' LEU . 9.2 t60 -179.97 66.58 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.145 -0.479 . . . . 72.43 111.013 173.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -67.77 127.89 34.48 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-O 120.929 0.395 . . . . 74.42 111.284 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -67.25 11.18 0.12 Allowed 'General case' 0 CA--C 1.552 1.058 0 N-CA-C 113.678 0.992 . . . . 71.2 113.678 -171.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -158.47 -175.97 5.62 Favored 'General case' 0 N--CA 1.472 0.643 0 O-C-N 121.77 -0.581 . . . . 73.53 110.963 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 55.5 m80 . . . . . 0 C--O 1.251 1.135 0 CA-C-O 118.15 -0.929 . . . . 74.03 110.231 174.353 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.568 ' HB3' ' HA ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 112.22 0.452 . . . . 75.33 112.22 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -94.89 124.15 38.76 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.157 -0.474 . . . . 50.15 111.505 178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.465 HD21 ' HG2' ' A' ' 1' ' ' MET . 2.9 mm? -120.99 174.42 6.64 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.068 0.461 . . . . 55.42 111.103 175.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.2 m -129.04 95.29 4.03 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.072 0.463 . . . . 71.14 110.692 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.647 HG12 HD22 ' A' ' 6' ' ' ASN . 61.8 t -88.13 113.97 26.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 116.436 -0.347 . . . . 73.12 111.774 -177.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.647 HD22 HG12 ' A' ' 5' ' ' VAL . 53.8 m-80 57.91 29.68 17.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.005 0.522 . . . . 64.24 112.001 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 87.31 7.88 75.71 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 120.89 -0.671 . . . . 71.11 113.301 -177.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -114.11 122.07 35.31 Favored Pre-proline 0 CA--C 1.539 0.537 0 O-C-N 122.625 -0.338 . . . . 74.31 110.975 177.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_exo -65.83 119.45 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.739 2.293 . . . . 74.31 112.997 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.8 p -130.08 127.74 40.48 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.155 0.502 . . . . 53.14 111.258 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 58.4 m -102.7 117.18 34.09 Favored 'General case' 0 N--CA 1.467 0.421 0 O-C-N 122.159 -0.338 . . . . 65.04 111.51 -178.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.417 HG23 ' SD ' ' A' ' 1' ' ' MET . 19.6 m -89.56 131.8 35.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 CA-C-O 120.892 0.377 . . . . 71.43 110.373 174.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.3 155.03 20.82 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.446 0.536 . . . . 71.33 112.446 -170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.49 -72.04 1.77 Allowed Glycine 0 CA--C 1.529 0.945 0 CA-C-N 115.986 -0.552 . . . . 63.45 113.77 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.46 166.97 12.95 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 112.416 0.524 . . . . 72.13 112.416 -176.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.568 ' HA ' ' HB3' ' A' ' 1' ' ' MET . 10.0 pt-20 -129.06 -31.93 2.09 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.097 -0.501 . . . . 74.33 112.177 177.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.1 p -140.08 130.64 25.58 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 121.003 0.43 . . . . 73.14 112.122 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.1 pp -170.72 165.45 8.09 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 115.967 -0.56 . . . . 72.45 111.5 177.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.754 ' HB2' ' HG2' ' A' ' 22' ' ' GLU . 48.7 m-20 -61.84 155.82 22.22 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 120.753 0.311 . . . . 73.53 111.376 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.9 t -56.88 -38.77 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 CA-C-O 121.071 0.462 . . . . 74.33 110.56 174.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.4 m -59.33 -41.92 90.25 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.082 -0.508 . . . . 71.41 111.783 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.754 ' HG2' ' HB2' ' A' ' 19' ' ' ASN . 15.3 mm-40 -63.58 -48.57 76.86 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.069 0.461 . . . . 74.51 110.527 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 53.0 tp -57.53 -46.3 84.02 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.136 -0.484 . . . . 75.03 111.068 176.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 34.4 tp -59.03 -44.02 91.68 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.103 0.478 . . . . 72.42 111.043 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 67.8 m -66.76 -30.42 70.63 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.021 0.439 . . . . 74.41 111.161 176.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.98 -35.93 77.28 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 73.42 111.013 175.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.3 mt -74.14 -32.56 63.2 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.122 -0.49 . . . . 65.41 111.844 178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 22.6 ttmm 64.95 85.54 0.14 Allowed 'General case' 0 CA--C 1.543 0.678 0 CA-C-O 121.387 0.613 . . . . 75.44 110.881 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.8 p -104.6 149.7 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 116.246 -0.434 . . . . 75.25 112.106 -174.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.88 121.84 20.65 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.451 -0.34 . . . . 70.44 110.98 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 21.6 mt-30 61.99 80.46 0.22 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.262 0.553 . . . . 64.43 110.759 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.427 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -55.31 -35.92 65.64 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.671 0.989 . . . . 55.15 113.671 -171.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -79.45 -22.72 43.78 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.216 0.451 . . . . 61.22 112.216 -177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CD1' ' HB3' ' A' ' 31' ' ' GLN . 9.4 m-85 -86.98 -11.85 49.25 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.512 0.56 . . . . 72.14 112.512 -171.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 32' ' ' ALA . 7.9 p -79.42 131.7 33.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 CA-C-O 121.235 0.54 . . . . 64.54 111.366 177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 65.7 m -115.89 128.3 55.68 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 116.503 -0.317 . . . . 70.44 111.457 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG12 ' HA ' ' A' ' 62' ' ' PHE . 34.9 m -137.67 140.91 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-O 121.106 0.479 . . . . 74.3 111.274 177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -111.09 113.25 25.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.458 0.647 . . . . 74.31 110.088 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.2 tp -75.23 104.96 6.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.009 -0.541 . . . . 74.35 112.195 -172.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.62 28.35 17.76 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 115.861 -0.609 . . . . 71.25 111.789 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.47 -20.04 14.06 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.362 -0.447 . . . . 61.23 113.727 178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -104.84 135.8 45.52 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 117.044 0.422 . . . . 74.33 111.376 -179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.9 p -88.23 134.82 27.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 CA-C-O 120.934 0.397 . . . . 74.42 111.728 -176.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.7 mp -110.65 141.98 43.15 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.313 0.578 . . . . 71.4 111.832 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -79.84 167.67 20.27 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.896 -0.593 . . . . 74.52 111.021 174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -57.15 -35.02 69.03 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 112.73 0.641 . . . . 73.0 112.73 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -96.55 -4.91 40.47 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.07 0.396 . . . . 71.32 112.07 178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.14 -15.53 56.9 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 112.254 0.464 . . . . 50.22 112.254 -177.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -59.35 -24.74 63.62 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.056 0.455 . . . . 73.0 111.957 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -78.78 -29.11 44.8 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.32 -0.4 . . . . 64.14 111.847 176.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -84.54 12.36 7.13 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.155 0.798 . . . . 70.32 113.155 -172.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 86.1 m -141.69 120.24 12.47 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 121.726 -0.609 . . . . 72.33 111.782 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 30.7 m -92.96 106.89 18.78 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.097 -0.501 . . . . 75.04 111.158 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.9 t -78.5 148.14 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 116.363 -0.38 . . . . 73.14 110.893 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 16' ' ' GLU . 17.0 ptpt -144.11 -173.18 3.94 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.839 0.352 . . . . 65.34 111.665 -178.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.524 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 10.2 t70 -66.94 112.74 4.49 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.194 0.521 . . . . 55.51 111.463 -176.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 104.66 63.42 0.66 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 116.105 -0.498 . . . . 75.23 113.042 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -154.2 172.58 17.37 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.895 -0.409 . . . . 75.35 109.895 177.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -123.23 94.56 4.29 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 112.811 0.671 . . . . 62.11 112.811 -174.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG13 HG22 ' A' ' 5' ' ' VAL . 4.8 p -88.94 95.86 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 CA-C-O 121.491 0.662 . . . . 63.23 110.809 175.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -79.88 103.16 9.59 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.376 0.608 . . . . 73.15 111.42 -176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.537 ' HA ' HG12 ' A' ' 37' ' ' VAL . 45.0 t80 -91.69 109.49 20.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.809 -0.632 . . . . 74.3 110.911 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 68.0 mt -72.76 149.8 43.37 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-O 121.066 0.46 . . . . 73.14 112.202 -177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 50.8 p90 -104.62 21.7 16.35 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.331 0.493 . . . . 65.13 112.331 -177.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -59.26 148.33 32.35 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.275 0.56 . . . . 71.44 112.47 -176.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 60.0 mtt -74.37 115.13 13.54 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.102 -0.499 . . . . 74.21 111.239 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -129.37 24.76 4.64 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.254 -0.498 . . . . 50.03 112.908 177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -90.63 -36.47 6.87 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.042 -0.599 . . . . 73.25 113.476 -177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.09 -61.4 4.67 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.292 -0.48 . . . . 62.24 113.009 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -70.7 118.38 13.42 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.874 0.368 . . . . 71.31 111.62 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 30.9 tp -109.91 112.61 24.74 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.016 0.436 . . . . 63.42 110.538 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -122.4 18.3 10.56 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 112.645 0.609 . . . . 62.22 112.645 -173.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 62.82 162.68 0.09 Allowed 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.16 0.505 . . . . 74.13 111.307 -170.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.1 m-70 -133.48 -58.49 0.88 Allowed 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.762 -0.586 . . . . 70.14 112.316 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -160.17 149.61 17.71 Favored 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.762 0.653 . . . . 63.43 112.762 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.8 m170 -106.81 150.34 26.45 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.197 0.522 . . . . 71.24 112.189 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -111.67 176.55 4.98 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.681 -0.69 . . . . 75.22 110.353 173.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.3 p80 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 119.228 -0.415 . . . . 70.31 111.977 -178.502 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 3' ' ' LEU . 24.9 ptp . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 120.742 0.306 . . . . 73.2 111.072 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -98.04 114.44 26.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.464 -0.334 . . . . 65.44 110.86 176.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.426 HD21 ' SD ' ' A' ' 1' ' ' MET . 91.3 mt -121.94 131.16 53.87 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.938 0.399 . . . . 74.11 111.715 -178.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 39.6 m -85.78 85.45 7.39 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.04 0.448 . . . . 72.31 111.001 177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.3 p -82.44 117.03 27.69 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.024 0.44 . . . . 71.53 111.615 -176.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 59.29 15.04 4.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.615 0.598 . . . . 72.13 112.615 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 108.22 -4.43 33.46 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.319 -0.467 . . . . 74.54 113.218 -177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -107.62 106.57 58.76 Favored Pre-proline 0 CA--C 1.541 0.633 0 O-C-N 122.584 -0.362 . . . . 73.44 111.545 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 20.4 Cg_exo -65.82 99.5 0.39 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 122.798 2.332 . . . . 72.31 112.877 177.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 47.5 t -112.79 139.14 48.67 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.143 0.497 . . . . 63.42 111.556 179.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 97.0 m -89.3 99.97 12.85 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 120.899 0.38 . . . . 74.33 111.355 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -85.89 111.04 20.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.22 0.533 . . . . 71.53 110.198 173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -86.55 161.09 18.73 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-O 121.233 0.539 . . . . 74.42 112.211 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.99 11.75 84.51 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 115.971 -0.559 . . . . 71.23 112.869 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.91 102.72 4.48 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 122.641 -0.329 . . . . 71.53 111.474 -177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -97.79 -29.94 13.07 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 120.732 0.301 . . . . 75.11 111.731 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.0 p -160.62 106.4 1.47 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 116.564 -0.289 . . . . 71.04 111.156 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.5 pp -143.79 156.53 44.52 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 121.163 0.506 . . . . 73.53 111.649 178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 49' ' ' PHE . 4.6 p-10 -83.09 164.27 20.38 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.359 -0.382 . . . . 73.3 110.973 177.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.408 HG21 ' CD2' ' A' ' 44' ' ' LEU . 46.1 t -53.84 -33.93 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 112.749 0.648 . . . . 71.02 112.749 -172.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.4 m -52.03 -54.67 27.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.274 0.559 . . . . 71.01 111.403 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -67.56 -33.0 74.14 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.985 -0.552 . . . . 53.12 111.592 178.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 tt -55.92 -44.68 78.51 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-O 121.035 0.445 . . . . 64.54 110.333 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 91.9 mt -61.15 -32.62 72.34 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 120.929 0.395 . . . . 60.12 111.252 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 43.6 t -66.34 -35.46 80.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.291 -0.413 . . . . 65.11 111.29 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.35 -42.95 92.74 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.112 0.482 . . . . 52.22 111.639 178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' N ' HD12 ' A' ' 27' ' ' LEU . 6.5 mp -82.48 -24.48 34.18 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.174 0.511 . . . . 71.53 110.777 175.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 64.0 tttm 63.04 84.8 0.14 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.7 0.8 . . . . 71.21 111.961 -179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.3 p -99.14 145.89 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-N 115.701 -0.681 . . . . 72.25 110.691 177.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.08 -55.32 8.47 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.023 0.439 . . . . 74.43 111.324 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 22.8 mp0 -91.73 78.44 5.48 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 116.407 -0.36 . . . . 72.02 110.822 176.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.424 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -64.93 -44.56 89.07 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.175 0.512 . . . . 72.12 111.356 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -63.58 -33.42 75.57 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.036 -0.529 . . . . 64.03 111.916 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.466 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 26.1 m-85 -109.11 9.1 26.26 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 112.763 0.653 . . . . 74.44 112.763 -167.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 32' ' ' ALA . 8.7 p -86.44 124.74 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 120.982 0.42 . . . . 70.53 110.998 176.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.8 m -85.09 109.52 18.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.17 0.51 . . . . 41.2 111.231 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 m -124.68 145.55 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 115.915 -0.584 . . . . 61.52 111.105 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -136.57 147.7 47.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.911 0.386 . . . . 75.31 111.068 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.556 ' HB3' HD22 ' A' ' 40' ' ' ASN . 10.6 mp -112.49 131.27 55.66 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 111.815 0.302 . . . . 61.42 111.815 -178.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.556 HD22 ' HB3' ' A' ' 39' ' ' LEU . 32.7 m-80 56.23 27.32 11.54 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 112.598 0.592 . . . . 73.23 112.598 171.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.26 18.57 57.17 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 121.481 -0.39 . . . . 71.23 113.721 -178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -131.98 131.69 42.81 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 122.364 -0.492 . . . . 51.32 110.199 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.66 127.02 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 121.366 0.603 . . . . 74.21 112.286 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.408 ' CD2' HG21 ' A' ' 20' ' ' VAL . 10.5 mp -94.39 136.79 34.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.523 0.677 . . . . 71.44 112.317 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.433 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 9.3 tp10 -66.25 142.2 57.77 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 115.56 -0.745 . . . . 74.5 110.711 172.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.9 ttp85 -52.25 -45.95 65.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.219 0.533 . . . . 74.15 111.177 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.433 ' H ' ' HG3' ' A' ' 45' ' ' GLU . 40.4 mt-10 -77.92 9.66 3.42 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 116.037 -0.529 . . . . 62.32 112.112 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -107.59 -10.21 15.72 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 122.186 -0.322 . . . . 71.03 111.376 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 22.5 m-30 -60.93 -24.75 66.28 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.159 0.429 . . . . 71.21 112.159 -177.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.468 ' HA ' ' ND2' ' A' ' 19' ' ' ASN . 3.6 p30 -84.34 -29.75 26.04 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.848 0.356 . . . . 73.44 111.663 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -80.19 -53.14 6.94 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.331 -0.395 . . . . 74.12 111.861 -177.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.406 HG21 HD21 ' A' ' 44' ' ' LEU . 62.4 m -63.2 98.74 0.15 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.831 0.348 . . . . 73.25 111.124 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 57.2 m -85.2 108.59 17.8 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.882 0.373 . . . . 71.01 111.21 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -78.45 133.67 29.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 120.977 0.418 . . . . 64.32 111.377 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm -128.86 -177.65 4.29 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.451 0.643 . . . . 71.0 112.063 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -61.62 122.57 15.61 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.593 -0.73 . . . . 72.34 111.884 -177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 96.29 31.58 7.14 Favored Glycine 0 CA--C 1.525 0.698 0 CA-C-N 116.353 -0.385 . . . . 23.33 113.603 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -108.96 160.62 15.87 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 117.04 0.42 . . . . 72.14 110.54 178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -120.17 99.11 6.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.053 0.454 . . . . 74.52 111.701 -177.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -95.64 131.19 43.07 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-O 121.227 0.537 . . . . 63.11 111.739 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -102.93 109.62 21.24 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.376 0.607 . . . . 65.41 110.829 177.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -113.05 108.88 17.93 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.703 -0.68 . . . . 73.24 110.54 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 54.1 mt -87.36 128.42 35.19 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.052 0.453 . . . . 73.43 111.841 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 36.5 p90 -81.63 33.94 0.38 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.304 0.483 . . . . 74.4 112.304 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -77.19 134.7 38.56 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-O 121.06 0.457 . . . . 55.51 111.733 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 81.8 mtp -127.59 132.04 49.87 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.315 -0.402 . . . . 72.13 110.863 174.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -142.06 39.73 1.36 Allowed Glycine 0 CA--C 1.525 0.677 0 C-N-CA 121.214 -0.517 . . . . 62.02 112.662 179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -109.72 23.11 22.67 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.433 -0.413 . . . . 54.41 113.41 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.83 -101.08 0.89 Allowed Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.285 -0.483 . . . . 62.53 113.227 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 66.58 116.35 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.737 0 CA-C-O 121.619 0.723 . . . . 73.42 112.284 179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' H ' ' HG ' ' A' ' 71' ' ' LEU . 3.6 pp -81.56 157.85 24.62 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 112.706 0.632 . . . . 74.11 112.706 -177.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -107.82 146.71 31.88 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.999 -0.546 . . . . 74.32 111.191 177.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -175.11 122.59 0.22 Allowed 'General case' 0 CA--C 1.544 0.74 0 CA-C-O 120.506 0.193 . . . . 70.24 111.314 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -119.59 114.59 22.47 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-O 120.927 0.394 . . . . 72.0 112.019 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 66.4 m80 -69.78 155.11 41.03 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.334 -0.393 . . . . 61.43 111.534 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -103.15 146.78 27.89 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.219 0.533 . . . . 62.54 111.695 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -114.79 139.71 49.51 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.018 -0.537 . . . . 72.45 111.267 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 49.4 m80 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.484 -0.77 . . . . 70.44 111.081 178.519 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HG3' HD11 ' A' ' 3' ' ' LEU . 19.7 ptp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.719 0.295 . . . . 71.02 111.403 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -101.81 133.28 46.81 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.624 0.37 . . . . 65.21 110.652 174.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.57 HD11 ' HG3' ' A' ' 1' ' ' MET . 1.6 mp -133.95 157.17 46.71 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 122.132 -0.355 . . . . 71.52 111.338 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.5 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 36.7 m -107.54 105.7 15.72 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.888 -0.412 . . . . 73.44 109.888 172.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG12 HG23 ' A' ' 60' ' ' VAL . 31.8 m -119.5 136.83 55.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 116.197 -0.456 . . . . 71.14 111.163 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.17 30.06 19.75 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 122.486 0.315 . . . . 73.02 111.443 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.28 21.0 79.5 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 120.923 -0.656 . . . . 75.21 113.372 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -128.86 142.89 46.59 Favored Pre-proline 0 N--CA 1.473 0.71 0 C-N-CA 122.568 0.347 . . . . 65.24 111.717 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.96 143.47 32.89 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.256 1.971 . . . . 74.23 111.859 171.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 99.7 p -146.1 162.81 37.11 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 122.183 -0.323 . . . . 61.21 111.406 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.0 m -142.42 107.64 4.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.738 0.304 . . . . 71.23 111.508 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 34.0 m -103.59 128.28 56.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 120.994 0.426 . . . . 52.13 111.21 177.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -78.39 157.26 29.1 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-O 121.067 0.461 . . . . 73.44 111.818 -177.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.78 -64.4 4.31 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.475 -0.393 . . . . 63.41 113.378 179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.23 107.03 1.46 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.185 0.439 . . . . 73.41 112.185 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -93.04 -45.11 8.07 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.404 -0.362 . . . . 74.52 111.582 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 58.8 m -153.68 129.41 10.1 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 120.851 0.357 . . . . 62.23 111.194 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.2 pp -158.05 152.5 24.64 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 112.137 0.421 . . . . 71.22 112.137 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.5 ' HB2' ' HA ' ' A' ' 50' ' ' ASP . 12.2 p-10 -61.35 154.68 23.34 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 116.321 -0.399 . . . . 73.44 111.457 175.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.418 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 47.1 t -53.38 -33.46 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 120.886 0.374 . . . . 45.52 111.518 -178.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.2 m -53.84 -49.47 68.34 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.381 -0.372 . . . . 73.15 111.545 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -68.96 -35.85 77.22 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.565 0.221 . . . . 71.51 111.454 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.61 HD22 HG21 ' A' ' 54' ' ' VAL . 64.8 tp -54.39 -50.82 66.65 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.095 0.474 . . . . 75.31 110.908 174.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -57.73 -41.56 82.1 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.164 0.507 . . . . 72.25 110.871 176.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.1 t -68.36 -29.5 68.23 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.817 -0.628 . . . . 71.4 111.597 178.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.75 77.32 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.027 0.441 . . . . 74.43 111.189 177.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.84 -21.51 57.19 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.082 0.468 . . . . 71.45 110.501 172.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 41.3 tttp 65.57 36.95 6.23 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.359 -0.837 . . . . 73.21 111.579 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.4 p -66.01 129.73 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 116.134 -0.484 . . . . 70.14 111.401 178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.15 -36.49 81.98 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.275 0.472 . . . . 64.52 112.275 -177.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -101.44 89.67 3.82 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 120.932 0.396 . . . . 71.35 111.422 179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.493 ' O ' HG12 ' A' ' 35' ' ' VAL . . . -92.42 -45.87 7.95 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.314 0.578 . . . . 64.0 110.635 176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.66 -25.66 40.61 Favored 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 115.676 -0.693 . . . . 75.53 111.719 175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -122.41 28.16 7.55 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.093 0.405 . . . . 72.25 112.093 -174.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' ALA . 11.7 p -89.5 139.46 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 CA-C-O 121.306 0.574 . . . . 71.22 111.971 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 27.5 m -97.95 99.82 11.13 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.351 -0.386 . . . . 73.54 110.444 175.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 27.4 m -119.27 136.59 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 120.852 0.358 . . . . 73.24 111.579 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 13.0 pt-20 -122.24 131.88 54.15 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.155 0.502 . . . . 71.43 111.377 177.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.761 ' HB2' HD11 ' A' ' 44' ' ' LEU . 2.4 tm? -88.35 99.9 12.6 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.208 -0.451 . . . . 72.15 110.413 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.563 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 63.89 1.34 1.11 Allowed 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 113.133 0.79 . . . . 72.25 113.133 176.522 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.32 -6.85 0.82 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.403 -0.904 . . . . 74.43 114.856 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -130.85 128.77 41.28 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 117.86 0.83 . . . . 74.04 112.102 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 9.7 p -66.34 139.54 21.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 CA-C-O 121.129 0.49 . . . . 75.04 112.304 -178.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.761 HD11 ' HB2' ' A' ' 39' ' ' LEU . 6.0 mp -92.5 147.16 23.12 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.159 -0.473 . . . . 75.41 111.445 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -75.87 149.77 37.75 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 116.098 -0.501 . . . . 63.13 110.336 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 47.5 mtp180 -48.33 -55.68 10.06 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 112.591 0.589 . . . . 61.33 112.591 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -81.98 23.93 0.67 Allowed 'General case' 0 CA--C 1.549 0.94 0 CA-C-O 121.326 0.584 . . . . 72.55 111.967 -178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -115.75 1.94 13.56 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 121.734 -0.604 . . . . 65.5 111.836 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -64.69 -30.28 71.29 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.207 0.447 . . . . 62.03 112.207 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 19' ' ' ASN . 14.5 m-20 -83.12 -32.5 26.68 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.875 0.369 . . . . 61.15 111.001 177.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -60.58 -40.33 91.35 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.09 -0.505 . . . . 74.41 112.082 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 85.7 m -95.85 119.96 35.28 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.99 0.424 . . . . 74.22 111.723 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 91.6 m -96.09 116.43 28.95 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 120.938 0.399 . . . . 64.23 111.616 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.61 HG21 HD22 ' A' ' 23' ' ' LEU . 49.3 t -74.6 142.03 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.558 0 CA-C-N 116.005 -0.543 . . . . 75.13 111.096 177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -142.83 -175.84 4.65 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.389 0.614 . . . . 74.25 111.61 -175.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.22 104.39 1.46 Allowed 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.756 -0.656 . . . . 71.11 111.972 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 113.74 32.2 2.14 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 121.197 -0.525 . . . . 44.13 113.818 174.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.74 138.1 48.77 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 121.328 0.585 . . . . 71.4 112.315 178.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -95.66 104.52 16.44 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.651 -0.704 . . . . 62.04 111.49 177.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -109.02 98.37 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 121.622 0.725 . . . . 75.44 110.404 175.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -72.94 99.54 2.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.731 0.777 . . . . 74.24 112.628 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -85.01 143.71 28.74 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.151 170.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.546 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.3 pt? -148.52 114.59 5.8 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.284 0.564 . . . . 71.45 111.771 -179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 64.64 22.4 12.61 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 115.774 -0.648 . . . . 73.21 112.087 178.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -112.98 121.35 44.38 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.756 0.313 . . . . 63.55 110.947 176.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 85.1 mtp -138.71 -174.21 3.77 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.9 0.381 . . . . 65.34 111.674 -178.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.18 42.99 0.06 OUTLIER Glycine 0 CA--C 1.526 0.752 0 C-N-CA 121.083 -0.579 . . . . 61.12 112.961 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 68.16 -107.71 2.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.415 -0.422 . . . . 70.31 113.658 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.78 -57.24 4.79 Favored Glycine 0 CA--C 1.53 0.984 0 C-N-CA 121.26 -0.495 . . . . 54.32 113.653 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? 67.99 113.12 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.394 0.616 . . . . 74.11 112.092 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 60.0 tp -76.95 96.79 4.44 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.298 0.57 . . . . 74.01 110.805 177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -80.48 115.6 20.08 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 116.177 -0.465 . . . . 42.42 111.866 -177.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -148.27 102.29 3.34 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 120.919 0.39 . . . . 74.21 110.934 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -86.95 147.18 25.86 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.673 0.389 . . . . 62.21 111.422 -177.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -92.53 130.78 38.08 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.91 0.386 . . . . 62.21 111.433 177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -68.53 -41.72 79.48 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.405 -0.361 . . . . 72.42 111.554 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 31.8 m170 -129.88 159.44 36.59 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 120.676 0.274 . . . . 61.31 110.788 176.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.775 -0.631 . . . . 70.23 111.394 178.63 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 120.916 0.389 . . . . 75.42 111.313 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -92.78 126.41 37.85 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.309 -0.405 . . . . 73.54 111.122 178.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 92.6 mt -126.36 134.92 50.94 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 120.937 0.399 . . . . 61.04 111.373 178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 m -94.6 99.35 11.5 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.959 0.409 . . . . 72.1 111.004 178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.439 HG12 ' O ' ' A' ' 60' ' ' VAL . 28.7 m -100.19 124.21 53.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 120.965 0.412 . . . . 72.25 111.464 -179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.405 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 55.6 m-80 54.87 43.22 30.31 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.115 0.483 . . . . 73.22 111.371 -178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.69 12.83 62.52 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 115.872 -0.603 . . . . 73.41 113.872 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -126.89 125.31 24.24 Favored Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 122.596 -0.355 . . . . 74.31 110.917 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.0 142.18 19.46 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.684 2.256 . . . . 63.51 113.819 -175.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.9 t -137.86 125.88 22.78 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.027 -0.533 . . . . 74.13 110.628 175.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 28.3 m -87.33 94.27 9.63 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.003 0.43 . . . . 72.02 111.536 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 m -94.78 95.78 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.491 0.662 . . . . 74.0 111.322 178.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -75.74 159.66 30.84 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.119 0.485 . . . . 64.4 111.373 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 92.78 -52.34 2.62 Favored Glycine 0 CA--C 1.521 0.451 0 C-N-CA 121.097 -0.573 . . . . 73.42 111.693 -174.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.61 123.36 23.86 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.724 0.297 . . . . 31.33 110.569 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -112.06 -48.02 3.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.264 0.554 . . . . 70.13 111.423 -178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 60.7 p -157.64 106.6 2.1 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.224 -0.444 . . . . 72.02 110.632 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.02 151.81 50.27 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.346 -0.388 . . . . 74.1 111.29 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 20.4 p-10 -74.49 157.22 35.92 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 110.136 -0.32 . . . . 71.4 110.136 173.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.502 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 60.7 t -51.01 -37.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 111.86 0.319 . . . . 72.43 111.86 -175.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 61.9 m -53.62 -51.75 62.07 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 120.821 0.343 . . . . 73.42 111.597 175.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.43 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 52.2 mm-40 -71.18 -29.2 64.88 Favored 'General case' 0 N--CA 1.469 0.525 0 O-C-N 122.246 -0.284 . . . . 61.4 111.756 178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.646 HD11 HG11 ' A' ' 60' ' ' VAL . 7.6 tt -60.39 -45.3 94.05 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.527 -0.546 . . . . 74.14 109.527 174.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 78.0 mt -63.88 -41.02 97.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-O 121.366 0.603 . . . . 70.45 110.206 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.43 ' HB3' ' HA ' ' A' ' 22' ' ' GLU . 37.0 t -60.47 -27.78 67.82 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.673 -0.694 . . . . 72.21 112.002 177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.95 -42.32 93.78 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.058 0.456 . . . . 73.12 111.314 176.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 27' ' ' LEU . 5.8 mp -88.68 -0.75 57.6 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.165 0.507 . . . . 72.41 110.465 174.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt 57.71 48.91 13.19 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.75 0.786 . . . . 70.44 111.101 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 56.3 t -81.54 88.51 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 115.853 -0.612 . . . . 52.4 110.259 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -53.92 -27.94 33.85 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.838 -0.619 . . . . 53.52 112.368 -179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 11.7 mm100 -83.92 45.69 1.11 Allowed 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 116.282 -0.417 . . . . 74.51 112.024 -176.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.32 -36.99 74.22 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.474 0.546 . . . . 72.12 112.474 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.44 -7.64 56.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 121.318 0.58 . . . . 75.2 111.449 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.458 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 5.8 m-85 -104.42 -50.61 3.29 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.276 -0.42 . . . . 74.22 111.455 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.5 p -70.46 136.82 25.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.195 0.521 . . . . 61.4 112.323 -175.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 46.2 m -112.06 140.41 46.76 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.109 -0.496 . . . . 73.04 111.053 177.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 62' ' ' PHE . 28.7 m -133.8 151.39 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 120.678 0.275 . . . . 71.22 110.842 176.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.56 126.12 51.29 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.709 0.766 . . . . 65.44 111.818 177.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -93.48 120.7 34.07 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.581 -0.736 . . . . 65.2 110.197 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.0 m120 56.51 26.36 10.85 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 120.988 0.423 . . . . 63.02 111.779 -175.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.67 12.92 68.31 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 121.092 -0.575 . . . . 45.14 113.226 -178.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -112.79 124.88 53.58 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 122.654 0.382 . . . . 72.11 110.438 178.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.6 p -78.01 128.36 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.199 0.523 . . . . 73.34 111.945 -176.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -100.15 139.99 35.03 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.428 -0.351 . . . . 64.32 111.179 177.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 21.3 mp0 -68.94 160.77 30.18 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.351 -0.386 . . . . 53.05 110.771 174.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -55.09 -36.14 65.34 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.023 0.44 . . . . 71.34 111.726 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -68.78 -39.21 80.31 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.246 0.545 . . . . 62.44 111.416 175.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.51 -17.3 63.77 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.538 0.57 . . . . 52.43 112.538 -176.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 23.3 m-30 -63.43 -33.48 75.65 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.985 0.422 . . . . 73.41 111.685 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -75.79 -32.26 59.8 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 116.37 -0.377 . . . . 71.3 111.46 -178.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -85.46 -50.95 6.87 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.329 0.492 . . . . 54.45 112.329 -177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.7 m -57.59 115.64 2.89 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.352 0.501 . . . . 44.52 112.352 -176.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.587 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 73.8 p -99.37 119.63 38.28 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.049 0.452 . . . . 62.15 111.44 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -96.22 140.52 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 116.172 -0.467 . . . . 60.25 111.09 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -131.26 -172.34 2.82 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.663 0.616 . . . . 73.43 112.663 -176.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -63.14 132.04 50.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.778 -0.646 . . . . 75.4 112.258 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.01 33.05 42.28 Favored Glycine 0 CA--C 1.524 0.6 0 CA-C-N 116.004 -0.544 . . . . 73.34 113.467 -179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -119.16 150.06 40.68 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 122.425 -0.456 . . . . 73.45 110.714 -177.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.33 83.71 2.1 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.129 0.49 . . . . 55.1 112.185 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.646 HG11 HD11 ' A' ' 23' ' ' LEU . 3.6 p -88.31 91.71 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 CA-C-O 121.357 0.598 . . . . 65.12 110.343 173.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.405 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 33.8 tt0 -71.35 92.55 1.07 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.526 0.679 . . . . 73.02 110.859 -177.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.567 ' HA ' HG12 ' A' ' 37' ' ' VAL . 71.6 t80 -73.25 110.19 7.35 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.284 -0.871 . . . . 71.1 111.139 178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 45.7 mt -74.31 152.84 39.55 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.123 0.487 . . . . 65.14 110.766 178.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -84.0 46.78 1.23 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.323 0.582 . . . . 54.52 112.441 -170.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.532 ' HB2' HG23 ' A' ' 35' ' ' VAL . 56.0 m-85 -61.26 -9.06 4.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 116.325 -0.398 . . . . 71.44 112.063 172.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 54.7 mtm -81.16 101.54 9.73 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 120.934 0.397 . . . . 73.34 111.108 176.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -109.9 -6.16 28.51 Favored Glycine 0 CA--C 1.523 0.563 0 CA-C-N 116.294 -0.412 . . . . 71.21 112.189 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.26 142.43 44.5 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 121.596 -0.335 . . . . 71.3 113.129 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -71.64 -42.77 53.91 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 121.029 -0.605 . . . . 74.11 113.444 -179.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt 66.92 118.64 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.173 0.589 . . . . 74.33 111.166 -177.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.41 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.4 pt? -48.75 -25.37 1.79 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.783 1.401 . . . . 74.25 114.783 -170.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -85.41 -45.56 11.75 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.22 0.452 . . . . 62.31 112.22 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 63.14 -174.11 0.16 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.199 0.524 . . . . 72.32 112.164 -178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 20.6 t-80 -113.96 20.94 15.33 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 120.998 0.428 . . . . 75.52 111.547 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -62.86 130.4 44.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.507 -0.315 . . . . 75.11 111.013 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 23.4 p80 -134.13 170.08 16.2 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.601 0.715 . . . . 54.34 112.654 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -125.67 152.1 45.69 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.293 -0.867 . . . . 41.45 110.189 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.91 -0.567 . . . . 54.52 111.316 178.411 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptt? . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 120.674 0.273 . . . . 74.04 111.527 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.4 m-20 -89.09 132.04 34.97 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.508 -0.315 . . . . 74.14 111.073 178.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.9 mt -136.36 131.22 33.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.981 0.42 . . . . 64.33 111.377 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 89.3 m -81.85 89.47 6.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.288 0.566 . . . . 72.02 110.073 172.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.59 120.09 35.15 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 116.026 -0.534 . . . . 74.42 111.552 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 8' ' ' LYS . 6.2 t-20 62.43 22.62 13.37 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-O 121.118 0.485 . . . . 72.53 111.67 176.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.99 -7.04 64.5 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.284 -0.484 . . . . 41.2 113.22 -176.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' NZ ' ' OD1' ' A' ' 6' ' ' ASN . 3.9 mppt? -113.91 127.07 27.23 Favored Pre-proline 0 CA--C 1.543 0.678 0 O-C-N 122.667 -0.314 . . . . 64.31 111.427 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 90.3 Cg_endo -79.34 139.12 14.46 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.648 2.232 . . . . 75.32 113.543 -177.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.1 t -149.75 159.36 44.41 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.748 0.309 . . . . 74.03 111.385 179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 94.0 m -109.72 112.39 24.41 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.93 0.395 . . . . 74.41 111.362 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 31.4 m -112.01 119.49 60.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 120.953 0.406 . . . . 72.22 111.464 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.87 166.38 20.96 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.724 0.297 . . . . 72.32 110.517 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.51 4.01 73.63 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 120.933 -0.651 . . . . 73.43 112.524 -174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -125.4 108.34 11.57 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.862 0.363 . . . . 65.32 110.987 -179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -101.81 -60.74 1.48 Allowed 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.387 0.613 . . . . 75.13 110.457 176.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.1 p -149.75 101.4 3.06 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 115.789 -0.642 . . . . 74.04 109.634 173.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 96.3 mt -125.03 133.06 53.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.145 0.424 . . . . 42.15 112.145 -170.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 3.7 p-10 -63.59 149.67 45.84 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.597 -0.274 . . . . 60.31 110.452 172.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.5 t -44.83 -42.14 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.641 0.608 . . . . 70.11 112.641 -173.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.431 ' HB ' ' ND2' ' A' ' 19' ' ' ASN . 86.6 m -50.83 -48.51 59.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 120.824 0.345 . . . . 60.12 111.795 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 25.4 mm-40 -65.04 -32.77 74.66 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.807 0.336 . . . . 61.21 111.25 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.498 HD11 HG11 ' A' ' 60' ' ' VAL . 6.9 tt -61.68 -50.04 74.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.937 0.398 . . . . 63.33 109.967 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 HG11 ' A' ' 29' ' ' VAL . 3.9 mm? -63.21 -33.66 75.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.861 0.362 . . . . 73.33 111.032 175.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 41.5 t -64.04 -41.34 97.44 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 120.984 0.421 . . . . 71.15 111.365 176.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.67 -33.23 70.71 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.155 0.502 . . . . 74.14 111.07 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.615 HD22 ' HB ' ' A' ' 29' ' ' VAL . 5.6 tt -71.25 -35.07 71.29 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.015 -0.539 . . . . 60.5 110.368 176.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt 60.17 73.45 0.48 Allowed 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.518 0.675 . . . . 75.32 111.461 -175.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.615 ' HB ' HD22 ' A' ' 27' ' ' LEU . 12.5 p -117.18 143.81 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 115.889 -0.596 . . . . 64.22 111.36 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.555 ' HB3' ' HA2' ' A' ' 68' ' ' GLY . . . -75.91 142.85 41.97 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.267 -0.424 . . . . 42.43 111.262 177.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.52 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 66.6 mt-30 71.12 37.58 1.21 Allowed 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.852 -0.613 . . . . 74.51 112.124 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.5 -37.24 75.16 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-O 120.946 0.403 . . . . 74.23 111.93 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 30.8 tp10 -73.4 -3.27 26.28 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 121.14 0.495 . . . . 74.0 111.555 177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 23.5 m-85 -119.76 -13.45 9.1 Favored 'General case' 0 CA--C 1.544 0.736 0 O-C-N 122.021 -0.425 . . . . 74.52 112.029 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.65 HG23 ' HB2' ' A' ' 65' ' ' PHE . 7.5 p -86.11 130.49 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 121.218 0.532 . . . . 74.5 112.341 -176.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.425 ' HB ' ' CE1' ' A' ' 65' ' ' PHE . 70.3 m -93.93 117.2 29.77 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.311 -0.404 . . . . 70.41 111.057 175.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.8 m -119.23 158.82 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.786 0.327 . . . . 72.41 110.984 175.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 11.6 pt-20 -127.87 133.01 49.32 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.628 0.728 . . . . 54.2 111.981 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.55 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.9 tm? -91.52 104.04 16.58 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.338 -0.846 . . . . 71.43 109.689 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.543 HD22 HD13 ' A' ' 39' ' ' LEU . 32.4 m-80 55.18 46.21 24.34 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.098 0.475 . . . . 65.52 111.408 -173.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.02 -3.79 74.38 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 121.474 -0.393 . . . . 60.45 113.946 -179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -96.59 111.38 23.54 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 122.567 -0.372 . . . . 61.21 111.112 -177.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.25 125.34 30.76 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-O 121.206 0.527 . . . . 72.14 112.219 -176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD21 ' HB2' ' A' ' 39' ' ' LEU . 1.4 mm? -97.76 152.1 19.49 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.003 0.43 . . . . 75.45 111.213 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -71.2 149.44 46.3 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 108.911 -0.774 . . . . 64.42 108.911 171.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -54.13 -38.11 65.08 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 112.174 0.435 . . . . 73.03 112.174 -175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -78.56 -29.96 46.6 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 121.194 0.521 . . . . 74.34 111.193 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.35 -17.01 40.48 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.461 -0.336 . . . . 74.32 111.846 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -56.95 -32.55 66.13 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 121.181 0.515 . . . . 73.3 111.201 174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -81.81 -24.85 35.66 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.094 -0.503 . . . . 75.41 111.431 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.13 -23.06 19.55 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.262 0.467 . . . . 60.21 112.262 -179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 88.8 m -88.67 106.65 18.47 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 122.144 -0.348 . . . . 74.22 111.56 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 76.3 p -85.57 115.6 23.37 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.01 0.433 . . . . 74.4 112.017 -178.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -91.17 132.78 34.79 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.35 -0.386 . . . . 71.35 110.804 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtpt -125.65 -177.32 3.87 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.149 0.5 . . . . 53.23 112.105 -177.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -58.33 143.23 45.58 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 115.886 -0.597 . . . . 43.22 111.872 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.43 34.74 90.09 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 116.23 -0.441 . . . . 64.13 113.809 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -116.81 -177.12 3.12 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 117.022 0.411 . . . . 71.0 110.081 178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -132.16 102.98 6.01 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 113.074 0.768 . . . . 51.11 113.074 -173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.498 HG11 HD11 ' A' ' 23' ' ' LEU . 4.0 p -96.69 111.22 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 121.309 0.576 . . . . 74.32 110.394 173.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.465 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 42.2 mt-10 -101.25 105.23 16.31 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.593 0.711 . . . . 70.03 111.957 -177.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -81.87 117.07 21.84 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 115.286 -0.87 . . . . 64.32 110.443 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 71.5 mt -79.1 -176.9 5.35 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 112.54 0.57 . . . . 74.55 112.54 -175.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -56.56 -2.26 0.07 Allowed 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.975 1.472 . . . . 73.25 114.975 -175.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.65 ' HB2' HG23 ' A' ' 35' ' ' VAL . 84.7 m-85 -69.1 94.32 0.65 Allowed 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 118.473 0.579 . . . . 61.03 111.695 -177.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 49.9 ttm -147.23 153.15 39.46 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.396 -0.366 . . . . 54.43 110.912 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.27 -21.02 2.96 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 121.005 -0.617 . . . . 54.12 113.305 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 30' ' ' ALA . . . 76.93 -58.14 3.53 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.227 -0.511 . . . . 52.43 113.469 178.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.4 -52.07 4.59 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 121.196 -0.526 . . . . 64.22 112.904 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -81.12 75.24 8.1 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.841 0.353 . . . . 62.14 111.031 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 74' ' ' HIS . 43.3 tp 31.07 90.72 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.13 1.159 . . . . 74.42 114.13 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -101.22 -25.06 14.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.759 0.314 . . . . 75.5 111.405 175.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 68.5 m-70 -142.33 126.28 17.23 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 112.219 0.451 . . . . 72.41 112.219 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . 0.485 ' HB2' HD11 ' A' ' 71' ' ' LEU . 59.0 t-80 -124.36 120.81 33.21 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 109.71 -0.478 . . . . 75.53 109.71 171.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -95.12 146.34 24.37 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 121.06 0.457 . . . . 63.15 112.111 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 72.5 m80 -88.05 105.69 17.65 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.36 -0.382 . . . . 71.03 110.387 173.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -144.47 146.52 32.48 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 120.808 0.337 . . . . 73.12 111.256 -176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.9 p80 . . . . . 0 C--O 1.249 1.07 0 CA-C-O 119.412 -0.327 . . . . 74.25 111.593 176.611 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 3' ' ' LEU . 24.5 ptp . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.664 0.268 . . . . 70.01 111.188 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -87.24 118.67 26.81 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 116.66 -0.246 . . . . 75.32 110.528 176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.515 HD11 ' SD ' ' A' ' 1' ' ' MET . 63.7 mt -127.93 169.7 13.67 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.178 0.513 . . . . 54.34 111.437 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.4 m -111.36 96.87 6.37 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 109.626 -0.509 . . . . 72.33 109.626 169.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 48.0 t -100.85 123.91 54.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.234 -0.439 . . . . 60.43 111.306 -175.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.858 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.8 OUTLIER 64.53 24.25 13.04 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 116.292 -0.413 . . . . 72.25 111.718 -179.651 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.2 6.31 88.12 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.348 -0.453 . . . . 35.4 113.078 -175.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -118.35 126.62 27.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 O-C-N 122.549 -0.383 . . . . 73.52 110.835 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -57.65 95.74 0.07 OUTLIER 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.421 2.081 . . . . 71.05 112.43 177.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.1 m -113.5 118.04 33.35 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.077 -0.511 . . . . 64.21 111.093 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 85.4 m -96.99 114.35 25.96 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.877 0.37 . . . . 74.32 111.487 178.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.2 m -93.68 120.64 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.125 0.488 . . . . 65.01 110.562 175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -78.61 154.78 30.0 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.032 -0.531 . . . . 54.45 112.022 -172.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 80.19 -45.46 3.02 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 121.257 -0.497 . . . . 75.31 113.298 179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.15 117.06 8.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.831 0.348 . . . . 70.33 111.906 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -107.23 -55.88 2.28 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 116.306 -0.407 . . . . 73.04 110.566 179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 38.6 m -141.93 122.39 14.08 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-O 120.821 0.343 . . . . 72.22 111.853 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.2 pp -157.72 160.58 38.05 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.264 -0.425 . . . . 61.3 111.021 176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 34.7 p30 -86.73 168.86 13.16 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.917 0.389 . . . . 73.31 111.175 177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.0 t -64.1 -29.28 46.9 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 116.55 -0.295 . . . . 72.22 111.449 -176.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 82.3 m -61.62 -42.17 98.51 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.742 0.306 . . . . 74.5 111.586 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.29 -47.91 77.67 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.796 0.331 . . . . 73.03 110.908 176.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 55.3 tp -55.92 -43.6 77.5 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 121.022 0.439 . . . . 54.14 110.825 175.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.3 tt -61.01 -43.39 98.96 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 115.982 -0.554 . . . . 53.3 110.6 175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 50.6 m -74.68 -17.34 60.69 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.235 -0.438 . . . . 71.35 111.891 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.61 35.93 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 120.861 0.362 . . . . 61.3 111.315 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' N ' ' A' ' 28' ' ' LYS . 2.8 pp -87.76 -17.79 30.87 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.519 -0.309 . . . . 75.4 111.705 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.43 ' N ' HD12 ' A' ' 27' ' ' LEU . 57.4 mtmt 60.06 85.56 0.11 Allowed 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 112.833 0.679 . . . . 72.13 112.833 176.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.35 117.32 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-O 121.184 0.516 . . . . 75.04 110.959 176.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.47 -26.69 68.66 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.158 -0.473 . . . . 65.21 112.207 -178.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.685 ' HG2' ' HG2' ' A' ' 66' ' ' MET . 23.4 mp0 -84.81 40.45 0.8 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.384 -0.371 . . . . 74.31 111.877 -176.136 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.19 -27.72 62.21 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.18 0.514 . . . . 74.12 112.131 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -69.65 -36.31 75.97 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.16 -0.473 . . . . 73.34 111.552 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -99.33 -17.16 18.17 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.554 0.576 . . . . 65.03 112.554 -171.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 p -54.2 113.12 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 N-CA-C 112.976 0.732 . . . . 75.02 112.976 -171.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 41.1 m -94.69 107.47 19.47 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.988 -0.551 . . . . 71.13 111.297 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 62' ' ' PHE . 31.5 m -141.32 147.94 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 116.426 -0.352 . . . . 70.24 111.195 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.29 137.03 43.95 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.039 0.447 . . . . 73.43 111.746 175.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.691 HD23 HD21 ' A' ' 44' ' ' LEU . 4.1 mm? -83.22 106.48 15.03 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.027 0.441 . . . . 54.41 110.621 174.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 61.6 11.02 3.62 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.377 0.671 . . . . 63.45 112.526 178.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.63 -10.26 7.61 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 120.992 -0.623 . . . . 44.53 113.914 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.54 114.94 29.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.294 -0.533 . . . . 75.31 111.639 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.6 p -66.56 148.89 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 121.109 0.48 . . . . 31.32 112.188 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.691 HD21 HD23 ' A' ' 39' ' ' LEU . 3.1 mm? -101.16 143.26 31.47 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.318 0.58 . . . . 64.25 112.259 -177.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -92.94 156.79 16.7 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 115.777 -0.647 . . . . 71.54 109.304 170.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 46' ' ' ARG . 61.3 mtt85 -40.43 -54.63 2.42 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 112.573 0.583 . . . . 75.42 112.573 -175.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -79.25 -14.28 59.14 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.319 0.489 . . . . 55.11 112.319 -177.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.03 -23.03 62.08 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.65 0.262 . . . . 53.31 111.222 176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.66 -37.23 73.04 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.895 0.379 . . . . 71.21 111.519 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.49 -36.59 52.52 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 120.97 0.414 . . . . 71.24 111.705 177.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.21 -56.99 4.34 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.268 0.47 . . . . 52.15 112.268 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.5 m -72.59 126.12 29.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.039 0.447 . . . . 54.2 112.045 -176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 75.6 p -105.95 138.3 42.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.203 0.525 . . . . 50.42 112.011 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG22 HD11 ' A' ' 39' ' ' LEU . 43.9 t -95.22 129.79 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-N 116.086 -0.507 . . . . 73.32 110.895 177.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -135.77 -179.76 5.85 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.279 0.561 . . . . 73.41 111.867 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -56.98 102.82 0.09 Allowed 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.974 -0.557 . . . . 64.23 112.267 -176.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 122.53 4.42 8.95 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.313 -0.47 . . . . 65.05 113.838 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -90.44 145.04 25.24 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.42 0.629 . . . . 74.01 112.162 -179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.15 131.76 51.1 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.78 -0.645 . . . . 51.02 111.168 176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 7.7 p -143.96 117.71 3.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-O 121.403 0.62 . . . . 72.35 111.435 178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.858 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 28.6 tt0 -101.38 96.56 7.24 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.5 0.666 . . . . 73.15 111.896 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.467 ' HA ' HG12 ' A' ' 37' ' ' VAL . 18.6 t80 -78.06 92.2 4.35 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.928 -0.578 . . . . 73.24 110.069 177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.78 135.5 56.69 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.29 0.848 . . . . 73.23 113.29 -175.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -83.37 18.98 1.63 Allowed 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.68 -0.691 . . . . 52.33 111.88 177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 19.1 p90 -54.74 -31.51 58.51 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.027 0.441 . . . . 75.43 111.816 -176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.685 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 18.0 tpt -102.32 117.91 35.74 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.115 -0.493 . . . . 65.15 111.189 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.7 13.6 2.48 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 121.077 -0.583 . . . . 43.51 113.347 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 77.58 -18.47 4.62 Favored Glycine 0 CA--C 1.532 1.111 0 C-N-CA 121.213 -0.518 . . . . 73.43 114.142 178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 5.89 81.67 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 121.328 -0.463 . . . . 64.13 113.88 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -90.57 88.76 7.26 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 122.349 -0.501 . . . . 72.33 112.114 -178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.441 ' N ' HD12 ' A' ' 71' ' ' LEU . 6.0 mp -106.34 155.23 19.74 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.576 -0.528 . . . . 71.42 109.576 170.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.37 95.47 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.055 0.455 . . . . 74.23 111.755 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -88.2 119.75 28.9 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.377 -0.374 . . . . 75.03 110.426 175.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -73.86 -43.05 59.83 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.467 0.543 . . . . 74.33 112.467 -173.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 68.35 164.59 0.23 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 122.517 0.327 . . . . 73.44 110.845 -177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -107.73 147.77 30.35 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.707 -0.621 . . . . 60.4 112.505 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -150.63 111.37 4.27 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.621 -0.718 . . . . 75.53 109.761 173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 118.785 -0.626 . . . . 71.24 111.997 -173.249 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 22.8 ptp . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.793 0.33 . . . . 72.41 111.517 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.2 m-80 -101.9 114.56 28.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 116.398 -0.365 . . . . 64.55 111.017 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.8 mt -118.86 127.76 53.81 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.081 0.467 . . . . 72.34 111.411 -176.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 28.2 m -82.4 97.7 8.49 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.28 -0.418 . . . . 72.34 111.462 -177.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.637 HG12 HD22 ' A' ' 6' ' ' ASN . 31.5 t -85.72 110.83 20.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 CA-C-O 120.918 0.389 . . . . 62.43 111.837 -175.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.637 HD22 HG12 ' A' ' 5' ' ' VAL . 52.2 m-80 57.74 25.62 12.07 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.164 0.586 . . . . 63.33 112.37 -178.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 101.03 -11.55 58.82 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 121.212 -0.518 . . . . 65.55 113.086 -178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.529 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 9.9 mptt -102.48 114.62 65.29 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.672 -0.311 . . . . 74.21 110.93 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 25.6 Cg_exo -63.32 116.45 3.62 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 122.8 2.333 . . . . 71.24 113.148 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.0 t -114.01 158.74 20.78 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.348 -0.387 . . . . 63.15 110.558 177.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 91.2 m -126.31 110.28 13.21 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 120.894 0.378 . . . . 64.51 111.868 -175.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.7 m -98.81 102.08 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 CA-C-O 121.451 0.644 . . . . 72.34 110.666 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -78.04 136.22 37.89 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.758 -0.655 . . . . 73.22 111.534 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.9 14.65 59.08 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 121.18 -0.533 . . . . 51.12 113.001 -177.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -103.04 101.74 11.73 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 122.592 -0.358 . . . . 73.43 111.352 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -106.82 88.12 2.68 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.932 0.396 . . . . 73.12 111.181 -177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.4 m 49.29 91.96 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.752 -0.658 . . . . 52.31 112.454 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.435 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.4 pp -129.0 153.83 47.19 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.062 0.458 . . . . 71.4 111.611 -178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 27.7 m-20 -72.34 160.73 31.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.469 -0.332 . . . . 75.22 110.828 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.425 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 37.0 t -56.38 -36.65 47.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 CA-C-O 120.968 0.413 . . . . 74.21 110.568 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 81.2 m -56.36 -52.03 66.08 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.96 0.41 . . . . 62.35 110.999 174.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 41.7 mt-10 -63.83 -34.45 77.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.305 -0.407 . . . . 71.13 111.44 178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -56.3 -45.93 80.02 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.919 0.39 . . . . 75.14 110.434 175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 81.3 mt -56.25 -32.93 64.95 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.983 0.42 . . . . 71.24 111.499 178.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.4 t -77.97 -32.82 51.57 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.122 -0.49 . . . . 70.13 111.291 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -70.59 -46.38 63.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.082 0.468 . . . . 74.22 111.417 177.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -71.52 -30.42 65.91 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.161 -0.472 . . . . 74.23 110.909 176.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.89 87.64 0.12 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.58 0.752 . . . . 70.12 112.575 176.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.0 p -139.11 148.53 23.75 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-N 115.792 -0.64 . . . . 73.04 110.936 177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.99 171.81 14.52 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 120.87 0.367 . . . . 64.41 111.867 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 57.17 39.07 29.13 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-O 121.057 0.455 . . . . 71.52 111.729 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.47 -33.27 71.09 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.189 -0.459 . . . . 42.14 111.961 -177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -68.72 -13.34 62.32 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 111.984 0.365 . . . . 74.25 111.984 178.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -128.17 4.7 5.82 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.458 0.54 . . . . 64.2 112.458 -172.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.508 HG22 HG13 ' A' ' 37' ' ' VAL . 14.6 p -70.71 132.06 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-O 121.551 0.691 . . . . 73.2 112.338 -176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 48.9 m -95.26 98.89 10.94 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.119 -0.491 . . . . 73.24 111.221 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.508 HG13 HG22 ' A' ' 35' ' ' VAL . 29.7 m -133.15 163.34 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 121.265 0.555 . . . . 75.35 112.08 178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -155.39 154.71 32.39 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.983 -0.553 . . . . 62.0 111.298 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.544 ' O ' HD12 ' A' ' 39' ' ' LEU . 3.4 pp -123.17 137.95 54.77 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.531 -0.304 . . . . 44.43 111.286 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 m-20 59.21 16.08 4.66 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 116.358 -0.383 . . . . 71.03 112.024 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.27 15.41 53.65 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 121.347 -0.454 . . . . 55.34 113.825 -179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -122.15 118.3 28.33 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 122.3 -0.529 . . . . 73.01 111.368 179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.68 135.13 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 CA-C-O 121.11 0.481 . . . . 72.45 111.927 178.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 44' ' ' LEU . 2.0 mm? -109.67 150.72 27.85 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 121.131 0.491 . . . . 60.43 112.092 -175.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 16.0 mp0 -69.36 162.18 27.83 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 116.146 -0.479 . . . . 72.43 110.76 170.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' NH2' ' HA ' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -57.02 -39.43 74.74 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.714 0.292 . . . . 62.41 111.32 178.443 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.56 -35.94 68.11 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 121.153 0.501 . . . . 73.31 111.038 175.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -64.56 -22.41 66.96 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 116.333 -0.394 . . . . 74.31 111.369 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 46' ' ' ARG . 17.5 m-30 -57.57 -39.33 76.49 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.646 0.26 . . . . 74.33 111.558 174.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.455 ' HA ' ' HB3' ' A' ' 19' ' ' ASN . 22.2 t70 -83.34 -35.51 25.11 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.241 0.543 . . . . 73.13 110.82 177.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.36 -23.57 67.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.258 -0.428 . . . . 74.01 112.09 177.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 39.9 m -103.77 115.78 31.1 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.787 0.327 . . . . 64.22 111.565 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 88.6 m -94.73 110.19 22.06 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.23 0.538 . . . . 41.12 111.801 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.48 142.72 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.56 0 CA-C-N 115.901 -0.591 . . . . 65.1 111.24 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 31.1 mtmm -130.07 -167.12 1.76 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.183 0.516 . . . . 72.34 111.929 -175.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.548 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 2.8 t0 -78.97 42.54 0.47 Allowed 'General case' 0 CA--C 1.546 0.825 0 CA-C-O 120.931 0.396 . . . . 73.45 112.045 -172.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.59 52.92 0.05 OUTLIER Glycine 0 CA--C 1.524 0.601 0 C-N-CA 120.406 -0.902 . . . . 64.23 113.426 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -126.12 123.7 38.89 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.237 0.541 . . . . 74.44 110.956 177.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.82 82.96 3.4 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.267 -0.424 . . . . 53.44 111.577 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 5' ' ' VAL . 5.7 p -83.47 104.93 12.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-O 121.529 0.68 . . . . 74.42 111.561 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 6' ' ' ASN . 41.3 mt-10 -85.84 100.61 12.18 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.442 0.639 . . . . 73.31 111.167 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -101.71 110.9 22.99 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.291 -0.868 . . . . 73.52 110.676 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.458 ' H ' HD23 ' A' ' 63' ' ' LEU . 2.2 pt? -137.54 155.06 49.67 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.521 0.563 . . . . 74.33 112.521 -173.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 65.24 9.11 5.35 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.764 1.024 . . . . 75.32 113.764 177.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -131.61 26.33 4.73 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 120.991 0.424 . . . . 74.44 111.505 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.431 ' SD ' ' N ' ' A' ' 66' ' ' MET . 1.5 mpt? -57.83 140.73 51.12 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.946 0.403 . . . . 64.04 111.617 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -146.68 -35.72 0.06 OUTLIER Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.28 -0.486 . . . . 53.31 113.475 -179.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 90.79 -117.35 5.1 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 121.173 -0.537 . . . . 74.35 113.151 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.04 33.6 69.96 Favored Glycine 0 CA--C 1.527 0.837 0 C-N-CA 121.305 -0.474 . . . . 53.44 113.053 -179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -112.89 126.05 55.04 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 121.329 0.585 . . . . 73.53 112.503 -176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 pp -88.91 178.66 6.37 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.985 -0.552 . . . . 60.41 110.397 171.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -148.06 132.22 17.37 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 120.837 0.351 . . . . 75.21 111.903 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -86.07 124.65 32.74 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 121.067 0.461 . . . . 72.31 111.488 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -58.47 120.74 9.35 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.845 -0.616 . . . . 74.11 111.962 178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -84.73 140.4 31.3 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 116.466 -0.334 . . . . 71.54 111.014 177.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.5 t60 62.8 111.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.302 0.572 . . . . 63.25 112.157 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -139.12 -166.58 2.06 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.235 -0.438 . . . . 73.32 111.169 -176.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 119.483 -0.294 . . . . 74.21 111.541 175.782 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.444 ' HB2' ' HA ' ' A' ' 56' ' ' ASP . 26.8 ptt? . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 120.846 0.355 . . . . 62.54 111.914 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -91.22 126.8 36.42 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.44 -0.345 . . . . 72.53 111.543 176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.529 HD22 ' HB3' ' A' ' 58' ' ' ASP . 74.7 mt -125.31 130.65 52.42 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.824 0.345 . . . . 71.14 110.889 178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 30.7 m -94.58 86.08 4.7 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.204 0.526 . . . . 73.51 111.151 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.2 p -89.1 122.44 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.253 -0.43 . . . . 64.54 111.181 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.9 m120 62.69 23.42 13.95 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 120.762 0.315 . . . . 73.04 111.568 179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.93 16.5 79.82 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 120.827 -0.701 . . . . 63.2 112.464 -174.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -113.23 131.58 22.82 Favored Pre-proline 0 CA--C 1.54 0.574 0 C-N-CA 122.78 0.432 . . . . 63.05 110.821 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -72.73 96.3 0.84 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.414 2.076 . . . . 72.15 112.961 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.0 t -98.76 102.15 13.79 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.098 0.475 . . . . 71.22 111.25 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.3 m -82.54 94.2 7.44 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.288 -0.414 . . . . 74.32 110.767 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 12' ' ' VAL . 30.9 m -93.63 102.99 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.539 0.685 . . . . 72.04 111.401 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -89.0 151.79 22.08 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.306 -0.407 . . . . 64.43 110.559 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.07 18.53 53.67 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.555 -0.618 . . . . 65.04 111.555 -170.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -142.46 116.2 9.22 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 123.119 0.568 . . . . 72.24 110.527 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -91.23 -62.65 1.4 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.416 0.626 . . . . 61.34 111.213 -177.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 55' ' ' LYS . 33.2 p -171.53 104.21 0.2 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.305 -0.861 . . . . 34.32 110.061 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -131.88 162.08 31.47 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 112.488 0.551 . . . . 63.03 112.488 -170.425 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -64.1 156.2 29.07 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.407 -0.36 . . . . 72.41 110.936 177.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 46.2 t -56.5 -35.6 44.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 CA-C-O 121.001 0.429 . . . . 75.44 110.437 176.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -59.03 -49.07 79.28 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 116.143 -0.48 . . . . 61.51 110.992 173.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 44.0 mt-10 -61.44 -35.81 78.61 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.275 -0.42 . . . . 75.43 110.967 177.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 60' ' ' VAL . 61.7 tp -60.53 -45.92 92.08 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.897 0.38 . . . . 63.02 110.815 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 20' ' ' VAL . 85.5 mt -60.07 -34.78 73.92 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.968 0.413 . . . . 44.21 110.821 175.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 48.5 t -67.9 -41.75 82.24 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 116.19 -0.459 . . . . 62.23 111.119 175.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.28 -40.69 90.24 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 116.261 -0.427 . . . . 41.42 111.709 178.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 88.7 mt -80.49 -11.36 59.68 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.991 0.425 . . . . 75.24 111.081 176.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 63.7 tttm 58.91 64.66 1.37 Allowed 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.665 0.745 . . . . 74.34 111.914 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 54.5 t -99.49 114.05 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.811 -0.632 . . . . 74.44 110.784 177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.58 -39.46 80.42 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.13 0.419 . . . . 62.32 112.13 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.496 ' O ' ' HB ' ' A' ' 35' ' ' VAL . 78.8 mt-30 -95.79 83.13 3.66 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.802 0.335 . . . . 74.53 111.649 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -83.83 -37.43 22.51 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-O 121.654 0.74 . . . . 75.24 110.421 175.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -67.36 -20.25 65.54 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.098 -0.955 . . . . 74.43 111.692 177.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -123.52 11.74 9.26 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.773 0.657 . . . . 74.14 112.773 -173.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.502 HG22 HG13 ' A' ' 37' ' ' VAL . 14.8 p -83.7 131.94 32.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.386 0.612 . . . . 75.12 112.19 -176.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.9 m -95.11 102.14 13.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 116.412 -0.358 . . . . 60.41 110.897 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.502 HG13 HG22 ' A' ' 35' ' ' VAL . 35.3 m -122.95 139.96 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.827 0.346 . . . . 51.34 111.621 178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -130.34 110.68 11.7 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 121.409 0.623 . . . . 74.05 111.555 176.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 10.0 mp -77.37 129.82 36.3 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.243 -0.435 . . . . 62.24 111.273 178.313 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.06 21.23 9.14 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.979 0.419 . . . . 70.42 111.549 172.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.76 19.82 49.92 Favored Glycine 0 CA--C 1.53 0.987 0 C-N-CA 121.311 -0.471 . . . . 73.13 113.343 -177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -133.79 125.58 28.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.952 0.376 . . . . 70.41 111.129 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.8 p -75.22 144.49 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 120.985 0.421 . . . . 70.13 112.021 -178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.405 ' HB2' ' HE1' ' A' ' 49' ' ' PHE . 9.9 mp -104.82 -179.78 4.04 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.419 0.628 . . . . 60.13 112.294 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -107.77 149.18 28.51 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.702 -0.681 . . . . 64.4 110.578 179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.545 ' HG3' ' N ' ' A' ' 47' ' ' GLU . 2.1 ptm180 -47.16 -52.98 14.15 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 113.71 1.004 . . . . 72.3 113.71 -171.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.545 ' N ' ' HG3' ' A' ' 46' ' ' ARG . 19.5 tt0 -95.39 -6.49 40.83 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 121.452 0.644 . . . . 42.34 110.753 -174.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.86 63.97 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.9 -0.591 . . . . 74.51 110.539 171.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.405 ' HE1' ' HB2' ' A' ' 44' ' ' LEU . 20.7 m-30 -51.14 -42.08 60.51 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.225 0.536 . . . . 73.11 110.893 174.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -66.16 -34.62 78.45 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.712 -0.676 . . . . 73.22 111.561 179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.95 -5.57 50.43 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.751 0.648 . . . . 64.3 112.751 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 53.4 m -104.81 116.18 31.57 Favored 'General case' 0 N--CA 1.476 0.86 0 O-C-N 122.286 -0.258 . . . . 75.22 111.437 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 74.1 p -95.59 113.18 24.81 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.699 0.629 . . . . 74.0 112.699 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD21 ' A' ' 39' ' ' LEU . 65.0 t -79.11 133.34 30.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 CA-C-N 116.133 -0.485 . . . . 62.13 110.798 173.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' HB2' ' A' ' 17' ' ' SER . 43.9 mtmt -131.92 -171.84 2.72 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.263 0.554 . . . . 74.51 112.024 -176.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.444 ' HA ' ' HB2' ' A' ' 1' ' ' MET . 22.9 t70 -66.17 124.53 22.87 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-O 121.091 0.472 . . . . 72.43 111.632 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 91.16 30.16 11.45 Favored Glycine 0 CA--C 1.525 0.673 0 C-N-CA 121.276 -0.488 . . . . 54.11 113.317 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.5 t70 -93.54 176.96 6.18 Favored 'General case' 0 CA--C 1.543 0.706 0 O-C-N 122.756 -0.261 . . . . 65.55 110.344 179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -141.22 42.46 1.78 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 120.829 0.347 . . . . 63.4 111.918 -177.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.5 ' HA ' ' HA ' ' A' ' 39' ' ' LEU . 3.7 p -56.2 102.2 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.671 0.748 . . . . 74.04 111.846 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -90.75 116.78 28.87 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 116.054 -0.521 . . . . 64.32 111.957 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -88.93 135.75 33.37 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 116.052 -0.522 . . . . 72.32 111.292 173.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.548 ' N ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -137.83 133.5 34.02 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.469 -0.332 . . . . 75.51 111.253 179.028 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 70.36 -19.61 0.21 Allowed 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.347 0.869 . . . . 70.33 113.347 176.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -103.68 80.66 1.81 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.891 -0.506 . . . . 74.51 111.863 178.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 65.9 mtt -145.38 120.99 10.44 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 116.107 -0.497 . . . . 61.31 111.319 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -116.71 -45.05 0.57 Allowed Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.346 -0.454 . . . . 32.1 112.404 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.44 -25.25 28.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 121.355 -0.45 . . . . 74.11 113.315 176.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.12 -78.16 0.81 Allowed Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.389 -0.434 . . . . 64.24 112.723 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' O ' ' HG3' ' A' ' 70' ' ' LYS . 59.1 pttt -89.0 104.03 16.6 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.322 0.582 . . . . 63.11 111.467 177.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 71' ' ' LEU . 7.3 mp -78.0 102.14 7.24 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.434 -0.348 . . . . 73.11 110.903 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 57.03 -163.74 0.17 Allowed 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 121.206 0.527 . . . . 73.0 111.883 -178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -123.72 -38.86 2.46 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 116.16 -0.473 . . . . 74.24 110.61 172.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 10.4 t60 67.59 123.72 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 CA-C-O 121.482 0.658 . . . . 71.34 111.334 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -79.77 134.44 36.36 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.571 0.582 . . . . 65.23 112.571 -174.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 25.9 m170 -113.22 157.51 21.63 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.022 -0.535 . . . . 72.41 110.036 173.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 9.8 p80 -137.04 -177.29 4.69 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.249 0.547 . . . . 73.5 112.274 -179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 118.817 -0.611 . . . . 74.41 111.302 -176.744 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.677 ' SD ' HD11 ' A' ' 3' ' ' LEU . 21.5 ptp . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 121.039 0.447 . . . . 62.1 111.728 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 65.7 m-20 -85.18 108.66 17.82 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.495 -0.32 . . . . 65.32 110.825 174.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.677 HD11 ' SD ' ' A' ' 1' ' ' MET . 70.5 mt -118.83 113.89 21.79 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.997 0.427 . . . . 63.34 111.762 -179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PRO . 49.7 m -75.69 99.04 4.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.317 -0.401 . . . . 70.14 110.577 175.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 54.1 t -102.51 121.64 53.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 CA-C-N 116.177 -0.465 . . . . 75.53 111.207 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.461 HD21 ' C ' ' A' ' 62' ' ' PHE . 7.8 m120 64.35 27.14 13.69 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.924 0.49 . . . . 73.12 110.715 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.62 0.03 88.04 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 120.859 -0.686 . . . . 23.44 113.595 -175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.43 ' HB2' ' NZ ' ' A' ' 8' ' ' LYS . 0.0 OUTLIER -104.39 110.05 63.64 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 117.298 0.549 . . . . 73.12 111.326 178.37 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 37.1 Cg_exo -61.33 103.92 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 122.848 2.365 . . . . 60.51 112.216 177.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.3 m -109.97 110.35 21.25 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.988 0.423 . . . . 65.02 111.842 -174.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 90.8 m -82.67 96.97 8.3 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.882 0.373 . . . . 72.4 111.383 178.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.3 m -93.74 104.72 16.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 CA-C-O 121.733 0.778 . . . . 72.01 110.844 176.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -72.81 147.59 45.33 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.251 -0.886 . . . . 71.05 111.407 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.14 -12.83 65.27 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 121.467 -0.397 . . . . 63.33 113.772 178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' HB3' ' HG2' ' A' ' 1' ' ' MET . . . -108.92 119.36 39.33 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.433 -0.451 . . . . 42.5 112.027 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.5 -73.8 0.33 Allowed 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.207 -0.451 . . . . 73.51 112.194 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.513 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 87.0 p -163.07 135.56 5.4 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 116.652 -0.249 . . . . 42.33 110.707 -178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 22' ' ' GLU . 1.0 OUTLIER -148.67 157.04 43.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-O 120.944 0.402 . . . . 73.4 111.944 -177.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 0.8 OUTLIER -72.31 170.02 15.02 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.708 -0.224 . . . . 61.12 110.852 177.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.601 ' HB ' ' HA ' ' A' ' 49' ' ' PHE . 58.8 t -62.16 -40.94 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 N-CA-C 109.973 -0.38 . . . . 74.24 109.973 172.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 88.0 m -53.94 -52.85 59.31 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.196 0.522 . . . . 74.11 110.597 172.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 8.5 mm-40 -61.5 -33.78 74.37 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 116.028 -0.533 . . . . 74.12 112.006 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 56.4 tp -62.52 -56.36 18.75 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.979 0.418 . . . . 75.45 111.139 178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.52 -30.75 71.52 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.785 0.326 . . . . 75.21 110.961 176.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 42.7 t -66.57 -37.51 85.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.027 0.441 . . . . 72.13 111.274 175.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.22 -36.86 80.17 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 116.33 -0.395 . . . . 71.11 111.204 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.7 mt -73.51 -29.08 62.25 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.299 -0.41 . . . . 73.4 111.085 175.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 67.26 16.07 10.08 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.174 0.59 . . . . 64.11 112.145 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.602 HG22 ' H ' ' A' ' 31' ' ' GLN . 11.4 p -72.5 140.01 18.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 CA-C-O 121.064 0.459 . . . . 74.0 111.438 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.58 -14.83 57.87 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.885 0.698 . . . . 74.44 112.885 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.602 ' H ' HG22 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -94.07 30.77 1.8 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 122.281 -0.262 . . . . 54.13 111.39 -179.163 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.6 -37.87 79.74 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.424 0.528 . . . . 71.51 112.424 -176.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -79.07 -10.79 59.93 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.156 0.503 . . . . 75.12 111.376 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.19 21.94 11.57 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.208 0.447 . . . . 71.22 112.208 -172.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.434 HG21 ' CE2' ' A' ' 62' ' ' PHE . 6.4 p -110.88 133.57 55.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.166 0.507 . . . . 71.05 112.068 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 84.8 m -74.76 84.36 2.14 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.278 0.561 . . . . 74.33 110.936 176.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -99.11 110.33 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 115.971 -0.559 . . . . 74.21 110.31 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 43' ' ' VAL . 10.5 pt-20 -118.2 119.65 35.32 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 121.734 0.778 . . . . 73.44 112.128 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.68 ' HB2' HD21 ' A' ' 44' ' ' LEU . 2.0 tm? -73.29 107.67 5.74 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.412 -0.813 . . . . 71.52 110.417 -177.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.537 ' N ' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER 58.53 15.84 3.85 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.044 -0.525 . . . . 73.44 111.818 -178.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.7 15.83 11.63 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 120.996 -0.621 . . . . 43.43 113.886 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -132.11 110.55 10.77 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 117.396 0.598 . . . . 74.31 110.899 175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.593 ' HA ' ' HA ' ' A' ' 38' ' ' GLU . 12.4 p -64.58 141.88 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 112.787 0.662 . . . . 63.22 112.787 -175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.8 mm? -94.02 143.74 26.09 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.407 0.622 . . . . 74.12 112.485 -176.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -77.4 154.43 32.69 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.717 -0.674 . . . . 50.44 110.536 173.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -48.26 -41.03 26.65 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.147 0.425 . . . . 65.34 112.147 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.32 -40.73 85.97 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-O 121.183 0.516 . . . . 74.11 111.485 174.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.57 -24.15 63.51 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.311 0.486 . . . . 65.1 112.311 -178.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.601 ' HA ' ' HB ' ' A' ' 20' ' ' VAL . 7.7 m-85 -49.48 -42.0 42.13 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 120.914 0.388 . . . . 75.53 111.728 176.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -82.77 -29.85 29.35 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.908 0.385 . . . . 73.01 111.648 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -83.92 -15.77 46.73 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 112.942 0.719 . . . . 73.14 112.942 -176.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 61.9 m -104.18 123.08 46.67 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 122.073 -0.392 . . . . 60.11 111.483 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 89.5 m -111.14 110.81 21.5 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.201 0.524 . . . . 65.03 111.726 -175.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.6 123.68 39.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.853 -0.612 . . . . 61.44 110.447 178.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -133.51 -175.37 3.79 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.977 0.417 . . . . 70.44 111.851 -175.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -59.05 129.6 42.94 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.045 0.45 . . . . 74.11 111.715 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 78.85 42.49 12.81 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.378 -0.439 . . . . 15.02 112.733 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -119.6 -173.15 2.47 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 109.699 -0.482 . . . . 61.12 109.699 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -142.95 102.65 4.05 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.069 0.461 . . . . 71.13 110.972 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 p -109.16 100.11 10.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-O 121.57 0.7 . . . . 73.32 110.557 178.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.573 ' HB2' ' HG3' ' A' ' 38' ' ' GLU . 5.1 mm-40 -76.86 105.99 8.26 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.839 0.828 . . . . 74.32 111.214 -176.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.461 ' C ' HD21 ' A' ' 6' ' ' ASN . 12.1 t80 -119.11 99.32 6.64 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.47 -1.241 . . . . 73.01 109.395 -178.268 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.482 HD23 ' N ' ' A' ' 63' ' ' LEU . 1.7 pt? -134.5 143.04 47.24 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.116 0.784 . . . . 72.51 113.116 -168.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 67.33 12.29 8.84 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 113.271 0.841 . . . . 71.41 113.271 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -129.29 164.82 22.69 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.296 0.57 . . . . 60.4 112.275 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 27.3 ttt -73.23 124.39 25.57 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.5 -0.773 . . . . 60.5 112.055 -176.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -145.02 -54.33 0.03 OUTLIER Glycine 0 CA--C 1.525 0.71 0 C-N-CA 121.347 -0.454 . . . . 53.25 113.038 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 91.42 -157.12 24.53 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 121.156 -0.545 . . . . 53.42 113.0 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.63 101.24 0.88 Allowed Glycine 0 CA--C 1.528 0.887 0 C-N-CA 121.056 -0.593 . . . . 71.1 113.031 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -121.69 144.83 48.55 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.047 0.451 . . . . 53.21 111.575 -178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.426 HD22 ' N ' ' A' ' 71' ' ' LEU . 3.1 mm? -96.56 54.85 1.38 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.158 0.504 . . . . 61.11 109.803 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -76.34 71.55 3.03 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.997 -0.547 . . . . 75.1 112.474 -172.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 38.95 58.07 1.83 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.539 0.736 . . . . 73.42 112.422 174.288 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -73.49 155.49 39.17 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 121.092 0.472 . . . . 74.52 112.084 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -61.65 113.26 2.62 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.838 -0.619 . . . . 71.0 111.272 -178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.8 p-80 -81.21 141.23 34.36 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.767 0.318 . . . . 75.42 111.687 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -178.06 138.32 0.19 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 122.723 0.409 . . . . 75.24 110.958 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 9.7 p80 . . . . . 0 C--O 1.252 1.19 0 CA-C-O 119.292 -0.385 . . . . 73.41 111.172 178.097 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 55' ' ' LYS . 24.8 ptt? . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.086 0.47 . . . . 72.44 111.895 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 -90.75 117.12 29.14 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 115.921 -0.582 . . . . 74.45 111.307 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.539 HD22 ' HB3' ' A' ' 58' ' ' ASP . 24.0 mt -116.82 179.14 4.1 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 110.309 -0.256 . . . . 62.0 110.309 176.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.561 ' HB ' ' HA ' ' A' ' 59' ' ' ALA . 26.6 m -146.84 134.58 21.15 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-O 120.697 0.284 . . . . 64.51 111.006 178.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.7 t -126.7 113.36 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 O-C-N 122.259 -0.276 . . . . 70.41 110.778 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.586 ' HA ' ' HG3' ' A' ' 61' ' ' GLU . 0.9 OUTLIER 63.27 38.28 10.48 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 120.894 0.378 . . . . 75.11 111.203 179.083 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.08 -2.91 67.65 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 120.887 -0.673 . . . . 52.21 113.791 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -99.99 113.99 65.46 Favored Pre-proline 0 CA--C 1.542 0.644 0 CA-C-N 117.075 0.438 . . . . 73.32 111.094 176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -60.52 151.11 77.64 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 122.848 2.366 . . . . 71.42 112.922 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 21.7 t -151.3 109.73 3.78 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.277 0.561 . . . . 54.44 111.3 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 39.0 m -85.24 107.35 17.24 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.908 -0.587 . . . . 65.24 111.245 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.6 134.22 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-O 121.047 0.451 . . . . 71.52 112.091 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -118.07 149.84 40.32 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.899 0.381 . . . . 70.44 111.143 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.99 32.28 2.67 Favored Glycine 0 CA--C 1.528 0.896 0 CA-C-N 116.32 -0.4 . . . . 64.32 113.111 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -143.96 123.24 13.02 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 122.567 -0.372 . . . . 70.31 111.013 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.22 83.4 1.89 Allowed 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 112.068 0.395 . . . . 72.22 112.068 -175.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 70.7 m 49.45 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 112.975 0.732 . . . . 74.24 112.975 176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.412 ' O ' HD12 ' A' ' 18' ' ' LEU . 1.1 pp -135.17 154.49 51.6 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.19 0.441 . . . . 60.3 112.19 -178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 53' ' ' THR . 7.4 p30 -71.73 167.8 19.12 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 121.037 0.446 . . . . 72.13 111.904 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.21 -42.21 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 116.288 -0.414 . . . . 62.12 111.939 -179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.628 HG23 ' HB1' ' A' ' 32' ' ' ALA . 92.7 m -59.86 -44.44 94.14 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 120.671 0.272 . . . . 74.0 111.538 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.405 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 36.5 mt-10 -66.91 -37.17 83.84 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 122.245 -0.285 . . . . 60.22 111.271 176.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.454 HD22 HG21 ' A' ' 54' ' ' VAL . 56.4 tp -56.01 -56.55 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-O 121.084 0.469 . . . . 63.12 111.341 177.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.582 HD22 HG11 ' A' ' 35' ' ' VAL . 4.5 pp -68.09 -26.4 65.81 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 120.918 0.389 . . . . 73.12 111.53 179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 24.7 t -65.77 -36.69 84.25 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.882 0.372 . . . . 64.21 111.015 176.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.16 -26.34 67.38 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 73.0 111.165 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -85.31 -3.06 58.71 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-O 121.279 0.561 . . . . 64.15 109.925 175.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt 65.74 28.2 11.04 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.189 0.596 . . . . 64.21 112.018 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG23 ' HB3' ' A' ' 27' ' ' LEU . 58.3 t -73.2 113.03 10.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 CA-C-N 116.526 -0.306 . . . . 64.32 111.007 177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.69 158.04 19.44 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.488 -0.324 . . . . 53.34 111.287 176.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.574 ' HB3' ' HB2' ' A' ' 34' ' ' TYR . 41.3 mt-30 60.69 72.44 0.52 Allowed 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.492 0.663 . . . . 73.05 110.769 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.628 ' HB1' HG23 ' A' ' 21' ' ' THR . . . -67.82 -16.24 64.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.07 0.767 . . . . 45.04 113.07 -171.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.01 -41.58 3.71 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.62 -0.264 . . . . 60.12 111.465 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' GLN . 22.5 m-85 -60.41 -21.18 61.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 112.037 0.384 . . . . 74.43 112.037 -177.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.582 HG11 HD22 ' A' ' 24' ' ' LEU . 10.1 p -60.26 149.61 7.14 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.092 0.472 . . . . 74.15 111.306 176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 97.2 m -116.04 113.81 23.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 120.745 0.307 . . . . 72.44 111.024 176.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.6 m -128.38 149.29 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.959 0.409 . . . . 74.5 111.176 178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 61' ' ' GLU . 9.2 pt-20 -128.91 125.99 38.74 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 121.002 0.43 . . . . 61.12 111.597 178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.619 ' HB2' HD21 ' A' ' 44' ' ' LEU . 0.2 OUTLIER -82.68 110.36 17.67 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.223 -0.444 . . . . 65.22 110.797 -178.251 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.7 m-80 63.03 29.63 16.34 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.204 0.526 . . . . 73.02 110.912 -176.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.28 2.51 85.42 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.043 -0.598 . . . . 73.12 113.456 -175.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -103.79 111.32 23.78 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 122.644 -0.327 . . . . 65.33 110.92 179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.4 p -72.28 138.03 22.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.409 0.522 . . . . 65.05 112.409 -176.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -109.65 161.48 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.037 0.446 . . . . 75.12 111.103 177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -90.71 155.17 19.01 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.145 -0.48 . . . . 74.44 109.892 176.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 2.3 mpt_? -53.99 -38.28 64.9 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 112.654 0.613 . . . . 71.24 112.654 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.35 -31.1 69.3 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 121.219 0.533 . . . . 73.01 110.804 176.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.52 -24.0 61.09 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.194 -0.457 . . . . 71.52 111.848 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -55.83 -41.1 73.76 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.403 0.621 . . . . 74.54 110.869 174.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -70.19 -37.86 75.21 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.202 -0.908 . . . . 51.41 111.869 178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -75.66 -33.75 60.44 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 112.191 0.441 . . . . 73.0 112.191 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -82.05 104.61 12.52 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.788 0.327 . . . . 72.52 111.046 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 74.0 p -94.39 110.74 22.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.198 0.523 . . . . 72.12 111.781 -178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.454 HG21 HD22 ' A' ' 23' ' ' LEU . 97.1 t -74.14 127.46 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-N 115.718 -0.674 . . . . 42.21 111.454 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.419 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 19.6 ptmt -167.99 87.99 0.25 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.146 -0.479 . . . . 74.43 111.684 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.9 t70 66.02 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.14 -0.482 . . . . 44.5 112.241 178.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.12 40.13 83.1 Favored Glycine 0 N--CA 1.464 0.532 0 C-N-CA 120.899 -0.667 . . . . 63.53 112.245 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.539 ' HB3' HD22 ' A' ' 3' ' ' LEU . 17.2 t70 -106.83 164.18 12.33 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 122.905 0.482 . . . . 74.03 111.957 -176.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' HB ' ' A' ' 4' ' ' THR . . . -151.52 72.55 1.04 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.838 -0.619 . . . . 72.21 110.699 175.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 60' ' ' VAL . 7.3 p -83.32 95.95 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 CA-C-O 121.801 0.81 . . . . 71.54 112.012 -179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.586 ' HG3' ' HA ' ' A' ' 6' ' ' ASN . 2.4 mp0 -73.7 103.7 4.36 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 121.189 0.518 . . . . 63.34 112.104 177.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 24' ' ' LEU . 11.7 m-85 -87.03 134.12 33.52 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.942 -0.572 . . . . 72.31 110.47 170.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.471 HD23 ' N ' ' A' ' 63' ' ' LEU . 2.1 pt? -148.06 130.33 15.6 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 112.625 0.602 . . . . 72.11 112.625 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 73.31 -31.39 0.22 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.253 1.205 . . . . 71.45 114.253 170.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -84.39 53.2 2.57 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 121.837 -0.539 . . . . 63.21 112.382 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.495 ' SD ' ' N ' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -155.01 139.19 16.55 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 116.52 -0.309 . . . . 61.53 110.708 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.495 ' N ' ' SD ' ' A' ' 66' ' ' MET . . . 174.99 -27.2 0.08 OUTLIER Glycine 0 CA--C 1.529 0.941 0 C-N-CA 121.209 -0.519 . . . . 61.52 113.402 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.6 122.9 25.93 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 121.341 -0.457 . . . . 30.21 113.558 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 137.97 -22.72 3.1 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.367 -0.444 . . . . 51.31 113.562 178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.8 tttm 67.8 144.75 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.474 0.654 . . . . 75.31 112.3 -177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -85.35 134.69 34.09 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.148 0.499 . . . . 63.22 111.166 174.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -58.39 -52.12 66.94 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 115.772 -0.649 . . . . 72.42 112.152 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 74.8 m-70 -119.04 -77.65 0.58 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 111.883 0.327 . . . . 64.21 111.883 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -171.28 151.69 3.18 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.016 0.376 . . . . 64.12 112.016 -174.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -87.72 -58.58 2.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.729 0.3 . . . . 72.42 111.053 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 67.11 104.42 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.993 -0.549 . . . . 65.05 110.919 -176.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -153.74 132.92 12.62 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.043 0.449 . . . . 73.03 111.936 -177.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 39.6 m80 . . . . . 0 C--O 1.253 1.256 0 CA-C-O 118.846 -0.597 . . . . 61.34 110.919 172.707 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.483 ' HG2' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.045 0.45 . . . . 70.41 112.01 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 11' ' ' THR . 2.3 m-20 -98.2 134.4 41.3 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.962 0.505 . . . . 73.44 110.803 176.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.521 ' HB3' HG12 ' A' ' 60' ' ' VAL . 2.7 mm? -126.48 134.9 50.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.773 0.321 . . . . 74.1 111.354 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.1 m -84.19 77.86 9.88 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.209 0.528 . . . . 74.11 110.357 175.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 60' ' ' VAL . 7.1 p -80.82 121.89 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.023 0.44 . . . . 63.44 111.923 -174.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.1 m120 61.04 18.54 9.05 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.34 -0.391 . . . . 72.44 111.683 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.94 -3.15 64.6 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.28 -0.486 . . . . 33.05 113.091 -176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' ' N ' ' A' ' 8' ' ' LYS . 10.3 mptt -108.29 132.87 20.8 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-N 116.819 0.31 . . . . 64.55 110.917 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.69 97.75 1.15 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 122.501 2.134 . . . . 53.5 113.61 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.1 t -98.47 179.42 4.71 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 116.035 -0.53 . . . . 44.24 111.096 175.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 2' ' ' ASN . 93.9 m -149.73 121.41 8.06 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 112.106 0.41 . . . . 73.21 112.106 -176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 12' ' ' VAL . 34.9 m -100.26 109.03 24.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 121.564 0.697 . . . . 74.32 110.488 172.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -77.42 151.46 34.75 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.104 -0.498 . . . . 71.31 111.788 -176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.7 -43.06 3.14 Favored Glycine 0 CA--C 1.528 0.864 0 C-N-CA 121.293 -0.48 . . . . 74.35 113.314 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.9 153.9 21.26 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.295 0.48 . . . . 72.33 112.295 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -135.91 -72.26 0.46 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.344 -0.389 . . . . 72.13 111.496 179.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.8 m -110.25 96.01 5.95 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.884 0.373 . . . . 74.41 111.38 -177.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 22' ' ' GLU . 83.6 mt -127.36 152.03 48.01 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.728 0.299 . . . . 74.12 111.637 -178.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -76.47 166.7 23.05 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.494 0.188 . . . . 54.23 110.613 173.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 61.9 t -59.42 -38.35 74.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.079 0.466 . . . . 73.22 110.352 174.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.9 m -59.62 -40.72 88.5 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.177 0.513 . . . . 73.03 110.776 172.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.443 ' HB2' ' HB3' ' A' ' 18' ' ' LEU . 6.0 mm-40 -69.58 -26.0 64.25 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.409 -0.36 . . . . 65.4 111.803 177.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.606 HD11 HG21 ' A' ' 54' ' ' VAL . 39.1 mt -63.71 -41.46 98.09 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.927 -0.397 . . . . 71.32 109.927 170.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.8 mt -59.88 -41.08 90.78 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.281 -0.418 . . . . 61.44 110.408 174.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 19.0 m -59.36 -54.17 49.82 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.04 -0.527 . . . . 62.51 111.409 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.73 -50.02 68.52 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 112.158 0.429 . . . . 21.11 112.158 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 90.6 mt -75.63 -6.22 49.33 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.503 -0.317 . . . . 64.44 111.715 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt 54.72 51.91 13.03 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.44 111.065 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 51.7 t -87.13 119.49 34.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 116.067 -0.515 . . . . 74.03 111.1 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.56 -28.86 65.22 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.934 0.397 . . . . 71.23 111.519 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.46 87.94 6.63 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.856 0.36 . . . . 64.41 111.513 -178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -97.75 -13.92 21.12 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.744 0.783 . . . . 75.42 110.624 174.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.26 -48.82 3.49 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.822 -1.081 . . . . 63.2 110.117 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 32.2 m-85 -86.64 44.78 1.18 Allowed 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.448 -0.796 . . . . 74.54 111.577 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.6 p -116.12 149.04 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 N-CA-C 112.673 0.62 . . . . 64.41 112.673 -174.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 82.1 m -145.41 112.44 6.03 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.056 -0.52 . . . . 61.41 111.027 177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 62' ' ' PHE . 35.7 m -144.46 160.44 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 122.422 0.289 . . . . 63.3 111.427 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.604 ' HG2' ' HB2' ' A' ' 61' ' ' GLU . 0.4 OUTLIER -133.62 147.86 51.5 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.561 0.696 . . . . 73.33 111.249 172.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.497 HD13 HD22 ' A' ' 40' ' ' ASN . 2.6 tm? -108.54 105.09 14.57 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.724 -0.671 . . . . 63.23 110.233 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.497 HD22 HD13 ' A' ' 39' ' ' LEU . 33.3 m-80 56.2 35.58 25.97 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 120.795 0.331 . . . . 71.44 111.434 -175.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.43 -17.56 57.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 121.127 -0.558 . . . . 51.04 113.617 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -84.58 100.34 11.35 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.447 -0.443 . . . . 74.14 111.121 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.46 140.42 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.363 . . . . 74.45 111.387 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' A' ' 39' ' ' LEU . 2.7 mm? -99.72 136.53 39.5 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 120.921 0.391 . . . . 55.24 111.552 -178.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -76.75 146.5 37.91 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.436 -0.347 . . . . 72.31 110.499 172.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.441 ' HA ' ' CE2' ' A' ' 49' ' ' PHE . 8.6 ptm180 -53.02 -21.82 4.98 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 121.1 0.476 . . . . 74.54 111.893 177.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -85.81 -27.67 24.98 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 112.558 0.577 . . . . 73.03 112.558 -177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -97.18 11.19 37.22 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.589 0.959 . . . . 65.2 113.589 -169.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 46' ' ' ARG . 18.4 m-85 -59.68 -49.17 78.8 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.245 0.461 . . . . 65.2 112.245 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -76.12 -23.86 54.89 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.074 0.464 . . . . 64.03 111.202 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -77.97 -17.12 57.53 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.11 0.411 . . . . 34.44 112.11 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.8 m -103.64 120.87 41.76 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.725 0.298 . . . . 63.31 111.377 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 40.4 p -89.9 150.14 22.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.424 0.63 . . . . 75.02 112.146 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.606 HG21 HD11 ' A' ' 23' ' ' LEU . 46.4 t -115.81 142.7 28.01 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 115.633 -0.712 . . . . 70.44 110.724 -179.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 21.3 pttm -137.47 176.35 8.78 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.027 0.442 . . . . 73.21 112.005 -176.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -70.46 145.85 50.69 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.026 0.441 . . . . 73.34 111.975 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 65.56 30.71 78.06 Favored Glycine 0 CA--C 1.524 0.637 0 CA-C-N 116.062 -0.517 . . . . 71.11 113.063 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -109.56 142.52 40.53 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.821 0.343 . . . . 72.05 111.121 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.0 85.57 5.58 Favored 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.88 0.696 . . . . 62.24 112.88 -173.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG12 ' HB3' ' A' ' 3' ' ' LEU . 5.6 p -86.94 107.96 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-O 121.492 0.663 . . . . 71.03 110.461 173.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.604 ' HB2' ' HG2' ' A' ' 38' ' ' GLU . 34.1 mt-10 -94.21 97.62 10.38 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.383 0.611 . . . . 74.14 111.247 -175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.621 ' HA ' HG12 ' A' ' 37' ' ' VAL . 42.5 t80 -89.56 115.9 27.31 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 115.528 -0.76 . . . . 72.33 111.22 -177.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.0 mt -91.8 125.16 36.41 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.87 0.367 . . . . 73.42 111.5 -179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -81.27 22.63 0.65 Allowed 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.902 0.334 . . . . 75.14 111.902 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 61.28 29.96 18.92 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.966 0.506 . . . . 74.52 111.729 174.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 66' ' ' MET . 0.0 OUTLIER 54.98 88.75 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.151 0.501 . . . . 71.14 111.179 -176.446 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -167.25 18.01 0.08 OUTLIER Glycine 0 CA--C 1.526 0.734 0 C-N-CA 121.102 -0.57 . . . . 75.23 113.321 -179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -97.42 -22.24 17.35 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.085 -0.579 . . . . 53.51 113.159 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 61.43 -84.4 0.03 OUTLIER Glycine 0 CA--C 1.527 0.825 0 C-N-CA 121.497 -0.383 . . . . 70.21 112.827 -177.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -134.2 30.09 3.63 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 122.766 0.427 . . . . 64.42 110.842 178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 91.2 mt 66.78 -172.55 0.19 Allowed 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.054 -0.521 . . . . 64.31 111.714 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -143.63 115.38 8.21 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 121.064 0.459 . . . . 64.24 111.404 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -128.98 78.31 1.85 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.219 0.533 . . . . 74.35 111.512 178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -87.54 -47.98 8.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.076 -0.511 . . . . 64.53 110.051 174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . . . . . . . . . 20.3 t60 65.15 153.75 0.06 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 116.077 -0.511 . . . . 73.44 111.626 176.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 29.0 m-70 -55.48 99.87 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.002 -0.436 . . . . 72.24 111.599 178.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -133.34 140.16 47.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.864 0.364 . . . . 74.41 111.139 176.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.252 1.186 0 CA-C-N 116.279 -0.419 . . . . 72.02 111.449 178.487 . . . . . . . . 0 0 . 1 stop_ save_